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ABSTRACT 
This thesis sets out to test the central hypothesis that the paradigm for clinical decision 
support needs to shift from a technology centred paradigm to a coherent ontological-
epistemological paradigm. This was achieved by formalising a coherent ontological and 
epistemological framework, and then applying it practically to clinical decision support. 
Initially the thesis reviews the need for a coherent philosophy in clinical decision support. 
It then goes on to describe the systematic analysis of established fundamental principles of 
philosophy, and the formalism of the ontological and epistemological framework. 
Following this the framework is applied to an analysis of clinical decision making and 
clinical decision support. The models derived from the analysis are then applied practically 
to the modelling of the management of acute renal failure patients in the intensive care 
setting. The results of this modelling are then combined with the decision models as the 
basis for the structure of a model of the decision making which controls the patient's renal 
replacement therapy. Finally the models representing the clinical problem and the clinical 
decision making process are used in the design and development of a prototype renal 
replacement therapy management system. 
The thesis concludes that a coherent ontological and epistemological framework provides 
clarity and insight during the analysis for and design of clinical decision support tools. The 
contributions of the thesis relate to the derivation and application of the framework, and the 
development of the renal replacement therapy management system. Thus the thesis is a 
foundation for future research in these two areas. 
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CHAPTER 
INTRODUCTION 
1.1 BACKGROUND 
The idea of using computer technology to support the medical decision making process first 
appeared in articles published in the late nineteen fifties, and experimental prototypes soon 
followed (Shortliffe, 1987). Shortliffe (1987) defined a decision support system as any 
computer program containing clinical data or medical knowledge designed to support 
medical decision making. The original concept of clinical decision support and the 
articulation of its meaning by Shortliffe reflects a technocentric view in the field. This 
view has led to many prototype decision tools being developed but an apparent failure to 
introduce decision support tools widely into medicine (Shortliffe, 1993). This in turn has 
led to the conclusion that a more problem centred approach is required in clinical decision 
support development (Coiera, 1995). Heathfield and Wyatt (1993) concurred with this 
view and proposed that a coherent philosophy was needed to better understand the problem 
domain, and to broaden the perspective on the development of clinical decision support. 
However, no such coherent philosophical foundation exists in the domain of clinical 
decision support. Therefore, if the role of a coherent philosophy in clinical decision 
support is to be examined it must first be constructed and then applied in the development 
of an application specific support system. Where the development of a clinical decision 
support system provides a practical source, application and test for the philosophical 
framework. 
The management of acute renal failure in the intensive care setting requires accurate fluid 
balance calculations, and expertise in the management of fluid, electrolyte and acid-base 
balance. The provision of decision support as an source of decision advice in the 
management of acute renal failure in the intensive care setting is a novel problem. Thus, 
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developing such a tool using a problem centred approach provides the opportunity for 
applying and developing the philosophical framework, in addition to making a contribution 
to the development of decision support for the management of acute renal failure in 
intensive care. 
1.2 HYPOTHESIS 
The central hypothesis of this thesis is that the paradigm for clinical decision support needs 
to shift from a technology centred paradigm to a coherent ontological-epistemological 
paradigm. The aim of the thesis is to test this hypothesis by addressing the following 
objectives: 
i) To construct a generally applicable philosophical ontology and epistemology as an 
holistic analytical foundation for clinical decision support. 
ii) To apply the ontology and epistemology in an analysis of clinical decision making 
and of clinical decision support. 
iii) To apply the ontological and epistemological framework to a clinical problem 
analysis, as the basis for the design of a clinical decision support tool. 
iv) To analyse the clinical problem of management of acute renal failure patients in the 
Intensive Therapy Unit. 
v) To produce a decision making model for the management of continuous 
venovenous haemodialysis therapy. 
vi) To design and develop a clinical decision support computer tool for continuous 
haemodialysis management. 
Through addressing these objectives the thesis presents a coherent ontological-
epistemological paradigm for clinical decision support. Moreover, by presenting a 
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ontological-epistemological paradigm the intention is to make a contribution to the debate 
on the philosophical foundations for clinical decision support. Such debate and 
examination of the philosophical foundation of clinical decision support will produce 
insight into the field, and give a structure for drawing out knowledge from the development 
of application specific prototypes. 
1.3 THESIS LA yaUT 
Chapter two entitled "Reflections on Clinical Decision Support" gives the justification for 
the philosophical framework developed in the thesis. To achieve this aim the objectives 
of chapter two are: 
i) To give a classic definition of clinical decision support (CDS). 
ii) To review the current status of the field of CDS. 
iii) To highlight inherent problems prevalent in CDS. 
iv) To question the assumptions at the basis of CDS. 
v) To justify the need for a coherent philosophical foundation in clinical decision 
support. 
The aim of chapter three, "Ontological and Epistemological Framework for Clinical 
Decision Support", is to construct an ontological and epistemological framework for 
clinical decision support. The objectives of the chapter are: 
i) To present an analytical structure linking philosophy, methodology, method, 
techniques and tools 
ii) To present a systematic review of the relevant fundamental concepts of philosophy 
which are used to construct the ontology and epistemology. 
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iii) To use concepts of philosophy to construct an ontology and epistemology as the 
basis for an analytical framework in CDS. 
iv) To apply the ontological and epistemological concepts to CDS. 
v) To characterise the multi-disciplinary nature of CDS in terms of the nature of 
science, technology and medicine. 
vi) To state the ethical codes defining good clinical behaviour. 
In Chapter four, "Decision Making and Decision Support", the ontology and epistemology 
are applied to an analysis of decision making and the role of decision support in the process 
of decision making. To this end the objectives are: 
i) To develop an ontological, epistemological and process model of decision making. 
ii) To analyse the clinical decision making process. 
iii) To develop a model of the process of rational clinical decision making. 
iv) To propose a technique for analysing clinical treatment decisions. 
v) To build a conceptual model of clinical decision support with an ontological and 
epistemological basis. 
vi) To define clinical decision support in terms used in the decision analysis. 
The Clinical Problem Assessment, chapter five, defines the material clinical problem to be 
addressed by the introduction of a clinical decision support system. The objectives of the 
chapter are: 
i) To specify the clinical problem as presented by clinicians. 
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ii) To present the clinical domain knowledge required in the analysis of the clinical 
problem. 
iii) To produce a systems analysis of the clinical problem. 
Clinical Decision Making, chapter six, produces a model of the decision making managing 
a patient's continuous venovenous haemodialysis treatment (CVVHD). The objectives are: 
i) To apply the model of clinical decision making to the problem of clinical decision 
support in the management of renal failure in intensive care. 
ii) To produce a protocol for making the CVVHD treatment decisions, and for 
qualitatively assessing the patient and treatment states. 
Chapter seven describes the prototype computer system design and development, and seeks 
to satisfy the following objectives: 
i) To specify the system requirements. 
ii) To produce an integrated system design for a complete lTD patient data 
management system, incorporating the design for a CVVHD decision support 
system. 
iii) To design and develop a prototype information system for the management of an 
lTD patient's fluid balance. 
iv) To specify the other modules required in the information system. 
v) To implement the CVVHD treatment decision model using a programming 
technique which allows for a natural representation of the model. 
Chapter 8, the discussion chapter, discusses the main points relating to philosophy, 
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methodology, method, technique, and tool application in each of the thesis chapters. 
Finally the conclusion, chapter 9, gives a brief assessment of how the objectives have been 
met, the contributions made to knowledge, and the possible future directions for the work 
described in the thesis. 
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CHAPTER 2 
REFLECTIONS ON CLINICAL 
DECISION SUPPORT 
2.1 INTRODUCTION 
In the previous chapter the idea that work in the field of clinical decision support (CDS) 
specifically, and medical informatics in general, has reached a reflective stage was 
introduced. It is the aim of this chapter to examine this idea in more detail and to justify 
the need for a coherent philosophy in CDS. 
A number of published papers have discussed the reflections on what clinical decision 
support is and its possible future development. The content of a selection of these papers 
is summarised below in sections entitled: current status of clinical decision support, and 
foundations for clinical decision support. 
2.2 CURRENT STATUS OF CLINICAL DECISION SUPPORT 
Clemmer and Gardner (1992) stated that, "The intent and purpose of medical informatics 
is to strengthen and improve decision making and patient care." The attempts to improve 
decision making and patient care have included the development of computer based clinical 
decision support systems. This use of computer programs in clinical decision support has 
led to a technology-centred view of CDS. A key paper defining clinical decision support 
and its characteristics from a technological viewpoint is Shortliffe (1987) which is 
summarised in section 2.2.1. Another technological view of the current status of and the 
possible future for artificial intelligence in medicine is given by Shortliffe in "The 
adolescence of AI in Medicine: Will the field come of age in the '90s?" (Shortliffe, 1993). 
In "Medical Informatics" Coiera (1995) suggests that there is a need to move away from 
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the techno centric view of clinical decision support and develop a deeper understanding of 
the clinical problem domain. In "The role of knowledge based systems in clinical practice", 
Coiera et al. (1994) goes on to suggest that from a better understanding of the problem 
domain better user interfaces will result and the educational use of CDS will be realised. 
The need for a deeper understanding of the problems inherent in the clinical domain is 
further suggested in the views of physicians on the potential role of CDS in medicine 
considered in Shortliffe (1989). 
2.2.1 Computer ｐｲｯｾｲ｡ｭｳ＠ to Support Clinical Decision ｍ｡ｫｩｮｾＮ＠ (Shortliffe. 1987) 
In this paper Shortliffe offers a definition, used by others (e.g. Miller, 1993), of a medical 
decision support system (MOSS). MOSS is broadly defined as any computer program 
designed to help health professionals make clinical decisions. The underlying computer 
technology used does not affect the categorisation of a computer program as a MOSS. The 
focus of the definition is that the system should support the clinical decision making 
process. The decision making processes identified as being generally supported are 
determining the nature of a patient's disease state, and formulating a plan for reaching a 
diagnosis or administering therapy. No more detailed description, or model, of the nature 
of the clinical decision making supported is given in the paper. In an elaboration of the 
broad definition Shortliffe focuses on the contents and functionality of the computer 
system. He goes on to state that any computer that deals with clinical data or medical 
knowledge is intended to provide decision support. The functionality of such a computer 
system is then broken down into three categories: 
i) Tools for information management; for example hospital information systems (IllS) 
and bibliographic reference sources such as MEDLINE. Information management 
tools provide the data and knowledge needed by the clinician, but they generally do 
not help the user to apply that information to a particular decision task. 
Interpretation is left to the physician as is the decision about what information is 
needed to resolve the clinical problem. Therefore there is no direct decision advice 
offered by information management tools. 
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ii) Tools for focusing attention. Examples include clinical laboratory systems that flag 
abnormal values and pharmacy systems that advise on possible drug interactions. 
Such programs are designed to remind the physician of diagnosis or problems that 
may have been over looked. Thus there is some in-built simulation of decision 
reasoning and general decision making advice output. 
iii) Tools for patient specific consultation. These tools provide customised assessments 
or advice based on sets of patient specific data. The output of the system is defined 
in the paper as being either diagnostic or treatment advice for the patient. 
Systems of types (i) and (ii) are reported to be operational and commercially available. 
Whilst the commercial production of the third category of MDSS has not yet matched the 
production of the first two categories, and it is the development of this type ofMDSS that 
has been the focus of much of the research in the field. To more precisely categorise the 
third category of decision support tools Shortliffe proposed four further classification 
criteria: 
i) System function, could be either: diagnostic, what is observed to be true about the 
patient's state, or action guidance, where the action advised could be either a 
monitoring or treatment action. With regard to the diagnostic decisions, it was 
reported that many physicians believe that, given a fixed data set, the majority of 
questions about which they seek consultation deal with what they should do rather 
than with what is true about the patient. If this belief is accepted as true this implies 
there is a greater need for action advice systems. 
ii) The mode for giving advice; this can be either passive where the clinician goes to 
the machine and seeks advice, or the machine can actively initiate advice when new 
data are detected. The second mode of operation has been found to be preferable 
and relies on the integration of the database function and the decision support 
function. 
iii) Consultation style; this is described as either consultative or critiquing. Passive 
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decision support systems operate as either consulting, where the program serves as 
an advisor in response to user enquiries, or critiquing, where the user inputs their 
own plan for the patient and this is then agreed with or disagreed with using 
reasoned justification. The critiquing system acts as a second opinion on the 
proposed action of the clinician. In the active advice mode described in point two 
the critiquing model can be applied to say drug prescriptions input by the clinician. 
iv) Underlying decision methodology. This includes: problem specific algorithms, 
generally designed by clinicians and then encoded for computer use; Bayesian 
statistics, these have been used extensively in diagnostic systems; decision analysis 
adds to Bayesian statistics the notion of decision trees and utility associated with 
the outcomes that could occur in response to an intervention; and the computer 
science subfield known as artificial intelligence, in particular expert systems which 
contain encoded expert knowledge to provide the kind of problem analysis and 
advice an expert might provide. 
Research into producing patient specific advice tools has been continuing for many years, 
the first papers on the subject of having a computer system to act as a patient specific 
diagnostic tool appeared in the late fifties. However, despite more than thirty years of 
research computer-based tools for patient specific advice are not commonly used on a 
routine basis in medicine. A possible reason for this could be that the complexity of the 
problem domain and the technology required has been underestimated. 
One of the major problem areas for CDS development was labelled human factors by 
Shortliffe. For example, it has been shown repeatedly that an ability to make correct 
diagnosis or to suggest therapy similar to that recommended by human beings is only one 
part of the formula for system success in CDS. One of the categories of human factors 
identified was logistical problems, such as the placement of a machine, ease of software 
use, and integration of data stores. These factors are important as it is unlikely that a 
physician will use a system which places a high data entry burden on them, or which is 
placed in a remote location. Another human factor centres on the mechanical issues at the 
user interface; the use of keyboard based interfaces is viewed as an unpopular option, and 
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it would be better to have a more intuitive interaction. The third human factor identified 
was the psychology of human-computer interaction: of particular importance is the ability 
of programs to explain their advice. It is reported by Shortliffe that there is evidence that 
an explanation capability is mandatory to encourage physicians to use decision support 
tools. Enough infonnation should be provided to allow the physician to detennine whether 
the computer generated advice is likely to be valid for the patient under consideration. 
Providing justified advice also gives a CDS system educational potential. 
In a later paper (Shortliffe, 1994) ubiquitous computing was identified as a possible way 
of addressing the problems related to the human-computer interaction. The concept of 
ubiquitous computing describes a situation where computers become part of the intrinsic 
world around us. One technique for achieving this goal is to design the structure of a 
system so that it is a representation of the way people actually work and think. Using such 
a representation in a system is thought to facilitate a natural communication between the 
computer and the user. To build such a ubiquitous system the mechanical and 
psychological issues previously identified by Shortliffe will have to be addressed; in 
addition to models of clinical working practices and decision making. 
Another major problem area in CDS is system evaluation. This is particularly true for 
expert systems as it is difficult to detennine acceptable levels of perfonnance. The 
technique of using a group of experts to perfonn an evaluation is inherently problematic, 
as there may be disagreement even among experts with similar training and experience. 
This problem is summed up by Shortliffe as there being no such thing as the correct answer 
to a clinical question. Thus the problem of evaluating a system in to demonstrate its 
effectiveness is a fundamentally difficult one if it must be accepted that advice given by 
different experts is going to vary. Moreover, any expert system using an expert's 
knowledge will be unique to that expert, and will be disagreed with on some level by other 
experts. Thus, it is a problem which goes to the root of the nature of medicine, and any 
evaluation of a system should include consideration of the differences in expert opinion. 
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Despite the problems with CDS development Shortliffe believes that the time is now right 
for expansion in medical informatics because of: 
i) The growth in microcomputers and easy-to-use software 
ii) The growing distress among health professionals regarding the amount of 
information they need to practice medicine. 
iii) The increasing fiscal pressure that encourages the practice of cost effective 
medicine, thereby leading clinicians to consider carefully the clinical utility and 
reliability of tests, procedures, and therapies. This is particularly true when the 
commitment of resources is expensive or risky. 
Thus there is the belief in a growing capability to provide computer based decision support 
tools and an increase in the potential demand for their services. Having examined 
Shortliffe's ideas on the what clinical decision support is, and some of the problems 
associated with human factors in system design, the next paper reviewed describes 
Shortliffe's later reflections on CDS. 
2.2.2 The Adolescence of AI in Medicine: Will the Field Come of ａｾ･＠ in the '90s? 
(Shortliffe. 1993) 
In this paper Shortliffe examines the role of artificial intelligence (AI) in medicine and how 
it may develop in the future. In the twenty years of AI research in medicine there seems 
to be a failure to introduce AI tools widely into medicine. How this apparent failure may 
be overcome has lead to many questions being asked about the role of artificial intelligence 
in medicine (AIM). In fact the general atmosphere in the field is one of self examination, 
as witnessed by questions raised on the AI in medicine mailing list. These include 
questions concerning the nature of AIM, the role of decision making models in clinical 
decision making, the criteria to be used for judging the success of AIM, and the resolution 
of technical difficulties in AIM development. 
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AIM is part of medical informatics (MI), and MI exists at the crossover of a number of 
disciplines, each one with its own experts. This interdisciplinary nature of medical 
informatics requires a willingness to be eclectic, and to avoid "religious" dedication to any 
single technique or set of approaches. Shortliffe sums this up thus, "it is in the synergies 
between AI methods and other techniques that the greatest hope for effective systems may 
lie." So in Shortliffe's view the development of the field of AIM relies on the eclectic 
consideration of different ideas and the bringing together of these ideas to satisfy the aims 
of AIM research. The aim of AIM research is defined as developing tools which enhance 
the effectiveness of clinical decision making, but which do not replace physicians or offer 
dogmatic (unreasoned) advice. As with his broad definition of clinical decision support in 
the first paper the emphasis is on supporting the clinical decision making process. 
To enhance the effectiveness of clinical decisions an understanding of the clinical decision 
making process is required. At present there is remarkably little emphasis on problem 
solving processes in medical education; the emphasis is on learning medical facts. Yet in 
Shortliffe's part time clinical practice he finds decision analysis methods and problem 
solving techniques useful. As an educator he fmds simple models of decision making are 
good for getting the message across, in particular he finds the hypothetico-deductive 
approach eminently teachable. These experiences seem to indicate that models of decision 
making could be useful in clinical practice and in support of effective decision making built 
into decision support systems. 
Much of the reflection on the role of AIM stems from its apparent lack of success. In 
judging success it is pointed out that the criteria used to make the judgement have to be 
carefully selected. Moreover, AIM research efforts require intermediate goals in the move 
towards the long term goal of an impact on the effectiveness of patient care. Thus there are 
many incremental steps of knowledge building to be done before reaching the final solution 
of an up and running clinical system. Furthermore it was pointed out that formal 
evaluations of the impact of systems on patient care do require careful consideration and 
planning, and thus they can distract a research team from development and ongoing system 
refinement. 
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The main conclusion of the paper concerns a technical issue in AIM. This is that the 
limited success in the use of AIM is due to a failure of integration more than any other 
factor. Thus the existence of an integrated network approach to AIM design is viewed as 
the main priority. One of the biggest reported problems for the use of past systems is that 
systems have been designed for single problems and have generally not been integrated into 
the routine data-management environment of the user. The belief is that physicians will be 
attracted to computers when they are useful for essentially every patient and when the 
metaphor for system use is consistent across the varied applications that are otIered. So 
before progress can be made in the field an integration of all patient data management 
systems (PDMS) and knowledge based systems (KBS) is required. Without the integrated 
infrastructure in place ShortlitIe believes there can be no progress. 
This view is a commonly expressed one and it is undoubtedly a technical issue which will 
have an impact on the use of AIM systems. However, other non-technological issues were 
articulated by physicians in research described in another paper (ShortlitIe, 1989) reviewed 
in section 2.2.5. Thus it is important to balance ShortlitIe's strong conclusions about the 
significance of an integrated infrastructure against the significance of other non-
technological problems that are inherent in CDS. 
2.2.3 Medical Infonnatics (Coiera. 1995) 
In this paper Enrico Coiera reviews the progress of the information sciences in medicine. 
The main lesson he believes that the medical informatics community cannot ignore is that 
any attempt to use information technology will fail dramatically when the motivation is the 
application of technology for its own sake rather than the solution of clinical problems. 
Thus any CDS project must be lead by a clinical problem rather than a technology looking 
for a clinical application. This implies an understanding of the clinical domain must come 
before the solution is proposed, be it a technology based solution or not. 
From taking the problem centred approach it is pointed out that the potential role of 
informatics in medicine is vast with the possibilities of studying all the facets of 
information in medicine. This includes the application of information technology (IT) in 
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medicine, but it is not exclusively the use of IT in medicine, since medical infonnation and 
knowledge exist regardless of the use of IT. The possible applications of informatics 
highlighted include: the design of decision support systems for practitioners; the 
development of computer tools for medical research; and in the study of the very essence 
of medicine, its corpus of knowledge. 
2.2.4 The Role of ｋｮｯｷｬ･､ｾ･＠ Based Systems in Clinical Practice (Coiera et al .. 1994) 
In this paper Coiera specifies guidelines consistent with the problem centred approach 
recommended in the previous paper. The lack of the utilisation of clinical diagnostic 
systems led Coeira to recommend the following guidelines for the development of CDS 
systems in general, and KBS systems in particular. 
There is a need to refocus on the clinical user when developing knowledge based 
systems (KBS) for clinical practice. Thus during development KBS designers 
should support clinicians requirements rather than dictate their work practices. 
Designing good user interfaces is not simply apost hoc cosmetic nicety, it depends 
critically on a deep understanding of the problem domain that must be developed 
prior to commencing system design. The implications of user interactions cannot 
be conceived of independently of the overall architecture of a system. 
KBS should focus on supporting the patient management process in its entirety not 
just the diagnostic stage. 
There is a need to build working applications today as well as conducting our 
research. 
Education for most clinicians is an ongoing process intimately woven into clinical 
practice. Decision support systems should be built with this type of support in 
mind, i.e. they should support the education of the user. 
Of particular interest is the view that the user interface depends on a deep understanding 
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and representation of the problem domain. Implied in this is that it is not sufficient to 
merely have a fancy graphical user interface bolted onto a poorly designed system. Also 
of note is the potential role of CDS in educating physicians whilst they are practising. 
U sing CDS systems at the point of care has the potential for extending formal education 
whilst clinicians are practising by encapsulating clinical knowledge and offering it to the 
user when required during practice. Thus the potential educational role of CDS is an 
important consideration when developing reasoned justification in a patient specific advice 
system. 
2.2.5 ｔ･ｳｴｩｮｾ＠ Reality: The Introduction of Decision Sup,port ｔ･｣ｨｮｯｬｯｾｹ＠ for Physicians 
(Shortliffe, 1989) 
This paper presents a summary of a market research project conducted in cooperation with 
a pharmaceutical company. The research consisted of six two hour discussion groups 
amongst six to ten physicians. Consideration of the comments made by physicians is 
particularly important if CDS systems are ever going to move into routine use. Some of 
the concerns raised express fears about the way computers could change their working 
practices. Other issues raised describe problems for CDS related to the very nature of 
clinical decision making. Finally there are issues raised which support the view that there 
is a need for the increased use of information technology in medicine. 
The fears expressed by the clinicians included: 
i) Fear of loss of rapport with the patient. This stems from the fear that a computer 
would act as a barrier between the physician and the patient, causing the interaction 
to become impersonal. 
ii) Fear of loss of control. Clinicians do not want to be told exactly what to do on all 
occasions. Their preferred model seems to be to have access to second opinion 
when they want it. 
iii) The fear of change. There is resistance to the introduction of computer based 
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systems which appear to be largely experimental. The attitude seems to be 
summed up by a feeling of why should they invest time and effort making changes 
when what they have now is working. 
iv) Fear oflegalliability if advice on what action to take is not followed and then a bad 
outcome results. Or alternatively if the advice offered is complied with and a bad 
outcome results then the question of who would be liable is another legal problem. 
The problems with CDS highlighted which go to the very nature of clinical decision 
making were expressed in the following points: 
i) The belief is that if a problem is messy and difficult to understand and solve for a 
clinician then surely it will be so for a computer system. Leading to the conclusion 
that the computer system will not be able to help the physician when faced with a 
messy problem situation. A quote from one of the physicians in the session 
summarises the point, "So I think those of us who use database searching use it to 
retrieve information which we then add to on the basis of things we know and have 
observed, using thought patterns we can't really quantify or describe so we can't 
expect the machine to handle it." 
ii) There is suspicion of the concept of artificial intelligence, and in particular expert 
systems. The concerns raised question the very concept of expertise, "(Medical) 
expert systems suffer from the fact that, in my view, the experts aren't expert and 
I wouldn't listen to their judgement in person. Having their views distilled in a 
machine wouldn't give them any more credibility .... When you find an expert who 
will talk on anyone field, you can find another expert who will say something a 
little different." This quote is consistent with Shortliffe's (1987) point in the above 
paper where he says that there is no one right solution to a clinical problem. 
iii) There seems to be a pervasive attitude in the medical profession towards the use of 
technology in clinical practice which is summarised by two quotes. 
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(a) "Make it simple and intuitive, like a telephone, and don't expect me to need 
to know how it works, and then there is a chance that I will embrace what 
you have to offer - if it addresses a real need in my practice." 
(b) "Doctors are resistant to some things but not to something that's easy and 
useful. You make it easy and useful and great, we'll use it. The problem is 
to have a computer deal with this huge vast area of knowledge and to expect 
us to trust what's coming out of that box... But if it saves time and money, 
doctors will love it." 
These quotes seem to make it clear that if a useful, intuitively operated system 
could be produced then doctors would use it. The problem then is defining and 
designing a useful and intuitive system. 
The issues supporting the perception of the need for information technology were expressed 
in the following views: 
i) The chaos of chart control. Hard copy paper patient records get lost and can be 
difficult to locate. This is particularly true for patients in large hospitals who have 
to be seen by a number of different specialists. In the sessions reported in the 
article this problem did not seem to immediately promote computer databases as a 
possible solution. 
ii) Physicians have a thirst for new information. The need for improved access to 
current information that is pertinent to quality diagnostic and management decision 
making was recognised in the article. The use of easily available on line services, 
such as those evolving on the Internet, are a possible integral solution to this 
problem. 
The problems raised in the paper related to the operation of clinical decision support 
systems were: 
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i) Decision support is viewed by some as a dogmatic dictator telling the doctor what 
to do. A reasoned second opinion is an essential for the operation of a CDS system. 
ii) Data entry is a barrier to the use of systems, particularly for writing a patient's 
history, doctors don't like keyboards. Having a speech driven interface is seen as 
an important requirement for overcoming this barrier and having usable systems. 
The broad range of issues raised above demonstrates the breadth of the field and the 
complexity of the domain the systems are to be applied in. In particular the complex nature 
of the clinical field CDS is to be applied in is raised. The need for, and the form of, a 
foundation to CDS which unifies all the complexities of clinical decision support and 
which an understanding of the clinical domain can be built on is reviewed in the next 
section. 
2.3 FOUNDATIONS FOR CLINICAL DECISION SUPPORT 
Included in the papers reviewed above is Shortliffe's (1987) definition of decision support. 
The focus of his definition is the computer programs used as decision support tools. This 
reflects the technology centred view of CDS. This view has led to much of the focus for 
the future development of clinical decision support being on the technology required. 
Indeed in the Shortliffe (1993) paper (section 2.2.2) his view of the future development of 
CDS is that it depends absolutely on an integrated network approach to CDS design. If 
computer based decision support tools are to be developed undoubtably this and other 
technological issues do need to be addressed. However, from the other papers reviewed it 
is apparent that there is a growing realisation in the CDS field that a deeper understanding 
of the clinical problem, and the role of CDS in addressing these problems, is the primary 
requirement (Coiera, 1995). Thus when considering the concept of decision support 
systems there is the need to take a more holistic view of what a decision support system is 
and to study the system as a whole in order to design effective decision support tools. After 
all any tool is only part of a larger system in which it is being used to satisfy a purpose. 
Moreover, the eclectic nature of CDS is complex; it includes elements of clinical medicine 
and information science. Thus there is a need to question the nature of CDS and from the 
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questioning to reach a better understanding of the foundations of CDS. 
The remainder of this chapter reviews papers concerned with the philosophical questioning 
of the foundations of CDS, and with what form the foundations should take. In a paper 
entitled "Question the assumptions" Coiera (1994) examines strategies for examining the 
apparent failure of CDS systems. In another key paper by Heathfield and Wyatt (1993) 
they stated that there is no coherent commonly accepted philosophy to guide the 
development of clinical decision support. Moreover, their hypothesis is that the definition 
of a successful methodology for CDS would follow from a coherent philosophy. 
Heathfield and Wyatt's article provoked several editorial comments. Musen (1993) noted 
that a philosophy was needed that recognised the systems we hope to build are not isolated 
computer systems, but whole systems that include health care workers, patients, families, 
and computers. Thus there is a need for a philosophy which takes an holistic view of 
clinical decision support systems. J van der Lei (1993) expressed concerns about the form 
of medical knowledge, and how it could be represented and extracted in a CDS system. 
Particularly when it has been observed that medical decision making is characterised by a 
large degree of inter and intra observer variability. This raises the problem of what expert 
knowledge is and how to use it in CDS. Hence he views a future direction of CDS research 
being into the nature of medical knowledge and how it can be modelled, validated and 
applied in the clinical setting. If there was a coherent philosophical foundation for CDS 
then a strategy for addressing the problem would be through an epistemological study of 
clinical knowledge. Lanzola et al. (1995) based their generic architecture for a medical 
knowledge based system on an epistemological model; demonstrating that there is an 
acknowledgement that models based on philosophical concepts do have a role in CDS 
development. Szolovits and Pauker (1993) support this notion of having a good philosophy 
appropriately applied to broaden the horizons in CDS. 
In Heathfield's and Wyatt's (1993b) reply to the editorial comments they make it clear that 
the objective of their paper was to make explicit the need for a systematic and objective 
review of the current status of CDS. Moreover, they felt that an holistic view of the field 
maybe required to solve some of the difficulties encountered so far. 
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The contents of the papers described above are examined in more detail below. 
2.3.1 Question the Assumptions (Coiera. 1994) 
In this paper two fundamental assumptions of CDS research are presented, and strategies 
proposed for examining the apparent failure of the CDS research to produce implementable 
systems. From an examination of the fundamental assumptions of CDS research it is 
suggested that the assumptions are not a sufficiently robust foundation for CDS research. 
Confirming the hypothesis that a deeper understanding of the problems CDS is attempting 
to address is required before being able to design technological tools to alleviate the 
problems. The two fundamental assumptions presented as forming the base of current 
research in CDS are : 
i) Health care workers require assistance with decision making because they are either 
prone to error (not effective) or because their efficiency can be improved. 
ii) Assistance with decision making can be provided by computer systems that "mimic 
or emulate at least part of the processes considered to belong to the human 
intellect" . 
According to Coiera's view these two assumptions have underpinned research into artificial 
intelligence in medicine for the last twenty years. During this time the extent of use of 
clinical decision support tools has not been as wide as originally expected. This leads to 
the obvious question of why this should be so. Coiera proposes three strategies for 
explaining the apparent lack of progress in CDS implementation: blame technological 
problems; question the observation that there has been a lack of progress in CDS, and 
question the assumptions that CDS is based on. A commonly adopted justification strategy 
is to explain away failure by blaming the technological tools that we have available to us. 
This leads to the following explanations and an approach to the problems of CDS of trying 
to invent bigger and more complex tools than already exist. 
i) The decision support technology is immature, and more research is needed before 
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it is to have a significant clinical impact. This explanation leads to the view that 
more effort directed towards technological advance will solve all our problems. 
ii) Technology is now adequately developed but we lack the appropriate informational 
infrastructure to support such systems. This is the view that everything depends on 
the database, without an integrated electronic medical record there can be no 
decision support. This is true, although holding up the lack of integration as the 
cause of all the problems with decision support is perhaps masking other causes of 
these problems. 
iii) The third explanation given is that there is resistance to the use of technology 
within the health professions which requires them to be educated to its benefits, and 
perhaps to be directed to its use by management. Against this it is argued that 
clinicians do adopt new technologies where clinical benefit has been established. 
One of the inherent problems with producing clinical benefit is the complexity of 
the clinical workplace which requires rigorous systems analysis before any system 
can be deployed. Finally an important point raised by Coeira is that clinical 
reluctance to adopt technology says something about that technology, and that 
clinicians criticisms should be treated as a source of information for learning from. 
The second strategy for examining the current difficulties in the field of CDS is to question 
the observation that CDS systems have not been successful. This was broken down into 
two explanations: 
i) The observation is the wrong one, there are decision support systems which are in 
use. As evidence of this Coiera cites his list on the world wide web which describes 
CDS systems which have been reported to be in use. The list describes the current 
status of each system and gives an index of the systems in use under the headings: 
acute care systems; decision support systems; educational systems; laboratory 
systems; quality assurance and administration systems, and medical imaging 
systems. The majority of the systems identified as in routine use are classified as 
laboratory systems. In addition to the status listing a brief description of each of the 
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systems is also available at the web site. A print-out of the contents of the list 
entitled "Artificial Intelligence Systems in Routine Clinical Use" is included in 
appendix A. 
ii) We have been measuring the wrong thing, our expectations were too high. In other 
words the wrong criteria have been defined for assessing the success of systems. 
The argument in this explanation is that it is not just the accuracy of the machine 
which is important it is the clinical outcomes which are important. Therefore, it is 
the change in clinical outcomes which should be measured. So, the criteria for 
measuring the clinical outcome need to be agreed and measured. Then if an 
improvement in the clinical outcome can be demonstrated the acceptance should 
follow, because doctors will adopt things which are felt to be useful. 
The final one of the three tacks for explaining the apparent lack of success is to question 
the assumptions themselves. This begins with the proposition that the two assumptions 
about the needs of the health care workers are wrong. If this proposition is accepted then 
the CDS community has perceived the needs of clinicians wrongly. When trying to 
establish the needs for CDS systems, potential users of the system are asked what their 
needs are. Unfortunately users are expert in what they do but not in what they need. To 
overcome this problem it is suggested that what we need is to really understand the decision 
making process we seek to support, and then to understand how this process can be best 
supported. It is noted by Coiera that in the majority of cases the cognitive study of the 
problems faced by doctors has been poor. Coiera sums up the problem thus, Ita 
fundamental understanding of the cognitive limitations we seek to support is lacking." 
When we understand the problems clinicians have in their work then we can better support 
their needs, but the support needs to be technically feasible. Therefore, it is important to 
match the technology to the problems found. It is postulated by Coiera that the reason why 
so many successful expert systems in medicine sit in clinical laboratories may well be that 
this is where the match for this technology is best. 
The conclusion of the paper is that generally CDS research projects have a strong technical 
content, but are poor in exploring the human element the technology is intended to support. 
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The paper also reaffirms that it is time to move away from considering only the tool which 
offers decision support. In the next paper a possible philosophical basis is proposed for the 
development of CDS. This is based on the assumption that, "a philosophy that is natural 
for the solution of a problem, or a class of problems will lead to paradigms and models, 
followed by methods, mechanisms and tools that are consistent with the methodology." ( 
Heathfield et aI., 1991) 
2.3.2 Philosophies for the DesiiD and Deyelo.pment of Decision SYPlNrt Systems 
Heathfield and Wyatt (1993) 
This paper reviews the progress of decision support to date and proposes a unified 
philosophically-based approach to clinical decision support system development. Typically 
the major reasons given for the low rate of utilisation of clinical decision support systems 
are: technical difficulties with knowledge representation and reasoning with uncertainty 
over time; failure to integrate the CDS systems into the information systems of hospitals; 
and problems of human -computer interaction. The over emphasis on a particular reasoning 
method such as in AI, is considered by the author to be a contributor to low system 
utilisation. Another root cause may be that projects are merely theoretical investigations 
of the problems, not systems for implementation. This could be particularly true for short 
term projects such as academic research projects where the goals are often to get papers 
published or construct a PhD thesis. Thus the goals of CDS projects are not solely the 
implementation of a system. Indeed there are many topics to be studied in the field of CDS 
including the modelling of human reason in order to understand the process better, and to 
test the applicability of a new methodology or new concept in the domain (Miller, 1993). 
If the goals of CDS projects are more complex than building implementable systems then 
the observation of the apparent failure in the field should perhaps be questioned as 
suggested by Coiera in the previous paper. In a similar manner to that proposed by Coiera, 
the technical explanations for the failure of decision support systems were no longer viewed 
by Heathfield and Wyatt as convincing due to the dramatic increase in processing power 
and storage capacity of computers, advances in GUI, and the increase in the number of IllS. 
Therefore, a prevailing view seems to be that it is not technical difficulties that are holding 
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back progress in CDS, although this is not a denial of the importance of software 
engineering techniques and tools in CDS projects. Essentially there is a need for tools and 
techniques to be part of a coherent philosophy for modelling the problem domain, and not 
the defining element of clinical decision support. 
This leads to the central hypothesis in the paper that the definition of a successful 
methodology will follow from a coherent philosophy. If the central hypothesis is accepted 
as true then there is a need for a coherent philosophy covering all aspects of analysis, 
design and development of a CDS, where a coherent philosophy includes the set of values 
and beliefs derived from past practical experience which are then applied in future 
development. At present there is no commonly accepted coherent philosophy to guide the 
development of clinical decision support systems. F our reasons were identified in the 
paper for a CDS philosophy not yet existing: 
i) A preoccupation with computer artifacts. The majority of time and effort on 
projects is spent using specific computer tools and techniques. This leads to a view 
of a problem in terms of the computer tools and techniques that are the most 
familiar to the designer. In the extreme, the drive to use a specific software 
technique and tools can drive the analysis of a problem. This would happen 
whenever the software tool to be used is chosen before the problem to which it is 
to be applied. So you have a tool and then look for a problem to solve with the tool. 
Once the problem is found, the solution is then dictated by the tool rather than the 
problem; the point being that knowledge of specific software techniques and tools 
should not dominate the problem solving process nor restrict the form the solution 
takes. However, when the project does reach the stage of system development a 
good understanding of the tools used is still required. The requirement for good 
understanding of the domain and the tools applied raises the requirement for multi-
skilled individuals, or teams, working on anyone system development. 
ii) Failure to adopt appropriate models for analysing a problem. This is a symptom of 
the first problem of using software tools and techniques as the drive in project 
development. The view in the paper is that a coherent philosophy applied to any 
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problem will result in the use of models, and thus analytical techniques and tools, 
that are consistent with that philosophy. Applying philosophy in this way should 
also lead to the development of novel methods when required. Failure to recognise 
the natural philosophy of a problem and a preoccupation with computer related 
artifacts causes tunnel vision, in terms of what can and cannot be accomplished. 
This may prevent the most appropriate solution being found, particularly where the 
most appropriate solution to a problem maybe not to use a computer at all. 
iii) Lack of a clear language for communicating a philosophy. For a shared 
understanding to be developed clear concepts are required to express a philosophy. 
During the development of a system a simple means of communicating between 
developers and users that elegantly expresses the relevant ideas would be a valuable 
tool. For example simple graphical representations or prototypes may facilitate 
better communication between the clinician and the system designer. 
iv) A disregard for organisational issues. The organisational environment in which the 
ｰ･ｲｳｯｮｮ･ｾ＠ on the project find themselves is very important. The need to ensure the 
suitable mix in a development team was highlighted above in point (i) and is vital 
to a projects progress. The skills required demand a mixture of visionaries as well 
as people with programming skills. Long term stability is important, and short term 
contracts do not enable understanding of the problem and potential solutions to be 
built up, or the trust of the users and their organisation to be gained. This is a 
particular problem for academic research projects which tend to be funded on fixed 
short term contracts, with no guarantee of continuity of funding. 
So there is a need for a coherent philosophy in CDS to gain a better understanding of the 
problem domain, and to move away from the blinkered view brought about by a 
preoccupation with computer artifacts. Having established the need for a coherent 
philosophy in CDS the next question is what form the philosophy should take. The form 
proposed in the paper is a development "philosophy". This was defined as a shared 
perception on how a problem or a class of problems should be solved in principle. It should 
originate from the basic principles of a discipline, and it is contrasted with a development 
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method which is defined as explicitly specifying all the steps in the development process. 
An example of a previous development method for CDS reviewed in the paper is one 
proposed by Shortliffe and Davis in 1975 which is an eight stage process: system design; 
development; evaluation of performance; evaluation of efficacy; small scale field 
evaluation; follow up studies; final amendments; and general release and marketing. It was 
noted that this has not been generally adopted in clinical decision support system 
development, and that systems rarely reach the final stage. 
Under the heading, "a philosophy for decision support system developers," a series of steps 
in the form of a development method is described in the paper. Figure 2.1 illustrates that 
the "philosophy" is in fact a development method, similar in structure to the method 
described above, containing the beliefs of the authors on how to develop a clinical decision 
support system. These beliefs are: 
i) Establish and clarify the need through rapid prototyping. Formalising the real 
requirements for a system is hard and often neglected. User involvement is vital at 
all stages of the prototyping so they can specify their requirements. Rapid 
prototyping allows for this level of user involvement, and is a popular technique for 
providing insight into system requirements. The prototype can be built by either 
using the prototype-discard-reimplement model or the operational prototype, where 
implementation is in the final language. 
ii) Try to use a coherent methodology for modelling the problem. Modelling the 
application area is a vital precursor to building a decision support system. Using 
analytical models such as flow charts can contribute to the understanding of the 
clinical domain. A major challenge for medical informatics is to discover the 
appropriate analytical techniques. Object oriented techniques are seen as one 
possibility for analysing the material domain, as the design process seeks to mimic 
the way in which people form models of reality. 
iii) The use of appropriate methods, mechanisms and tools. If there is a coherent model 
of the clinical problem this will facilitate the choice of appropriate reasoning 
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methods, techniques and tools. Tools should be chosen on the basis of how 
consistently they represent the analytical method and modely and on the amount of 
training that project personnel will need to use them. 
iv) Need for evaluation. A system must undergo laboratory testing throughout the 
prototyping process to ensure safety and usability. This must be followed by field 
testing to assess its impact both intended and unintended on its users, patients and 
the health care system. A system must be successfully evaluated before it is 
commissioned for use. 
v) Need for professional approach to implementation maintenance and support. The 
effort required to develop, maintain and support a system is often severely 
underestimated. Many clinical systems require a professional approach which is 
only available from a commercial organisation or a local technical group. For 
example the monitoring of the system has to continue during routine use to detect 
unforeseen problems. Furthermore, the system development is an on-going process 
consisting of correcting software errors, porting to different hardware platforms as 
necessary, and updating software periodically. 
Although there is no explicit philosophy given as a basis for the above development method 
a need for one is implied in the requirement for a coherent methodology to analyse the 
problem domain. An explicit philosophy includes views on and models of the nature of 
reality and knowledge. These models then form a coherent basis on which to build the 
coherent analytical methodology for understanding the problem domain. The ontology, 
view of reality, provides a contextual view for analysing the problem, and the 
epistemology, theory of knowledge, provides a basis for analysing the knowledge of the 
domain. The epistemology also gives a foundation for constructing a knowledge base. 
Despite the lack of such an explicit philosophical basis there is undoubtably value in 
Heathfield and Wyatt's proposed development method, which comes from the authors' 
experience of developing CDS systems, specifically the ACORN system (Wyatt, 1989). 
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In summary the paper is a worthwhile attempt to propose a positive solution to some of the 
problems of CDS system development. It concludes that it is not technical problems which 
prevent the implementation of CDS it is a failure to appreciate the nature of the decision 
problems and a mismatch in motivations between developers and users. Although it is 
likely that novel technology will still be required in CDS systems, it should not be the sole 
focus for future research. A philosophy of how to build a CDS is central to the 
development of such systems and also to the discipline of medical informatics as a whole. 
At present this does not exist, probably because medical informatics is still an evolving 
discipline in search of an explicit philosophical foundation. The view in the paper is that 
a coherent philosophy applied to a problem will result in the use of models, and thus 
analysis methods and tools, that are consistent with that philosophy. Although an explicit 
philosophy was not given in the development method proposed a need for one was implied. 
2.3.3 Critiques of the Views of Heathfield and Wyatt 
As mentioned at the start of section 2.3 Heathfield and Wyatt's paper provoked several 
editorial comments. The comments focus on the evaluation, nature of clinical knowledge, 
the need for a systemic approach, proposals for the way forward in CDS and requirements 
for a CDS system. 
With respect to the evaluation of CDS technology van der Lei (1993) noted that regular use 
of computer technology is a trailing indicator rather that leading indicator of success. He 
used the example of the utilisation of the electronic patient record (EPR) by GPs in 
Holland. It was observed that despite the form of the EPR for GPs not changing markedly, 
recently there has been an increase in their utilisation. The situation is similar for CDS and 
intermediate goals that allow evaluation on a finer level of granularity are required; 
utilisation is viewed as too late an indicator to be the sole criterion for judging success. 
This reaffirms the need for goals other than implemented systems in CDS research. 
Van der Lei agreed with many of the comments made in Heathfield and Wyatt's 
development method. However a major issue which in his view is missing is an 
appreciation of a fundamental problem when constructing expert systems. When 
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attempting to capture and use expert clinical knowledge there are problems with casting 
medical knowledge in a fonnalism. A reason offered for this is that medical knowledge is 
only in part scientific knOWledge. Vander Lei thinks ideally judgements should be based 
on scientific knowledge, but with limited data this cannot always be the case. Therefore 
there is an inherent uncertainty in decision making due to lack of data. l'bis is one 
explanation for the large degree of inter and intra observer variability observed in medical 
decision making. The question then posed by van der Lei is, "If experts confronted with 
identical situations yield different judgements, on what foundation shall we build a 
system?" This issue of disagreement amongst experts also affects the issue of system 
evaluation discussed above. The issue of medical knowledge is felt to be so fundamental 
that research into the nature of medical knowledge is seen as an important focus for future 
work in the field of CDS; in addition to the nature of the knOWledge. how to model that 
knowledge, and how to apply it in different settings. From such cross disciplinary research 
the anticipated result is insight, and possibly much later CDS systems. Vander Lei goes 
on to state that when building systems for use the focus will be increasingly on the 
environment in which clinical decisions are made. This will be partially realised in systems 
which allow health care workers to communicate and interact, particularly where a team 
of workers is involved. 
Musen (1993) identified two major problems with CDS development to date: namely the 
computer has not been viewed as part of wider clinical working practices, and that by 
regarding medical knowledge as a set of extractable propositions that can be stored within 
a computer our view of the decision making process itself is necessarily narrow. In 
Musen's view systems that do not integrate into the work patterns of health care providers 
and that do not address the perceived needs of those providers simply will not be used. The 
impasse to widespread utilisation of CDS systems has occurred because the informatics 
community has viewed the purpose of clinical decision aids as that of offering the health 
care workers "knowledge" that would otherwise be missing. This is held to be a failure to 
appreciate the nature of decision problems and a mismatch between developers and users 
motivations. If there is a technical issue that workers in medical informatics have 
misunderstood it is the nature of medical knowledge itself. There is a need for a philosophy 
that recognises that the "systems" to be built are not computer systems, but rather systems 
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that include health care workers, patients, families and computers. 
Szolovits and Pauker (1993) also doubt the adequacy of present methods to solve the 
problems of clinical decision support. Thus they view the work of medical informatics as 
being in large part basic research that will provide better definitions of the clinical tasks 
which require support and will provide a new, more flexible set of software tools to address 
these problems. A good philosophy appropriately applied at the basis of this research will 
broaden our horizons and not limit our perspectives on some of these possible solutions. 
Miller (1993) added the following observations on the nature of the clinical domain and the 
corresponding requirements for an ideal CDS system. Physicians select human 
consultations with another physician based on the perception that they have skills and/or 
knowledge they do not possess. Repeated consultation occurs on the basis of the 
consultant's apparent accuracy and reliability. As a model for consultation a CDS system 
needs to display these characteristics. Furthermore, physicians normally check a system 
against their own knowledge and against certain common sense reality checks, for example 
whether the system recognises pregnant men as not being possible. Thus the importance 
of a relevant, effective and up to date knowledge base is paramount. Finally Miller stated 
that as many of one quarter of all information needs in a clinical setting may require the 
tailoring of general medical knowledge in patient specific manner; making patient specific 
advice a paramount requirement for CDS. 
In their reply to the editorials, Heathfield and Wyatt (1993b) made clear that the purpose 
of their first paper was to make explicit the need for a systematic and objective review of 
the current status of the discipline. Having expressed the need they, hoped to provoke the 
medical informatics community to take stock of where it is and to plan for the future. Their 
definition of decision support was "those systems containing and reasoning using medical 
knowledge." Once more this raises the issues highlighted by van der Lei related to the 
nature of clinical knowledge and suggests the need for epistemology in CDS research. 
In their reply Heathfield and Wyatt go on to state that the primary goal of medical 
informatics is to help health care workers to improve patient outcomes. As solutions are 
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sought which satisfy this goal, new approaches need to be tried. In looking for new 
approaches Heathfield and Wyatt agree that a useful philosophy broadens horizons without 
limiting perspectives, and that an holistic view of the problem is required. The role of 
science within a coherent philosophy for CDS is examined in the articles reviewed below. 
2.3.4 The Scientific ｾｰｲｯ｡｣ｨ＠ in Clinical Decision Support 
As already noted, the focus of much of the development of CDS has been on the 
engineering of technological tools. The relationship of CDS to science and how science 
can be used in CDS has not been examined deeply. Two articles have reviewed the status 
of medical informatics (Lincoln and Essin, 1992, and Seelos, 1992) and suggested the need 
for the application of science in medical informatics. 
Lincoln and Essin (1992) observed through their attendance at major international medical 
informatics meetings that there seemed to be a lack of challenging fundamental problems 
which were relevant to the whole community present. This observation led to the belief 
that medical informatics does not have a scientific basis, which was further reinforced by 
the observation that there appears to be no framework or set of hypotheses about how 
chosen tools interact with health care data. Their proposed start point for forming a 
hypothesis is the observation that the challenging "real world" of health care is filled with 
non-standard situations as the focus is on patients suffering with non-standard conditions. 
This raises the fundamental problem of how to model the real world of health care. By 
focusing on engineering solutions to the problems the underlying science that must be 
developed to support these solutions is often obscured. This view suggests the need to 
investigate the role of science in medical informatics and its relationship with engineering. 
The view in the paper is that by using the scientific hypothesis testing method the 
foundations of medical informatics can be more clearly stated. It is thought this will 
produce deeper discussions at meetings and more opportunity for research investigations 
in the field. 
Seelos (1992) thinks the historical development of medical informatics is in the process of 
advancing from art to science, from craft to methodology. The question according to 
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Kuhn's theory of scientific revolution is whether a new paradigm for medical informatics 
has to be acquired in the near future; one which upgrades the discipline from a pre scientific 
era to an advanced scientific stage. Historically medical informatics, generally conceived 
as the application of information science in medicine, claims to be the science of the nature, 
the construction and the application of algorithms in medicine. This has lead to a 
development by accumulation, which is typical of a prescientific era in a discipline. The 
need to move medical informatics away form this prescientific era is based on two reasons 
put forward by Seelos: 
i) There is a lack of organised knowledge (theory) in medical computing to promote 
our practical work and to scientifically substantiate appropriate curricula as well as 
generally accepted educational concepts. 
ii) There is an increasingly diverging articulation of the actual paradigm, manifested 
by differentiation and specialisation. 
These two justifications are thought to clearly indicate a deficiency of the traditional 
paradigm. Thus there is a need for a new paradigm in medical informatics. The new 
paradigm proposed by Seelos is to adopt a holistic view of the whole health service, and 
deal with the all the information flows in the health service not just the biological and 
medical information flows. This systemic approach is labelled comprehensive health care 
informatics (CHCI). The propositions put forward in support of this paradigm were: 
i) IT is instrumental in the sociological organisation which medicine is a part of, 
therefore medicine cannot ignore the possibilities of IT in health care, e.g. use of 
the Internet as an information source. 
ii) Medical informatics is applied to a complex cross over of different disciplines. 
Only a mixture of methods from say medicine, IT, economics, statistics, sociology, 
and legal science is adequate for a comprehensive interdisciplinary statement. 
iii) Medical informatics aims to support all the processes of health care in its practical 
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as well as in its theoretical aspects. 
iv) The object produced by medical informatics is a medical information system. This 
has to contain medical models as well as models of the wider system. 
v) Medical informatics has two main aspects: the analysis of the information processes 
in medical informatics, and the engineering of computer systems to solve problems 
related to these processes. 
vi) The methodology of medical informatics is the application of systems engineering 
and information management theories to problems in the field of medicine and 
health care. 
Adopting a new approach in medical informatics is further supported by this article. The 
move towards a scientific age is seen as requiring a new paradigm, namely taking a 
systemic view of the health care system; this supposedly being scientifically justified by 
the six propositions above. Such a systemic view is not inconsistent with the need for a 
coherent philosophy expressed by Heathfield and Wyatt. 
2.4 THE NEED FOR AN ONTOLOGICAL-EPISTEMOLOGICAL PARADIGM 
Shortliffe's (1987) definition of CDS focuses on the potential role computer programs can 
play in aiding clinicians in their decision making. The definition goes on to analyse 
decision support tools from the functional aspect of the computer system, rather than from 
a model of the decision making process in which the tools are to be used. This is a 
reflection of the technology centred approach which has been prevalent in CDS. Two 
papers by Shortliffe (1987; 1993) highlight the fact that despite many years of using this 
approach to produce patient specific clinical decision support tools they are not commonly 
used on a routine basis in medicine. This has led to questions being asked about the 
technology focused paradigm used in CDS. 
Coiera (1995) stated that a shift is required in CDS away from the technology focused 
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paradigm to a more problem centred approach. Specifically Coiera (1994), whilst reflecting 
on the assumptions on which CDS is based, states that a better understanding is needed of 
the clinical decision making process that is to be supported. How this may be achieved, 
and how solutions can be provided for the problems found, is suggested by Heathfield et 
al. (1991): "A philosophy that is natural for the solution of a problem, or a class of 
problems will lead to paradigms and models, followed by methods, mechanisms and tools 
that are consistent with the methodology." This idea is examined further in Heathfield and 
Wyatt (1993), where they propose that there is a need for tools and techniques to be part 
of a coherent philosophy for clinical decision support, and not the defining element of 
clinical decision support. Such an approach is needed to move away form the paradigm 
which is preoccupied with computer artifacts, and to form analytical models to reach a 
better understanding of the problem domain. Extending this concept of using analytical 
models to better understand the problem domain there is also the need to form models of 
how the proposed CDS solution will impact on the problem domain. The form of the 
philosophy put forward by Heathfield and Wyatt (1993) is a set of beliefs, derived from 
their practical experience, on how to develop a CDS tool. In other words their philosophy 
is another expression of a development method. Although this is not devoid of merit it 
does not fulfil their identified requirements for a coherent philosophy which forms the basis 
for a coherent methodology for CDS. Thus the form of the coherent philosophy for CDS 
is not entirely dealt with in their paper. In the editorial comments which followed 
Heathfield and Wyatt's paper, van der Lei (1993) suggested that the issue of medical 
knowledge is so fundamental that research into its nature is an important focus for future 
work in the field of CDS; in addition to the nature of the knowledge, how to model that 
knowledge, and how to apply it in different settings. This implies that there is a need for 
a coherent epistemology, theory of knowledge, to be included within the philosophy for 
CDS. The need for a coherent epistemology in CDS is further supported by the view of 
Musen (1993): "If there is a technical issue that workers in medical informatics have 
misunderstood it is the nature of medical knowledge itself,"; Coiera (1995) stated that 
applications of informatics in medicine include the study of the very essence of medicine, 
its corpus of knowledge; the problem of clinical expert knowledge validation by agreement 
between experts as highlighted by Shortliffe (1987); and in connection with this the 
questioning of the notion of what constitutes clinical expert knowledge (Shortliffe, 1989). 
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Thus within a philosophy for CDS there is the need for a coherent epistemology which 
includes an examination of the nature of medical knowledge. To form a coherent 
epistemology it needs to be linked to a coherent ontology, as this defines the view of reality 
of which there can be knowledge. 
The other reason for having a philosophical ontology for CDS is that it provides the basis 
for forming the required systemic, or holistic, view of the problem domain and the role of 
decision support in the domain (Musen, 1993, and Seelos, 1992). By defInition the 
ontology defInes a view of the world, thus anything that is perceived to exist within this 
view must fit into the ontological model in some way. Therefore, an ontology is the 
starting point for building the model based understanding of the problem domain advocated 
by Heathfield and Wyatt (1993). 
Furthermore, there is a need to consider the multidisciplinary nature of CDS, the two main 
disciplines being engineering and medicine. Lincoln and Essin (1992) and Seelos (1992) 
suggest that the role of science in CDS needs to be also included in a systemic analysis of 
CDS. Therefore the three established disciplines at the core of CDS are science, medicine 
and engineering, each one being an important ingredient. The role and relationship 
between these disciplines in CDS are important elements in a coherent view of CDS, 
particularly in terms of the methodology to be adopted. Through the application of the 
ontology and epistemology in an analysis of these three disciplines a coherent view of role 
and relationship of the disciplines in CDS will be formed. 
Thus adopting a paradigm based on ontological and epistemological concepts will provide 
insight into the nature of the problem domain, clinical decision support, medical 
knowledge, and the role of technology, medicine and science in CDS. All of these have 
been identified as important factors in shifting clinical decision support away from its 
technology focused paradigm. 
2.5 SUMMARY 
This chapter has examined in more detail ideas introduced in chapter 1. Thus this chapter 
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has examined the technology centre paradigm used in CDS, and proposed that a shift of 
paradigms to an ontological-epistemological paradigm is required for the development of 
the field of clinical decision support. 
The next chapter shows how the structure of a analytical framework for CDS is built up on 
the ontological and epistemological foundation. Through a systematic review of 
fundamental philosophical principles a practical ontology and epistemology are formulated 
for application to CDS. Also there is a characterisation of CDS in terms of the three 
established disciplines of engineering, science and medicine. 
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Proposed Development "Philosophy" 
Problem Recognise problem jstiCS 
Apply method to .. Select appropriate 
analyse problem analytic method 
ｓ･ｬ･｣ｴｾ｡ｴ･＠Use software to 
build system software tool 
Select laluation Evaluate system's 
.. 
impact on problem goals and methods 
l 
Figure 2.1 Heathfield and Wyatt's development method 
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CHAPTER 3 
ONTOLOGICAL AND 
EPISTEMOLOGICAL FRAMEWORK 
3.1 INTRODUCTION 
As discussed in the previous chapter there is currently an absence of any clear philosophical 
framework in the field of clinical decision support (CDS). This unfulfilled need for a 
coherent philosophy must be resolved if CDS is to be grounded on a holistic analytical 
framework. The role of the philosophy in such a framework is to define a coherent basis 
for building a coherent methodology for CDS. Thus the coherent philosophy is at the base 
of the analytical framework for CDS. This chapter shows how the structure of the 
analytical framework is built on the philosophical foundation. In addition to this the 
chapter also describes the generic ontological and epistemological framework, which forms 
an holistic analytical foundation for clinical decision support. The construction of the 
ontology and epistemology is based on a systematic review of the relevant fundamental 
concepts of philosophy. 
With the aim of characterising the nature of CDS beyond the philosophical basis an 
analysis of the natures of the multiple disciplines (technology, science and medicine) of 
CDS is presented in section 3.4 of the chapter. The natures of the three major disciplines 
are presented and analysed using the ontological and epistemological models. Furthermore, 
with the aim of identifying the influence of each discipline in CDS, models of the 
relationships between the processes and the knowledge in each of the disciplines are 
constructed. 
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3.2 STRUCTURE OF ANALYTICAL FRAMEWORK 
Chapter two included Heathfield and Wyatt's (1993) arguments for a coherent philosophy 
in decision support. In an earlier article Heathfield et al. (1991) summarised the potential 
power of a coherent philosophy in a analytical framework thus: 
itA philosophy that is natural for the solution of a problem, or a class of problems will lead 
to paradigms and models, followed by methods, mechanisms and tools that are consistent 
with the methodology." 
Unfortunately no definition of paradigms, models, methods, mechanisms, tools, 
methodology is offered by Heathfteld et a1.. Neither is their a relational structure made 
clear in the paper. It is only implied in the quote given that a philosophy is at the 
foundation of formulating a problem solution. For the levels of analysis built on the 
philosophical foundation Ackoff(1962) offers a scientific structure for defining them and 
the relationships between them. Four levels of analysis identified by Ackoff in the applied 
scientiftc research process are defined thus: 
i) Tools, a physical or conceptual instrument that is used in scientific enquiry. e.g. 
mathematical symbols, computers, random numbers. 
ii) Technique, a scientific course of action, or ways of using scientific tools; e.g. the 
use of calculus (technique) to find the minimum or maximum of a curve. 
iii) Method, determines the way techniques are selected in science. Methods can be 
expressed as rules for choosing a technique; for example the method for choosing 
between techniques for determining the maxima and minima of a curve. 
iv) Methodology is the collection of different methods. It involves the study of 
scientific methods, the objective of which is an improvement in the methods. The 
method for determining a curves maxima or minima could be one of the methods 
within a methodology. 
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Although Ackoff proposed this structure for applied scientific research it does have an 
analogous application in technology. For example in computer programming, compilers 
and editors are tools used in software development; whilst techniques define the steps 
involved in using the software tools to achieve a goal, and methods define how the 
techniques are selected. Therefore, the same structure will be used for the analytical 
framework developed here. 
The four levels of classification defined above exist within the philosophical framework 
as depicted in figure 3.1. The most general level depicted in this figure is the encompassing 
philosophY, and the most specific is an individual tool. Applying rationalism to link the 
levels of the framework, the philosophy provides the general framework for analysis and 
for deriving a general methodology. The methodology describes the methods to be used. 
The methods describe the rules for choosing from the available techniques, whilst the 
techniques are descriptions of the procedures for achieving pre-defined goals. Which tools 
are to be used and how is specified in the techniques. 
The five levels of figure 3.1 provide a useful framework for analysing problems and the 
solutions to be adopted. Constructing and then applying the ideas in the framework 
provides a basis for fmding solutions to problems and analysing these solutions. Thus it 
satisfies the two aims of applied scientific research defined by Ackoff (1962): to find 
answers to questions, and to develop the procedures used for finding the answers. Thus 
applied research should lead to a problem specific solution and procedures for more 
effectively finding solutions to other problems. The philosophical basis defines a generic 
analytical basis for a group of problems and solutions, whilst at the lowest level the tools 
applied in a technique to a specific problem provide a problem specific solution. 
The flow in the construction of the ideas in the framework is given in figure 3.2. The 
concepts used at each of the levels of the framework are derived from existing ideas in the 
relevant disciplines. The two main philosophical concepts used in the analysis are ontology 
and epistemology. Within the philosophical analysis lie the methods, techniques and tools 
of science, technology and medicine which are applied in CDS. 
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The added value of the framework is in the practical application and synthesis of the 
concepts, as depicted in figure 3.2. Using philosophical models allows for a general high 
level analysis of the problem. This analysis can then be applied down through the levels 
of the framework and provides the operational context for the methods, techniques and 
tools. So techniques are applied within a high level analysis of the problem. There is also 
feedback from each of the lower levels, for example from tools to techniques. Thus the 
techniques and tools can be adapted as experience is gained in their application. The 
practical experience can then feedback to higher levels to adapt methods, methodology and 
philosophy. 
The advantages of this framework for analysis over the commonly used technique centred 
approach include the more generic levels of analysis. This will give a more holistic view 
of the problem and will seek the development of techniques appropriate to the problem. 
This counters the approach commonly used in CDS to date, which is to start with a 
prescribed technique then to find a problem to apply it to; this being put forward as one of 
the core reasons for the lack of utilisation of the systems developed to date. Logically this 
is not surprising; consider the simplified analogy of having a tool box only containing a 
shiny new hammer. The motivation is to use the hammer, so a problem is sought. The first 
problem which is found is to secure a screw into a flat wall. The hammer must be used, so 
the screw is hammered into the wall. The results, if any, are ineffective and nothing can 
be supported by the screw in the wall. Starting with a technique, or tool, is too much of a 
bottom up approach. What is required is a top down approach where there is first an 
analysis of the problem, followed by the development of appropriate techniques and tools. 
Then by recognising that the problem is to secure a screw into the wall the appropriate tools 
for the job will then be selected. Thus the framework for analysis proposed in this thesis 
adopts a top down analysis, beginning with philosophy. 
3.3 PHILOSOPHY 
An individual's philosophy in the simplest sense is an expression of their view of reality 
(Ferm, 1969). In terms used in systems science an individual's philosophy expresses their 
world view, or Weltanschauung. Etymologically, philos is Greek for lover, and sophia 
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means wisdom, thus we have philosophy meaning a lover of wisdom. Fundamentally the 
discipline of philosophy is concerned with expressing a view on the nature of reality, 
ontology, and the related view on the theory of knowledge, epistemology. These two 
concepts are at the core of the framework for philosophical thinking. To express the 
philosophy using established concepts they initially must be understood and then applied 
in the construction of the framework. Thus the benefit of applying twenty five centuries 
of philosophical insights to focus and clarify issues in CDS will be realised (Sowa, 1995). 
Philosophy does not exist in isolation it is a body of principles and general concepts which 
underlay a given branch oflearning, a major discipline, a religious system, or any important 
human activity. It includes the application of these principles in the domain of their 
relevance, e.g. the philosophy of history. A philosophy does not spell out the detailed 
action to be taken in specific instances; rather it deals with underlying ontological and 
epistemological concepts which are relevant to whole classes of problems. Therefore, it 
provides a generic basis for problem analysis. One of the principles for a good philosophy 
is that it should make a difference in its application. A philosophy which is not usable is 
sterile and will not make a difference. Thus, the process of thought, dialectic, begins with 
its foundation in philosophical concepts, and a reasoned argument begins with a 
philosophical expression of the world view taken. 
In addition to the need for a coherent philosophy in CDS there are other benefits to taking 
a philosophical approach. Firstly, there is the benefit realised from considering what are 
the foundations of thought in the field of research in CDS; particularly in terms of how the 
roots of the world view taken, or Weltanschauung, can be expressed in philosophical terms. 
By questioning these views in a philosophical manner, making explicit the philosophy 
adopted, and applying the philosophy, a deeper understanding of CDS can be achieved. 
Secondly there are the epistemological questions raised by the drive to make a contribution 
to knowledge in the thesis, and the use of knowledge in clinical decision support. 
In forming a philosophical root it is helpful to make it explicit, as the author putting 
forward the argument, and the reader of the argument, can develop their thoughts based on 
the philosophical root. O'Connor and Carr (1987) sum up the value of this expression thus, 
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"Language enables us to make our beliefs detailed and precise; it also puts them into 
permanent and stable form which unexpressed beliefs tend to lack." If beliefs on the root 
of thought are not made explicit, at best they are only implied and at worst there is no 
coherent philosophy at all. Such an unexpressed philosophy can leave the foundation of 
thought stagnant and unquestioned. Contrary to this an explicit philosophy is made 
available for others to question, a necessary quality of a good philosophy. 
There are two main aspects of the thesis which deal with knowledge. The core aim of 
research is to make a contribution to knowledge; whilst CDS attempts to represent and use 
clinical knowledge to aid the clinical decision making process. Whenever attempting to 
deal with knowledge in a meaningful way there is a need to understand and define 
knowledge. This consideration raises the epistemological questions of what is knowledge, 
what are the sources of knowledge, the scope of the knowledge, and how can the reliability 
of knowledge be judged. If an attempt is to be made at representing human knowledge of 
a domain the answers to these epistemological questions lie at the core of such a 
representation; the core understanding of the "nature of knowledge" aiding the processes 
of representing present knowledge and adding to it. 
3.3.1 Rationalism 
Katz (1993) defined logic as being formalisation of meaning, and without it rational 
discourse would not be possible. In other words logic is the mental tool used to make sense 
of the world. The two types of logic commonly defined are: 
i) Deductive, or syllogistic, or Aristolean, logic literally means the putting together 
of propositions. Application of deductive logic is the reasoning from laws and 
theories to predictions and explanations. For example deductive logic can be used 
to combine proposition A, All humans are mortal, with proposition B, Jenny is 
human, to reach conclusion C, Jenny is mortal. If both A and B are true then it 
follows that the conclusion C is true. 
ii) Inductive logic starts with data from observation and proposes new theories and 
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laws, or propositions which link the data. F or example in making a statistical 
correlation between two variables inductive reasoning is being used to derive the 
relationship. 
Either type of logic can be used to reach a logical conclusion. In addition to the two 
classical classifications of logic Ferm (1969) described the application of deductive logic 
in philosophy. F erm labelled this philosophical logic, which is based on working out some 
theory or insight and then applying it to show its ramifications and its illumination of the 
nature of reality. This application of logic is essentially the view taken by Descartes in 
seeking a philosophical foundation to gain greater insight in to solving a problem (section 
3.4.1). Another example of philosophical logic is Hegel's triadic dialectic of thesis and 
antithesis followed by synthesis; this is described in greater detail in section 3.4.4. Through 
two conflicting ideas a synthesis of ideas produces a new, possibly better, thesis. The 
synthesis then becomes the starting thesis for beginning the process again. Applying 
Hegel's dialectic in a philosophically logical way will, in theory, lead ultimately to an 
absolute synthesis of ideas. However, as Hegel's critics have pointed out such an absolute 
synthesis of all ideas has yet to be attained. The use of what Ferm called philosophical 
logic is discussed in more detail below. 
3.3.2 Philosophical Reason 
Descartes, a rationalist, believed that any problem needs to be broken down to its simplest 
factors. It is then in reasoning from the simple to the complex that we gain insight and 
understanding (Gaarder, 1991). The simplest analysis of a problem is in ontological and 
epistemological terms. By building on and applying such an analysis it is proposed in this 
thesis that a deeper understanding of the problem of CDS will be achieved; eventually 
leading to more robust solutions to the problem, as the problem specific solution is built 
on the foundation of a coherent philosophy, figure 3.1. 
Feinstein (1967) in figure 3.3 expressed in a simplified manner his view of how philosophy 
can be considered as being at the root of reasoned thinking in medicine. This diagram 
clearly shows the effect philosophy has on the other levels of thinking and how it impinges 
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on all that flows from it. The points on the circle are joined by reasoned thought and each 
of these points impact on each other through this linkage. Although in this simplified 
diagram Feinstein has shown his view to be that mathematics is the basis for clinical 
medicine, which is not the absolute view of the author. Despite this disagreement on the 
detail of the view expressed there is still the clear illustration of philosophy being at the 
root of reasoned thought. Moreover, the diagram illustrates how the root philosophy can 
be influenced by the circular nature of the thought process. 
Applying rationality the broad concepts of philosophy lead to the development of theories, 
laws and rules and to the detailed methods of applying them. Without rationality in a 
philosophy it is not possible to apply the philosophy to situations which are subordinate to 
it. A philosophy forms an intellectual superstructure or overall strategy which moulds and 
guides the development of a discipline. By logical combination and extension philosophy 
forms a larger body of derived principles on which a discipline may find a secure 
foundation. The discipline provides an intermediate intellectual structure or strategy which 
moulds and guides the attack on categories of problems. A practitioner, when dealing with 
an immediate and particular problem, must develop from their knowledge of a discipline 
a specific attack or tactic which resolves the problem. 
Applying the philosophy in the context of the framework in figure 3.1, previously 
described; the stages to the development of a rational practical philosophy in this 
framework are: 
i) Build the ontological and epistemological framework; 
ii) Apply the ontology and epistemology in a generic analysis of CDS ; 
iii) Apply the framework to structure the application specific problem analysis and 
CDS system development; 
iv) Evaluate the ontology and epistemology in the light of the practical experience. 
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The first stage of developing a philosophical framework is to build the ontological and 
epistemological models. 
3.3.3 ｂｵｩｬ､ｩｮｾ＠ an ｏｮｴｯｬｯｾｹ＠ and ｅｰｩｳｴ･ｭｯｬｯｾｹ＠
There are a number of ways to construct views of ontology and epistemology. The possible 
bases for constructing these views proposed by Ferm (1969) are: radical scepticism; 
eclecticism; a chronological study of past philosophies; mysticism; authoritarianism; 
deductivism, or positivism. Ferm added to these by proposing a critically evaluative 
approach, where you take the best of all of the these approaches, but not in an absolutely 
eclectic manner. To decide which basis to use for building the philosophy here, each of the 
approaches is briefly considered below. 
Pure radical scepticism is the approach which has traditionally been followed in philosophy 
(O'Connor and Carr, 1987). Radical scepticism takes the stance of doubting the existence 
of everything, including the very existence of knowledge. Radical scepticism in its most 
extreme form becomes purely destructive, leaving only doubt and uncertainty. Indeed it 
was radical scepticism which led Descartes to arrive at the famous words "I think therefore 
I am." Two of the points of this quote are that the thought process must begin from some 
start point or set of assumptions, and that radical scepticism doubts the very thought 
process from which it seems to come. Without any accepted base assumptions there is 
radical scepticism and doubt, which leaves an incoherent philosophy with no point of 
origin. Thus, in its purest form radical scepticism does not allow for the construction of a 
system of thought. Therefore, scepticism will only be used to refine the philosophy 
developed in this thesis, it will not be the sole basis for it. 
The second basis put forward for constructing a philosophy is eclecticism which is based 
on taking all philosophical ideas and combining them. Considering all the opposing views 
on philosophy which have been expressed this approach would lead to an inconsistent and 
incoherent philosophy. A chronological study of philosophy provides an historical context 
for different philosophical view points. Thus it gives a reference point for a systematic 
review of philosophical thought. 
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Another basis used for philosophy building is mysticism, this is based purely on the 
supernatural experiences of mystics. Despite the sense in which these experiences seem 
real to the mystic there is a lack of verifiability, and efficacy in these methods for building 
a philosophy. 
Authoritarianism, the fifth basis identified for building a philosophy, is simply basing a 
philosophy on the word of a figure of authority. Authority is contextual and not universal 
therefore it cannot be held to be a method for building a general philosophical basis. 
As has been discussed above the coherence of a philosophy is based on a reasoned 
argument, deductivism. It is by the application of reason, or logic, that sense is made of the 
world and understanding attained. Through the application of logic it is possible to 
construct an ontology, epistemology and knowledge base. Therefore reason plays a central 
role in forming an understandable philosophy. The deductivist builds a philosophy based 
on deductive logic, building on a set of propositions. The main weakness of this method 
being that the reasoning may begin from untrue propositions, then a false view of reality 
will be formed. For example, if your propositions are that mice live on cheese and that the 
moon is made of cheese, then you could conclude by deduction that mice live on the moon. 
But the original proposition is false and hence the conclusion is false. The positivist view 
helps to complement this problem by basing propositions on observations of the world as 
perceived by human senses. So, combining the two it is possible to reason from 
perceptions of the world. 
The importance of using established philosophical concepts for clarity and insight was 
highlighted above. Therefore, the study of fundamental philosophical theory is relevant to 
building an ontology and epistemology. The question is how to use the established theory. 
Of the options proposed by Ferm (1969) radical scepticism, eclecticism, and 
authoritarianism have been rejected. This leaves a chronological study and a systematic 
analysis of philosophy theory, with the application of positivist experience from the 
development of a CDS system. Therefore, the approach taken here will be to build the 
philosophy using a systematic review of fundamental philosophical theory combined with 
a brief history of modem western philosophy; whilst the positivist experience from the 
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development of a CDS system will inform the building process. 
3.3.3.1 Criteria for iudf:inf: a philosophy 
When building a philosophy it is important to set up criteria for judging its value. Ferm's 
(1969) qualities for a good philosophy are that it should be: 
i) Generally applicable; a good philosophy should express fully the world view being 
taken; 
ii) Vital; the philosophy should make a contribution to understanding reality; 
iii) Coherent, or harmonious; it should not contradict itself; 
iv) Disciplined; it should be reasoned and carefully studied; 
v) Consistent with material reality; 
vi) Capable of being questioned and revised. 
Points (i), (ii), and (vi) are generally applicable to all forms of good philosophical ontology 
and epistemology, whatever the basis used for constructing the philosophy may be. Thus 
as a minimum criteria set a good philosophy should satisfy these. Points (iii) and (iv) 
represent criteria that a good rationalist philosophy should comply with, while point (v) is 
relevant to a building a good materialistic positivist. The approach taken in the thesis is to 
construct a rationalist philosophy that includes a material element. Therefore Ferm's 
criteria for a good philosophy apply to the ontology and epistemology described in this 
chapter. 
3.4 A BRIEF HISTORY OF MODERN WESTERN PHILOSOPHY 
The purpose of this brief history of modem western philosophy is to give a historical 
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context to the concepts of philosophy described in the section 3.5 of this chapter. Thus the 
history begins with a brief discussion of Descartes and finishes with a brief review 
contemporary philosophy, including existentialism. 
3.4.1 Continental Rationalism 
3.4.1.1 Rene Descartes (1596-1650) 
Descartes is commonly acknowledged as the founder of modem philosophy (Russell, 
1961); where the focus of modern philosophy is on man and his place in the world as we 
perceive it to exist. Descartes' main concern was with what we can know; certain 
knowledge. His second great concern was with the relationship between body and mind. 
Following the Renaissance the need to assemble contemporary thought into one coherent 
philosophical system once again presented itself. Descartes attempted to construct a 
complete philosophical system or edifice by questioning all that had gone before him 
(Gaarder, 1995). In the view of the rationalists this required the breaking down of a 
compound problem into as many single factors as possible. Then the root concept for the 
philosophy is taken from the simplest idea of all. As a rationalist Descartes believed that 
philosophy should reason from such a root concept up to more complex ideas. Only then 
would it be possible to construct a new insight. Rationally this has to come through our 
application of reason, in forming a connected understanding starting from a root idea of 
philosophical thought. 
In seeking the root of philosophical thought Descartes started from the postulate that you 
should doubt everything. Thus Descartes went beyond the lessons of older philosophies 
by doubting all that had come before. Then he went on to doubt even what our senses 
appear to tell us, pointing out that what appears to us in a dream can appear to be real. 
Radical scepticism of this form had led others to this point but no further. However, 
Descartes realised the only thing he could be certain of was that he doubted everything. 
Doubt is an expression of thought, therefore the root idea for his philosophy was that he 
was a thinking being, and thus he existed. Thus I think therefore I am is the root principle 
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of Descartes' philosophy. 
Descartes was the first of the continental rationalists; convinced that certain knowledge is 
only obtainable through reason. This conviction is based on the rationalist view that the 
more self evident a thing is to one's reason, the more certain it is that it exists. According 
to rationalism whatever we perceive with our reason corresponds to reality, thus in addition 
to the perceived thinking self there is another out there material reality. During the 
development of continental rationalism the new physics was offering an increasingly 
mechanistic view of this material reality. Thus it brought into question the relationship 
between the body and soul. Previously the soul had been considered to be all pervading in 
nature. However, the emerging view was that surely the soul could not be explained in 
such a mechanistic way. This lead to Descartes' second concern of the link between the 
body and soul. 
Descartes maintains that there are two different forms of reality, or two substances 
(Russell, 1961). One is thought (mind), and the other is extension (matter). Thought was 
viewed as being quite independent of matter, and vice versa. In Descartes', also referred 
to as Cartesian, dualism there is a sharp division between the realities of mind and matter. 
In Descartes' metaphysics it is the existence of God that makes it possible for man to know 
the world (Marias, 1967). Thus God is the connecting bridge between the two substances 
of thought and extension. So, the Cartesian metaphysical view consists of the substances 
of mind and body governed by the infinite God (Marias, 1967). 
In the theory of the material world Cartesianism is rigidly deterministic. Owing to the idea 
of parallelism between the mind and matter mental events were held to be equally 
deterministic. This combination of the metaphysical view with the deterministic nature of 
each leads to the occasionalist view, where the clockmaker (god) constantly synchronises 
the two clocks (thought and extension) which have no direct relationship whatsoever. 
As the father of modem philosophy Descartes influenced many of those who came after 
him, including the other two major continental rationalists Spinoza and Leibniz. 
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3.4.1.2 Baruch Spinoza (1632-1677) 
Spinoza accepted from Descartes and his contemporaries a materialistic and deterministic 
physics, and sought within this framework to find room for reverence and a life devoted to 
the good. Like Descartes Spinoza was a rationalist (Gaarder, 1995). Spinoza however 
rejected Descartes' split between thought and extension. He believed there was only one 
substance, or reality, and at times he referred to this as God, or nature. 
According to Spinoza's philosophy an attribute of the single substance is that which the 
mind perceives as a constituent of its essence (Marias, 1967). There are an infinite number 
of attributes of the single substance, God, but only two are perceived a constituents of its 
essence: thought (cognition) and extension (extension). These essences are the same as 
Descartes' substances but by labelling them essences of Spinoza has demoted them in the 
ontological hierarchy. 
Spinoza's metaphysics, or ontology, is the best example of "logical monism"; the doctrine 
that the world as a whole is a single substance, none of whose parts are logically capable 
of existing alone. Spinoza thought that the nature of the world and of human life could be 
logically deduced from self evident axioms. The whole of such a view is difficult to accept; 
it is incompatible with modem logic and with scientific method, where facts are linked to 
observations. Empirical data is the source and expression of such facts. Moreover, the 
concept of substance is one which neither philosophy, or science can currently accept 
(Russell, 1961). 
In Spinoza's logical monism there is only one clock (God) With two visible faces, or 
attributes. Thus there is no communication between the two attributes only 
correspondence. There is strict parallelism between the two attributes of the single 
substance. Just as there is an exact correspondence between ideas and matter, so there is 
a strict parallelism between the soul and the body. Thus mans' mind and body is governed 
by the deterministic natural law that he must follow. This lead to Spinoza's belief that only 
one type of freedom remains open to man: knowledge. The knowledge he speaks of is the 
knowledge of God. The intellectual love of God is for Spinoza the culmination of both 
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philosophy and human life. When a man knows what he is, he knows that he is not free and 
does not feel constrained or coerced, but determined according to his essence; therefore, 
reason is freedom. 
3.4 .1.3 Gottfried Wilhelm Leibniz (1646-1716) 
Like Descartes and Spinoza, Leibniz based his philosophy on the concept of substance 
(Russell. 1961). However, he held that extension cannot be an attribute of substance. After 
rejecting extension the only possible essential attribute remaining was soul. Thus 
according to Leibniz the metaphysical structure of the world consists of an infinite number 
of souls, or monads (Marias, 1967). Monads are the basic substances, substances without 
component parts, which group to form complex things. These elemental monads cannot 
decay or perish through disintegration, nor can they be built up from parts. The monad is 
force; or force of representation. Every monad actively represents or reflects the entire 
universe from its own perspective. This representation of the universe is active; it is the 
monad's purpose, tendency; a desire that arises from the monad's ontological basis itself, 
from its own reality. Everything that happens to a monad arises from its own being, from 
its internal possibilities; the monads are completely insensitive to external influences. 
Thus Leibniz proposes a pluralist multiplicity of substantial monads which contain strictly 
within themselves all their ontological possibilities. Monads are windowless, which leads 
to the problem of how can there be communication in such a pluralist reality. This problem 
is overcome by saying that the internally defined reality and purpose of each monad is in 
harmony and defined by God. This concept was labelled pre-established harmony by 
Leibniz. Using the clock analogy once more in pre-established harmony there are many 
clocks; the clockmaker (God) has made them in such a way that they remain in harmony 
without any further interference or synchronisation. Thus God is the source of all 
knowledge when he made the monads. We only have knowledge of all things around us 
by the action of God. Thus the only windows the monads do have all open up to God, not 
to each other. 
From Descartes to Leibniz there is an almost unquestioned acceptance that God does exist. 
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This is seen as central to giving unity to the ideas that they express, and despite the fact that 
God and philosophy are separate, each of their philosophies features God in some central 
controlling way. This unifying idea of a single deity at the centre of everything came 
increasingly into doubt during the eighteenth century. Especially the ideas that all 
knowledge is a priori and that the source of knowledge is God. 
3.4.2 British Empiricism 
The British Empiricists were: John Locke; George Berkeley, and David Hume (Gaarder, 
1995). By definition an empiricist derives all knowledge of the world from what the senses 
tell us. This view was summed up by Aristotle thus, "There is nothing in the mind except 
that which was first in the senses" (Gaarder, 1995). To the empiricists if we do have an 
idea that cannot be related to experienced facts then it will be a false conception. Thus, the 
empiricists criticised the seemingly previously contrived philosophical systems, which by 
their maxim seem to be based on pure fantasy. 
3.4.2.1 John Locke (1632-1704) 
Locke may be regarded the founder of Empiricism; the doctrine that all our knowledge 
(with the possible exception oflogic and mathematics) is derived from experience (Russell, 
1961). Locke is viewed as being less dogmatic than the rationalists. 
All knowledge is viewed by Locke as coming from experience. Prior to experience the soul 
is like a clean piece of paper on which nothing has been written, no knowledge is innate 
(Marias, 1967). Locke classified two classes of perception: external perception of physical 
states by means of the senses, or sensation; and internal perception of physical states, or 
reflection, where reflection operates on the material introduced by sensation. 
Built on these perceptions there are two levels of ideas: simple ideas which are formed from 
a single sense or from several senses simultaneously, or from reflection, or finally from a 
combination of sensation and reflection; and complex ideas which are the result of the 
activity of the mind, which combines or associates simple ideas; memory being the basis 
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on which complex ideas are fonned. Simple ideas leave an impression on the mind, 
memory, which are then later associated with other ideas to fonn more complex ones. Thus 
all ideas proceed from experience by means of successive abstractions, generalisations and 
associations. 
Locke distinguishes simple ideas with objective validity (primary qualities) from those 
which have only subjective validity (secondary qualities). The primary qualities (number, 
figure, extension, motion) belong to the bodies and cannot be separated from them; the 
secondary qualities (colour, odour, taste) are subjective sensations of the man who 
perceives them. In Locke's view sense data (primary qualities) we receive cannot be 
subjective because we do not control them. In Locke's view space and time are qualities 
of the external world and thus they are perceivable. 
Locke's empiricism limits the possibility of knowledge, with respect to the potentially 
infinite knowledge of God which went before in rationalism. Moreover, in Locke's view 
there is no a priori knowledge from God. Locke is also generally suspicious of 
metaphysics. He thinks in tenns of concrete detail rather than of large abstractions. His 
philosophy is built up in piecemeal fashion rather than the grand design of a complete 
system as proposed by the rationalists. 
Locke's system is viewed as being so full of paradoxes that it is logical inconsistent with 
itself. Thus it cannot be wholly true, by the rule of coherence. Russell (1961) even states 
that Locke's philosophy is wrong. Locke's drive is to propose a philosophy which is 
credible with common sense and to move away from the grand metaphysical systems of the 
rationalists. Generally the British Empiricist philosophy is more piecemeal than the 
continental rationalist style. 
In Empiricism, a comparatively modest conclusion is drawn from a broad survey of many 
facts (Russell, 1961); whereas in Leibniz for example a vast edifice of deduction is 
pyramided upon a pin-point of logical principle. In Leibniz if the principle is completely 
true and the deductions are entirely valid then all can be held to be true, and the system can 
be said to hold. However, if there is the slightest flaw in the fundamental principle or in 
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the deduction then the whole system can be said to fall. On the contrary in Empiricism the 
base of the pyramid is on the solid ground of observed fact, and the pyramid tapers upwards 
not down to a single point of a fundamental principle. Consequently the pyramid of ideas 
is more stable and a flaw here or there can be rectified without real disaster. Within the 
British Empiricist movement the heirs of Locke include Berkeley and Hume. 
3.4.2.2 Georae Berkeley (1685-1753) 
Berkeley, an Irish Bishop, also based his philosophy on what he ｰ･ｲ｣･ｩｶｾ＠ and thus was 
an empiricist (Gaarder, 1995). Locke's theory of ideas lead Berkeley into the realm of 
metaphysics (Marias, 1967), although for Berkeley matter does not exist. Moreover, 
primary and secondary qualities are just as subjective; all qualities are the content of 
perception; there is no material substance behind the ideas. The existence of matter is 
exhausted in it being perceived. The entire material world is but a representation, or 
perception. According to Berkeley the only thing which does exist is the spiritual self 
which we have an intuitive certainty of. Physical science establishes laws or connections 
between phenomena, which are understood as ideas. These ideas proceed from God. Thus 
we literally live, move and exist in God. 
The denial of the material world is viewed by Russell (1961) as being his major 
contribution. However, Russell does see fundamental problems with this view. On the one 
hand Berkeley argues that we do not perceive material things, only qualities of them, such 
as colour, or smell, or sound, or hot/cold etc. Then he goes on to say that these things are 
merely mental and cannot be associated with an extended cause. In this he is relying on the 
fact that everything is mental, but nothing is both mental and material. Russell's 
fundamental criticism of this view is that if something is an object of the senses, some mind 
is concerned with it; but it does not follow that the same thing could not have existed 
without being an object of the senses. 
In terms of the form of ideas Berkeley does not believe general ideas exist; he is a 
nominalist. For example there cannot be a general idea of a triangle as it is either 
equilateral, isosceles, or scalene, whereas the general idea does not involve such 
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distinctions. 
3.4.2.3 David Hume 0711-1776) 
Hume is one of the most important among philosophers, because he developed to its logical 
conclusion the empirical philosophy of Locke and Berkeley, and by making it self-
consistent made it incredible (Russell, 1961). This view is shared by Gaarder (1995) who 
saw Hume as tidying up all the woolly concepts that went before him. Hume's intention 
was to investigate every single idea to see if it corresponded to reality; as perceived through 
the senses. He sought the answer to the question: from which impression does this idea 
originate? 
Hume broke perceptions down into two different types: impressions, the initial perception 
of say a burn; and ideas, the recollection of a burn (reflective memory). An impression is 
more strong and lively than an idea, and both can be either simple or complex. Every 
simple idea has a simple impression which resembles it, and vice versa, although complex 
ideas need not resemble impressions (Russell, 1961). 
For example the complex idea of heaven compounded up from pearly gates and streets of 
gold, all of which have been put together from simpler impressions of an earthly concept. 
He also examined the idea of God and came to a similar conclusion that he is the 
compounded idea from our relationship with our own father, and from concepts of infinite 
intelligence, goodness etc. 
Hume opposed all ideas that could not be traced back to corresponding sense perceptions. 
Hume did not believe in the unalterable ego. In his view there is no underlying personal 
identity beneath or behind these perceptions and feelings which come and go. This was as 
Hume perceived his own ego, "I never catch myself at any time without a perception and 
can never observe anything but the perception." (Russell, 1961) 
With regard to the laws of nature Hume's view is that it is meaningless to say that we have 
experienced the laws of nature. We have merely experienced what we interpret to be their 
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affects. For example it is not possible to experience that a stone will always fall. It is usual 
to say the stone will fall because of gravitation but we have never experienced such a law. 
The only experience we have is the perception of stones falling. 
Hume's view on the law of causation is that just because one event is observed to follow 
another does not mean it is caused by it. For example thunder appears to follow lightning 
thus it could be assumed that lightning causes thunder. However, lightning does not cause 
thunder; they are both caused by an electrical discharge. According to Hume, causal 
connection only signifies a relationship of coexistence and succession. When a 
phenomenon repeatedly coincides with another or succeeds it in time, by virtue of 
association of ideas we call the first cause and the second effect, and we say the latter 
occurs because the fonner takes place. In Hume's view no matter how many times this is 
observed it does not allow us to affirm a causal link in the sense of an absolutely necessary 
condition. 
Hume's rejection of the concept of cause and effect leads to a sceptic's view that 
knowledge cannot achieve metaphysical, or absolute, truth. What Hume is proposing is 
that all we have is subjective impressions which we build ideas upon, thus there is no 
absolute knowledge. Russell (1961) states that Hume's scepticism is something that has 
not been refuted fully since; that is the scepticism which springs from his rejection of the 
concept of cause and effect derived through observation (induction); although Kant, 
following in Hume's footsteps, did attempt to address this issue by investigating the 
problem from its roots upwards. 
3.4.3 The Romantic MOYement 
From the early part of the eighteenth century to the present day philosophy, art and 
literature and even politics, have been influenced positively or negatively by a way of 
feeling which was characteristic of what, in a large sense, may be called the romantic 
movement (Russell, 1961). Historically Romanticism reacted against the inherited 
rationalism, and is said to be Europe's last common approach to life (Gaarder, 1995). 
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The first great figure in the movement was Jean-Jacques Rousseau (1712-1778). Prior to 
romanticism prudence was regarded as the supreme virtue; intellect was valued as the most 
effective weapon against subversive fanatics; polished manners were praised as a barrier 
against barbarism. By the time of Rousseau many people had become tired of safety and 
wanted excitement. The romantics aimed at vigorous and passionate individual life. 
The romantic movement as a whole is characterised by a substitution of aesthetic for 
utilitarian standards. They valued what they considered to be beautiful: the tiger over the 
utilitarian earth worm. The romantics liked the strange (e.g. ghosts and pirates) and this 
is most commonly expressed in fiction. They felt inspired by what was grand, remote and 
terrifying. For example the romantics favoured the middle ages over science. 
The romantics admire strong passions of whatever kind, no matter what the consequences 
may be. Hence the type of man encouraged by romanticism is violent and anti-social, an 
'anarchic rebel, or conquering tyrant. In the view of the romantic movement, by throwing 
off the social constraints introduced by morality, man can then be true to his passions and 
by doing so elevate himself to a God like status. Revolt of solitary instincts against social 
bonds is the key to the philosophy of the romantic movement. 
They had a strong belief in nationalism which sprung form the belief that friendly relations 
towards others is based on a belief that friends can be regarded as a projection of oneself. 
In love the consequence of this idea is incest between blood relatives. Only by having 
friends that are a projection of oneself is it possible to break through the conflict of self and 
social constraints. Hence the popularity of nationalism amongst romantics. 
In its extreme form Romanticism can be viewed as reactive and morally corrupt, and a view 
that the majority seemed to lose by the time they were thirty years old. Russell (1961) 
sums up a fundamental problem with romanticism thus, "Man is not a solitary animal, and 
so long as social life survives, self-realisation cannot be the supreme principle of ethics." 
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3.4.4 German Idealism 
3.4.4.1 Immanuel Kant (1724-1804) 
As a scholar of philosophy Kant was familiar with the rationalism of Descartes, Spinoza 
and the empiricism of Locke, Berkeley and Hume (Gaarder, 1995). Kant felt that each 
view was too monolithic and he sought to form a view which acknowledged that both 
reason and sensation play a part in the formation of knowledge. He sought to create a 
transcendental theory of knowledge, where this knowledge is to be the bridge between the 
ego (mind) and the things (matter). 
In Kant's view ideas are ideas of things, thus there are two elements of an idea. Kant draws 
a distinction between things as they appear to us, phenomena, and things as they are in 
themselves, noumenal. The noumenal is not knowable, all that is knowable are the 
observed phenomena. The view formed of the observed phenomena is shaped by the a 
priori knowledge of the mind. Kant labelled his view the Copernican revolution in thought, 
as he saw it as being similar to the shift brought about by Copernicus' discovery that the 
Earth revolves around the Sun. 
Kant identified space and time as our two forms of intuition, and these forms are a priori. 
Thus space and time precede everything we experience. So everything is perceived as a 
series of processes in space and time. In Kant's phenomenalist view what we perceive will 
first and foremost be perceived in space and time. 
The a priori knowledge of space and time shape our sensory experience, perceptions, of the 
world around us (the ego). These perceptions are then further interpreted according to 
twelve a priori concepts defmed by Kant. The twelve concepts are divided into four sets 
of three (Russell, 1961): 
i) Of quantity: unity, plurality, totality 
ii) Of quality: reality, negation, limitation; 
iii) Of relation: substance and accident, cause and effect, reciprocity; 
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iv) Of modality: possibility, existence, necessity. 
As can be seen these include the relational a priori concept cause and effect. Thus Kant 
deals with Hume's scepticism by saying that causality is an a priori relational concept that 
the mind imposes on the observed phenomena. 
So the two elements that contribute to man's knowledge of the world are: the external 
conditions that we cannot know of before perceiving them, the source of knowledge; and 
the internal conditions of the mind, space, time and causality, which describes the form of 
knowledge. The important development from Kant's philosophy was that of Hegel 
(Russell, 1961). 
3.4.4.2 GeorK Wilhelm Friederich HeKel (1770-1831) 
Hegel was the culmination of the German idealist movement that started with Kant 
(Russell, 1961). In addition to being influenced by Kant, Hegel was also influenced by the 
Romantic movement (Gaarder, 1995). 
Hegel saw three stages in the development of knowledge: thesis; antithesis, and synthesis. 
The start point for this dialectic process is the thesis, then in response to this the antithesis 
is generated followed by the synthesis of the thesis and antithesis. Thus in the dialectic 
process it is through the negation of arguments and the development of antithesis and 
synthesis that ideas logically develop. Each synthesis of the dialectic process contains all 
the earlier stages; as it were in the "solution" of each stage of the process. As an example 
of this process Descartes rationalism can be considered to be the thesis; Hume's empiricism 
the antithesis, and Kant's phenomenology the synthesis. Kants synthesis then becomes the 
new thesis to be refuted. Thus, Hegel's triadic dialectic can be used to describe historical 
change in ideas. 
Applying Hegel's dialectic demonstrates the subjectivity of truth. All knowledge is human 
knowledge, and in Hegel's view human knowledge is constantly expanding and progressing 
through history. The only fixed point philosophy can hold onto is history. There are no 
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timeless truths. Hegel distinguishes mere infonnation from conceptual knowledge, in 
which the concepts of things are described. 
3.4.5 More Recent Western Philosophy 
Influenced by the above philosophers, more recent movements extended and expanded on 
the ideas reviewed above. In contemporary thought the human person and human activity 
remain at the main centre of philosophical interest. Within contemporary thought there are 
several different movements. These include: pragmatic; empiricist; linguistic; idealist; 
vitalist; phenomenological; existentialist and metaphysical (Walsh, 1985). 
3.4.5.1 Praimatism 
According to William James (1842-1910) the whole function of philosophy ought to be that 
it makes a difference to our lives when applied in our daily actions (Marias, 1967). In his 
published writing he spoke of human intelligence as an active, selective agent of adjustment 
whose function is to guide action (Walsh, 1985). According to James' pragmatic theory 
truth is what works, what turns out to be right. True ideas are those which work, which 
lead to success, and which give various kinds of satisfaction. To be true ideas must prove 
consistent with other ideas conformable to existing fact, and subject to experimental 
corroboration and validation. Theories thus become instruments not answers to enigmas. 
Thus according to James' view truth is relative to human desires and aims. Truths are 
human valuations. To recognise something as true or false is to recognise it as useful or 
useless to mankind. A belief is true when it has been verified that it ''works'' for man. 
Although in a broader sense James does not mention what the common goal, or purpose, 
ofman is. James' critics thought that utility can be a sign of truth but it is not the (formal) 
constitutive cause of truth (Walsh, 1985). 
John Dewey (1895-1952) is another member of the pragmatic school of thought. The true 
function of philosophical thinking according to Dewey lies in its being directed to resolving 
indeterminate or problematic situations by effecting changes in the environment and in man 
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himself (Walsh, 1985). Dewey's view hinges on the idea that thinking and acting are 
intimately related in man's attempt to adjust and survive in his environment. Thus thinking 
is seen as a natural biological power whose function is instrumental in solving problems. 
In Dewey's view for each problematic situation the true hypothesis is the one which 
transforms the problematic situation. Thus, knowledge is derived through verifying ideas 
in practice. Moreover, there are no absolute or first truths that are given or known with 
certainty. 
3.4.5.2 Positivism 
The law of three states is the basic proposition of Auguste Comte's (1798-1857) positivist 
philosophy (Marias, 1967). According to Comte there is a progression in thought from the 
theological to the metaphysical and finally to the positive. 
Theological could perhaps be more accurately referred to as the religious or mythical state. 
The theological or fictitious state is provisional and preparatory. This state, in which the 
imagination predominates, corresponds to the infancy of the development of Human 
thought. At the centre of this view are supernatural causes and explanations for events. 
The next state is the metaphysical or abstract state and it is essentially critical and 
transitional. It is the intermediate stage between the theological and the positive. In it 
absolute knowledge is still sought. Metaphysics seeks to explain the nature of beings, their 
essences and their causes. In the previous state God is viewed as being at the centre of 
everything, the creator and controller. In the metaphysical state this is substituted for 
nature. However, this unity is weaker and the character of the metaphysical state is critical 
and negative, and merely a preparation for the next state. 
Finally the positive or real state is the definitive one. In it imagination is subordinated to 
observation. Positivism seeks only facts and their laws. Not causes or origins of essences 
or substances; all that is inaccessible (Marias, 1967). Positivism relies on the positive that 
which is given; it is the philosophy of the datum. This is the final state in which the mind 
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eventually seeks only the laws of phenomena. 
The positive spirit is relative. The study of phenomena is never absolute, but relative to our 
organisation and our situation. The loss or gain of a sense would completely change our 
world and our knowledge of it. Knowledge must incessantly come nearer and nearer to the 
ideal limit fixed by our necessities. The goal of knowledge is rational foresight: see in 
order to foresee, foresee in order to provide (Marias, 1967). 
3.4.5.3 Neo-positiyism: 
Ernst Mach (1838-1916), an Austrian physicist and philosopher, is widely regarded as the 
father oflogical positivism and as the real master of the Vienna circle (Walsh, 1985). Mach 
developed the empiricism of Berkeley and Hume into a philosophy of radical empiricism. 
In Mach's view scientific theory is simply a device for predicting the course of our 
sensations of things. He views sense experience as the basis and origin of all scientific 
knowledge. Applying this view the only scientific theories or hypothesis that are 
admissible are those that can be tested in sense-experience. As the scientific laws so 
admitted are based on sense experience they can only be considered to be summary 
descriptions of phenomena. 
Jules Henri Poincare (1854-1912) a philosopher of science stated that theories are 
convenient rather than true (Walsh, 1985). One theory or suggestive model may be 
superseded by another theory which is more fruitful than the first. In his view theories are 
conventions that depend on the scientists free choice between alternative ways of imaging 
or explaining the natural world. 
In Moritz Schlick (1882-1936) view scientific knowledge seeks to know the relations 
between physical magnitudes; thus metaphysics must be denied the status of scientific 
knowledge. The meaning of a proposition is in whatever observations or experiences show 
whether or not it is true. A proposition only has meaning if testable or confinnable 
propositions can be derived from it. 
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Karl Popper (1902-1996) contradicted this view of verification through positive verification 
when he pointed out that it is falsifiability not verifiability that is the essential criterion for 
the scientific character of discourse, and this is the hallmark of science (Walsh, 1985). 
Thus our present scientific knowledge is simply that body of knowledge which so far, in 
history, survived all sustained and systematic attempts to falsify it. Scientific theories 
eventually become provisionally accepted by successful submission to empirical tests. 
Thus, falsifiability distinguishes the empirical theories from the non-empirical. 
3.4.5.4 Existentialism 
Existentialist philosophers include Martin Hiedigger (1889-1976) and John Paul Sartre 
(1905-1980) (Gaarder, 1995). Existentialism starts from humanity itself; it is humanistic. 
Man must decide for himself how to live. Existence is the key word in relation to the 
position that man finds himself in. We each have to find our own way to live and work it 
out for ourselves, through our conscious human thought. We are totality responsible for 
everything we do. There is no eternal truth out there guiding us and telling us what to do. 
We are totally free to make our own choices. Our freedom obliges us to make something 
of our lives, and not just to join the flock. We each one of us perceive a situation according 
to what our interests in the situation are. 
3.4.6 History of Modem Western Philosophy Summary 
The purpose of this section has been to provide a historical context for the philosophical 
concepts systematically reviewed and applied elsewhere in the thesis. Thus this section 
gives a historical reference point for the ontology and epistemology described in sections 
3.5 to 3.11. 
3.5 ONTOLOGY 
Having established the basis for building a philosophy and the required qUalities of a 
philosophy, the first component in any philosophy to be considered is ontology. According 
to Ferm (1969) ontology, the nature of reality, can be analysed by addressing two 
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questions: 
i) How many realities are there? 
ii) What is the nature of each of those realities? 
In considering the answers to these questions the ontological view sought will be the one 
which best represents a meaningful basis for an analysis of the CDS problem. 
3.5.1 Number of Realities 
In terms of the number of realities these can be broken down into three views: 
i) The monist view considers there to be a single reality. 
ii) Dualism takes the view that there are two realities. 
iii) Pluralists see the world as consisting of multiple realities. 
There are a number of implications attached to each of these views, in particular the level 
of analysis and abstraction in each of the views. The monist view of reality involves the 
most analysis and abstraction of experience to arrive at the one unifying view on reality. 
At the other extreme the pluralist sees reality as being made up of many different 
experiences none of which are related, each representing its own reality. The dualist views 
requires some degree of analysis of experience down to one of the two views of realities, 
but not to the extent of attempting to put all these experiences down to one unifying 
experience. This implication is considered in more detail below in an analysis of each of 
the views. 
3.5.1.1 Monism 
Monism considers there to be one single unifying reality of all things, everything is of this 
-66-
one reality. An example of monism being Spinoza's logical monism described in section 
3.4.1.2. Central to the concept is the ordered and united universe, in which everything is 
interrelated or tied in together. This whole in which everything is united has qualities 
which cannot merely be considered by studying the sum of the parts in it. Essentially it 
expresses an holistic view of the world, and is traditionally seen as the system builders view 
of the world. However, expressing a system in monist terms is a denial of another world 
which the system model is merely an abstraction of. Therefore for effective systems 
thinking and system model testing there has to be a reconciliation of the abstracted or 
idealised system and its material manifestation. The testing of a system model against its 
physical manifestation is fundamentally an admission of the dual nature of reality. 
Therefore, in terms of ontology, systems building is not an expression of a single monist 
reality. 
The strongest point in favour of the monist view is an epistemological one. This is 
essentially that all it is possible to know about reality is held in the mind, therefore there 
is only one true reality and this is held in the mind. However, such a monist view assumes 
that reality can only be exist in the mind, and takes no account of the reality which exists 
regardless of and beyond the ideas and perceptions of the mind. Another criticism of 
monism expressed by Ferm is that monism represents the supreme sophisticate putting all 
sorts of "humpty dumpties" together even though they are not related. 
Monism represents an over analysis of reality and an over simplification, a denial of the 
existence of an "out-there". Moreover, it does not represent an ontology which is 
meaningful when considering the activity of systems modelling. Therefore for this thesis 
monism will not be taken as the basis for constructing an ontological model. 
3.5.1.2 Dualism 
The dualist view is that reality can be analysed down to two realities, existing together. 
The exact nature of the realities is not fixed. The most orthodox natures of dualism are 
mind and body, Descartes' the thinking world and the extended world (section 3.4.1.1). 
These two realities are fundamentally real and separate, although there is an interaction 
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between the two realities. It is this interaction between the two realities in dualism which 
leads to doubt over the existence of two opposite and exclusive poles. Leading many 
dualists back into the monist analysis of reality. However, when considering the mind and 
body natures of a dualist view of reality it is possible to see how the two can be real and 
separate. 
Applying the dualist realities of the mind (idealist) and body (materialist) to the process of 
building a system, the abstraction of the material reality occurs in the idealist reality. There 
is then an expression of the idealised abstraction back in the material reality, followed by 
a comparison of the material system expression with the original material reality the system 
abstraction is attempting to represent. At the most fundamental level this process could be 
used to describe the process of the mind's conceptualisation of material reality, and the 
expression of the conceptualisation in language. A simple example of such a model 
formulation is the drawing and subsequent use of a road map. The road map is merely a 
conceptualisation, and simplification, of the material road system which does exist 
regardless of the existence of the map. The map is a material manifestation of an idea of 
how to represent the material reality of the road system. Therefore, dualism represents a 
system builders view of reality. 
3.5.1.3 PluraliSm 
Pluralism is fundamentally centred on the idea that we have many different experiences and 
that each separate experience defmes reality, a view expressed in existentialism. The belief 
is that we live in a fortuitous world, a world of chance, where nothing is planned and 
anything could happen. The world is viewed as a mess made of many separate people, 
phenomena and ideas. 
To a pluralist a totality is merely an abstract, the parts are not really parts they exist, as they 
are observed, in there own space in a whole. Thus it is the least analytical of the three 
views on the number of realities. In this existentialist extreme there is no analysis, or 
reason, merely existence, or being. In a way it represents an anti-intellectual ontology; 
where intellectual activity is normally centred on analysing, understanding and linking 
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observations under unifying theories. Under this philosophy there is no necessity in the 
concept of scientific law and order no absolute underlying unity which ties it all together. 
For example, the law of gravity is merely a description of the observation of objects in 
space, there is no underlying unity. Thus, as a philosophy for intellectual endeavour it does 
not provide a useful basis; particularly when considering systems modelling which by its 
very nature involves some analysis, abstraction and unification of the experiences of the 
material world. 
3.5.2 Nature of Reality 
Within any reality its nature can be thought of as being either (Ferm, 1969): 
i) Idealist, essentially reality is a set of ideas. 
ii) Materialist, everything is matter. 
iii) Dynamist, all is energy, movement and flux. 
iv) Neutralism, none of the above apply to reality it is nothing in particular. 
So, the question now is what is the nature of the realities in the two realities which are to 
be adopted in the dualist ontology. The dualism combined with a descriptive view of the 
nature of the realities is fundamental to an expression of a world view. Thus it sets the 
context for the analysis which follows in the thesis. 
3.5.2.1 Idealism 
An idealist reality is akin to human thought, or the human mind. Reality is based on a 
world of ideas, the world is in the mind of the beholder. Ferm (1969) classified four 
essences of idealism; these are outlined below and their possible role in decision making 
is assessed. 
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i) Reason is of the essence, rationalistic idealism is the application of logic. For 
example by the application of deductive reasoning formulating new ideas. In this 
view man is a purely rational being. As an ideal rationalism can form the basis for 
decision making. 
ii) Emotion is of the essence, romanticism, or affectivistic idealism, views moods at 
the root of human ideas not reason. Moods are viewed as closer to the nature of 
man than his rational processes. This is an unsystematic view of idealism, since 
feelings are spontaneous. Reality is something which is experienced and felt rather 
than understood. Such romanticism does not feature in the philosophy of science, 
although it does undoubtedly affect human experience of life. Thus decision 
making could be influenced by romanticism. 
iii) Impulsive irrationality is the essence, voluntaristic idealism views ideas as being 
driven by man's will; for example the drive to reproduce, the drive for survival. In 
voluntaristic idealism the will is fundamental, it shapes reason and dominates the 
passions. It is this inner passion which drives us on to achieve other things, choice 
is the determining factor in life. These choices have no foundation in rationality as 
there is only the passion in us all which drives us on. From an epistemological 
view we go on without knowing all the answers, because not everything is a 
justified true belief, or known, it is merely a belief. In this view there is not a belief 
on the nature of reality, and therefore no application of philosophical logic. Any 
decision to take an action, or make a choice, is only consistent with a deep internal 
drive. There is no considered application of logic, only pure impulsiveness. 
iv) The totality of the self is the essence; here the idealist reality is a totality of 
personality. It is not simply rational or emotional or voluntaristic, but a mixture of 
all three. This analysis of the idealist reality relies on considering its nature as 
being akin to that of personality with all its different facets. Thus decision making 
can be influenced by application of rationalism, emotion or free will. 
The most holistic of these views on the nature of an idealist reality is the totality of 
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personality. In this analysis of the nature of idealism all of the essences described in one 
to three constitute the total nature of idealism. For example, man uses his powers of reason 
to solve problems rationally, he has emotional responses to situations, and takes action to 
ensure his continued survival. Thus, all essences of idealism are involved in an idealist 
reality. However, in terms of intellectual pursuit man strives to display rationalistic 
idealism, to the extent that this nature of idealism is held in highest regard and the others 
are often dismissed rather than acknowledge. Although, when considering decision making 
in the idealist reality of the mind all of the essences describing its reality influence the 
process of decision making. Analysing the decision making process on different levels can 
illuminate this further. For example, a man decides to work to earn money to eat and 
survive, voluntaristic, on another level his emotional response to his environment may 
affect how effectively he makes decisions, romanticism, and finally when faced with a 
technical problem he may apply deductive reasoning to solve it, rationalism. Thus 
voluntarism influences the perception of a need which drives an action, romanticism 
defines the emotional context of the decision making, and rationalism defines a mental 
process which can be applied when seeking the solution to a problem. Which of the 
categories of idealism have an influence will depend on the stage of the decision making 
process. 
3.5.2.2 Materialism 
Materialist reality is akin to the physical world. In materialist reality matter is fundamental, 
both its function and its form. An example of a materialist view of reality is the atomic 
view of all matter in the world consisting of atoms. Under this theory all matter can be 
broken down into its constituent atoms. For scientists with a monist view of reality, the 
nature of the reality is material. In this view the mind function and form is explained in 
terms of a brain consisting of many nerve cells and with electrical impulses travelling 
between them. In a material reality it is science which will give us our understanding and 
knowledge of the material reality. The materialistic monist believes the only thing truly 
real is the physical world that we inhabit. Although through observation this does seem to 
be a reasonable explanation of reality, it is a denial of the involvement of the mind in the 
conceptualisation of the material world. 
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3.5.2.3 Dynamism 
Dynamism views the nature of reality as pure energy, neither spiritual or physical. The 
world is in a constant state of flux or change. Heraclitus expressed this view by stating that 
everything flows, all is flux, the only thing unchanging is the flux. Reality is seen as a 
dynamic process which is available to us in our non-intellectual, non-analytical, immediate 
insights. Dynamism is a reality in which activity systems are in action and reaction to one 
another. Under dynamism with its constant flux systems exist in an unstable manner. The 
fact that a system can be identified implies there is sufficient stability for the observation 
to be made and that not everything is in a constant state of flux. Epistemologically this is 
a expressed in the need to gather reliable knowledge of reality. Reliability implies that 
there is some consistency. Therefore, for reliable knowledge there must be stability and 
consistency. 
Dynamism does offer a view though on how the dual realities of mind and body can 
interact with one another; where to the observer the mind and the body are entities with 
sufficient stability to assess them as systems in an idealist level of abstraction. The 
movement between the two realities being by a dynamic transference of energy from the 
idealist to the material reality, and vice versa. Such dynamic change is then observable in 
the material reality. 
3.5.2.4 Neutralism 
A neutral reality has no character of force. It is not any of the previous three in nature. 
Reality only exists in pure experience, it just is. There are no entities, patterns or forms. 
There is no idealist analysis or judgement of the world around us just experience. There 
is no material existence, or dynamic interaction in the world. As for pluralism, this 
existentialist ontology offers no analytical basis for a decision making or for systems 
modelling. 
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3,5,3 Ontoloiical Model 
The analysis of ontology was to firstly consider the question of the number of realities and 
then the nature of each of these. There are three classifications for the number of realities: 
monist or single reality; dualist or double reality, and pluralist or multiple reality. The 
nature of a reality may be either: idealist, all ideas; materialist, all matter; dynamist, all 
constant flux, or neutralist, there is no nature. The ontological model is to be applied to an 
analysis of systems modelling, decision making and decision support. The criteria for 
deciding which philosophical concepts to include in the model is related to how well the 
concepts apply to systems modelling and decision making, 
Monism, in an idealist sense, is traditionally seen as the system builder's view of the world. 
However, expressing a system in monist terms is a denial of the material world which the 
system is merely an abstraction of. Therefore for effective systems thinking and system 
model testing there has to be a reconciliation of the abstracted or idealised system and its 
material manifestation. Testing of a system model against its physical manifestation is an 
admission of the dual nature of reality. Therefore, in terms of ontology, systems building 
is not an expression of a single monist reality. 
A pluralist analysis of reality is essentially the existence of a number of neutralist realities 
all existing at an experiential, or existentialist level. The application of such a concept to 
systems analysis would not provide any greater insight than that which is immediately 
observable, 
Dualism takes the views that there are two separate and distinct realities. The most 
orthodox natures of dualism are mind and body, Descartes' the thinking world and the 
extended world. Applying the dualist realities of the mind (idealist) and body (materialist) 
to the systems modelling process. The abstraction of the material reality occurs in the 
idealist reality. There is then an expression of the idealised abstraction back in the material 
reality, followed by a comparison of the material system expression with the original 
material reality the system abstraction is attempting to represent. Therefore, dualism 
represents a system builders view of reality. Movement between the two realities is by a 
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transference of energy across a dynamic bridge from the idealist to the material reality, and 
vice versa. The dynamic interaction, or processing filter, between the two acting as a cross 
over point, as depicted in figure 3.4; examples of the filters being human perception for 
observing matter, and language used to express what exists in the mind. Thus the ontology 
can be viewed as an idealist reality, encompassing all the essences described above, 
interacting with a material reality. This view of reality modelled in figure 3.4, will form 
the basis for an analysis of the epistemology to be used, and as a philosophical model of 
the decision making process. 
Onto logically decision making is a process involving the interaction of the idealist and 
material reality. In the idealist reality actions are decided on and then converted by a 
process in the dynamic bridge into actions. The actions then cause a disturbance, or 
reaction, in the material reality which is observed and converted back into ideas for adding 
to the next decision making cycle. This is a general model of decision making applicable 
to all categories of decision, including intuitive and rational based decisions. 
3.6 EPISTEMOLOGY 
The ontological model gives a framework for building up an epistemology, the theory of 
knowledge. The ontology defmes the realities which there can be knowledge of, and where 
knowledge can exist. Knowledge is thus a function of a view of reality as it can only exist 
within this view, and is knowledge of the realities portrayed in the ontology. 
Epistemology is useful in the context of understanding the nature of knowledge, and using 
this understanding to analyse its role in decision making and knowledge based systems. 
Important aspects of knowledge are its truth and validity, which will also be covered in this 
section. O'Connor and Carr (1987) define the four key concerns of epistemology as 
follows: 
i) Giving an account of the nature of knowledge. 
ii) The sources of knowledge, with the nature and modes of acquiring knowledge. 
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iii) To defend criteria for judging knowledge against radical scepticism, which 
questions the very existence of any knowledge. 
iv) The scope, or context, of the knowledge of the realities expressed in the ontological 
view. 
Katz (1993) defined epistemology as the study of what knowledge is, how it can be 
obtained, and how it can be validated. This three part definition corresponds to the first 
three parts of the definition by O'Connor and Carr. O'Connor and Carr add to this the 
importance of the scope of the knowledge in an ontological context. Therefore, in defining 
an epistemology for decision support the four aspects of knowledge to be considered are 
its: nature; scope; sources, and validity. Each of these aspects of knowledge will be 
considered in the following sections. 
3.7 NATURE OF KNOWLEDGE 
Knowledge can be defined in different ways: 
i) Knowledge is a rich form of information, often expressed as facts, rules, 
relationships, assumptions, tasks, etc. (Tansley and Hayball, 1993) 
ii) Knowledge is relationships, facts, assumptions, heuristics, and models derived 
through the formal or informal analysis or interpretation of data. (Shortliffe, 1990) 
iii) Knowledge comprises a set of formulae, rules, or heuristics that can be used to 
create information from data (or other pieces of information). (Deutsch et al., 1994) 
iv) Knowledge is commonly understood as justified true belief. (O'Connor and Carr, 
1987) 
The first three definitions come from the development of knowledge based systems. 
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Hence, the emphasis in these definitions on the representation of knowledge as a form of 
information. Combining these three definitions of knowledge representation into one; 
knowledge can be represented as rich information which contains facts, rules, assumptions 
relationships, heuristics and models. The emphasis here is on the expression of knowledge 
in the material reality. Such a representational definition does not describe the nature of 
knowledge in a philosophical manner, that is it is not a general definition of knowledge, 
and there is no mention of any judgement of the truth of knowledge. Therefore this 
definition is too restricted in its applicability, and a more general definition is needed. 
A philosophical definition of knowledge provides the basis for a definition which could be 
useful in knowledge based system development. Such a general definition includes the 
fundamental aspects of the nature of knowledge. With a better understanding of these 
fundamental aspects it will be possible to analyse more fully the complexities of dealing 
with the concept of knowledge. For example an appreciation of the subtleties of knowledge 
could aid in structuring the process of knowledge elicitation from a knowledge source. 
Furthermore, when seeking to make a contribution to knowledge there needs to be an 
appreciation of the nature of knowledge. 
The definition which does satisfy the criteria for a philosophical definition of the nature of 
knowledge is the fourth one as quoted by O'Connor and Carr. Here knowledge is expressed 
as justified true belief. This definition of knowledge uses the concept of belief to define 
the nature of knowledge. So before considering the criteria for jUdging what makes a belief 
knowledge, the concept of belief is analysed. 
3.7.1 Belief 
Traditionally there are two philosophical models of belief: the mental model, where belief 
is viewed as a mental occurrence of the believer, and the behaviourist model, where belief 
is viewed as the material expression of behavioural dispositions. Both types of model are 
process models, the mental model describes the acquiring of a belief, whilst the 
behaviourist model represents the expression of belief. The mental models exist in the 
idealist reality, and the behaviourist model is a material model. An ontological view of the 
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two models is given in figure 3.5. 
3.7.1.1 Mental model of belief 
In his mental model of belief Hume summed up belief as a "lively idea related to or 
associated with a present impression". In arriving at this definition Hume was attempting 
to address the question of what is the process involved in moving from perception through 
to belief of how future similar events will occur. Such a model of belief could be 
considered to be a model of the acquisition of knowledge. 
Extending Hume's lively idea Cook Wilson's mental model considered belief as two 
separate acts: 
i) Entertaining the proposition P; 
ii) The assenting to or adopting of the proposition. 
The first act entertaining a proposition involves formulating and then considering the 
proposition without making a commitment either way on whether the proposition is true 
or false. To adopt the belief entertained then involves accepting the belief. The basis for 
judging the belief varies according to the criteria for judging it. Beliefs are held after the 
assenting stage of the process described in the definition. Therefore, the more propositions 
someone entertains and assents to then the more beliefs they will acquire. If the 
propositions in question are domain specific and linked with each other in a logical manner 
then a set of linked beliefs will be formed. Where these beliefs constitute knowledge, the 
beliefs gained through experience form a knowledge base of domain expertise. Thus, the 
notion of expertise through exposure to propositions under the mental model does reinforce 
the notion of using experts as a source of knowledge in knowledge based system 
development. 
The acquiring of belief, or knowledge, is only one aspect of belief. There is also the aspect 
of belief concerned with holding, or having, a belief. The behaviourist model attempts to 
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describe how the beliefs held are expressed in actions. 
3.7.1.2 Behayiourlst model of belief 
The behaviourist model states that beliefs manifest themselves in the action of an 
individual. Braithwaite's theory of belief in action interprets belief, as in I believe in 
proposition P, as the conjunction of two propositions: 
i) I entertain P, 
ii) I have disposition to act as ifP were true. 
The problem with the second proposition here is in the connection of an action with the 
belief that P is true. Even when considering an individual expressing a belief P there is no 
absolute technique for saying they do definitely hold the belief. An individual's actions and 
words can lie about their belief. However, in a more general sense some propositions do 
have a direct impact on actions. For example when trying to find a set of keys, if you 
believe the keys were left in the top drawer, your action will be to look in the top drawer. 
Therefore, held beliefs do influence actions, but not always in a transparent way. This 
problem of identifying held beliefs is fundamental to the problem of knowledge elicitation 
when developing a decision support system. 
Taking decision support to be advising on the choice of an action from several alternatives 
there needs to be a link in the system between the system knowledge and the system 
recommendations. By having a transparent link between the knowledge and the advice 
offered deductive justification of the advice is made available. The link between these two 
is normally determined by an expert knowledge source. This raises the question of how 
does the expert interpret their own cOIUlection between held beliefs, or knowledge, and the 
actions they normally perform. This is one of the very fundamental problems of knowledge 
elicitation of expert knowledge. Any knowledge elicitation does require some acceptance 
of the behaviourist model as being true. 
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3.7.1.3 Beliefsummary 
In swnmary there are two models of believing, acquiring belief and expressing a belief. 
The mental model theories above attempt to analyse the first category, whilst the models 
based on action attempt to describe the second. These can be combined by considering 
firstly the building or accepting of a belief, and then the acting or using of a belief. The 
first stage will be an actively mental one where the proposition is questioned against 
previously held beliefs before it is added to them. Then once a "map" of beliefs is 
constructed, and held in memory, these will be used in the reactions to problems faced by 
an individual. This model of beliefs can then be applied to knowledge. as knowledge has 
been defined as a type of belief. 
In developing a model of knowledge the mental models of belief confirm that knowledge 
is formed and stored in the idealist reality, and expressed and put to use in the materialist 
reality. Therefore, it is possible for knowledge to exist without there being any material 
expression of the knowledge. This reinforces the point that a definition of knowledge 
which only describes an expression of knowledge is not describing its absolute nature. The 
mental model provides a basis for the analysis of how knowledge, or expertise, is acquired. 
The behaviourist model can be used to provide insight into the process of knowledge 
elicitation. 
3.7.2 Truth 
The distinction between belief and knowledge needs to be made, as not all beliefs can be 
considered to be knowledge. Knowledge, a justified true belief, can withstand critical 
examination. Specifically, to be classified as knowledge a belief must be able to be judged 
true according to the criteria for truth described below. In the context of using knowledge 
in decision support the concept of truth is fundamental to an assessment of validity of the 
knowledge, and in assessing the "true" state of matter when offering decision support. 
Ontologically truth exists as a concept in the idealist reality. Truth is a judgement made 
in the idealist reality; truth does not exist outside this reality. In the material reality matter 
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cannot know truth. It is only when matter is being observed through the application of 
perception and ideas that truth about matter can be said to begin to exist. To put it another 
way truth is a quality assigned to knowledge and knowledge only exists in the reality of 
ideas, therefore truth can only exist in ideas. For example, consider a scientific experiment 
running in a laboratory isolated form all observers. Running in isolation the material reality 
of the experiment contains no concept of what is true. Matter by nature does not contain 
ideas or make judgements. The truth value of the results of the experiment can only be 
judged when observation of the results are made. The judgement will be made according 
to observation and interpretation using previously held ideas, or concepts. This judgement 
will depend on the observer's perceptive skills, their knowledge base of ideas and their 
analytical ability. To sum up truth exists in the mind of the beholder. Therefore, any truth 
will have a subjective element. This is a fundamental problem when trying to construct an 
"objective" knowledge base. 
One implication of the view of an idealist truth is that there is no universal truth in the 
material reality waiting to be discovered. Any laws concerning the behaviour of matter are 
idealistic interpretations of observations. 
The three aspects of analysing truth, as attached to a belief are: 
i) The acquiring of a true belief, applying the mental model of belief. 
ii) How can truth be expressed, applying the behaviourist model of belief. 
iii) How can the truth of a belief be tested. 
Acquiring a true belief involves the process of: 
i) Entertaining proposition A. 
ii) Testing the truth of the proposition and finding it to be true or false. 
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Following this process a knowledge base will be added to. The expression of a truth 
follows a similar two stage process: 
i) Entertaining a proposition A as being true. 
ii) Expressing, or behaving, in accordance with the belief that A is true. 
In both of these processes there is some judgement on the truth of a proposition. Therefore, 
a proposition can be viewed as the truth carrier or truth bearer. To publicly test such a 
proposition there needs to be some expression of the belief before this can be done. 
3.7.2.1 Expression of truth 
Some truth bearers are essentially linguistic but they need not always be. For example an 
action may be an expression of an internally held truth. However, the expression of truth 
by action is limited. A large number of truths rely on language to express them. 
So, what is the nature of the linguistic truth bearer, the proposition. A statement of truth 
is an affirmation about some observed material phenomena, for example, there is a black 
cat lying on the mat. The levels of truth in this statement are first that it is a correct 
description of a possible state of affairs. In other words is it coherent with the present 
world view, do cats lie on mats. The second level of truth is the context of the statement, 
or the space and time being referred to by the statement. A proposition can be regarded as 
the cognitive content, or meaning, of a statement of truth; each of the meanings, or 
interpretations, of a statement being represented by an individual proposition. For the 
above statement three propositions can be analysed as representing the meaning of the 
statement: the cat is black; the cat is lying down, and the cat is on the mat. So, propositions 
are the breakdown of the meanings of a sentence, and are subject to the same tests of truth 
as any truth statement. Their value is in expressing one of the facts or meanings of a 
statement. Thus they are more precise than general sentences and offer an object which can 
be tested for truth in the public domain. 
Redundancy theory address the problem of how truth can be expressed in language. The 
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basic representation of truth is a proposition, "Snow is white." If such a proposition is 
represented by P, redundancy theory holds that to say, "P is true" is the same as simply 
stating," P", or "P is false" is the same as "Not pIt. Therefore, adding true and false does 
not add meaning to the proposition as they are merely adjectives which do not add meaning 
to the proposition and are therefore redundant. Therefore to express a truth it is sufficient 
to state, "P," it is not necessary to state, IIp is true." 
3 .7.2.2 Truth tests 
The judgement of truth, or a proposition, can be philosophical or non-philosophical. The 
categories of truth test which do allow for critical reflection, or the philosophical criteria 
for truth are: 
i) Coherence theory is concerned with the knowledge being consistent with what is 
known already. In this theory harmony of ideas is the essence of truth, the 
emphasis is on building a systematic body of knowledge. Applying this theory 
depends on the knowledge base and the logic used to judge the coherence of the 
proposition under test. The theory's most fundamental assumption is that the 
knowledge base already in existence is true. Thus, this test should not be 
considered to be a revealer of absolute truth, but a test of the consistency of a 
proposition with what is already known. Coherence testing can be considered to 
be the "it makes sense" test of truth. In other words if there is no logical 
contradiction of the proposition under test with that which is already known then 
the proposition makes sense. 
ii) Correspondence theory, is the correspondence of a proposition to a fact or an 
observation of material phenomena. Under this theory a proposition represents one 
entity, the expression of a truth, and the other entity is a fact, the observation of 
matter. It is the correspondence of one entity to the other which acts as a test of 
truth. This can be thought of as the correspondence of truth bearers, propositions, 
with truth donors, or physical observations. An illustrative example of this theory 
is a map which corresponds to the material terrain which it represents. Here the 
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map is synonymous with the proposition and the area it represents synonymous 
with the facts. The testing of the "truth" of the map will rely on firstly the 
interpretation of the map, using the concept of the language of a map, and then a 
visual test of its correspondence with an observation of the observed surroundings. 
Obviously the interpretation of the map as a true representation of an area will 
depend on the skills of the user of the map. Thus, the interpretation of facts is 
governed by perception, and moulded by the concepts, or ideas, through which 
reality is interpreted. 
iii) Pragmatic theory states that if an idea works then it is functionally true. This theory 
was developed by the pragmatists William James and John Dewey (section 3.4.5.1). 
To the pragmatist a true statement is one which is useful; a true theory is one which 
works in practice. Therefore, this theory is concerned with measuring the utility of 
propositions to assess their truth. The utility of any idea, or proposition, is a matter 
of judgement and dependent on a set of goals. Therefore, subscribing to this theory 
involves the adoption of the view that truth is always contextually dependent on a 
purpose. As there is no universal context or purpose then pragmatism holds there 
is no universal or absolute truth. Moreover, truth is fluid and open to change, 
revision and new plateaus. Therefore knowledge of the world is constantly 
changing and evolving. Both humanistic pragmatism, where the truth satisfies the 
goals of the human race, and the experimental scientist, or positivists, subscribe to 
this view of truth. To the pragmatist the more a truth works the more certain it 
becomes. 
The judgement of a proposition about material reality will involve the application of the 
correspondence theory, as an observational test, and the coherence theory as a logical test 
of the proposition. The pragmatic test can be applied as another level of testing applying 
correspondence and coherence to judge if a pragmatic purpose has been satisfied. The tests 
of truth outlined above allow for critical reflection on the truth of a proposition, thus they 
provide a philosophical test of truth. Moreover, they can be applied to testing the validity 
of any knowledge base containing propositions on the material reality. 
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The non-philosophical criteria for judging truth, which are not by nature open to 
philosophical question, are: 
i) Truth from an authority; the authority could be a church, parent, social group, or 
one of many more sources. One fundamental problem with this criteria for truth is 
that different authorities disagree on the truth of propositions. Therefore, accepting 
as true without question a proposition from a single authority is not the basis for 
obtaining a philosophical truth. 
ii) Truth appealing to feeling, an emotional response to a proposition which gives a 
feeling that it is true. The problem with linking truth to feeling is that emotions can 
be very unstable. Thus, the context of a truth becomes dependent on a fickle 
emotion. 
iii) Truth by general agreement of a group; truth is whatever the majority of people 
believe to be true. There have been many cases through history where the once 
commonly held belief is now almost universally agreed to be false, for example the 
notion of the earth being flat. Therefore, just because the majority of people believe 
a proposition to be true does not make it true. 
iv) A priori or self evident truths are truths which are prior to experience and are an 
expression of the nature of the mind. To set a proposition as self evident does not 
leave it open to philosophical reflection. 
v) Intuitive truth is truth as revealed to an individual by some inner insight. The 
intuition being something beyond reason makes it difficult to question the validity 
of the truth. 
All of the last five categories of truth are non-philosophical because they lack critical 
reflection and can border on the dogmatic. In its purest fonn dogmaticism makes no room 
for question. Thus any truth which can be classified in this way, and has not been subjected 
to any critical analysis is not valid as a rational source of justified true belief; although, the 
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five non-philosophical bases of truth can be used as a source of propositions which are then 
tested using the philosophical tests of truth. Thus the source of propositions to be 
entertained can be philosophical and non-philosophical. However, the philosophical tests 
of truth act as the test for fonning a reasoned and validated knowledge base. In a practical 
sense the three philosophical truth tests offer a basis for the validation of propositions in 
a clinical knowledge base. 
3.7.3 Summary on Nature of Knowledae 
Knowledge is defined as justified true belief. The mental model of belief offers an 
understanding of how knowledge is acquired by the process of entertaining a proposition 
or idea and then the assenting to or adoption of the proposition. The behaviourist's model 
of entertaining a proposition and then acting as if the proposition were believed, offers an 
insight into how knowledge is applied. 
The major distinction between belief and knowledge is the concept of truth. Truth is a 
judgement formed on a belief, and so exists in the mind of the believer. A truth may be 
expressed in a tested proposition, where a proposition expresses a single meaning of the 
form "the snow is white". For a proposition to be analysed as true it needs to be tested 
according to coherence, correspondence, or pragmatic theory. Only then can a proposition 
be defined as a justified true belief, or knowledge. 
In the development of knowledge based systems there are the two stages of knowledge 
acquisition and knowledge utilisation. Knowledge acquisition can be seen as a process 
described by the mental model of belief, with a test of truth before the belief is adopted as 
knowledge. Knowledge utilisation can be described by the behaviourist's model, 
particularly where a proposition is acted on in an explicit and transparent manner. The 
testing of the truth of the knowledge acquired and utilised is embedded in each process. 
In acquiring knowledge the truth of a proposition should be tested before being added to 
a knowledge base, then when the knowledge is utilised it can then be tested again and 
modified if necessary. Thus knowledge as it exists in the idealist reality, in an open system 
of ideas, is a dynamic entity. 
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The testing of truth during knowledge acquisition could be performed according to 
correspondence theory and coherence theory. Applying correspondence theory, a fact 
which corresponds to the proposition could be looked for. Applying coherence theory the 
knowledge can be tested for logical consistency with the established knowledge base. How 
the observations are performed, and the coherent knowledge base used, are important 
considerations when applying these tests in practice. In the clinical domain the 
observations will have to be performed by a suitably qualified person, and the wider the 
agreement that can be reached on the observed facts the greater the power of the test. The 
established knowledge base used to test for coherence needs to be fixed and agreed upon. 
One possibility is to test clinical knowledge for coherence with established physiological 
and pathophysiological knowledge. Then if the proposition is contradictory to this 
knowledge it can be rejected. However, testing a piece of clinical knowledge referring to 
patient treatment against this knowledge does represent only a shallow test of the 
knowledge. Finding an established deeper clinical knowledge base is difficult partly due 
to the dynamic nature of clinical knowledge. This is a fundamental problem when 
applying coherence testing to new clinical knOWledge. 
Knowledge, once acquired, can then be further tested when utilised. Providing knowledge 
can be linked to an action, then a proposition can be tested by applying the pragmatic test 
of knowledge. This is fundamentally testing whether or not the knowledge works, or 
satisfies perviously defined purposes. For example if an ethical purpose of clinical decision 
support is to improve patient care, then a pragmatic test of a knowledge base used in 
decision support would be to see if it improves patient care. Following the pragmatic test 
there needs to be a reappraisal of the knowledge used, in a similar manner to how the 
knowledge was judged in the first instance. So there is a feedback loop back into the 
knowledge base; thus knowledge can potentially be updated and changed in a dynamic 
manner. 
When assessing knowledge it should be remembered that truth is always contextual, both 
in terms of its acquisition and utilisation. Therefore there is no absolutely true knowledge 
only degrees of belief. The belief which is nearest to absolute is that which is held to be 
most true, and most justified is normally the most unshakable or most absolute, but all 
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knowledge is contextual according to the "map" of belief which already exists. To use the 
analogy of the map, a new piece of knowledge has to have its place clearly marked on the 
map so its interrelation to other knowledge is clear. On such a map we could have 
propositions representing fixed places on the map, and the connecting roads could be seen 
as being analogous to the reason used to connect these propositions. However, just as 
places and roads can change it is important to remember the dynamic nature of knowledge. 
Throughout history there have been examples of commonly held knowledge, for example 
the sun revolves around the earth, which are now considered to be false, and hence are no 
longer on the knowledge map. Therefore, when defining and testing knowledge the context 
of formulation and application should be defined also. How to define the context, or scope 
of knowledge is considered below. 
3.8 THE SCOPE OF KNOWLEpGE 
The highest level for an analysis of the scope of knowledge is ontologically. It has been 
established above that knowledge exists in the idealist reality and is expressed in the 
material. The existence of a reality is established by the knowledge we have of it. 
Therefore, at the highest level there exists knowledge of all aspects of the ontological 
model. This is depicted in figure 3.6 as an encompassing ellipse within which there is 
conceptual knowledge. Within this ellipse are all the concepts used to make sense of 
reality. This category of knowledge defmes the knowledge base used to make judgements 
on the coherent truth of all new propositions. A systems model could be considered to 
represent conceptual knowledge when it is being used to make sense of a specific domain. 
F or example conceptual knowledge of diseases is used in the process of making clinical 
diagnoses. Within the realm of concepts of the whole of reality it is useful to define two 
further categories of knowledge: 
i) Knowledge of the state of a reality, for example knowing a patient has a high 
concentration of potassium in their blood. 
ii) Know how, which is knowledge of how to perform an action or make an 
observation. 
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These latter two categories of knowledge will be influenced by the conceptual knowledge. 
For example any interpretation of the state of matter is dependent on our knowledge of the 
concepts of matter. This is clearly demonstrated in a specialist domain such as nephrology 
where the concepts of normal kidney function will be an influence. In clinical care 
conceptual knowledge will determine what monitoring actions are taken, and then know 
defines the way the actions are performed. This implies some previous experience, or 
knowledge gathering, to learn how to perform the activity and observational techniques. 
The interpretation of observations into ideas on the state of reality will be influenced by the 
conceptual knowledge used to interpret the observations to form knowledge of the state of 
reality. So, knowledge of the state of reality is dependent on information gathering, the 
know how needed to gather the information and the conceptual knowledge used to interpret 
the information. 
3.9 SOURCES OF KNOWLEDGE 
Two main classifications of the sources of knowledge are rationalism and empiricism, one 
from sensation and the other from reflection. These classifications originate from two of 
the major movements of modem philosophy: continental rationalism and British 
empiricism (section 3.4). Rationalism, or "getting at the essence", is founded in the reason 
of the mind. As a source of knowledge rationalism in its purest form takes the view that 
all knowledge comes from the application of reason and does not have to involve 
experience. Implied in rationalism is a priori (from what is prior) knowledge, that is prior 
to experience. A proposition is a priori if its truth can be established by means independent 
of empirical investigation or observation. At the other extreme is empiricism which takes 
the view that all new knowledge comes from experience. This is a posteriori (from what 
is posterior) knowledge, referring to the view that all knowledge must follow experience 
via the senses. 
The problem with these two extreme views is that one precludes the other. Immanuel Kant 
(section 3.4.4.1) agreed with the empiricists in that he believed all our knowledge of matter 
is founded on experience. However, he extended the ideas of the empiricists by stating that 
it is our reason which determines how the world is perceived. The concepts of the world 
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already held, a priori knowledge, influence the way sensory observations of matter are 
interpreted. For example the concept of states of the material world existing in space and 
time is an a priori concept recognised by Kant, and applying this concept to sensory 
observations means they are interpreted as phenomena in space and time. Interpreting 
experience in this way means that the mind can never "see things exactly as they exist in 
the material sense" but that knowledge of matter only represents an expression of the way 
in which phenomena are experienced. Another expression of this idea is that there are two 
worlds that which we observe (phenomenalism) and that which is the noumenal (real) 
world. This view has been labelled phenomenalism, all that we can know of material 
reality is as it appears to us. Beyond the application of reason in perception Kant also 
specified the use of concepts to make sense of perceptions in a coherent reasoned manner, 
for example in the categorisation of perceptions into groups. Thus there is the application 
of rationalism to the categorisation of perception according to a priori knowledge. 
Onto logically as an analysis of the source of material knowledge, Kant's view is consistent 
with the model of ontology proposed above. In this ontological model the observational 
boundary, or filter, between mind and matter can be used to represent the noumenal world 
on the material side and the phenomenalist world on the idealist side. The phenomena 
perceived are then interpreted using conceptual knowledge in the idealist reality. 
According to Kant the two stages are interdependent on one another and one without the 
other does not lead to new knowledge. The Kantian epistemology is also illustrated in the 
model describing the scope of knowledge. Here know how is applied to sensations to form 
perceptions and conceptual knowledge is applied to these to form new knowledge. The 
process of knowledge building in this way is illustrated in a process model, figure 3.7. 
Thus, to build a knowledge base specific to a domain of reality requires experience of 
events in that domain and the required a priori conceptual knowledge to form knowledge 
from the observations. For a knowledge based system to emulate knowledge formation it 
needs to contain the structure for interpreting observations, conceptual knowledge to judge 
the observations, and the necessary process logic to form new knowledge. 
·89· 
3.10 VALIDITY OF KNOWLEDGE 
Considering the process of knowledge acquisition, storage and application, as depicted in 
figure 3.8, an analysis of the validity of knowledge of material reality can be considered at 
the acquisition stage and the application. Knowledge is valid at the acquisition stage if it 
complies with the description of knowledge given in the section on the nature of 
knowledge. Thus, if on acquisition knowledge is tested for truth according to the above 
criteria it can be labelled valid. The test of truth or validity in the application stage is the 
pragmatic truth test. Thus if the application of the knowledge satisfies a practical purpose 
it can then be judged to be valid. In the field of technology the emphasis is on the testing 
of knowledge in its application. This is discussed in more detail below in the consideration 
of the philosophy of technology. 
The judgement of knowledge validity is a function of the idealist reality the knowledge 
exists in. In other words the validity of knowledge is dependent on the context of the 
idealist reality it is being interpreted in. In addition to the idealist context there will also 
be a material context which knowledge is acquired in and applied to. Applying the a priori 
concepts of space and time means the context of material phenomena will be defined in 
terms of space and time. 
For knowledge based systems applied in decision support they exist to aid the solution to 
a practical purpose. Therefore, the emphasis is on the pragmatic test of knowledge validity. 
However, if the applied knowledge has not first been tested for truth in its formation this 
could invalidate its application. 
3.11 EPISTEMOLOGICAL MODELS 
The four aspects of epistemology to analyse knowledge here are the: nature; scope; source, 
and validity of knowledge. The broad definition of knowledge is a justified true belief. 
This can be expressed in the form of a proposition. A proposition in application to material 
objects is of the general form object A is B, where B is a property of A. 
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Knowledge as justified true belief requires firstly the act of believing followed by the 
judgement of truth. Two models of belief have been proposed: the mental model, and the 
behaviourist's model. The mental model applies to the acquisition of a belief, or 
knowledge. Firstly mentally entertaining a proposition and then subscribing to the belief. 
The behaviourist's model is concerned with the connection of holding a belief and then 
acting in accordance with that belief. This leads to a three stage model of knowledge 
acquisition, storing and application, figure 3.8. 
The criteria for judging truth can be categorised as philosophical and non-philosophical. 
The philosophical criteria allow for critical testing of truth. Whereas the non-philosophical 
require a degree of unquestioning acceptance, and in extreme cases can be dogmatic. The 
philosophical tests for truth are the correspondence test, the coherence test, and the 
pragmatic test. Broadly the correspondence test is concerned with supporting a proposition 
with an observable fact. The coherence test using the current knowledge base to test for 
logical coherence of a proposition with other knowledge. The pragmatic test is concerned 
with testing the utility of ideas to test their truth. If a proposition is proven to meet a 
practical purpose then it is held to be true pragmatically. All of these tests of truth can be 
applied in building a knowledge base. 
Knowledge is formed in the idealist reality, but applies to both the idealist and the material 
reality. Here the interdependence of ontology and epistemology is apparent. An ontology 
is defined by what is known of reality, the realities it is possible to have knowledge of are 
defined by ontology. An analysis of the scope of knowledge of reality is represented in 
figure 3.6. At the highest level conceptual knowledge defines a view of reality and 
provides the context in the idealist sense for interpreting other knowledge. The lower level 
knowledge is knowledge of the states of reality and know how on interaction between the 
two realities. Knowledge of the state of material reality is normally defined by some 
quantitative or qualitative measurement technique. Thus know how is applied in applying 
the technique to gain knowledge of the state of matter. 
The source of knowledge has been traditionally been viewed as empirical or rationalist. 
However, these two views contradict each other and each one taken in isolation does not 
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adequately describe all sources of knowledge. Kant proposed a compromise to this conflict 
in the form of phenomenalism. Phenomenalism takes the view that all observations of 
matter are the result of the application of a priori knowledge to form perceptions. The a 
priori knowledge includes the concept of interpreting observations, or sensations, in terms 
of the a priori concept of space and time. The perceptions formed in this way are then 
rationally processed using other a priori conceptual knowledge into new knowledge. Thus 
the source of knowledge is both empirical and rational. 
The validity of knowledge is judged according to the criteria for truth discussed above. 
Applying the model of stages of knowledge developed above this judgement can be made 
at the stage of knowledge acquisition and knowledge application, where the context of the 
idealist and material reality in which they are made determine the judgement of validity. 
3.12 THE MULTIDISCIPLINARY NATURE OF CLINICAL DECISION SUPPORT 
A characterisation of the multi-disciplinary nature of CDS needs to consider many 
elements. The structure of these elements is shown in figure 3.9. At the root of figure 3.9 
is the generic philosophy described above. The remaining elements of CDS illustrated in 
figure 3.9 are more specifically related to the domain of interest. According to Shortliffe's 
(1987) definition of clinical decision support the production of a computer decision support 
tool is the aim of CDS development. Hence, the drive to use technology in CDS to produce 
decision making tools means that technology plays a role in defining the nature and central 
methodology of CDS. The application domain for the technological artifacts of CDS is a 
medical one, thus the nature of medicine is relevant, particularly the ethics defined in 
medical philosophy. A large part of the knowledge base of medicine and technology is 
based on scientific knowledge thus the nature of science is an element in the nature of CDS. 
This section will consider the nature of these three remaining disciplines and model the 
relationship between them. 
3.12.1 TechnolQiY 
Technology comprises the sum of the resources which increase the efficiency of human 
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activity, e.g. trains and telecommunications. All societies can be said to apply technology 
in relation to their problems of food, shelter, and transport. The instrumental function of 
the technological process is to direct the use of resources according to human purposes. 
Thus the technological process is always limited by the availability of resources. 
Technology is driven to satisfy the defined purpose of the material artifact, or tool, being 
constructed. When judging success the criteria used are essentially ones of corroboration, 
mainly social and legal. Seeking corroboration involves demonstrating that the defined 
social purpose has been satisfied within the legal framework. The criteria applied when 
judging a technological artifact include: durability; reliability; sensitivity; pragmatic 
effectiveness; cost effectiveness; rapidity of production; or a combination of these or 
similar better criteria. In summary technology is concerned with the efficient use of 
resources to satisfy a material social need. 
3.12.1.1 OntolOKY and epistemoloKY oftechnoloKY 
Technology aims to produce material artifacts to solve material problems. This involves 
the processes of the abstraction of the problem into a set of ideas and an abstract 
representation of the design of the artifact. These characteristics of technology are 
summarised in the ontological model of technology in figure 3.10. Materially technology 
exists in the material problems and in the material artifacts it produces. The idealist 
abstraction or representation of these material factors exists in the mind. The link between 
the two is in the realisation of the design of material artifacts and in assessment of observed 
material phenomena. 
Epistemologically technological knowledge exists in the mind as justified true belief. The 
major test of the truth of the belief and the validity of the application of the knowledge is 
a pragmatic one. The scope of technological knowledge is represented in figure 3.11. The 
how to knowledge covers techniques for how to realise ideas in practice and how to assess 
the material problem and artifacts. For example knowledge of how to produce a car more 
cheaply. There is also knowledge of material problems and artifacts derived from the 
observation of material phenomena. The conceptual knowledge includes the ideals guiding 
good practice which will be influenced by the ethical codes of the culture within which the 
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technological activity is taking place. Asimov (1974) defined a set of ideals for the 
engineering design process: 
i) NEED; design must be a response to individual or social need which can be 
satisfied by technological factors. 
ii) ECONOMIC WORTHWHILENESS; the goods or service, described by the design, 
must have a utility to the consumer that equals or exceeds the sum of the costs of 
making it available to them. 
iii) FINANCIAL FEASIBILITY; the operations of designing, producing and 
distributing the good must be financially supportable. 
iv) OPTIMALITY; the choice of a design concept must be optimal among the available 
alternatives; the selection of a manifestation of the chosen design must be optimal 
among all permissible manifestations. 
v) DESIGN CRITERION; optimality must be established relative to a design criterion 
which represents the designer's compromise among possibly conflicting value 
judgements that include those of the consumer, the distributor and his own. 
vi) ECONOMIC WORTH OF EVIDENCE; information and its processing has a cost 
which must be balanced by the worth of the evidence bearing on the success or 
failure of the design 
vii) MINIMUM COMMITMENT; in the solution of a design problem at any stage of 
the process, commitments which will fix future design decisions must not be made 
beyond what is necessary to execute the immediate solution. This will allow the 
maximum freedom in finding solutions to sub-problems at the lower levels of 
design. 
In the domain of CDS an additional ideal of design is that it must perform in accordance 
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with medical ethics. Codes of medical ethics are described in the section on the nature of 
medicine. The principles underpinning the design process are (Asimov, 1974): 
i) PHYSICAL REALISABILITY; the object of a design is a material artifact or 
service which must be physically realisable. 
ii) MORPHOLOGY; design is a progression from the abstract idea to the concrete 
material. This gives a vertical structure to a design project. 
iii) DESIGN PROCESS; design is an iterative problem-solving process. This gives a 
horizontal structure to the design process. 
iv) SUB-PROBLEMS; when attending to the solution of a design problem, there will 
be uncovered a substratum of sub-problems; the solution of the original problem is 
dependent on the solution of the sub or unforeseen problem. 
v) REDUCTION OF UNCERTAINTY; design is a processing of information that 
results in a transition from uncertainty about the success or failure of a design 
toward certainty. 
vi) BASIS FOR DECISION; a design project is terminated whenever confidence in its 
failure is sufficient to warrant the non-commitment of resources necessary for the 
next phase. 
vii) COMMUNICATION; a design is a description of an object and a prescription for 
its production; therefore, it will have existence to the extent that it is expressed in 
the available mediums of communication. 
The vertical structure of the design process, highlighted in point two above, progresses 
from an idealised abstraction to a material manifestation and is defined by the system 
development cycle, or design process. The traditional top to bottom waterfall model of this 
process follows the following stages: 
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i) Requirements analysis, abstracting the users material needs the artifacts produced 
are to satisfy. 
ii) The design phase, production of the design ideas. 
iii) Development phase, building a prototype and validating its operation. 
iv) Evaluating the artifact produced in the users environment. 
v) Commissioning the operation of the technology. 
vi) Post commissioning maintenance and upgrades. 
How the waterfall model is applied will depend on the size and complexity of the project 
undertaken. The horizontal structure of the design process, described above as an iterative 
problem solving process, means that although the above process may describe the order the 
tasks start; there is iterative movement within each of the stages and between them. So for 
example during the development phase of the project it may be necessary to reassess the 
requirements for the system. 
3.12.1.2 Science and technoloaY 
Science and technology are terms which are sometimes used synonymously. However, 
there are important distinctions as well as similarities between them. The aims of each 
discipline distinguishes them clearly: 
i) Progress in science aims to increase knowledge 
ii) Progress in technology aims at creating new artifacts to increase effectiveness. 
Thus the intended product of scientific enquiry is knowledge, while technology seeks to 
produce tools to solve problems. To sum up this fundamental difference: science is to 
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understand, whilst technology is to engineer. The nature of scientific problems is a 
problem of not having adequate knowledge to explain an observed scientific phenomena. 
A technological problem is defined by a set of material goals which are not satisfied by the 
observed phenomena. In science a given material reality is investigated, and in technology 
a material reality is created according to a design. Figure 3.12 shows the scientific and the 
technological processes operating in parallel to one another. The nature of the scientific 
process and the knowledge it produces are discussed in section 3.12.2. 
Pure science is a method of investigating nature by the experimental method in an attempt 
to satisfy the need to know. The task is to understand nature. The relationship between 
science and technology in figure 3.12 shows the scientific task of understanding nature 
operating in parallel to technology. The parallel nature of their operation means the two 
processes can operate independently from one another. However, there is some crossover 
between the two where scientific knowledge is applied in technology, and technological 
artifacts are used in the scientific experimental procedure. Examples are given below to 
illustrate the central ideas of figure 3.12. 
There is not always a direct link between scientific and technological progress. For 
example how to make a car more cheaply does not add to scientific knowledge. Moreover, 
new scientific knowledge will not be utilised in technology until a social purpose requires 
it. It may be that there is no technological use for scientific knowledge, for example 
knowledge of the existence of a star in the milky way. 
Tools can be used in tasks without any scientific theoretical knowledge of how the tools 
perform the tasks, e.g. it is possible to know that a drug cures a certain illness without 
knowing exactly all of the in-vivo biochemical reactions involved. Moreover, tools can be 
designed without knowledge of the scientific laws which describe their behaviour. 
Anthropologically there are societies with technology but nothing recognisable as science; 
but there are no societies without technology. Moreover, scientific explanation is not a 
prerequisite to the understanding or solution of a technological problem. 
Technology presupposes nature can be manipulated and modified to serve human needs, 
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science presupposes a regularity in nature; and technology has to take account of 
economical and social factors which science does not. One impact of this is that 
technological artifacts have to comply with certain safety standards, these standards do not 
impact on the product of the scientific process. The reason for this is technology seeks 
social and legal corroboration whilst science does not. Science may even seek to refute the 
corroborated view point. 
However, the drive for technological progress can often lead to investigation of the related 
pure science problems, for example in semi-conductor devices. So scientific discovery can 
be technology-led. Where the scientific knowledge produced has a direct impact on the 
application of technology. Also scientific progress can be dependent on the technological 
tools available for experimentation, for example in the development of measurement 
technology in physics. 
A scientific understanding of the technological problem and of the resources being applied 
to it can aid the process of effective technological design. Therefore application of 
scientific knowledge in technology does constitute effective practice. This is particularly 
true where there is novelty in the problem and the methods required to solve the problem. 
The innovation required in a novel situation can be informed by and include the use of 
science. Although the goal of technology is not a better understanding of nature, it is 
satisfaction of a material need; therefore in the design task technology is the master and 
science the slave. 
The application of science in technology is to solve the sub-problems that require solution 
before reaching the final design solution. This could involve the application of science at 
all stages of the process including the problem analysis. 
3.12.2 Science 
Seelos (1992), and Lincoln and Essin (1992) confirmed the need for a more scientific 
approach in CDS. In the context of the technological goal of CDS, science is an important 
procedure and source of knowledge for the medical problem domain and the technological 
solution. Scientific knowledge and the scientific method are often used without question. 
However, in adopting a philosophically rationalist approach to the domain of CDS it is 
necessary to examine the meaning of these terms and how they can be applied in the 
domain. Moreover, a world view incorporating science can be more fully expressed by 
examining the basic concept of what science is. 
Scientific thought grew out of natural philosophy, thus despite the two now seeming to be 
separate subjects they are closely related. Here the ontological and epistemological bases 
for science are discussed, as are the main ingredients of the scientific method. The use of 
science in research is well established, the scientific age has existed for many years now. 
Lastrucci (1967) sums up the position of science thus: 
" ... .in the competitive arena of opposing logical and methodological systems, all 
presumably devoted to the discovery of truth, scientific method has become the 
strongest intellectual tool that man has devised for furnishing verifiable and 
predictable answers to questions of demonstrable fact." 
So if science is to form part of the world view for CDS the first question to be answered is 
"what is science?" Lastrucci (1967) defined science as: 
"An objective, logical, and systematic method of analysis of phenomena, devised 
to permit the accumulation of reliable knowledge." 
In Lastrucci's definition reliable knowledge refers to knowledge which permits better 
predictions than could be made by chance or guesswork alone. In this definition the 
product of science is a set of reliable justified true beliefs. Ackoff (1962) defined the 
products of scientific enquiry as: 
i) A body of information and knowledge which enables us to control the environment 
in which we live. 
ii) A body of procedures which enable us better to add to this body of information and 
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knowledge. 
These two sources agree science is essentially a knowledge building methodology, 
concerned with the interpretation of perceived material phenomena. Ackoffs definition 
adds that the application of the knowledge is to better control the world we live in. 
3.12.2.1 OntoloiY and e.pistemoloiY of science 
Onto logically science exists within the dualist view represented in figure 3.4. The view 
expressed in this model is the view of the author, and does not represent a traditional 
monist materialist view. Within this ontological model science focuses on the 
interpretation of material phenomena. In the idealist reality exist the abstracted concepts 
and constructs, or theories, on the nature of matter. The dual of idealism is matter which 
is the source of phenomena studied. The product of the study of the material phenomena 
is an expression of the abstracted scientific knowledge. Therefore there is a bias in science 
towards materialism. However this does not preclude the study of material manifestations 
of ideas, as in psychology. 
Although science exists within an ontology its main focus is epistemological. An analysis 
of the epistemology of science can be broken down into four stages as for the description 
of philosophical epistemology used above. These four stages are the: nature; scope; source, 
and validity of scientific knowledge. 
Scientific knowledge has been defined above as reliable knowledge, or in philosophical 
terms reliable justified true belief. Reliable refers to being able to make predictions more 
accurately than by chance or guesswork alone. A central tenet of the description of 
scientific knowledge is the interpretation of scientific truth. Lastrucci (1963) defined three 
concepts which define the structural levels of truth in scientific knowledge as: 
i) Postulates defme the fundamental assumptions which must be accepted before the 
logical reasoning can begin, therefore they are not knowledge, they are purely 
beliefs which define the idealist context of the map of knowledge. 
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ii) Propositions, discussed in earlier in the philosophy section, are not reducible 
logically and are of the form the snow is white. 
iii) Statements of fact are propositions which have been verified by observation of 
material phenomena. 
Scientific reasoning begins from a set of a priori postulates and hypotheses in the form of 
propositions and seeks observations of material phenomena to confirm or deny the 
propositions. The point of the establishing a scientific truth rests on establishing material 
facts. Where a material fact is supported by objective evidence. The testing of the truth 
of individual propositions is based on: 
i) Logical positivism, the belief that propositions have factual meaning only when 
they can be confirmed by empirical evidence. This is an application of the 
correspondence truth test discussed above. 
ii) Pragmatism states the ultimate test of the value of an idea is its usefulness in 
satisfying a practical purpose. Pragmatism as a test of truth applied to an idea, or 
proposition, is discussed above. 
The primary test of these two is logical positivism, or correspondence theory, as in the 
empirical experimentation of science. In terms of the application of science to a wider 
social purpose the pragmatic test is applied. 
The level of scientific truth attributed to a proposition will depend on the available 
empirical evidence. Absolute truth for all time and space is not obtainable as any scientific 
proposition relates to current perceptions of phenomena and these can change over time. 
Lastrucci (1963) states that truth is relative to the state of knowledge at the time; based on 
the available evidence, facts, and the logic used to form the knowledge base. Therefore the 
expression of scientific truth is fluid over time and a statement of absolute truth is never 
achieved. An analogy for truth in science is of a proposition measured on a spectrum of 
truth, with absolute falsehood at one end and absolute truth at the other. Scientific 
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propositions contain probable truth represented by a point in the spectrum. The greater the 
weight of empirical evidence there is to support the proposition then the higher the 
probability of it being true. 
Potential future human experience is infinite, or not totally predictable, and new 
experiences can lead to a new interpretation of phenomenon and thus a reinterpretation of 
present knowledge. Science allows for this as an open system of ideas. The impact of this 
characteristic being that science is willing to accept new ideas or truths and discard old 
ones. A closed system of ideas does not accept any new ideas and has a fixed knowledge 
base, such as religious dogma in certain philosophies. 
Thus science adds a new concept to the level of truth in a knowledge base and relates it to 
the weight of evidence supporting a proposition; allowing for the concept of degrees of 
truth in the evaluation of a knowledge base. 
The second aspect of scientific epistemology is the scope of knowledge. Lastrucci's 
definition of science states that the central concern of science is the interpretation of 
material phenomena. Considering the model of knowledge scope in figure 3.13, the scope 
of scientific concepts of matter, know how and material state knowledge is targeted to this 
goal. The emphasis being on scientific conceptual knowledge of matter, know how of 
procedures for controlling and measuring material phenomena, combined with knowledge 
of the state of matter. 
Scientific conceptual knowledge is broken down into classifications of objects. The 
classifications are expressed in concepts and constructs. Where concepts are an idea or a 
generalised idea of a class of objects, and constructs are a structure expressing an orderly 
arrangement of concepts into a single whole. The concepts and constructs used to classify 
objects are expressed in declarative definitions. Reducing knowledge into classes using 
definitions is central to scientific thinking. Thus a scientific conceptual knowledge base 
is founded on definitions of the concepts and the constructs. The required qualities of a 
definition are: 
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i) It should be inclusive of all things denoted by it yet exclusive of all things not 
denoted by it, i.e. it must be precise and distinctive. 
ii) Definitions should not be circular, i.e. not referring to themselves. 
iii) Definitions are more clear if they are stated in the positive not negative. i.e. do not 
form a definition around what lies outside the classification. 
iv) Definitions should be clear and unequivocal. 
The source of scientific knowledge on the material phenomena has its roots in philosophical 
thought. In the philosophy section describing the source of knowledge it was argued that 
phenomenalism is the source of knowledge. Applying phenomenalism, conceptual 
knowledge is used to interpret sensory observations of the material world. The a priori 
conceptual postulates that are the foundation of scientific reasoning are those given in 
Lastrucci (1963): 
i) All events have a natural cause. Naturalness, while including man, refers to objects, 
conditions or events which exist or operate independently of man's manipulation 
of them due to forces existing beyond his creation of them. 
ii) Man is part of the natural world, when studying man scientific thinking can be 
applied just as it be would for any other natural object. 
iii) Nature is orderly and regular, events do not occur haphazardly. The natural world 
can be observed to obey certain "natural laws" abstracted by man to help him to 
understand the whys of the world. Thus the attention of the scientist is focused on 
seeking the qualitative and quantitative relationships which exist between and 
among natural phenomena. 
iv) Nature is classifiable as uniform, which leads to taxonomy (functionally arranged 
classifications). These classes are necessary to represent the large mass of 
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knowledge which is growing all the time. 
v) Nature is pennanent; a lump of coal studied today will be similar enough to permit 
valid generalisations to be made about it to hold true for a period of time. 
vi) All objective phenomena are eventually knowable; there are no intellectua1limits 
placed by nature on man's search for knowledge. 
vii) Nothing is self evident; science seeks objective, empirical verification of facts, it 
cannot accept facts merely based on custom. 
viii) Truth is relative to the existing state of knowledge; truth in science is simply the 
best professional judgement available at any given time. Knowledge changes in 
quality and quantity, necessitating the reappraisal of phenomenon. Proof in science 
is always only within the bounds of the experimental technique. 
ix) All perceptions are achieved through the senses; all knowledge is acquired from 
sensory perceptions. Empirical demonstration is the ultimate test of the validity of 
all theoretical speculations about objective phenomenon and the resultant 
predictions. 
x) Man can trust his perceptions, memory, and reasoning as reliable agencies for 
acquiring facts. Accepted rules of reasoning and sensorial perceived data take 
precedence over mere mental notions or ideas. 
These postulates defme the world view and characteristics of science. Furthennore, 
consideration of these postulates is important when assessing the Validity of the application 
of scientific knowledge. In the context of the application of scientific knowledge these 
postulates need to be valid to the perceptions they are applied to. The validity, or truth, of 
any scientific knowledge is only within the context of the scientific experiment used to 
evaluate its truth. Beyond the confmes of the scientific experiment the validity of the direct 
application of the knowledge requires further testing. An important test of the validity of 
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the application of scientific knowledge being a pragmatic one. Where the context of the 
application will determine whether or not the knowledge proves to be valid in the pragmatic 
sense. 
3.12.2.2 Scientific procedure 
Ackoffs (1962) essential characteristics of scientific procedure are: 
i) A procedure for answering questions, and 
ii) A procedure for developing more effective procedures for answering questions and 
problems later. 
Thus there are two main aims to the scientific procedure. The first is in finding the solution 
to the question being faced, and the second is optimising how the solution is achieved. 
Fulfilling the second aim involves discussing the ways work should be done in the future 
in the light of what has been found during the research period. This then enables an 
improvement in the research procedures employed. Ackoffs four levels of elements used 
in the scientific research process were defined in section 3.2. These have been applied to 
building a philosophically based scientific framework for the analysis of CDS. 
The framework is being proposed to promote a top down approach in CDS beginning with 
an analysis of the problem. This rational approach of firstly defining the problem is 
endorsed by Ackoffs and Lastrucci's analysis of the stages of scientific research. During 
the technological process of building a CDS system the scientific procedure is used to 
develop knowledge of the problem and potential solution of the problem. The six phases 
of applied research defined by Ackoff give a structure for performing the process when it 
is directly applied to aiding the solution of a material problem: 
i) Formulating the problem; 
ii) Constructing the model; 
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iii) Testing the model; 
iv) Deriving a solution from the model; 
v) Testing and controlling the solution; 
vi) Implementing the solution. 
The first three stages of this process are defined in more detail by Lastrucci's eight stage 
process of more pure scientific research: 
i) Formulation of the problem by a statement of an empirically testable proposition, 
forming a hypothesis; 
ii) Literature search for relevant data and methods; 
iii) Research design, including the selection of techniques and the rationale for their 
choice; 
iv) Determination of the boundaries of the investigation; 
v) Gathering data and processing it into workable form; 
vi) Interpretation of the data; 
vii) Verification of the interpretation, conclusion. By either: 
a) confirming or questioning the results of other studies. 
b) confirming or rejecting the original hypothesis. 
viii) Presentation of findings in a report. 
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As stated above the aim of the scientific process outlined above is to produce reliable 
knowledge. Therefore, the scientific method is applied where a empirically testable 
proposition is presented. The problem of CDS is mainly a technological one, although 
there are issues relating to knowledge building methodology within the technological 
problem. 
3.12.3 Medicine 
Medicine is essentially an ethically driven activity, where a clinician seeks to act for the 
good of the health of their patients. Ethics are encapsulated within a philosophical view 
and they represent a particular type of knowledge governing decision making and behaviour 
in the clinical domain. For example a basic ethic of medicine is the Hippocratic oath, 
where it is stated to always act in the interest of continuing the life of the patient wherever 
possible. It is this ethical knowledge base, or code, which is the core knowledge base for 
defining acceptable clinical activity. The ethics in a philosophy for clinical decision 
support need to be consistent with the ethical principles applied by the human decision 
makers using the decision support. If the advice offered by a decision support system is not 
in ethical agreement with the user then it is unlikely that the user will accept this advice. 
Hence, the ethical principles expressed in the philosophy of medicine form an important 
part of any clinical decision support system. The source of an ethical code, or set of ethical 
postulates, is complex and not purely rational. In a domain such as medicine, ethics are 
defined by medical associations and colleges, and upheld by ethics committees. These 
definitions are encapsulated in doctors' ethical oaths, some of which are described below. 
In addition to operating within a set of ethical codes, the medical process shares 
characteristics with the technological process; mainly in the function of the two processes 
being to effectively solve a material problem using a limited pool of available resources. 
Similarly clinical practice is informed partially by science but not exclusively; although the 
study of medical science is a reliable source for an understanding of the conceptual 
knowledge base of medicine. 
Medical science takes a mechanistic materialist view of the body. A person is reduced to 
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a set of constituent parts, which are then subjected to scientific investigation and treatment; 
hence the splitting of the medical profession into specialisms such as nephrology and 
neurology. The approach is mechanistic in that there is always an underlying assumption 
of cause and effect. This is manifest in the often asked question: what factors have caused 
the state of health A to be followed by the state of disease B. The deterministic approach 
leads to the approach of attempting to detect findings, signs and symptoms of disease. The 
subsequent action then concentrates on treating the symptoms to return the patient to health 
state A. The advantages of applying mechanistic materialism in medical science include: 
advances in the treatment of infectious diseases; surgical removal of diseased areas, and the 
prevention of illness through immunisation. However, by applying scientific classification, 
medical science treats people as though they belong to homogenous groups, seeking to 
represent an individual as a unique occurrence of the universal. A weakness of this 
approach is that it does not allow for the heterogenous nature of individuals presenting with 
different symptoms. 
Extending the ideas of mechanistic materialism leads to the belief that it is possible to 
explain all the biological processes in the body in physio-chemical terms. These processes 
can then be represented in a series ofhaemostats which respond to their surroundings in an 
appropriate controlled way according to the information received. This idea has been 
applied in compartmental modelling, where sub-systems of the body are represented by 
biochemical mass storage compartments. However, unlike in a machine, not all the physio-
chemical processes in the body are known. Therefore, using this approach cannot be used 
to represent the complete body in physio-chemical terms. Moreover, the description of the 
body in completely physio-chemical terms is highly complex, and often impractical to 
apply to routine clinical decision making. 
The clinical activity may be informed by medical science but it does not explain the whole 
activity, although the conceptual classifications used in medical science and clinical 
practice are related. The activity which goes beyond that explained in the mechanistic view 
is studied through practical clinical experience of solving the problems of actual patients. 
The knowledge base gained from this activity can be expressed as a set of conditional 
propositions guiding the decision making. The truth of the propositions is judged using the 
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tests of truth described in the earlier philosophy section: coherence; correspondence, and 
pragmatism. Due to the variability of individual clinical experience the practical 
knowledge base varies between individuals more than the medical science knowledge base. 
An ontological and epistemological analysis of the clinical activity which produces the 
practical knowledge base is given below. 
3.12.3.1 ｑｮｴｯｬｯｾ［ｹ＠ and epistemolo.:;y of clinical practice 
The dualist ontology applied to clinical practice has the patient state in the material reality 
and the clinical decision maker in the idealist reality (figure 3.14). The clinical decision 
maker observes phenomena of the patient state and then by applying their prior conceptual 
knowledge make decisions regarding the actions to be taken. The view of the patient state 
is abstracted by the clinician according to the observed phenomena and their prior 
knowledge of patient conditions. Further analysis of the ontological model of clinical 
decision making is the subject of the next chapter. 
The nature of clinical knowledge is the same as the definition given in the philosophical 
definition, justified true belief; implying there has been a judgement of truth of a 
proposition. Ultimately the truth test of the knowledge relating to a clinical action is 
whether it has fulfilled a pragmatic purpose, where the purpose of a clinical action is to act 
in the interests of the health of the patient. The clinical actions are guided by codes of 
ethics which act as set of ideals to define good behaviour. In addition to the ethical codes 
the scope of clinical conceptual knowledge covers treatment and monitoring techniques, 
over and above scientific medical knowledge of the body. Applying the concepts of 
phenomenology to clinical experience the source of clinical knowledge is observed 
phenomena of patient state and the effect of treatment interventions. The valid application 
of knowledge to a patient is one of the more difficult aspects of clinical judgement due to 
the individual nature of each patient. Every case is different, and it is rarely possible to 
make generalisations about all patients with disease X or requiring treatment Y; hence the 
use of specialisms in medicine to build up detailed specific knowledge about specific 
categories of patient problems and their treatment. Further analysis of how knowledge is 
applied in a rational model of clinical decision making is discussed in the next chapter. 
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3.12.3.2 Ethical codes 
As mentioned above medicine is essentially an ethically driven activity. These ethics are 
enshrined in ethical codes. The oldest of the ethical codes recognised by medicine is the 
Hippocratic oath, Hippocrates having lived between 470 and 360 B.C. (Orr and Pang, 
1993). This has been developed by medical colleges and organisations since to take 
account of the social context it is to be applied in. The international code of medical ethics 
of the world medical association, 1949, encapsulates most of the Hippocratic ideals and 
adds some relevant to modem day practice. This code defines the general duties of doctors 
as follows: 
A doctor must always maintain the highest standards of professional 
conduct. 
A doctor must practice his profession uninfluenced by motives of profit. 
Any act, or advice which could weaken physical or mental resistance of a 
human being may be used only in his interest. 
A doctor should certify or testify only to that which he has personally 
verified. 
The following practices are deemed to be unethical: 
Any self advertisement except such as expressly authorised by the national 
code of medical ethics. 
Collaborate in any form of medical service in which the doctor does not 
have professional independence. 
Receiving any money in connection with services rendered to a patient other 
than a proper professional fee, even with the knowledge of the patient. 
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The code then goes on to define the duties of doctors to the sick: 
A doctor must always bear in mind the obligation of preserving human life 
from conception. Therapeutic abortion may only be performed if the 
conscience of the doctors and the national laws permit. 
A doctor owes his patient complete loyalty and all the resources of his 
science. Whenever an examination or treatment is beyond his capacity he 
should summon another doctor who has the necessary ability. 
A doctor shall preserve absolute secrecy on all he knows about his patient 
because of the confidence entrusted in him. 
A doctor must give emergency care as a humanitarian duty unless he is 
assured that others are willing and able to give such care. 
The duties of doctors to each other prescribed in the code are: 
A doctor ought to behave to his colleagues as he would have them behave 
to him. 
A doctor must not entice patients from his colleagues. 
A doctor must observe the principles of "The Declaration of Geneva" 
approved by The World Medical Association. 
The final duty mentioned is the international code of medical ethics is that doctors should 
observe the principles of the declaration of Geneva. The declaration of Geneva was first 
adopted by the World Medical Association in 1948, following the inhumane atrocities of 
the second world war. It was subsequently updated in 1968 by the World Medical 
Assembly. The declaration was intended to replace the outdated Hippocratic oath and it 
states: 
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At the time of being admitted as a member of the medical profession: 
I solemnly pledge myself to consecrate my life to the service of humanity; 
I will give my teachers the respect and gratitude which is their due; 
I will practice my profession with confidence and dignity; 
The health of my patient will be my first consideration; 
I will respect the secrets which are confided in me, even after the patient has died; 
I will maintain by all the means in my power, the honour and the noble traditions 
of the medical profession; 
My colleagues will be my brothers; 
I will not permit consideration of religion, nationality, race, party politics or social 
standing to intervene between my duty and my patient; 
I will maintain the utmost respect for human life from the time of conception; even 
under threat, I will not use my medical knowledge contrary to the laws of humanity; 
I make these promises solemnly, freely and upon my honour. 
The principles above guide the clinical activity, thus they form an important part of the 
clinical decision making knowledge base. Any clinical decision making, including that in 
decision support systems, should not contradict these ethical principles. Thus when 
building a clinical decision support system the above principles constitute a core set of 
propositions defIning the system operation. For example in the international code of ethics 
it is stated that when a doctor has insufficient ability to deal with a situation another doctor 
should be summoned. The impact of this on CDS systems is that the boundary of operation 
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ofa system must be clearly defined, and when it is beyond the scope of the system to offer 
advice this should be clearly stated. The right of the patient to confidentiality stated in the 
declaration of Geneva, requires the secure storage and transmission of all patient data in a 
CDS system. 
3.12.3.3 Relationship of clinical practice to science and technoloiY 
Figure 3.15 shows the relationship between science and medicine. This is similar to the 
relationship between science and technology described above. The two processes operate 
independently, but scientific knowledge can have an impact on clinical practice. Also, 
clinical needs can define the need to gain further scientific knowledge. Clinical practice 
is fundamentally different from the scientific experiment, in that the clinician is not 
conducting a controlled repeatable experiment (Feinstein, 1967). 
The relationship between technology and clinical practice is that technological tools can 
be used to perfonn clinical actions during the monitoring and treatment of patients (figure 
3.16). Moreover, as a social need clinical practice can define the purpose for a 
technological artifact. 
3.13 SUMMARY 
The systematic review of philosophical concepts, and the construction of the ontological 
and epistemological models in this chapter have provided a foundation for the rational 
analysis and development of clinical decision support. The philosophy developed is the 
foundation of the analytical framework shown in figures 3.1 and 3.2. These figures 
illustrate how methodology, method, technique and the application of tools can be built up 
from a philosophical basis. 
Ontologically a dualist view has been adopted for use at the most generic level of analysis. 
A model illustrating this view is in figure 3.4, the nature of the adopted dualities are 
idealism and materialism. Linking the two is the dynamic interaction between ideas and 
matter. 
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Clinical decision support systems involve the use of knowledge in their development and 
within their structure. Therefore an understanding of knowledge from an epistemological 
view point is fundamental to the development of CDS systems. Analysing the nature, 
scope, source and validity of knowledge has provided a framework for this understanding. 
Consideration of the testing of truth within the nature of knowledge provides the basis for 
evaluating knowledge. The three tests which allow for philosophically critical testing of 
truth are: coherence testing; correspondence, and pragmatic testing. 
Clinical decision support is primarily a technological process, therefore the driving goal is 
the material need to be satisfied by the artifact produced. However, technology, science 
and clinical practice all have an influence on the development of CDS systems. The nature 
of each of these disciplines has been analysed in order to model how they interact. Figures 
3.12, 3.15 and 3.16 show how the three separate processes have an impact on each other 
and how they may influence each other. 
The philosophical models and framework proposed in this chapter will be used in the next 
chapter as the basis for an analysis of clinical decision making and the role of clinical 
decision support in the decision making process. 
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Figure 3.1 Contour map of analytical framework 
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Figure 3.5 Ontological model of knowledge formation , use and expression 
CONCEPTUAL KNOWLEDGE 
IDEALIST 
REALITY 
KNOWHOW MATERIAL 
REALITY 
ｋｎｏｗｌｅｄｇｅｴＭＭｾ＠
OF STATE OF 
"MIND" ｾＭＭＭｻ＠
ACTION 
KNOWLEDGE 
OF STATE OF 
ｾｒｅＭＭａＭｃＭｔＭｉｏＭｎｾ＠ MATTER 
KNOWHOW 
Figure 3.6 Classifications of knowledge 
-117-
KNOWLEDGE OF NEW 
MATERIAL ｾ｀ｉｃａｌ＠ CONCEPTUAL 
PROCESSING PHENOMENA KNOWLEDGE 
T 
I 
I 
I 
I 
I 
I 
I 
PRIOR 
PRIOR CONCEPTUAL 
KNOWHOW KNOWLEDGE 
Figure 3.7 Phenomenalist model of knowledge formation 
------------------------------------- -------1 
I 
I 
I 
I 
1 
I 
I 
I 
I 
I 
1 
KNOWLEDGE 
ACQUISITION 
---
1 IDEALIST REALITY 
I 
I 
KNOWLEDGE KNOWLEDGE 
I 
1 
1 
STORAGE ..... EXPRESSION/ 
I 
APPLICATION I 
I 
I 
I 
I 
------- -----------------------------------
Figure 3.8 Process of knowledge acquisition, storage and expression 
-118-
ｾ＠
Figure 3.9 Elemental disciplines of clinical decision support 
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CHAPTER 4 
DECISION MAKING AND DECISION 
SUPPORT 
4.1 INTRODUCTION 
Chapter three described the ontological and epistemological models to be used in a generic 
analysis of clinical decision support. This chapter applies these models as the basis for an 
analysis of decision making and decision support. 
To support decision making in an effective manner there first needs to be analysis of what 
decision making is. Through an analysis and modelling of decision making it is possible 
to focus on the stages of the process which can be supported and how they can be 
supported. Without an appreciation of the decision making to be supported there can be 
no rational attempt at building a decision support system. Thus the first section of this 
chapter aims to analyse decision making using a series of generic models. At the most 
generic level this begins with a philosophical analysis applying the ontological and 
epistemological models described in chapter three. From these, process models are 
developed and applied to clinical decision making. In the section following the decision 
making analysis, the potential role of decision support in clinical decision making is 
investigated through a similar analytical process. 
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4.2 DECISION MAKING 
4.2. 1 ｏｮｴｯｬｯｾｹ＠ of Decision ｍ｡ｫｩｮｾ＠
An ontological model of decision making is presented in figure 4. I. The model represents 
a material problem situation as present in technology, medicine and science. The problem 
exists in the material reality, and the decision making occurs in the idealist reality. The first 
stage of the decision making cycle is for the decision maker to perceive the material 
problem. This perception is dependent on many things, most obviously the perceptive 
skills of the observer. Moreover, the assessment of the perceived material phenomena as 
a problem situation will depend on the point of view of the observer. Included in this point 
of view will be a set of material goals that they are seeking to satisfy. In relation to these 
goals Daellenbach (1994) defined a material decision problem as the situation where, " a 
person or a group of individuals would like to achieve one or several goals, or maintain 
current levels of achievement." Thus a problem situation exists where there is a perception 
of either goals not satisfied or of the possibility that goals satisfied now may not be in the 
future. Once the problem has been abstracted from the material domain the process of 
decision making then begins in the idealist realm. The product of the decision making 
process is an action; this may be an action to increase the amount of knowledge of the 
problem, or it may be an action to dynamically impact on the material problem. The action 
will lead to an outcome which will be perceived as a set further material phenomena. This 
then leads back into further decision making, and so the cycle repeats itself. These 
processes are depicted in a generic process model of decision making, figure 4.2. 
The ideas impacting upon the decision making process will be influenced by the nature of 
the idealist reality being considered. A philosophical description of the nature of idealism 
was given in the previous chapter. The conclusion was that the complexity of idealism can 
only be explained by the concept of the totality of personality. This concept holds that the 
nature of idealism is a mixture of rationalism, romanticism and voluntarism. In rationalism 
reason is the essence, and it is the application of logic which governs all decision making. 
Romanticism holds that emotion is of the essence, and it is the emotional response to a 
material problem which governs decision making. Impulsive irrationality is the essence of 
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voluntarist idealism, where it is simply an individual's will which motivates and shapes 
their decision making. So, decision making is influenced by a complex mixture of these 
classifications of idealism. Figure 4.3 illustrates how decision making may be classified 
using the three natures of idealism. The areas in the figure represent the possible 
classifications of the nature of decision making. Thus it is possible to apply rationality, 
romanticism and voluntarism individually in decision making. Moreover, a decision can 
be characterised as having elements consistent with two of the classifications of idealism. 
For example voluntarism could define the goal for a rational decision making process. In 
the drive for continued survival man employs rationalism to solve the problems which 
conflict with this goal. An emotional response to observed phenomena can combine with 
rationalism in decision making. For example a response of emotional unhappiness could 
drive the decision maker to seek a rational solution to achieving a state of happiness. The 
emotional response to phenomena can also define which of the voluntaristic goals are acted 
on. For example a fear response could invoke the goal for individual survival. The central 
portion of figure 4.3 represents the interaction of all three idealistic natures, this could 
happen through the emotional response to phenomena defining the voluntaristic goals for 
applying rationalism to satisfying the voluntaristic goals. Thus, all of the combinations of 
idealist natures can influence each other during decision making, figure 4.4. 
Voluntarism, free will, and romanticism, or emotional response, are highly dynamic and 
can vary between individuals and even for the same individual at different times. Therefore 
it is not possible to construct detailed generic models of voluntaristic and emotional 
decision making which can be consistently applied to different instances of their application 
in decisions. By definition these categories of decision making are not consistently 
coherent with logic or the available knowledge base. Making decisions in an inconsistent 
manner does not allow the decision maker to learn about the problem domain, and thus 
does not logically lead to improved decision making. To build a model of decision making 
there need to be consistent characteristics of the process which can be abstracted into the 
model representation. The consistent factors of voluntarism and romanticism are not 
analysable further than to say they have an affect on decision making. Thus, figures 4.3 
and 4.4 represent the extent of the analysis of the affect of voluntarism and romanticism on 
decision making. Applying these models to decision making shows that rational processes 
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do take place within a voluntaristic and emotional context. The context of rationalism in 
decision making is summarised in figure 4.5. Analysing rationalism, consistent application 
of logical reasoning and available knowledge, in decision making offers the most scope for 
developing a coherent model of the decision making process. Then through the consistent 
application of these models to decision making the rational elements of the process can be 
abstracted and the lessons learnt utilised in future rational decision making. The process 
models of rational decision making are described in the section 4.2.3. 
4.2.2 EpistemoloilS of Decision ｍ｡ｫｩｮｾ＠
The epistemology of rational decision making is concerned with the application of 
knowledge in the cycle of decision making. The nature of the knowledge required in 
decision making is justified true belief. This implies the knowledge must be believed by 
the decision maker, in the sense of mentally assenting to the knowledge and acting upon 
the knowledge. The truth of the belief can be assessed according to many criteria as 
discussed in the previous chapter. However, the three tests of truth which allow for critical 
appraisal of belief, and hence rationality of knowledge, are: correspondence; coherence, and 
pragmatism. In a rational approach to decision making these are the three criteria to be 
used in testing the truth of the categories of knowledge discussed below. 
The scope of knowledge applied in decision making could be any knowledge available to 
the decision maker. The fundamental elements which must be present for rational decision 
making are knowledge of material phenomena, conceptual knowledge, and knowledge of 
the techniques needed to interact with the problem. These different levels of knowledge 
are depicted in figure 3.6 from the previous chapter. Language can be used to express 
knowledge at these different levels. 
Material phenomena, or state knowledge, can be expressed in the form of propositions, of 
the form "snow is white." The interpretation of this proposition relies on the application 
of conceptual knowledge, in the example this includes concepts of white and of snow. 
Following the conceptual interpretation of a material proposition testing its truth can be 
done on two levels. Firstly physical verification, applying the correspondence test, can be 
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sought. Thus if it is observed snow is white then it becomes a justified true belief 
(knowledge). An alternative test of a proposition is the coherence test. If knowledge 
already exists that snow is white, then the proposition is accepted as true on the grounds of 
logical agreement with prior knowledge. If prior knowledge was that snow was black, then 
there is obviously logical disagreement and further testing of the prior knowledge and the 
proposition is required. The more correspondence and coherence a proposition has then the 
greater the certainty in its truth value. 
Know how can be expressed in the performance of an action, or as the description of a 
process. Included in the description is a statement of the goal or purpose of the process, 
and a series of activities or tasks which describe the process. For example know how of 
making a snow ball can be expressed in the action itself, or in the description of the process 
as follows: 
GOAL: Make a snow ball 
i) Find snow 
ii) Pick up snow in hands 
iii) Compress snow into a round ball 
iv) Release pressure 
v) Review results and modify if necessary 
In this simplified illustrative example each of the stages of the process will involve the 
interpretation of the task using conceptual knowledge, and then the application of the 
interpretation in material action. The truth of know how is ultimately in whether or not the 
purpose or goal has been satisfied, the pragmatic truth test. The satisfaction of the purpose 
is dependent on the effectiveness of the process and the material context it is applied to. 
Therefore ifby applying the above set of tasks a snow ball is made then the know how can 
be said to be pragmatically correct for the snow used. If the main goal is not satisfied then 
the know how is not pragmatically true in the material context it was applied to, and may 
need modification. Another truth test which can be applied to know how is other 
knowledge of how to achieve the goal. Then comparing one process with another to see 
which produces the most effective results. 
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The conceptual knowledge which is used to interpret the expression of know how and state 
knowledge exists in a web of interconnected constructs containing different concepts. 
Figure 4.6 illustrates the conceptual hierarchy for the concept of snow. Here five concepts 
have been linked to snow: white; cold; light; solid, and soft. Each of these concepts are part 
of a deeper construct, for example white is part of the construct defining relative visible 
colours. The source of the knowledge defining the construct of colours is perception of the 
material phenomenon of colour. Thus conceptual knowledge of matter can be traced back 
to its source in the experience of material phenomena. Using all the different levels of 
knowledge during decision making in a rational and explicit manner allows for the testing 
and development of a knowledge base. 
As illustrated in figure 4.1 the source of problem knowledge which begins the decision 
making cycle is the observed material phenomena. If there is no knowledge of the material 
phenomena which constitute the problem there will be no perception of the problem state. 
The prior know how and conceptual knowledge will be applied to the phenomenal 
knowledge to form an abstracted view of the problem. Prior knowledge of strategies for 
solving the problem will then be applied to decide on the course of action to be taken. The 
prior knowledge available to the decision maker will partially depend on their experience 
of the problem domain. If the decision maker has a large amount of experience they are 
assumed to be an expert decision maker, because of their large amount of prior knowledge 
of the domain. 
The validity of the knowledge applied in the decision will be judged by the perceived 
outcome in the material domain. If the purpose or goal of the decision maker has been 
satisfied then it can be pragmatically judged that the knowledge applied is valid. The 
decision evaluation stage is thus dependent on the goals of the decision maker, which are 
defined during the problem assessment. The validity of the know how and conceptual 
knowledge are further reinforced by their application to similar future problem scenarios. 
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4.2.3 Process Models of Decision Makin" 
The ontological model of decision making showed the material problem and the decision 
maker as two separate entities. Acting between these two entities are the decision maker's 
perception of material phenomena and the action taken to alter the material phenomena. 
This leads to the three stage general model of decision making; problem perception; 
decision making, and action, figure 4.2. This model can be used to describe voluntaristic, 
emotional and rational decision making; the difference being that it is possible to analyse 
the rational decision making process in more detail as it is more explicit and includes more 
consistently applicable concepts. 
Rationalism implies consistency according to the concepts of logical reasoning and 
application of the available knowledge in the reasoning. Rationalism in decision making 
can be used actively during the decision making process to decide on a course of action, or 
it can be used to justify a decision made on voluntaristic and/or emotional grounds. In 
seeking a rational approach to decision making it is important to use rationalism actively 
in the decision making not as a justification for an emotional or voluntaristic decision. 
Where the decision has been made on this basis there should be acknowledgement of their 
influence. It is through the consistent application of logic that a new understanding of the 
process of decision making, and the knowledge used in it, will be achieved. 
Bidgoli (1989) represented the process of rational decision making as a four stage model, 
figure 4.7. The four stages of the model are: intelligence; design; choice, and 
implementation. Intelligence gathering includes collecting information on the observed 
phenomena and assessing the problem. The design phase involves generating alternatives 
for solving the problem, and evaluating the feasibility of the proposed solutions. The aim 
of the choice phase is to select the most effective of the alternatives. Finally in Bidgoli's 
model is the implementation of the chosen solution. 
Although Bidgoli's model provides a good basis for building a model of decision making 
it does have two main shortcomings. The first is the lack of feedback to the intelligence 
stage from the implementation of the solution. Following implementation further problem 
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assessment is necessary to ascertain whether the problem has been solved or not. The other 
necessary stage following the problem reassessment is an evaluation of the previous 
decision, where the aim of the decision evaluation is to judge the effectiveness and 
efficiency of the decision making already performed. Without a mechanism for decision 
evaluation the same inappropriate decisions could be made to solve the problem. 
The more complete model of rational decision making is shown in figure 4.8. The rational 
process has been shown operating in the context of voluntarism and romanticism. Thus 
even though rationalism is strived for the affects of the other idealist natures cannot be 
ignored. The defining factor of the core rational decision making process is that it should 
withstand maximal examination when applying reason and relevant knowledge (Colste, 
1992). To withstand this test requires the application of reason and knowledge during the 
decision making process. Moreover, to aid the examination of the decision, each stage the 
process should be explicit and transparent. An analysis of reason, or logic, was given in 
section 3.3.1 of the philosophy chapter. The two core concepts oflogic are: deductivism, 
reasoning from propositions, and inductivism, forming propositions from observations. 
Inductivism is applied in forming propositions which define the state knowledge, or facts, 
the form of which is analysed above. Deductivism is used in the reasoning including in the 
assessment of the problem, and in the application of conceptual knowledge in the process. 
The relevant knowledge applied during reasoned decision making includes all the 
categories of knowledge discussed above: state knowledge; know how, and conceptual 
knowledge. What knowledge within the categories of know how is relevant will be proven 
by pragmatically testing it in its application. 
In figure 4.8 the first stage of the rational decision making process is the problem 
assessment. The problem assessment will include a definition of the problem in terms of 
the definition of the problem state A and the long term goal state B. The long term goal 
state is the state which at the start of the decision making process it is thought should be 
observed in the material domain. The goal state can be reasoned from conceptual 
knowledge, know how and philosophical principles, for example ethical codes. 
Alternatively it could be defined by romantic or voluntaristic ideals. The problem state 
assessment depends on these goals and the current state knowledge of the material problem 
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domain. the expression and testing of the state knowledge being an integral part of the 
explicit state knowledge gathering. Reason is applied to compare the goals and define the 
problem, obviously if A equals B there is no problem. The definition of the problem will 
include what is trying to be achieved, e.g. reduce the patient's plasma potassium 
concentration. 
The previous decision analysis follows the problem assessment. The goal of this stage is 
to judge the effectiveness and efficiency of the decision made in the previous cycle of 
decision making. Effectiveness of a decision is defined as the goals of the decision being 
satisfied by the decision making process (Bidgoli, 1989). Efficiency is a measure of the 
resources used to effectively solve the problem, and can be expressed as a cost (Bidgoli, 
1989). Thus efficiency is a function of effectiveness, and with zero effectiveness there is 
zero efficiency no matter what the costs may be. Effectiveness can be judged by comparing 
the decision goals of the choices made in the previous cycle with the observed outcomes 
in the current problem assessment. If the cost of implementing the previous decision can 
be evaluated this can be used to assess the efficiency of the decision. Thus the 
effectiveness and efficiency of previous decision making can be used to inform the next 
cycle. If the decision has been proven to be ineffective when applied to the material 
problem, this could preclude the option in the next decision cycle. The counterpart of this 
is where the previous decision is effective which gives scope for improving the efficiency 
of the next decision. 
Using the decision evaluation and problem assessment, options for action are derived from 
state and prior knowledge for achieving goal state B from the present state A. One source 
of options is prior knowledge of actions used to solve a similar material problem 
previously. Another source for possible options is new techniques derived from related 
problem domains. Each of the options for action generated will have an attached purpose 
and description of the action. For inclusion as an option the purpose of the option should 
be logically consistent with the problem definition. 
Assuming there are then two or more options some judgement must then be made to choose 
between them. The criteria for making the choice should be logically derived from 
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knowledge of the options and the problem context. Once selected the criteria are 
consistently applied. Possible criteria for selecting options are: resource limitations; 
knowledge limitations, and predicted effectiveness of the option. If either the resources are 
not available or the knowledge to use them is unavailable then the option is only an 
idealistic one, not a pragmatic one. Where resources and know how are not constraints then 
the option to choose is the one predicted to be the most effective. 
The bases for making a rational choice are the reasoned application of knowledge of the 
problem assessment, knowledge of the previous decision evaluation, and knowledge of the 
availability of material resources, the aim of the choice being to choose an option which 
will diminish the problem. Following the choice of action to be taken it will be 
implemented, depending on the material availability of resources and know how. The 
action, and the passage of time, will lead to a new state in the problem domain which will 
require a reappraisal of the problem situation. If the gap between the goal state and the 
observed state is still unacceptable then a repeat of the cycle may be needed. Thus decision 
making is an iterative process, where until the pragmatic criteria of goal satisfaction is 
achieved the decision making cycle will be repeated. Alternatively there may be a need to 
reappraise the criteria used in the original goals, as by tackling the problem the decision 
maker will have increased their knowledge of the problem domain and what is 
pragmatically achievable within the present constraints. 
The expression of all the knowledge and reasoning used at each of the stages of the decision 
making process can aid the analysis of what is to be done and what has been done; 
providing the opportunity for learning about the structure of the process and the knowledge 
applied during the decision making. 
The first component of the problem assessment is the comparison of the material goal state 
compared to the observed material state. The first stage in this process is to specify the 
ideal goals for the domain, and how they are to be assessed. Using the assessment criteria 
a qualitative or quantitative assessment of the observed phenomena is made and compared 
to the goal state. Any difference between the goal state and the observed state will 
constitute a problem of varying magnitude. The difference between the goal state and the 
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observed state defines the problem to be solved. F or example if it is a goal for an 
individual to attain their ideal body weight, and their observed weight is too high then the 
problem is how to reduce their weight. The opposite of this being where an individual is 
below their ideal weight, then the problem is how to increase their weight. 
The process of representing the options and arriving at the choice of an option can be 
represented using a decision tree, figure 4.9. The start point of each tree represents a 
decision node or root, and the branches represent a decision option. The branches show 
what possible actions can be taken whilst the structure of a decision tree indicates the order 
in which the actions are to be chosen. The branches coming from one node of the tree 
represent mutually exclusive options. The choice between the options is made according 
to the evaluation of a decision variable(s). Alternatively a decision table can be used, 
where the upper rows specify variables to be evaluated and the lower rows specify the 
corresponding action to be taken when the evaluation is satisfied. If it is possible to define 
all the decision options a decision can be modelled using a tree, or a decision table. Using 
a decision tree for a limited number of options offers a clear representation of the choices 
to be made. The knowledge used to make the decisions can be attached to the nodes and 
applied in practice when using the decision tree. 
When specifying the decision tree the knowledge applied at the decision points in the tree 
can be defined by a set of conditional state knowledge propositions of the form if 
proposition A is true then choose option 1; the test of the truth of proposition A being the 
correspondence test, i.e. a material phenomena corresponding to A being observed at time 
TI . The options in the tree are defined by know how of what is possible in the context of 
the problem. If the problem is a common one it may be possible to apply the same decision 
tree to different instances of the problem. 
The actions to be performed are defmed by the tree, and the know how required to perform 
the actions can be attached to each of the options. Thus the implementation of the actions 
is supported by the application of the tree. 
Attached to the options in the decision tree are the goals the decision option is seeking to 
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satisfy. The evaluation of the decision made is then a pragmatic one, where the outcome 
state is judged against the goal state, and where the next cycle of decision making is 
informed by the outcome of the previous decision. Thus if a course of action was taken 
which did not produce the anticipated results then the option choice can be weighted 
accordingly in the next decision making cycle. In this way the decision maker "learns from 
their mistakes and their successes." 
4.2.4 Clinical Decision ｍ｡ｫｩｮｾ＠
Shortliffe (1987) stated, "Medical practice is medical decision making," thus the process 
of decision making is fundamental to clinical practice. The cycle of clinical decision 
making in the lTV setting goes through three phases as described by Friesdorf et al. (1994), 
figure 4.10. These three phases begin with the gathering of information on the patient's 
state of health, then an evaluation of their state of health, and depending on the evaluation 
moving onto treatment. Whilst they are being treated the patient's state of health and 
treatment are monitored and inform the next evaluation of their state of health. 
Onto logically the activity of these three stages can be considered to occur as shown in 
figure 4.11. From figure 4.11 there are three types of matter which are included in the 
clinical problem. These are: the patient's state of health; the treatment resource being used 
to control the patient state; and the monitoring resource used to gather information on the 
patient. In the idealist reality exist the counterpart decision making processes which control 
the three types of matter. These exist in a hierarchy where the patient state decision making 
governs the treatment and monitoring decision making. For example if no treatable 
problems are found with the patient state then further treatment action is unlikely. In figure 
4.11 the monitoring and treatment actions act on the material of the clinical problem, and 
monitoring information is fedback to inform the processes of decision making. The 
ontological model of clinical lTV decision making leads to the modification of figure 4.10, 
as the patient state evaluation is controlling both the monitoring and treatment decision 
making. The extra arrows in figure 4.12 show that it is possible to move from patient 
evaluation to further monitoring before beginning treatment, and that monitoring of the 
treatment will inform the treatment decision making cycle. 
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The process models of decision making developed in the previous section can be applied 
to each of the three decision making processes identified above, with figure 4.12 defining 
how the three processes interact. Figure 4.13 shows the three processes of patient state, 
treatment, and monitoring decision making operating together. The start point is the 
evaluation of the patient state from the initial perception of their state. Where the decision 
cycle has already occurred the prior decisions are assessed for their effectiveness. 
Following this, options for future action will be derived from the results of the initial 
evaluation and clinical know how of what is appropriate for the patient. Prior clinical 
knowledge and knowledge of the patient state will then be used to make the choice of 
action to be taken. Once chosen the actions to be performed will be ordered with the 
required goals. The actions can be treatment and/or monitoring actions. Each of the 
actions will have their own decision making cycle to go through. 
The treatment decision making begins with an assessment of the present patient treatment, 
then if the present requirements are not being satisfied options for satisfying the treatment 
goals are generated. The options at this stage will be determined by clinical goals, resource 
availability and knowledge of which options are appropriate. Using available clinical 
knowledge the choice of treatment options will be made, followed by the implementation 
of the chosen treatment. After implementation the treatment state assessment is repeated 
and the previous treatment decision is evaluated. 
The monitoring activities to be conducted are governed by the patient state evaluation and 
the treatment decision making. The patient state is assessed on the data gathered during the 
monitoring activity. Information is also required to assess the state of treatment being 
delivered to the patient. Thus the monitoring activities and their goals are defined by the 
two other processes. The cycle for monitoring decision making follows the general cycle 
discussed above. The variables affecting monitoring decisions will include the availability 
of resources and the timing of the measurements to be taken. The information generated 
by the monitoring activity is fedback to assess the patient and treatment state. 
The application of knowledge in these three levels of decision making can be characterised 
by applying the epistemological analysis of decision making to the patient state decision 
making. To make the evaluation of the patient state knowledge of the observed material 
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phenomena of the patient state is required. This is interpreted using conceptual knowledge 
of clinical patient states, and tested by correspondence and coherence. Where the state 
knowledge is "Potassiwn is high," this is interpreted as the concentration of the potassiwn 
ion in plasma is high. The "web" of conceptual knowledge used to make the assessment 
on the first layer will have concepts of concentration, potassiwn, plasma and high. These 
concepts will then be linked to deeper conceptual knowledge of physiology, 
pathophysiology and prior clinical experience, figure 4.14. The relationship between these 
three deeper forms of knowledge is a complex one which is difficult to defme. At this stage 
of the analysis the generic model in figure 4.14 represents the extent of the depth of the 
modelling of the conceptual knowledge base. 
In the decision making process know how and conceptual knowledge are applied to the 
options for actions and the choice of actions. Know how is then applied to performing the 
material action. The knowledge application is similar for the treatment and monitoring 
decision making, although the conceptual knowledge used will be of treatment and 
monitoring respectively. 
The decision making framework described above is a general analysis of clinical decision 
making in the lTV. How the framework is applied will depend on the decision making 
being analysed. At the highest level it provides a breakdown of clinical decision making 
in the lTV. Thus it provides an analytical tool for breaking down the problem into 
analysable sections. Moreover, through the structuring and expression of decision making 
required when applying the framework, a greater insight into the decision making process 
can be achieved. This includes the explicit connection of knowledge to actions giving the 
opportunity for pragmatic testing of knowledge. Furthermore using the model of decision 
making to structure clinical decisions offers a framework which can be directly supported 
by decision support systems. 
4.3 DECISION SUPPORT 
Shortliffe (1987) defined clinical decision support as any computer program that deals with 
clinical data or knowledge and which performs one or more of the following tasks: 
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serving as a tool for information management; 
helping health care workers to focus attention; 
giving advice in the form of a patient specific consultation. 
Bidgoli (1989) defined management decision support as: 
A computer based information system consisting of hardware/software and the human 
element designed to assist the decision maker at any level. 
Turbain's (1993) definition of management decision support is as follows: 
A decision support system is an interactive, flexible and adaptable CBIS (computer based 
information system), specially developed for supporting the solution of a particular 
management problem for improved decision making It utilises data, it provides easy user 
interface, and it allows for the decision maker's own insights. Decision support also utilises 
models (either standard and/or custom made), it is built by an iterative process (frequently 
by end-users), it supports all the phases of decision making, and it includes a knowledge 
base. 
One point all these definitions have in common is that a decision support system is defined 
as computer based. Although encapsulating decision support onto a computer does allow 
for testing of the techniques and technology used it does not address fundamental problems 
of how decisions are made and can be best supported. A decision support system exists as 
a material entity but it does not have to be in the form of a computer system. Another 
common point in the above definitions is that a decision support system is built to aid the 
decision making process, not to replace the decision maker. Therefore, the counterpart of 
the material decision support system in the idealist reality is the decision maker. 
4.3.1 Decision SUl}Wrt Ontoloa;y 
The place of decision support ontologically is as a material abstraction of the decision 
making process, figure 4.15. Decision support exists to offer advice to the decision maker. 
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The functionality of decision support is essentially an epistemological one, offering 
information to the decision maker which gives them knowledge relevant to solving the 
material problem. The epistemological function of decision support is discussed in more 
detail in the following section. 
Decision support supplements the decision making options already known in the idealist 
reality. Its main use being when uncertainty exists in the decision maker's mind, the 
idealist reality, on what a decision should be or on how to make a decision. Where the 
decision maker has no uncertainty on the problem assessment or on course of action then 
they will not require decision support. Therefore, the ideal role for decision support is 
where it can offer advice to the decision maker who has a high degree of uncertainty on 
how to reach a decision. This may be due to inexperience of the decision maker, or high 
complexity of the problem. Both of these factors are relevant to the problems faced in 
clinical decision making. 
4.3.2 Decision Syp'port ｅｰｩｳｴ･ｭｯｬｯｾ＠
The epistemological function of decision support is to apply knowledge required in the 
decision making process. The exact knowledge required will be decision specific, and 
hence depends on the problem to be solved. However, there are certain epistemological 
characteristics of the knowledge which are general. 
The knowledge needs to be explicitly stated and true. Therefore, the knowledge contained 
in a decision support system requires testing. The three types of testing of the embedded, 
or prior, knowledge and the generated knowledge are: coherence testing for logical 
verification; correspondence testing for observational verification, and pragmatic testing 
for test of purpose. The coherence test is applied to all types of knowledge providing there 
is a knowledge base of related propositions available. The correspondence test needs to be 
applied to all propositions relating to material phenomena. The pragmatic test is applied 
to any proposition which has a function or relates to an action. 
The scope of knowledge of a material decision making problem includes knowledge of the 
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state of matter, know how and conceptual knowledge. The relation of these three 
classifications is illustrated in figure 3.6 and discussed in section 3.7. The conceptual 
knowledge is embedded in the decision support system, and consists of knowledge relating 
to the decision problem. The conceptual knowledge provides the a priori structure for the 
application of know how and the interpretation of state knowledge. The state knowledge 
is time varying and thus will be generated during the operation of the decision support 
system. The application of the know how depends on the embedded conceptual knowledge, 
the state knowledge, and the specified pragmatic goals of the application. All the 
categories of knowledge used in a decision support system need to be logically linked 
together to aid user understanding of the system, and for internal and external coherence 
checking of knowledge. 
The source of the different categories of knowledge in clinical decision support is primarily 
observation of clinical phenomena. For the state knowledge this will be time varying. The 
clinical know how is based on an accumulation of clinical experiences of actions linked to 
resulting phenomena. The conceptual knowledge will be based on clinical phenomena and 
phenomena as interpreted by medical science. Therefore, medical science contributes to 
a clinical knowledge base in decision support at the conceptual level. 
4.3.3 Process Models of Decision SWport 
Ideally decision support should provide an aid to effective rational decision making at all 
stages of the decision making process, by offering problem sensitive justified advice to the 
decision maker. How decision support can be used as an aid to all the stages of the rational 
decision making process is shown in figure 4.16. For the purpose of the illustration 
decision support has been applied to the problem of clinical treatment decision making. 
The supported decision maker still goes through the decision making cycle in their mind, 
and this is supported by the "simulated" decision making cycle in the material reality. 
Therefore it is vital to have a representation of the decision making process which both the 
decision maker and the decision support system can apply to the problem. If the whole 
decision making cycle can be abstracted it is possible to simulate and use the simulation 
to support the whole process, or just sections of it as required. Advice is then offered to the 
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decision maker at each stage of the process. For example all the possible options for 
treating a patient in disease state B. The simulation of the rational decision making process 
will require abstraction of the knowledge used by decision makers in similar problem 
scenarios. 
Therefore the first stage of decision support is to characterise the material problem which 
is the subject of the decision making. This includes the goals for the decision and the 
variables to be used for the assessing the problem and the decision effectiveness. A crucial 
point here is that "simulated" decision support is problem specific. Therefore for such a 
decision support system to be useful there needs to be a commonly occurring problem, with 
consistent characteristics. Characteristics of the problem include the problem goals, the 
assessment variables, options for action and the criteria for choosing the options. The 
options for action in the decision support system can be represented using a decision tree. 
Then by applying abstracted knowledge at each of the nodes the preferred option can be 
recommended, with the elicited knowledge as justification for the advice. Finally the 
implementation of the decision can be supported by descriptions of the techniques and tools 
needed to complete the actions. 
Knowledge plays a role in all rational decision making, as illustrated above in the model 
of clinical decision making. Thus a "simulated" decision support system will require an 
abstracted knowledge base to inform the simulation, and to justify the advice to the user. 
By simulating the decision making process in a rational manner it is implied that some form 
of artificial intelligence (AI) will be required to perform the task. Expert systems, a branch 
of AI, attempt to mimic human thought in a specific area (Bidgoli, 1989). 
The role of "simulated" decision support is to simulate one or more of the stages of decision 
making and offer reasoned advice to the user on what the outcome of the stage could be. 
This is a high level modle of decision support; below this level it is possible to support the 
decision at lower levels. A lower level model of decision support is as a knowledge source 
to be used during decision making. The form of the knowledge could be state knowledge, 
know how or conceptual knowledge. The information management tool described by 
Shortliffe fits into this category of decision support, where an information system is the 
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source of state knowledge which the decision maker uses to assess the problem. Thus there 
is not advice on whether or not a problem exists, only access to information for the decision 
maker to come to their own conclusion. 
Information on options for solving the problem could be offered to give the decision maker 
knowledge of what can be done, or what has been done by others in the past. For example 
when presented with a patient suffering from renal failure the system could offer the 
decision maker information on general treatment strategies for managing the problem, 
without necessarily recommending how to choose between the options or which option to 
take. Applying Shortliffe's definition this could be considered a system which focuses the 
decision makers attention on available options. Both the state information and the 
information on decision options are problem sensitive. Therefore the information offered 
could be considered to be decision support, and has been considered to be so by Shortliffe. 
The highest level knowledge support which could be offered to the decision maker is 
conceptual knowledge. This could operate like a text book type of reference where the 
information offered was related to the problem domain, but not specific to the problem. 
The analogy being that the decision maker looks up the description of concepts for an 
explanation of their meaning. 
The last three categories of supporting the decision maker are perhaps better described by 
the phrase knowledge support rather than the term decision support. The phrase decision 
support is reserved to describe systems which actively offer problem sensitive justified 
advice to the decision maker for any stage of the decision making process (figure 4.16). 
Thus a decision support system would offer advice on what the problem assessment is, 
what the options for action are, what the chosen option is and how to complete the chosen 
option. While a knowledge support system adds to a decision maker's knowledge of the 
problem and the options for action, it does not simulate the decision making process. 
Building a decision support system is essentially a technological problem, where in 
response to a social need a technological tool or artifact is designed. Therefore, the 
methodology which gives the structure to designing a decision support system is the 
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engineering design cycle discussed in the previous chapter. This process can be informed 
by scientific knowledge as outlined in the previous chapter. The methodology of clinical 
decision support proposed here is not tied to a particular computing technique. The 
technique should be defined by the problem, not the problem constrained by the technique 
to be applied to it. In the past the development of decision support systems has too often 
been technique driven rather than problem driven (Heathfield and Wyatt, 1993). 
The problem domain of medicine is a complex one with a large knowledge base in many 
different specialisms. The knowledge base is informed by medical science (figure 3.15) 
ethical codes of practice, and empirical clinical practice. Therefore, in building a 
knowledge base for clinical decision support there need to be elements of both medical 
science and clinical experience. 
4.4 ONTOLOGY AND EPISTEMOLOGY IN CDS SYSTEM DEVELOPMENT 
The reasons for developing the ontological and epistemological models in the thesis are to 
provide a basis for a coherent analysis of the nature of clinical decision support, and for 
application to a problem specific clinical decision support system development. The 
ontological model is fundamental to this approach as it defines the world view taken in all 
subsequent analysis and development. The primary purpose of the ontological model 
developed in the thesis is to represent the decision making process, and to show how 
decision making can be supported by a decision support system, thus providing a basis for 
analysis which is not centred on the technology used in a decision support system. 
The world view expressed in an ontological model provides a basis for including all the 
entities that are perceived to exist in the realm of CDS. Thus it is the foundation for 
fonning an holistic view of CDS. The form of the model is important as it is the start point 
for an ontological analysis of a problem scenario. For example basing an ontological model 
on a monistic materialist view of reality will provide a different model of a problem 
scenario compared to that based on a dualistic materialist-idealist view. 
All entities that are deemed to exist in CDS can be defined within the context of an 
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ontological model. In addition to defining the existence of entities the model can also be 
used to represent the relationships between them. Using a dualist ontological model (figure 
3.4) all the entities in the problem domain, in both the material and idealist reality, and the 
relationships between them can be defined. For example in the ontological model of 
decision making the relationship between the decision maker, in the idealist reality, and the 
decision problem, in the material reality, is shown in figure 4.1. Then extending the 
ontological model to include a representation of decision support, figure 4.15, gives a 
structure within which all of the elements relevant to clinical decision support can be 
included. Thus the ontological model provides a structure for analysing all the entities in 
the supported decision making, and avoids focusing solely on the technological tool which 
is providing the decision support. Ontologically it can be clearly seen that the decision 
problem and decision maker exist despite of, and independently of, the clinical decision 
support system, clearly illustrating that the decision support system exists only as a tool in 
the material domain and exists for the decision maker to use when they need it. 
In chapter three the ontological model was also used to analyse the entities involved in the 
three main disciplines which impact on CDS system development (technology, science, 
medicine). From the definition of CDS and this analysis of the three main disciplines the 
production of a CDS system has been characterised as a technological problem. The 
ontological model of technology, figure 3.10, defined the dual realities involved in the 
technological process: a problem and artifact in the material reality, and abstractions of the 
problem and artifact in the mind. The first stage of the technological process is an 
assessment of the problem to be addressed by the introduction of the technological artifact. 
The problem to be addressed in CDS has been characterised above as a decision problem. 
Ontologically the clinical decision problem has been represented by the problem in the 
material clinical domain and a clinical decision maker in the idealist reality. Therefore, 
when building a CDS system there needs to be an analysis and modelling of the material 
clinical problem, followed by an analysis and modelling of the clinical decision making 
process to be simulated. The modelling of the clinical decision making follows the 
assessment of the clinical problem, as knowledge gathered during the problem assessment 
forms an integral part of the modelling of the clinical decision making. The results of these 
two processes are then used in the CDS tool development. The development of the CDS 
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tool follows the modelling of the clinical domain and the decision making as the structure 
of the CDS tool will depend on the output of both the earlier modelling processes. This is 
particularly true for the model of the decision making process as it is converted into a 
dynamic decision making model in the decision support system. 
The ontological models of the clinical decision support and clinical decision making are 
used in a manner similar to that described above to structure the next three chapters of the 
thesis. According to the ontological model of decision making there first needs to be the 
perception of a material problem. Perception implies representation, therefore the next 
chapter of the thesis presents the medical knowledge used to represent the material 
problem. Then from figure 4.1 it can be seen that acting on the material problem there is 
the clinical decision making process. This process is analysed and represented in the 
decision model in chapter six. Following the description of the decision model is a 
description of the prototype CDS tool developed for decision support in the management 
of CVVHD therapy in the lTU. 
Epistemologically the knowledge included in each of the next three chapters can be 
analysed using the model of the scope of knowledge (figure 3.6). Chapter five begins by 
building up the conceptual medical knowledge base used to describe the material clinical 
problem. This conceptual knowledge base is built up on well established common 
knowledge from medical science of normal kidney function (Physiology) and abnormal 
kidney function (pathophysiology). Following the conceptual knowledge is a systems 
analysis of the clinical problem and a representation of the know how used to control the 
patient's failed kidney function. This knowledge is represented by models of the processes 
of patient management with descriptions of the goals of the therapy processes and the 
measurements recorded. 
Expanding on the conceptual knowledge and know how described in chapter five, the 
decision making model in chapter six encapsulates elicited clinical knowledge to define 
decision goals and decision rules for each of the decision nodes in a decision tree. These 
goals and decision rules all depend on predefined clinical variables. The representation of 
the clinical knowledge in the decision tree is tested for coherence with knowledge on 
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patient state and haemodialysis treatment taken from other reference sources. This 
coherence checking forms the first stage of knowledge base verification, according to the 
three criteria for philosophically assessing truth as defined in chapter three. 
Another criterion for verification of the knowledge base is pragmatism. Producing a 
dynamic version of the decision making model in a CDS computer based prototype 
provides an opportunity for the pragmatic verification of the decision making knowledge 
base. The prototype development described in chapter seven is based on the medical 
knowledge modelled in the first two stages of the system development. In addition to this, 
chapter seven also includes technology specific knowledge of system requirements, system 
design and system coding. There is also some pragmatic validation of the application of 
this technological knowledge in the form of results from the functional testing of the 
dynamic operation of each of the decision nodes in the decision model. 
To summarise the ontological modelling of this and previous chapters defines the structure 
for the CDS system development; whilst the epistemological modelling describes the 
breakdown of the application specific knowledge and the verification tests to be applied to 
the knowledge described in the subsequent chapters. 
4.5 SUMMARY 
The ontological and epistemological concepts developed in the previous chapter have been 
applied in the analysis of decision making and decision support. Based on these concepts 
models representing the clinical decision making process have been derived, and the role 
of decision support in this process represented. 
The ontological model of the clinical decision making is used in the next two chapters to 
structure the analysis of the clinical problem of acute renal failure management in the 
intensive care unit. The analysis is based on relevant conceptual knowledge from medical 
science, and builds up a representation of the clinical problem of acute renal failure 
management. The model of the clinical decision making managing the acute renal failure 
is based on the models of clinical decision making developed in this chapter. 
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CHAPTER 5 
CLINICAL PROBLEM ASSESSMENT 
5.1 INTRODUCTION 
The model of decision making in the previous chapter established problem assessment as 
the first stage of the process. Moreover, the production of a CDS system has been 
characterised as a technological problem. The ontological model of technology, figure 
3.10, defined the dual realities involved in the technological process: a material problem 
and artifact in matter, and abstraction of the problem and artifact in the mind. Thus the first 
stage of the technological process is a representation of the material problem to be solved. 
Therefore, when building a CDS system there needs to be an analysis and modelling of the 
material clinical problem, followed by an analysis and modelling of the clinical decision 
making process to be supported. The aim of this chapter is to present an analysis of the 
clinical problem, including the domain knowledge. The analysis and modelling of the 
clinical decision making process is described in the next chapter. 
The material clinical problem assessment defines the knowledge of matter to be used in the 
solution to the problem. The clinical problem assessment begins with an analysis of the 
established knowledge of the clinical problem domain. The clinical problem to be 
addressed centres on treating a patient with acute tubular necrosis (A IN) on an intensive 
therapy unit (lTV), where the focus is on compensating for the patient's impaired renal 
function using renal replacement therapy (RRT). The core established knowledge relevant 
to the problem is medical science's knowledge of the kidney , and knowledge of the 
techniques available for treating the patient. 
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5.2 CLINICAL PROBLEM ANALYSIS 
Patients suffering acute renal failure on a district general ITU may need to receive renal 
replacement therapy to keep them alive. Until recently this has usually involved sending 
patients to an ITU with support from an on-site specialist renal unit. For a very ill ITU 
patient their condition could be made worse by having to make such a journey to another 
hospital. The patient outcome can be improved by having the appropriate intensive care 
as close as possible to the point of presentation of the patient (Short, 1993). Short (1993) 
also states that acute uraemia occurs in the setting of serious systemic illness and its 
management should be performed as a component of the general management of the patient 
in the same way as respiratory support. 
The current situation in the NHS, where each hospital is a provider in the health care 
market place, has raised the importance of cost control in each of the hospital trusts. This 
pressure has been felt particularly by ITU, as high expenditure is needed to keep them 
operational. If the resources are available to treat the ITU patients in house, then only the 
marginal cost of their renal replacement treatment will be borne from having to treat their 
renal failure. However, if the patient has to be referred to another hospital, then the 
referring hospital will bear the full cost of the patient's intensive care at the other hospital. 
So, from a costing viewpoint there is a lower cost impact on the hospital if it treats the 
patient on its own lTU. Moreover, there is the complication of being able to find a bed in 
another hospital that has specialist nephrology support. 
With the advent of trust hospitals in the NHS and the availability of Continuous 
VenoVenous HaemoDialysis (CVVHD) it is now desirable and possible to treat renal 
failure patients in a general lTU. Clinicians at the Mayday University Hospital have 
identified two clinical problems with treating renal failure on a general lTU using CVVHD: 
i) A large volume offluid is exchanged in patients undergoing CVVHD. Maintaining 
the fluid balance in these patients requires accurate fluid balance calculations. At 
present there is scope for inconsistencies in the fluid balance calculations. This 
need was also expressed in Groth and Collinson (1993). 
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ii) An expert with experience in managing fluid and electrolyte balance will not be 
available 24 hours a day to offer advice to staff operating the CVVHD. 
The initial aim of this chapter is to present the clinical knowledge which defines the 
concepts used to describe the analysis of the clinical problems above. Familiarity with 
these concepts is necessary to understand the terms used by, and the problems faced, by the 
clinicians. The conceptual knowledge represents the prior knowledge used to interpret the 
observed phenomena and fit the observations into a preconceived construct of ideas. 
Therefore a CDS system needs to use the same concepts which are used by the clinician. 
Building on the core conceptual knowledge the second aim of this chapter is to describe the 
results of the systems analysis of the material clinical problem in the lTU at the Mayday 
University Hospital. The objective of the systems analysis is to establish a model 
representing the fluid and biochemical flows into and out of the ARF patient. These two 
main aims are broken down into a series of objectives: 
i) To present the conceptual domain knowledge which describes renal failure in terms 
of physiology and pathophysiology. 
ii) To describe the treatments modalities used for treating renal failure in the lTU. 
iii) To describe the clinical problem of managing ARF in the lTU at the Mayday 
University Hospital. 
iv) To give a description of the use of continuous venovenous haemodialysis in the 
lTU at the Mayday University Hospital. 
The knowledge covered in objectives one and two represents the most firmly established 
conceptual knowledge, and includes the scientific medical knowledge at the foundation of 
nephrology. This foundation knowledge was used as a basis for understanding the clinical 
problem and for structuring the systems analysis. Moreover, the scientific basis of the 
foundation knowledge means it is the most reliable, or truthful, source of knowledge 
available in the domain. 
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The problem specific knowledge comes from a systems analysis of the clinical management 
ofCVVHD in the Mayday University Hospital ITU. The concepts used in this analysis are 
consistent with the those used in the relevant classifications of medical science described 
below. 
5.3 CLINICAL DOMAIN KNOWLEDGE 
Domain conceptual knowledge represents the base level of the knowledge required when 
building a knowledge based decision support system. The domain conceptual knowledge, 
as in figure 3.6, defines the concepts used to interpret the observed material phenomena and 
actions. This is particularly applicable to a highly technical field such as medicine which 
has its own specialised vocabulary. Without a basic conceptual knowledge structure it is 
not be possible to analyse the clinical problem, or offer a solution, in terms used in the 
clinical domain. Such a deep level of understanding of the problem is fundamental to 
building an effective system (Heathfield and Wyatt, 1993). This is because the conceptual 
knowledge of the domain defines the foundation of the clinical world view. Moreover, the 
medical science domain knowledge presented here represents the most widely accepted 
knowledge relevant to the clinical decision making process. Thus, it can be used to judge 
the coherence and the validity of the more contentious, elicited, clinical knowledge used 
in the treatment decision making. 
Taking scientific knowledge as the start point is assenting to the mechanistic material view 
of medicine described in chapter 3. One impact of this approach is to reduce the body to 
a set of interacting systems, for example the heart and lungs. The kidneys are abstracted 
as one of these interacting systems, and the corresponding medical specialism is 
nephrology. 
The clinical problem domain is essentially that of a nephrologist working in the high 
dependency environment, making clinical decisions on patient care. Nephrology is the 
specialism in medicine concerned with the anatomy, physiology and pathology of the 
kidneys. Therefore, knowledge of kidney physiology and pathophysiology is foundation 
knowledge for the problem analysis and clinical decision making. Scientific knowledge 
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of the kidneys in the normal and abnormal state is the most reliable source of domain 
knowledge available. Therefore using this knowledge as a start point is the best way to 
begin to understand the problem domain. 
5.3.1 The Kidney 
This section first gives a description of the concepts used to define the kidney and its renal 
function, followed by a description of the aspects of the body's physiology affected by the 
renal function. The knowledge contained in this section forms the foundation of the 
knowledge used in the problem analysis and the clinical decision making. In particular this 
section offers an understanding of how the body's systems function normally, and how 
potentially fatal changes in their function can be compensated for in renal repalcement 
therapies. 
5.3.1.1 Anatomy of the kidney 
The two kidneys are situated at the back of the abdomen behind the peritoneum, on either 
side of the vertebral colwnn. Each adult kidney is approximately 11 cm long, 6 cm wide, 
3 cm thick, and weighs approximately 145 g. The kidney produces urine which flows via 
the ureter into the bladder. This acts as a reservoir for the urine. The arrangement of the 
kidneys in relation to the bladder, abdominal aorta and inferior vena cava is shown in figure 
5.1. 
The two main regions of the kidney are the cortex and the medulla, (figure 5.2). The cortex 
is the outer region of the kidney and is dark in colour due to its highly vascular nature. The 
medulla is the paler inner region of the kidney, and is divided into a number of renal 
pyramids. The apex of each pyramid is known as the papilla. 
5.3.1.2 Kidney blood suWly 
The kidneys receive just over 20%, approximately 1.1 I min'l, of the cardiac output (Lote, 
1982). In terms of the blood flow per unit tissue mass this is almost equivalent to ten times 
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the coronary blood flow. Such a high blood flow helps to sustain the plasma filtration rate 
of approximately 125 ml mino \ (20% of renal plasma flow rate) at the glomeruli of the 
kidney. 
Blood is supplied via the renal artery from the abdominal aorta. The blood leaving the 
kidney drains into the inferior vena cava via the renal vein. The physical layout of the renal 
artery system is shown in figure 5.3. The renal artery branches out into several interlobar 
arteries. These feed into the arcuate arteries, which pass along the boundary between the 
cortex and the medulla. The interlobular arteries come off of the arcuate arteries at 90° 
flowing towards the outer surface of the kidney. The interlobular arteries divide out into 
the afferent arterioles. These then flow into the glomerular capillaries of the nephron. 
A flow chart representing the flow of fluids through the kidney is shown in figure 5.4. 
After passing through the Bowman's capsule of the nephron the glomerular capillaries 
merge and flow into the efferent arteriole. The efferent arteriole is an example of a portal 
vessel as it carries blood from one capillary network to another. The capillary network that 
it flows into is the network flowing around the nephrons. There are two classifications of 
capillary network in the kidney: 
i) The peritubular capillaries which surround the cortical elements of the nephron. 
The efferent arteriole in the outer two thirds of the cortex feed into this type of 
network. 
ii) The vasa recta capillaries; these follow a hairpin course into and out of the medulla, 
where they flow around the juxtamedullary loops of Henle and the collecting 
tubules. The efferent arterioles in the inner third of the cortex form some 
peritubular and some vasa recta capillaries. 
The capillaries surrounding the nephron drain into the renal vein via the interlobular, 
acurate and interlobar veins. 
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5.3. 1.3 ReiYlation of blood flow tbrouib the alomerulus 
Over an approximate range of mean perfusion pressures of 90 to 200 mmHg the blood flow 
into the glomerulus is constant at approximately 1.11 min-I (figure 5.5); this constant flow 
is due to the ability of the afferent and efferent arteriole to vasoconstrict. 
At a nominal mean arterial pressure of 100 mmHg the afferent and efferent arteriole are 
unconstricted. If there is an increase in arterial blood pressure the afferent arteriole 
constricts thus reducing the blood flow to the glomerular capillaries. Upon a fall in blood 
pressure the efferent arteriole constricts and the afferent arteriole remains relaxed, thereby 
increasing the blood flow. Therefore, the blood flow through the glomerular capillaries is 
kept constant over a range of blood pressures. 
Below a mean blood pressure of approximately 90 mmHg the glomerular blood flow 
decreases swiftly, so a low blood pressure causes perfusion problems in the glomerulus. 
Above 200 mmHg the glomerular blood flow increases, but less rapidly than it decreases 
below 90 mmHg. 
5.3.1.4 Renal function 
The kidney plays a central fole in the regulation of the cellular environment of the body. 
The renal function is summarised in figure 5.6. A more detailed description of these 
functions is given below: 
i) The kidney excretes waste products of metabolism by a combination of 
ultrafiltration and secretion. 
ii) The blood pH is regulated by the control of the plasma concentration of free 
hydrogen ions. 
iii) The effective circulating fluid volwne is regulated by responding to control signals 
from the sympathetic nervous system and the hormone control system. 
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iv) Regulation of plasma osmolarity is achieved through the response of the 
hypothalamus to changes in the plasma osmolarity. 
v) Control of plasma electrolyte levels is effected by the processes of ultrafiltration, 
secretion and reabsorption. Thus, the kidney exerts indirect control over the level 
of electrolytes in the other fluid compartments of the body. 
vi) Regulation of the red blood cell mass is achieved by the excretion of erythropoietin 
which acts in the stem cells of the bone marrow, stimulating red blood cell 
production. 
When the kidneys fail it is the loss of these functions which need to be compensated for by 
treatment. The operation ofhaemodialysis acts to compensate for the loss of functions (i) 
to (v). Functions (ii) to (v) will be discussed in more detail in later sections. This section 
will continue with a description of the operation of the functional units of the kidney. 
5.3 .1.5 The nephron 
The central functional unit of the kidney is the nephron. The kidney produces urine by the 
interaction of the nephron with the renal capillaries, interstitial fluid space of the kidney, 
and the collecting tubules (figure 5.7). 
Each kidney contains approximately one million nephrons. All nephrons have the 
following constituents, illustrated in figure 5.8: glomerular capillaries; Bowman's capsule; 
proximal tubule; the loop of Henle, and the distal tubule. However, there are two different 
classifications of nephron, figure 5.9: cortical nephrons, andjuxtamedullary nephrons. In 
each kidney approximately 85% (850,000) of the nephrons are cortical nephrons with the 
remaining 15% (150,000) beingjuxtamedullary. The cortical nephrons have short loops 
of Henle and lie almost entirely in the cortex, whilst the juxtamedullary nephrons have long 
loops ofhenle which go deep down into the medulla. This physical difference between the 
nephrons means that their loops of Henle perform differently. However, the other parts of 
both types of nephron perform the same functions. 
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5.3.1.6 Nephron function 
The glomerular capillaries carry the blood into the blind ended Bowman's capsule. 
Approximately 11 % of the blood volume in the capillaries is filtered into the capsule. 
Which constituents of blood pass through the glomerular membrane is mainly determined 
by their molecular weight. Generally filtration of molecules with a molecular weight above 
70,000 is insignificant. Blood cells, platelets and plasma proteins have a molecular weight 
greater than 70,000. Substances with a molecular weight less than 7,000 pass through the 
glomerular membrane virtually unimpeded. The closer the molecular weight is to 70,000 
the smaller the proportion of substance in the filtrate (figure 5.10). So the substances in the 
filtrate include water, inorganic salts, food substances and waste products such as 
creatinine. 
The rate of flow of filtrate into Bowman's capsule, the Glomerular Filtration Rate (GFR), 
is typically 180 I day' I . However, the volume of urine per day is of the order of 1.5 1. 
Therefore, most of the glomerular filtrate is reabsorbed into the blood. 
The proximal tubule plays an important role in the reabsorption of fluid. Approximately 
70% of the fluid (126 I day·l) in the filtrate is reabsorbed into the peritubular capillaries. 
The high percentage of fluid reabsorption is mainly due to 70% of the sodium ions being 
reabsorbed. This sets up an osmotic gradient across the tubule boundary across which 
water flows. 
The proximal tubule also reabsorbs 80% of the potassium ions, 70% of the calcium ions, 
and 90% ofbicarbonate and phosphate ions. In addition, all of the glucose and amino acids 
are reabsorbed in the proximal tubule. 
As indicated above the differences between the cortical and juxtamedullary nephrons are 
the different lengths of the loop of Henle and the structure of the capillaries around the 
loops. These differences are the reason why only the juxtamedullary nephrons, 15% of 
nephrons, playa significant role in concentrating the urine. Concentration of the urine is 
achieved by the creation of a hyperosmotic environment in the renal medulla. 
-162-
The creation and maintenance of the hyperosmotic renal medulla can be analysed as shown 
in figure 5.11. The difference between the factors increasing the osmolarity (system inputs) 
and factors decreasing the osmolarity (system outputs) determines the osmolarity of the 
medulla. 
The factors increasing the osmolarity of the medulla are: 
i) The counter current multiplier effect in the loop of Henle. 
ii) The passive diffusion of urea from the collecting tubule into the medulla 
interstitium and the loop of Henle. 
The factors decreasing, or limiting, the osmolarity are: 
i) Blood flow through the vasa recta capillaries. 
ii) The volume of water entering the medulla. 
iii) The diffusion along the length of longitudinally the medulla interstitium. 
The counter current multiplier effect in the loop of Henle is illustrated in figure 5.12. The 
process is driven by the ascending limb, where chloride ions are actively transported into 
the interstitium and sodium ions passively follow. The ascending limb is relatively 
impermeable to water when compared to the descending limb. Therefore, more water flows 
out of the descending limb, up the osmotic gradient created by the movement of sodium 
ions. So, the osmolarity of the descending limb is higher at the bottom than at the top, 
whilst the osmolarity of the ascending limb is lowest at the top, figure 5.12. 
Half of the peak osmolarity, 1400 mosm 1-\, in the renal medulla is due to sodium ions and 
the remainder is related to the urea concentration. In the presence of anti-diuretic hormone 
(ADH) the medullary collecting tubule is permeable to urea, thus it escapes into the 
interstitium of the medulla. From the interstitium it enters the loop of Henle which 
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increases the osmolarity of the medulla interstitium and the loop of Henle. When ADH is 
not present then the osmolarity of the medulla is lower as urea is not able to escape into the 
interstitium. 
The vasa recta capillaries have two important characteristics which help to maintain the 
hyperosmotic environment of the renal medulla. These are: 
i) The low blood flow through a hairpin capillary network. They receive 1 to 2%, 11 
to 22 ml min-I, of the total renal blood flow. 
ii) The counter current exchange in the capillaries of solutes and water maintains the 
osmolarity of the medulla. 
However, some of the solute is removed from the medulla by the vasa recta. Ifno solute 
was removed there might be no limit to the counter current multiplication effect in the loop 
of Henle. Other factors which limit, or decrease, the osmolarity of the interstitium are 
water entering the interstitium from the collecting tubule and the descending limb., and the 
diffusion of solutes longitudinally in the interstitium. 
The term distal tubule is a purely anatomical description for where the thick ascending limb 
of the loop of Henle joins the cortical collecting tubules. Functionally it is the same as the 
thick ascending limb. 
The collecting tubules are not strictly speaking part of the nephron, although they do play 
an important part in their function. Each collecting tubule receives approximately six 
nephrons in the cortex of the kidney. In the medulla the tubules join together in successive 
pairings to form a duct of Bellini at the papilla. The collecting tubules are involved in the 
control of the plasma volume, plasma osmolarity, plasma electrolyte concentrations and the 
acid base balance. 
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5.3.1 .7 Glomerular filtration rate 
Glomerular filtration rate (GFR) is an important parameter of renal function, especially in 
determining the severity of renal failure in clinical practice. The GFR is the rate at which 
the kidneys filter plasma and is typically 125 mil-I. 
GFR can be estimated by measuring the plasma clearance rate of a substance that is filtered 
in the nephron, but not reabsorbed, secreted, synthesised or metabolised. Plasma clearance 
is only a conceptual measure, as the diffusion of solutes would prevent any volume of 
plasma from being completely cleared. The concept of plasma clearance assumes that a 
certain volume of plasma is completely cleared of the solute, and the remainder has the 
same concentration as when it entered the kidney. Therefore, the clearance is a measure 
of how effective the kidney is at removing substances from extracellular fluid (ECF). The 
formula used to calculate the clearance of a substance from plasma is: 
where, Cy = clearance of substance y (ml min-I) 
Uy = amount of substance y in urine (mg ml-I) 
V = urine flow (ml min-I) 
Py = concentration of substance y in plasma (mg ml-I) 
(5.1) 
If a substance is only filtered in the kidney, then the steady state clearance of the substance 
will be equal to the steady state GFR. Only the steady state values can be considered as 
transient changes in GFR cannot be detected by changes in urine concentration. 
Clinically GFR, or kidney function, is estimated from the creatinine clearance. Creatinine 
clearance is used as creatinine is freely filtered and not reabsorbed, synthesised or 
metabolised by the kidney. Although, creatinine is secreted to some extent in the proximal 
tubule, this does not detract from its use in giving an indication of GFR. 
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5.3.1 .8 Hormonal control of renal function 
There are four main hormones that affect the renal function. Their source and affect on 
renal function are summarised below: 
i) Anti-diuretic hormone (ADH) is excreted from the posterior pituitary gland. ADH 
increases the permeability of the collecting tubule walls to water and urea, thus 
promoting water retention. 
ii) Aldosterone is secreted from the adrenal cortex. It stimulates the reabsorption of 
sodium and the secretion of potassium in the collecting tubule. 
iii) Atrial natriuretic peptide (ANP) is released from the walls of the cardiac atria. ANP 
causes increased renal loss of sodium by decreasing reabsorption of sodium. 
iv) Parathyroid hormone (PTH) originates from the parathyroid gland. There are two 
affects on renal function: increased calcium reabsorption in the distal tubule, and 
decreased phosphate reabsorption in the proximal tubule. 
The control processes involving these hormones are described further in later sections. 
5.3.2 Kidney Control of Body Physio}OKY 
This section aims to give the physiological knowledge of the normally functioning 
individual, and the role the kidney plays in controlling the body's physiology. The control 
exerted by the kidney over the body's physiology is described by its renal function. It is 
these functions which have to be compensated for when the renal function diminishes or 
ceases. The treatment used for the replacement of renal function is generally 
haemodialysis. Haemodialysis changes the patient's fluid, electrolyte and acid-base 
balance, in addition to removing waste catabolites. Thus, an introduction to the physiology 
of the body's fluids, electrolytes, acid-base balance and metabolic processes is given here. 
-166-
5.3.2.1 Fluid physiololO' 
Water is the main constituent of the body. Total body water (TBW) varies with age and 
sex over the range of 45 to 60% of body weight. For an average 70 kg man around 60% 
of the body weight (42litres) is water, while for a woman it is approximately 52% of body 
weight. The total body water is divided into two main compartments: 
i) The intracellular fluid (ICF) is all the fluid in the cells of the body, including the 
blood cells. The ICF compartment contains two thirds of the total body water, 28 
litres in the average man. 
ii) The extracellular fluid (ECF) is all the other fluid in the body, including the fluid 
between the cells and the remaining fluid in the vessels of the body. One third of 
the total body water (14litres) is in this compartment.. 
The ECF compartment splits down into the plasma compartment, 9.5% ofTBW, and the 
interstitial fluid, 23.8% ofTBW. An illustration of the connection between the different 
fluid compartments is shown in figure 5.13. 
5.3.2.2 Effectiye circulatinK volume 
The effective circulating volume refers to that part of the body fluid contained within the 
vascular space which is effectively perfusing the tissues. Effective perfusion involves 
blood flow through the capillaries as this allows exchange of nutrients, gases and 
metabolites between tissues and blood. Effective circulating volume is a concept related 
to blood and ECF volume, but it may vary independently of them. 
Changes in effective circulating volume are indirectly detected by stretch receptors: in the 
renal afferent arteriole; the arterial baroreceptors, and right atrium. 
Decreased stretch of the afferent arteriole in the kidneys causes the secretion of renin from 
cells in the arteriole. Renin acts on the plasma substance angiotensin to form angiotensin 
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I which is converted angiotensin II in the lungs. Angiotensin II has several actions: 
i) Causes aldosterone release from the adrenal cortex 
ii) Directly stimulates sodium and water reabsorption in the renal tubule 
iii) Acts as a potent vasoconstrictor 
iv) Enhances the sensitivity of blood vessels to noradrenaline 
v) Stimulates thirst 
Figure 5.14 includes an illustration of the renal response to hypotension. The arterial 
baroreceptors detect changes in arterial blood pressure and by interaction with the 
sympathetic nervous system bring about rapid changes in cardiac output and peripheral 
resistance. A fall in blood pressure causes vasoconstriction which shunts blood flow from 
the skin, gut and kidneys towards the heart, lungs and brain. In addition an increase in the 
heart beat, tachycardia, is caused by the arterial baroreceptor response to a fall in blood 
pressure. The vasoconstrictive response can be initiated in seconds and persist for hours. 
The longer term responses, hours to days, involve the hormonal control system of the body. 
Over a longer period of time the arterial baroreceptor's activity can influence the release of 
the anti-diuretic hormone (ADH) from the pituitary gland. 
The stretch receptors in the right atrium also influence the release of ADH. A fall in the 
filling, caused by the blood pressure decreasing, increases the release of ADH. An increase 
in the filling of the atrium leads to a decrease in ADH release. Atrial natriuretic hormone 
(ANH) is also released in response to changes in atrial filling. ANH causes increased renal 
loss of sodium by decreasing the sodium reabsorption, thus it counteracts the action of 
aldosterone. 
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5.3.2.3 Osmolarity 
The osmolarity of a solution is determined by the number of particles per unit volume of 
solvent, i.e. the sum of all the solute concentrations in the solution. 
Osmolarity is measured in osmoles per litre of water, where the relationship between 
osmoles and moles is expressed as: 
osmole = no. of moles x n (5.2) 
where n= number of particles each mole dissociates into. 
For example, the number of osmoles in a solution containing 1 mmole of sodium chloride 
is 1.75 mosmoles. This is because sodium chloride dissociates into sodium and chloride 
ions, but the dissociation is only 75% complete. Osmolarity is expressed in osmoles per 
litre of water, whilst osmolality is expressed in osmoles per kilogram of water. In practice 
there is very little difference between these two as the density of water is approximately 1 
kg I-I. 
5.3.2.4 Osmotic pressure 
If two solutions of different concentrations (osmolarity) are separated by a semi-permeable 
membrane, which is permeable to water but not to the solute, then there will be a net 
movement of water across the membrane. The movement of water generates an osmotic 
pressure which can raise the level of the more concentrated solution above the level of the 
less concentrated solution. 
It is important to note that an osmotic pressure will only exist if the membrane is 
impermeable to the solute. In such a solution the solute is called an effective osmole. If 
the solute can easily cross the membrane it is an ineffective osmole. 
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5.3.2.5 Plasma osmolarity 
Water can rapidly cross the cell membranes between the ICF and the ECF compartments. 
Therefore, in any given tissue osmotic equilibrium will be reached within seconds of any 
disturbance of osmolarity, in the ECF or the ICF, of the tissue. However, this localised 
rapid transfer of water does not mean that complete equilibration occurs between the ECF 
and the ICF throughout the whole body within this same time period. The reason for this 
is that fluid normally enters the body through the gut and must then be transported by the 
blood to all the tissues in the body before complete equilibration occurs. In the normal 
person it can take as long as 30 minutes to achieve equilibration throughout the body after 
drinking water. After allowing for such an ingestion time it is reasonable to use the 
osmolarity of the plasma as a measure of the osmolarity of all the fluid compartments in 
the body. 
The major osmole in plasma is sodium, and for a healthy individual the plasma osmolarity 
is roughly twice the sodium concentration. This is supported by comparing the normal 
osmolarity of plasma, which is in the range 280 to 290 mosmoll- I , with the typical sodium 
concentration in plasma, 142 mmoll- I . 
5.3.2.6 ｒ･ｾｵｬ｡ｴｩｯｮ＠ of plasma osmolarity 
The ratio of total body water to total body sodium determines the osmolarity of plasma, 
since sodium is the major osmole in the body. In the body it is the balance between water 
intake and water loss that determines its osmolarity, rather than changes in the sodium 
balance. Over a period of time the water intake must balance the loss if the plasma 
osmolarity is to remain within normal limits. 
Osmoreceptors in the hypothalamus sense plasma osmolarity, and regulate thirst and ADH 
secretion, as shown in figure 5.15. A rise in osmolarity of the plasma stimulates the release 
of ADH, thereby causing water retention in the kidney and a reduction in osmolarity. 
When there is a combination ofhypovolaemia and hypo-osmolarity, conflicting signals are 
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sent to the ADH mechanism in the pituitary gland. In this situation it is the hypovolaemia 
that takes precedence, and water retention occurs in response to increased ADH secretion. 
So, the pressure sensors of the body and the osmolarity sensors both operate to help 
maintain the fluid balance in the body. 
5.3.2.7 Electrolyte physioloKY 
An electrolyte is defined as a compound which when in solution dissociates into positively 
charged cations and negatively charged anions (Eccles, 1993). The body fluids contain a 
mixture of cations, anions and solutes such as glucose and urea. Despite the complexity 
of the body fluids, the electrical charges on the cations and ions always balance. In the ICF 
the major cations are potassium, calcium and magnesium; the major anions are phosphate 
and negatively charged proteins. Potassium is the most abundant cation in the ICF. The 
main cation in the ECF is sodium, and the major anions are chloride and bicarbonate. 
5.3.2.8 Potassium balance 
The majority of the body's potassium is in the ICF compartment, 150 meq I-I, with only a 
small quantity in the ECF compartment, 4 meq I-I. The large difference in concentrations 
is maintained by the active pumping of potassium into the cells in exchange for sodium. 
Potassium continuously diffuses down a concentration gradient out of the cell. This creates 
a resting cell membrane potential of -70 to -90 mV (Eccles, 1993). Changes in the ECF 
concentration change the cell membrane potential, which can lead to decreased excitability 
of the cells. Therefore, changes in the plasma concentration of potassium cause changes 
in the activity of excitable tissues such as nerve and cardiac muscle, with symptoms such 
as muscle weakness and cardiac arhythmias. 
Factors influencing the plasma concentration of potassium are illustrated in figure 5.16. 
There is an intracellular balance between potassium and hydrogen. An increase in the ECF 
hydrogen ion content, acidaemia, causes more hydrogen to enter the cell and displace the 
potassium. Thus, acidaemia can be accompanied by hyperkalaemia . 
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In normal renal function potassium is readily excreted by the kidneys. The potassium 
balance in the body is regulated by secretion in the collecting tubules. Renal secretion is 
influenced by two factors: 
i) Aldosterone secretion from the adrenal cortex. 
ii) Plasma concentration of potassium, and exchange with the ICF compartment. 
If renal function is viable, hyperkalaemia is unlikely to develop. However, in renal failure 
hyperkalaemia can quickly result. Hyperkalaemia can be defined as a plasma concentration 
greater than the upper laboratory limit; this is typically 5.5 meq 1-\. Cardiac abnormalities 
may be apparent once the plasma concentration exceeds 6 meq 1-\, and muscle weakness 
occurs above 8 meq 1-\. 
5.3.2.9 Other intracellular cations 
Phosphate, calcium, and magnesium are found mainly within bone and the ICF. Despite 
being small, the ECF concentration of these ions has a marked effect on the excitability of 
the neuromuscular system. The relative concentrations of the three ions is a balance 
between intestinal and renal excretion. Absorption and excretion are regulated by the 
parathyroid hormone (PTH) and the active metabolites of vitamin D. 
Within the body phosphate occurs in the form ofP04• Nonnally the majority of phosphate, 
85%, is in the bone, with approximately 14.0% in the intracellular compartment, and only 
0.02% in plasma. The normal balance of phosphate, or homeostasis, is determined by the 
absorption of phosphate across the intestine and renal excretion of phosphate. The kidneys 
are the main regulator of plasma phosphate concentration. The renal threshold for 
phosphate excretion is close to the normal plasma concentration, and in normal conditions 
any increase in phosphate concentration is rapidly followed by an urinary excretion. Thus 
for a patient suffering kidney failure their plasma phosphate levels will rise. 
Hyperphosphataemia can be defined as plasma phosphate concentrations above 1.35 
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mmoUl (Willatts, 1987). Acute hyperphosphataemia can cause hypocalcaemia by reducing 
the availability of ionised calcium in plasma. Hypocalcaemia is only a risk with acute 
hyperphosphataemia as parathyroid hormone secretion restores plasma [CaH ] in chronic 
hyperphosphataemia. 
Ninety-nine per cent of calcium is found in bone, 0.9% is in the intracellular compartment 
and approximately 0.1 % is in extracellular fluid. Only half of the plasma concentration of 
calcium exists as physiologically active free calcium, [CaH ], ions. The remainder is bound 
to proteins or other anions. The availability of calcium ions is reduced by the presence of 
bicarbonate and phosphate, and increased by the presence of free hydrogen ions. For the 
normal adult the excretion of calcium from the kidneys balances the absorption across the 
intestine. Plasma calcium ion concentration is regulated by parathyroid hormone secretion 
which controls renal, intestinal and bone mechanisms. 
Hypocalcaemia occurs when the total plasma Ca is less than 2.20 mmoi/i. This can be 
caused by renal failure and be a life threatening emergency as the increased excitability of 
the neuromuscular system can lead to tetanic seizures and respiratory arrest. In milder 
cases there may be parasthesias and hyperreflexia. Hypocalcaemia predisposes to cardiac 
arrhythmia. 
Magnesium is found mainly in bones and the intracellular compartment. Less than 1 % is 
found in the extracellular compartment. Free magnesium ions in plasma influence 
neuromuscular excitability. Hypermagnesaemia, above 0.9 mmoVl, can occur during renal 
failure, and it depresses the activity of cardiac and skeletal muscle. 
5.3.2.10 Acid-base pbysioloKY 
An acid is a substance that can donate hydrogen ions, protons, and a base is an acceptor of 
hydrogen ions. The regulation of the concentration of hydrogen ions within and around the 
cells is vital for survival. All of the proteins of the body are influenced by hydrogen ion 
concentration and the rate of any enzymatic reaction can be disrupted by changes in the 
hydrogen ion concentration. Furthermore, the plasma concentration of hydrogen ions 
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affects the distribution and state of ionisation of electrolytes such as potassium and calcium. 
Therefore, disturbances in hydrogen ion concentration can cause serious electrolyte 
disorders. 
The pH of the body can be expressed in tenns of blood concentration of the free hydrogen 
ions, the normal body pH being around 7.4: 
(5.3) 
Note that pH measures only the concentration of free hydrogen ions and buffered ions are 
not included. Buffering of the hydrogen ions effectively stabilises the concentration of free 
ions, and the buffer systems in the body play an extremely important role in controlling the 
free ion concentration around the cells. 
The main source of hydrogen ions is the body's metabolism. There are two types of acid 
generated by the metabolism: 
i) Carbonic acid. The carbon dioxide from the metabolising tissues is hydrated in the 
red blood cells to fonn carbonic acid (H2C03). This carbonic acid then dissociates 
into hydrogen and bicarbonate ions. 
ii) Non-carbonic acids (H+ A") are also produced from the cellular metabolism. 
Examples of these are mineral acids, such as sulphuric acid, and organic acids, for 
example lactic acid. 
The hydration of carbon dioxide is described by the following chemical equation: 
(5.4) 
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The daily production of carbonic acid is in the region of 11 eq and the daily production of 
non-carbonic acids is in the range 50 to 100 meq. There is only approximately 40 nanoeq 
I-I of free hydrogen ions in the blood. Therefore, most of the hydrogen ions produced in 
the body are buffered by a base. 
The carbonic and the non-carbonic acids are buffered on different buffers and excreted by 
different mechanisms. The hydrogen ions from the carbonic acid are buffered in the blood 
cells by haemoglobin. In the lungs the hydrogen ions are liberated by the oxygenation of 
the haemoglobin. The freed hydrogen ions combine with bicarbonate ions and form carbon 
dioxide as shown in the above chemical equation, and the carbon dioxide is discharged 
from the lungs upon expiration. 
The non-carbonic acids do not have a gaseous form, therefore their excretion involves the 
kidneys. These acids are buffered on the bicarbonate ions in the interstitial fluid. As 
shown in the chemical equation below the bicarbonate is consumed during the buffering 
process. 
(5.5) 
The carbon dioxide generated on the neutralisation of the acid is lost via the lungs. The 
sodium salt is transported in the blood and filtered by kidneys into the renal tubule, figure 
5.17. The acid (HA) is effectively regenerated in the renal tubule, where the hydrogen ions 
are buffered on urinary buffers. Whilst the acid is excreted, the bicarbonate ions are 
reabsorbed into the blood, as are the sodium ions. 
5.3.2.11 Maintenance of blood pH 
There are several different buffer systems in the body. In such a mixture if the pH of one 
buffer system is fixed, or controlled, all the other buffer systems in the body will equilibrate 
around this pH. The controlled buffer system in the body is the carbonic acid-bicarbonate 
system, which responds to changes in the blood pH. 
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The pH of a buffer system is determined by the relative concentrations of the anion and the 
weak. acid. In the carbonic acid-bicarbonate system the concentration of the carbonic acid 
is directly proportional to the partial pressure of carbon dioxide. The equation describing 
the relationship between the pH and the relative concentrations is the Henderson-
Hasselbach equation: 
pH = pK + log [He031 
peo2 x 0.03 
where, pK = constant = 6.1 for the carbonic acid-bicarbonate system. 
(5.6) 
In this equation the bicarbonate plasma concentration is controlled by the renal system and 
the partial pressure of the carbon dioxide is controlled by the respiratory system. 
5.3.2.12 Distwbances in acid-base balance 
Acid-base balance can best be described by plotting a graph of bicarbonate concentration 
against blood pH (figure 5.18). Also plotted on this graph is the contour representing a 
peo2 of 40 mmHg, the normal level, and the body buffer line. The body buffer line 
describes the variation of bicarbonate with pH for whole blood, where the buffering action 
is mainly due to haemoglobin. The graph illustrates the following definitions of acid-base 
disturbances: 
i) Respiratory acidosis is any point on the body buffer line where the pH is lower than 
7.4 and the peo2 is greater than 40 mrnHg. 
ii) Respiratory alkalosis is any point on the body buffer line where the pH is higher 
than 7.4 and the peo2 is less than 40 mmHg. 
iii) Metabolic acidosis is any point on the 40 mmHg contour where the pH is less than 
7.4, and the bicarbonate concentration is less than 24 meq I-I (24 mmol/l). 
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iv) Metabolic alkalosis is any point on the 40 mmHg contour where the pH is greater 
than 7.4 and the bicarbonate concentration is greater than 24 meq 1.1• 
Points on the graph not on the lines described above represent a combination of acid-base 
disturbances. For example, point P on the graph represents a combination of respiratory 
acidosis and metabolic acidosis. Note that the pH can still be 7.4 despite there being an 
acid-base disturbance. The pH level of the blood is defined by the terms acidaemia, an 
arterial blood pH less than 7.4, and alkalaemia is a pH greater than 7.4. 
In acute renal failure the most common disturbance in acid-base is metabolic acidosis, and 
as mentioned above this disturbance is often associated with hyperkalaemia. 
5.3.2.13 Measurements of acid base balance 
An arterial blood sample is used to measure pH, PaC02, HCO) and base excess. Normal 
values for each of these are in the range: for pH 7.36 to 7.44; PaC02 3S to 42 mmHg; HCO) 
22 to 28 mmol/l, and base excess is -2.3 to +2.3 mmolll (Willatts, 1987). Base excess is 
the base concentration of whole blood measured by titration against a strong acid to pH 
7.40 at a PaC02 of 40 mmHg at 37°C. For negative values (base deficit) titration is 
performed against a strong base. It is an attempt to quantify the excess or deficit compared 
to normal of bicarbonate in the blood. Thus a positive base excess is equivalent to having 
an extra bicarbonate buffering capacity available, as in alkalosis, and a negative value is 
equivalent to not having enough bicarbonate buffer, as in acidosis. 
In renal failure the kidney is unable to excrete excess hydrogen ions, thus metabolic 
acidosis occurs. The excess hydrogen ions are buffered on bicarbonate, causing the 
bicarbonate concentration to fall. Typical values indicating metabolic acidosis are: pH less 
than 7.36; PaC02 less than 35 mmHg, and HCO) less than 18 mmol/l (Willatts, 1987). 
This bicarbonate concentration represents a base excess of -6 mmolll, taking the reference 
bicarbonate concentration to be 24 mmoi/l. 
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5.3.2.14 Metabolic processes and uraemic toxicity 
Metabolism is the sum of physical and chemical processes which control the internal 
environment of the body. The two constituents of metabolism are anabolism and 
catabolism. Catabolism relates to destructive chemical transformations by which energy 
is made available for the uses of the organism, whilst anabolism is the building of more 
complex chemicals in the body from simpler ingredients. It is the destructive catabolic 
process which result in the waste products which are secreted by the kidney, the theory 
being that some of these catabolites are poisonous to the body and so if not excreted their 
affects could be fatal. 
Uraemic toxins produced in the body during uraemia have effects in the body similar to 
systemic poisoning (Vanholder et aI., 1989). However, knowledge of exactly what these 
toxins are is not complete. So, two nitrogenous marker substances are taken as an 
indication of the levels of these toxins in the body and how well the kidneys are removing 
the toxins. These two substances are urea, from catabolism in the liver, and creatinine, 
from catabolism in the muscle tissue. The plasma concentration ofboth of these substances 
is measured to monitor the renal function of the patient during treatment. Moreover, the 
clearance rate of creatinine is used to calculate the glomerular filtration rate. 
5.3.3 PathQphysioloKY of Acute Renal Failure 
Patients suffering from acute renal failure (ARF) on an ITU will have at least one other 
organ in failure, such as the liver or lungs, which may even be the cause of the ARF. 
Patients with isolated ARF will ordinarily receive treatment in a renal unit. The mortality 
ofpatients in ARE, receiving renal replacement therapy, on an ITU is approximately 75% 
to 80%, mainly due to their underlying condition. 
A broad definition of ARF is the abrupt cessation of renal function. It is perhaps more 
relevant to consider the pathophysiology of the condition. Generally the pathophysiology 
of ARE is classified into one of the following three categories: pre-renal; intra-renal, or 
Parenchymal, and post renal. 
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Post-renal ARF includes those conditions caused by an obstruction in the flow of the urine. 
The obstruction may result in anuria «100ml/day urine), however this will not always be 
the case. Treatment of post-renal failure involves the location of the obstruction and its 
removal, possibly by ultrasonography. 
Pre-renal ARF is the reversible disturbance of renal blood flow in response to fluid or 
haemodynamic derangements. It is most frequently caused by relative or absolute volume 
depletion resulting in a decrease in renal blood flow. The decreased renal blood flow will 
cause a fall in the glomerular hydrostatic pressure and thus the glomerular filtration rate 
decreases. A lower glomerular filtration rate means patients will often be oliguric (urine 
volume > lOOmllday, but, <500mllday). Early correction of the hypovolaemia by 
administration of colloid or crystalloid fluids quickly reverses the pre-renal failure. 
Treatment should be administered as early as possible to prevent the progression of pre-
renal into intra-renal failure. 
Intra-renal ARF is characterised by cell damage and tubular dysfunction in the nephrons. 
In hospitalised patients in whom reversible pre-renal and post-renal failure have been 
excluded, ARF is usually due to acute tubular necrosis (Schrier et al., 1990). Acute tubular 
necrosis (A 1N) may be induced by renal ischaemia, such as prolonged pre-renal failure, or 
by toxic injury to the nephrons. Causes of toxic A TN are nephrotoxic drugs, or toxic 
microbial products, or inflammatory mediators in the circulation, or a combination of the 
preceding factors. Inflammatory mediators may be produced during septicaemia, septic 
shock or multi system organ failure (MSOF). Ischaemic A TN usually results in oliguria 
whilst toxic A TN can produce either oliguria or polyuria (urine >400mllday). A TN is not 
immediately reversible on removal of the insult, but is normally a self limiting pathological 
process rarely persisting for more than four weeks. During the 'self healing' process some 
form of renal replacement therapy, such as haemodialysis, to take over the excretory 
function of the kidneys is required. 
5.3.4 Renal Replacement Therapy for Acute Renal Failure 
Acute tubular necrosis (A TN) requires renal replacement therapy. Renal replacement 
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includes intennittent haemodialysis, where the patient receives treatment for approximately 
4 hours every other day, or equivalent. The treatment operates at high flow rates, rapidly 
altering biochemical concentrations and fluid balance. The problem for the lTV patient is 
that these rapid changes cause large cardiovascular changes which put a large strain on their 
cardiovascular system. Thus, continuous renal replacement procedures are preferred to the 
intermittent process. Two of the continuous therapies used in the lTU are continuous 
haemofiltration and continuous haemodialysis. The vascular access for these can be either 
via an artery or a vein, with the return being into a vein. The vascular access is used to 
define the treatment, thus there is continuous aterio-venous haemodialysis and continuous 
veno-venous haemodialysis, a difference between the two being that veno-venous therapy 
requires a blood pump. Otherwise the function and operation of the two continuous 
therapies is similar. Descriptions of continuous veno-venous haemodialysis (CVVHD) and 
continuous veno-venous haemofiltration will be used as a basis for describing renal 
replacement in the lTU. 
Continuous venovenous haemodialysis (CVVHD) is a renal replacement therapy where 
blood is pumped from the patient's venous system and returned to the venous system. A 
schematic representation of the procedure is given in figure 5.19. The treatment is 
administered continuously over a 24 hour period, providing there are no reasons for 
stoppages. The aims of dialysis are to remove unwanted solutes and excess fluid from the 
patient. Haemodialysis relies on two principles for the removal of solutes and fluid from 
the blood: 
i) Diffusion, or conduction across the semi-permeable membrane. This relies on the 
concentration of a solute being higher on one side of the membrane than the other. 
The solutes to which the membrane is permeable will flow to the side of the 
membrane with the lower concentration. 
ii) Ultrafiltration of water and convection of solutes across the semi-permeable 
membrane. Convection relies on there being a pressure difference across the 
membrane, the trans-membrane pressure (TMP). The pressure gradient will force 
water through the membrane and the water will drag through the solutes with it. 
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The TMP has a hydrostatic and an osmotic component. 
These two processes mean that dialysis is an effective way of removing solutes and fluids. 
Haemofiltration relies solely on ultrafiltration which means it is not as effective at 
removing solutes from the blood. Haemofiltration may be used if the patient is in a 
severely fluid overloaded state and a lot of water has to be removed quickly. The process 
involves the filtration of the blood and the replacement of lost fluid into the blood, figure 
5.20. A description of the application of both of these therapies in given in the systems 
analysis of the clinical problem below. 
5.4 SYSTEMS ANALYSIS OF THE CLINICAL PROBLEM 
The Mayday University Hospital is a district general hospital in the Croydon area, south 
of London. The hospital does not have its own specialist renal unit, therefore in the past 
it has had to send ARE patients requiring dialysis to St Helier Hospital, where there is a 
renal unit to support the ITU. To overcome this problem Dr S Morgan set up the operation 
of the CVVHD service at the Mayday, thus reducing the likelihood of having to transfer 
acutely ill patients. The problems of fluid data management and lack of constantly 
available expertise have been identified as two potential areas requiring support. 
5.4.1 Intensive Therapy Unit 
The Intensive Therapy Unit (ITU) is concerned with treating patients suffering acute failure 
of vital functions, whose underlying condition is potentially curable. When treating these 
patients the driving goals of the lTV are to support their failing vital functions and to 
prevent the development of further failures in vital functions. Vital functions include the 
renal system, central nervous system, respiration, cardiovascular functions, gastrointestinal 
function, endocrine system together with humoral and immune function. The two main 
classifications ofITU are: 
i) A general lTV caring for a wide variety of patients, including those with a life 
threatening medical illness, multiple trauma following an emergency, in recovery 
-181-
following major surgery, and those receiving treatment that requires intensive 
monitoring. 
ii) A specialised lTV where a specific pathology is treated, for example a Coronary 
Care Unit (CCU), paediatric lTV, or neurological lTV. 
The lTV at the Mayday University Hospital falls into the category of general lTV. 
The nature of the patient conditions mean that the lTV has a high resource requirement. 
In terms of staffing the ratio of nurses to patient for the most severely ill patients is one to 
one. Even for the less ill patients the ratio is still normally one nurse to two patients. In 
addition to this, depending the size of the unit, a team of physicians led by a consultant will 
be required. The patients require intensive use of monitoring equipment whilst on the unit. 
So, there is a need for a lot of capital intensive monitoring equipment in an lTV. This high 
resource requirement makes treatment ofITV patients expensive, Gilbertson et al. (1991) 
calculated the average cost of treating a patient on the lTV for one day at £757. For 
dialysed patients suffering acute respiratory and renal failure this cost rose to £938 per day. 
5.4.2 Patient Profile 
The patient group for this project are lTV patients with two or more compromised organ 
functions, where the kidney is one of the organs in failure, and the patient is normally on 
a respirator. In addition to this, the renal function of the patient will be in AlN and require 
renal replacement therapy on the lTV. Only the adult lTV is being considered so the 
patient will be of adult proportions. Approximately thirty such patients a year are treated 
on the lTV at the Mayday University Hospital. Nationally the number is of the order of 50 
patients per million population (Renal Association, 1991), in total approximately 2,900 
patients per year. 
5.4.3 Analysis of Patient ManAiement in the Mayday lTV 
The renal function essentially controls the fluid and biochemical balances of the body. 
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Therefore, the clinical problem is essentially one of controlling the fluid and biochemical 
inputs and outputs from the patient. The purpose of this section is to provide a systems 
analysis of the problem of managing the whole of the patient's fluids and biochemistry, 
with the intention of defining the material clinical problem by representing and analysing 
all of the flow elements affecting the patient. Thus the context of the operation of the renal 
replacement therapy will be defined. 
A flow diagram representing a patient receiving renal replacement therapy in the ITU is 
shown in figure 5.21. Between each of the boxes in the diagram flows a volume of fluid 
and a quantity of biochemical substances. Each of the flows represents a factor which can 
potentially change the patients fluid balance and their biochemistry. A detailed description 
of the components of this flow analysis is given below. 
5.4.3.1 Phases of treatment 
The principal goal of the management of ATN is to sustain the life of the patient until they 
no longer need to receive dialysis therapy on the ITU. Achieving this goal is a two phase 
process; a resuscitation phase, followed by a recovery phase. The two most immediate 
threats to the life of the patient from A TN are fluid overload, leading to pulmonary oedema, 
and hyperkalaemia, leading to cardiac arrest. Therefore, the patient must first be supported 
through a resuscitation phase where the following two goals must be satisfied: removal of 
excess fluid from the patient ,and removal of excess potassium from the patient's serum. 
After the resuscitation goals have been satisfied the patient goes into the "recovery" phase, 
where the goals are: 
i) To maintain the patient in a state of fluid balance; 
ii) To maintain the serum potassium levels around the optimum level; 
iii) To treat any other electrolyte imbalances, particularly phosphate; 
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iv) To treat the acid-base imbalances, as acidosis is often associated with A TN, 
v) To reduce the levels of urea and creatinine in the serum. 
The main renal replacement therapies used to treat A TN at the Mayday ITO are continuous 
haemodialysis or haemofiltration. 
5.4.3.2 Continuous yenovenous haemodialysis 
A schematic of the set up Continuous Veno Venous Haemodialysis (CVVHD) shown in 
figure 5.19. The equipment used in this set up on the ITU at the Mayday University 
Hospital is: 
i) A Gambro BMM 10-1 blood monitor, which pumps the blood around the blood 
circuit and displays the blood flow rate and venous line pressure. 
ii) A flat plate polyacrylonitrile (AN69-Biospal) dialyser where the dialysis occurs. 
iii) A Gemini infusion pump, which controls the flow of the dialysate and displays the 
rate of infusion of the. 
iv) The dialysate used is 5 litre bags ofhaemofiltration fluid. 
v) The anticoagulant used in the circuit is heparin, or sometimes prostacyclin. 
Figure 5.19 can be considered as two circuits: the blood circuit and the dialysate circuit. 
Firstly consider the blood circuit: 
Access to the patient's blood supply will be into a major vein, the subclavian, 
femoral or internal jugular, via a double lumen dialysis catheter. 
The saline solution, mixed with heparin, is used to prime the extracorporeal blood 
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circuit and to administer extra fluid to the patient when required. 
The blood pump takes blood out of the patient's vein at approximately lOOml min' I. 
The rate of blood flow through the pump is indicated on a blood flow meter. 
The heparin pump delivers anticoagulant to the blood before it goes through the 
dialyser. The reasons for using the anticoagulant is to prolong the useful life of the 
filter and to prevent coagulation in the extracorporeal blood circuit. 
The dialyser consists of a semi-permeable membrane: on one side of the membrane 
flows the blood and on the other the dialysate. The blood flows through the 
dialyser in a countercurrent direction to the dialysate. This prevents undesired 
diffusion of solutes back into the blood. In the filter waste products and plasma 
water are removed from the blood. Solutes can also flow from the dialysate into the 
blood. This is used for the treatment of acidosis where acetate, lactate or 
bicarbonate diffuse from the dialysate into the blood. 
The bubble trap is there to prevent air getting into the patient's blood supply. 
The venous pressure sensor indicates the pressure in the return, or venous, line of 
the blood circuit. 
Now consider the dialysate circuit: 
The Dialysate is delivered from two 5 litre bags of fluid. These bags are suspended 
above the infusion pump. 
The Gemini infusion pump is used to administer the dialysate at the prescribed rate. 
The rate of dialysate flow will vary between 1 to 2litres per hour. 
The heater is used to heat up the dialysate to 37 degrees celsius, thus reducing the 
temperature gradient over the filter membrane. 
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The dialysate travels along its own path through the filter in a counter current 
direction. 
The dialysate is collected in a waste bag and once an hour the volume is measured 
in a measuring cylinder. The waste bag is moved between the height of the dialyser 
and the floor to alter the TMP, thus altering the volume of fluid removed from the 
blood. 
It is normal working practice to change the dialyser once every 72 hours. Although, to 
monitor filter performance comparisons of the concentrations urea and creatinine in the 
waste dialysate against the plasma values are made twice a day. When the filter is 
operating at full efficiency the ratios of concentrations should be 1:1. A ratio of 0.75:1 
indicates that the dialyser should be changed as it is no longer removing sufficient solutes. 
The states, or stages that define the operation of haemodialysis are: 
i) The set-up state - this includes positioning all the equipment and priming the blood 
and dialysate circuits before connecting to the patient. 
ii) The transient state- where the dialysate and blood pump speeds are changed one or 
more times in two hours. 
iii) The steady state - where the dialysate and blood pump speeds are constant for two 
or more hours. 
iv) An alarm state - where an alarm on the blood pump or the infusion pump is 
activated. 
v) The shut-down state - where the patient is removed from the dialysis equipment. 
-186-
Hourly charting of the following measurements is carried out by the nurse: 
blood flow rate; 
venous blood pressure; 
dialysate infusion flow rate; 
quantity of anticoagulant delivered; 
volume of saline introduced, and 
the volume of waste dialysate collected. 
From figure 5.20 it can be seen that the set up for CVVHF is similar to CVVHD. The main 
differences are: 
Only ultrafiltration is taking place in the filter. Therefore, CVVHF is used 
primarily to remove excess fluid from the patient. It does not remove solutes from 
the blood as well as CVVHD, neither can it be used to treat acidosis in the same 
way as CVVHD. 
Substitution haemofiltration fluid is delivered directly into the blood circuit. It can 
be introduced into the blood circuit before or after the filter. 
The equipment used in CVVHF is the same as that used in CVVHD, the difference is in 
how the components are connected. The stages of the haemofiltration process are the same 
as those for CVVHD. The hourly measurements are the same apart from: 
Substitution flow rate is measured instead of dialysate infusion flow rate, 
The volume of waste measured should be recorded as ultrafiltrate. 
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By allowing the removal of fluid from the patient, dialysis and filtration enable the 
administration of other fluid therapies such as nutritional, drug and colloid transfusions. 
The detailed knowledge used to make the treatment prescription decisions for the steady 
state treatment operation is given in chapter 6. 
5.4.3.3 Nutrition 
The nutrition is delivered in liquid form via a naso-gastric tube (enteral feeding) or directly 
into the patients blood supply (total parenteral nutrition). Which method is used will 
depend on whether the patient's gut function is viable. The desired nutritional levels for the 
patient's feed are: 
i) A high calorie content 
ii) A protein content commensurate with the patient's metabolic state 
iii) High amounts of essential and non-essential amino acids 
iv) Additional electrolytes and trace elements, for example zinc, required by the patient 
The goals of nutritional therapy are: 
i) To minimise fluid and electrolyte imbalances 
ii) To maintain adequate nutrition - typically, patients will receive 2000 calories a day 
iii) To maintain an anabolic state - tissue catabolism develops rapidly during ATN, 
resulting in raised plasma urea levels, acidosis and hyperkalemia. Therefore, proper 
balanced nutritional management is essential. 
iv) To minimise uraemic toxicity 
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Measurements to be recorded: 
i) The volume of fluid used to administer the nutrition, to be taken hourly by the ITU 
nurse 
ii) The prescribed nutrition 
iii) The nutritional intake of the patient (FEED IN - FEED OUT) 
5.4.3.4 Drua infusion 
This consists of various infusions of different drugs delivered in infusion fluid. Continuous 
infusions are delivered by a pump or on a drip basis, whilst bolus injections are delivered 
by syringe. The goals of drug therapy include: 
i) The treatment of sepsis. This is one of the most important reasons for 
administering drugs during CVVHD. Sepsis is one of the prime medical causes of 
ATN, and can be caused by infection around the venous access. Thus sepsis is one 
of the prime causes of death in A TN. 
ii) To raise the patient's blood pressure using inotropes 
iii) To treat acidosis using bicarbonate 
A complication for A TN patients is that drugs are normally eliminated from the body via 
the kidneys. However, a patient with severely compromised renal function will rely on the 
CVVHD for the disposal of the drugs from their body. Thus the interaction between the 
drug and the dialyser membrane is vitally important when considering the drug 
prescription. The actual effectiveness of the drug needs to be monitored closely as the drug 
is administered to the patient. The measurements to be recorded are: 
i) Volume of fluid used to deliver the drugs. For continuously delivered drugs this 
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will be an hourly nursing measurement, whilst for bolus injections the volume will 
be recorded when the drug is injected. 
ii) The amount of the drug prescribed by the doctor. 
iii) The type and quantity of drug actually delivered. 
From the hourly measurements cumulative totals will be worked out for the 24 hour period. 
A comparison of the amount actually delivered against the amount prescribed needs to be 
assessed and adjusted for. 
5.4.3.5 Colloids 
These are the replacement blood products delivered to the patient, such as blood cells, 
plasma and platelets. The goals of administering colloids are: 
i) To keep the patient's haemoglobin and platelets at the correct level 
ii) To replace lost plasma 
There is an important balance in the coagulation of the blood for patients receiving 
CVVHD. Low coagulation is needed in the CVVHD circuit, but the patient's clotting 
capability cannot be removed completely. This is particularly critical where patients have 
suffered haemorrhaging. The measurements to be recorded are: 
i) The volume of fluid administered per hour 
ii) Blood products prescribed 
iii) Blood products delivered 
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5.4.3.5 Blood out 
The main reasons for significant blood removal or loss are: 
i) Blood drains and fistulas from the patient 
ii) Patient haemorrhaging 
Measurements taken on the blood removed from the patient are: 
i) Clotting times of the patient's blood 
ii) The volume of blood loss from the drains, fistulas and haemorrhaging 
iii) The laboratory variables, normally measured twice a day, relevant to the renal 
function of the patient include the following: 
(a) Blood pH 
(b) Base Excess 
(c) Plasma creatinine levels 
(d) Plasma potassium levels 
(e) Plasma phosphate levels 
(f) Blood urea nitrogen (BUN) 
5.4.3.6 Urine 
This is fluid passed from the patient's kidneys. The purpose of collecting urine is to use the 
measurements to define the patient's renal function. The prime measurement is that of the 
volume of urine passed per hour. From daily analysis of the urine the following 
concentrations can be obtained: creatinine; urea; potassium, and sodium. 
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5.4.3.7 Gastric output 
This refers to all fluid output from the stomach, including naso-gastric aspirated fluid. The 
volume of fluid from the stomach is measured in terms of volume of output per hour. 
5.4.3.8 Insensible water and sensible sweat loss 
Insensible water loss and sensible sweat loss are two separate processes. Insensible loss 
is the passive diffusion of water from the lungs and the skin. Sweating is an active 
physiological processes where water and solutes are lost from the skin. In practice on the 
lTV the insensible losses are estimated to be 500m1 per day. The sweat losses are estimated 
to be SOOml per day for every degree rise in patient temperature. Doubt over the validity 
of these estimates was expressed by the clinicians at the Mayday University Hospital. 
Therefore, the reasonableness of these estimates and the possibility of using a quantitative 
model to calculate an individual's insensible losses is assessed in the next section. 
5.5 ESTIMATING INSENSIBLE AND SWEAT LOSSES 
The two processes of insensible and sensible sweat loss from the body are separate. The 
insensible loss involves only a passive physical process, while sensible losses are the result 
of an active physiological process. 
5,5. 1 Insensible Loss 
Insensible loss from the body is the continuous passive diffusion of water from the body 
(Brebner et aI., 1956). The insensible water loss contains essentially no electrolytes 
(Wilson, 1992). The two components of insensible water loss are : 
i} The Respiratory Water Loss (RWL). 
This is water which is lost from the body upon the expiration of humidified air from 
the lungs. The addition of water vapour to the inspired air takes place in the 
respiratory system. 
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ii) The Transepidermal Water Loss (TEWL). 
This is the passive diffusion of water through the skin. It has been shown that 
TEWL occurs even in the absence of sweat glands (Brebner et aI., 1956; Cox, 
1987), therefore sweat glands are not involved in TEWL. 
5.5.2 Sensible Sweatini 
Sensible sweating is the active loss of water and electrolytes through the skin. Sweating 
occurs as a result of a thermoregulatory or an emotional response of the brain. There are 
two types of sweat glands (Epstein and Sohar, 1985) : The apocrine glands which are 
involved in heat and emotionally induced sweating, and the eccrine glands, which form the 
majority of the sweat glands, are involved only in the thermoregulatory process. The 
reported electrolyte content of sweat varies over a range of values. A range of values 
suggested by Wilson (1992) is: Sodium 40·50, Potassium 5·10, and Chloride 45·50 mEq 
1-1. 
5.5.3 TechniQyes Used to Estimate Insensible loss 
From a review of articles on the subject, it is clearly common practice to use the same 
estimate of insensible losses for every patient. However, there have been some attempts 
to construct quantitative models. A recent attempt to build a detailed quantitative model of 
the total insensible losses, was that of Ultman (1987). As in the definition of insensible 
losses the model has two main components, the R WL and the TEWL. Models of these two 
components of the insensible loss were reviewed separately. 
5.5.3.1 Respiratory water loss 
The principle of respiratory water loss (R WL) is that unsaturated air enters the lungs and 
during exchange of gases in the alveoli it becomes saturated with water vapour (Ferrus et 
ai, 1980). By this process the expired gas has a higher water vapour content than the 
inspired air. The limit ofRWL occurs when the inspired air is already saturated, then there 
is no net increase of water vapour in the alveoli, so R WL is zero. It is generally accepted 
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that alveolar gas is fully saturated and at the core body temperature (Reithner, 1981). 
However. several authors (Ferrus et aI., 1980; Newburgh and Johnston, 1942; McCutchan 
and Taylor. 1951) have shown that the expired gas at the mouth or nose is not saturated. 
The two quantitative models presented below take account of the unsaturated nature of the 
expired air. 
(1) Quantitative Models 
(a) Ultman (1987) and McCutchan & Taylor (1951) 
Ultman states that the net rate ofRWL is a product of the mass flow of air per hour, IDa. 
with the difference between the expired, Ye, and ambient inspired absolute humidity, Yi . 
R WL per hour = m. ( Ye - Yi ) (5.7) 
For definitions of the terms in this expression see appendix B. McCutchan and Taylor 
(1951) performed an experiment on five healthy males and found that the change in the 
absolute humidity from inspired to expired air was :-
Ye - Yj = 0.02645 + ＰＮＰＰＰＰＳＶＱｾ＠ - 0.798Y j 
where ｾ＠ = temperature in fahrenheit of inspired air 
Yj = absolute humidity of the inspired air 
Ye = absolute humidity of expired air 
(5.8) 
Equation 5.8 shows that as the inspired absolute humidity rises the RWL goes down, and 
the inspired air temperature has a relatively small influence on R WL. Expressing equation 
5.8 using temperature in degrees celsius,Tj 
Yc - Yj = 0.02761 + 0.0000650Tj - 0.798Yi (5.9) 
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Combining the McCutchan and Taylor equation with the expression for m. in appendix B, 
equation B 1.3: 
RWL = (fRR X VT x 72,240)(0.02761 + 0.00006S0T j - 0.798Y j ) (5.10) 
Appendix B shows how absolute humidity can be expressed in terms of relative humidity, 
equation B5.3, which is a more common measure of humidity. Thus, equation 3.4 can be 
expressed as: 
RWL = (72,240 fRR VT)(0.02761 + 0.00006S0T j - 0,496RU.lUlvp) (5.11 ) 
100Pr -RH jxpvp 
Assuming the environment of an lTV in northern Europe is constant, and using figures 
suggested by Cox (1987) of room temperature around 24°C and relative humidity of 40%, 
then 
RWL per unit volume = (72,240fRR VT)0.023 (5.12) 
Wilson (1992) and Cooney (1976) state that for a standard man, the typical minute volume 
(fRR VT) is approximately 0.006 m3 min-I. So, at a room temperature of 24°C and a relative 
humidity of 40% and for a 'standard man' weighing approximately 70 kg: 
RWL = 10.10 g h-I 
Obviously this figure for R WL is only valid for the conditions stated above, but changes 
in conditions can be accommodated by the model. 
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(b) Ferrus et al. (1984) 
The other main body of work in the area of RWL has been conducted by Ferrus et al. 
(1984). They performed 345 experimental runs on seven (two female and five male) 
healthy subjects. The aim of the Ferrus study was to derive an expression for the mass of 
water vapour expired per litre ofBTPS ventilation. The first correlation Ferrus produced 
by multiple linear regression analysis showed that: 
MVE = 28.70 - 0.27fRR + 0.22Tj + O.l4RHpvp 
100 
(5.13) 
where MV E = mass of water vapour expired per litre of ventilation (mg dm-3) 
fRR = respiratory rate or frequency (min-I) 
Tj = inspired air temperature ee) 
RH j = relative humidity of the inspired air 
Pvp = the vapour pressure of water at Tj (Torr=mmHg) 
In a similar manner to the above, this expression shows that the expired gas water content 
is partly determined by the inspired gas temperature and the humidity of the ambient air. 
It also shows that the quantity of water vapour expired is partly determined by the 
respiratory rate. Ferrus suggested this dependency may be due to a 'time dead space', which 
can be thought of as the time taken for water to diffuse into the inspired air in the mouth 
and the tracheobronchial tree. Two different time dependent mechanisms were put forward 
that may account for this phenomenon: 
i) Diffusion of water vapour from the wet surface into the gas phase, and/or 
ii) Water supply from underlying tissues & salivary glands to the wet surface. 
This theory was supported when four of the subjects held a five second apnoea at the end 
of inspiration and a large increase in the mass of expired water vapour was observed. 
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Considering the theory of the time dead space, Ferrus also showed a strong positive 
correlation between MV E and the respiratory period (T 0. That is the longer the respiratory 
period, the more time is available for the process of water exchange in the respiratory 
system and the more saturated the expired air will become. Replacing fRR by T R results in 
the following equation 
MVE = 20.9 + 0.87TR + 0.22Ti + 0.14Pi (5.14) 
where TR = respiratory period (s) 
Ti = inspired air temperature (DC) 
Pi = inspired partial water pressure (Torr) 
The third and final correlation performed by F errus, replaced the respiratory rate and the 
tidal volume with the minute volume. By this correlation the following expression was 
derived: 
MV E = 24.27 - 0.09V m + 0.22Ti + 0.27pi (5.15) 
where V m = minute volume (dml ) 
Ti = inspired air temperature (DC) 
Pi = partial pressure of inspired water vapour (mmHg) 
However, the coefficient for the minute volume represents a variation of 0.9 mg for every 
10 dml minot variation in minute volume. Thus, in practice the dependency on minute 
volume can be neglected. 
Equation 5.15 does not take account of the effect of varying the respiratory period, 
therefore using equation 5.14 or 5.15 is preferable. In practice the respiratory rate is 
probably more commonly measured, so the equation 5.14 is likely to be the most practical 
equation to use. 
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The expression using MVE to calculate the RWL is :-
RWL = (Volume respiration per hour)(MVE - MV,) mg h-t (5.16) 
where MV E = mass of water vapour per volume of expired gases (mg dm-3) 
MVJ = mass of water vapour per volume of inspired gases (mg dm-3) 
From the expressions given in appendix B: 
RWL = (60 X VT X fRR )( 28.70 - 0.27fRR + 0.22Tj+ 
UQOfT:lllipvp)(O.14RHpvpl-0.749RHpvP) 
100 (PTIOO - RHpvp) 
where RWL= Respiratory Water Loss (mg h-I) 
V T = tidal volume (dm3) 
fRR= respiratory rate (min-I) 
T j = inspired air temperature caC) 
PT = total ambient pressure (mmHg) 
RH = ambient relative humidity 
Pvp= water vapour pressure at Tj (mmHg) 
(5.17) 
For the typical conditions used previously, where the minute volume is 6 I min-t, the 
respiratory rate is 12, the ambient temperature is 24°C, the ambient total pressure is 760 
mmHg and the relative humidity is 40. 
RWL= 11,515 mgh-t = 11.51 gh-t 
(2) Estimates ofRWL 
All the estimates of R WL listed here are based on the assumption that the expired air is 
saturated. 
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(a) Cox (1987) 
From the assumption given above, Cox states that a theoretical loss via the lungs is 28 g m,3 
of expired air, For the standard man this implies a RWL of 10.1 g h,l. This value was for 
an approximate room temperature of 24°C and a relative humidity of 40%. 
(b) Cooney (1976) 
States that the RWL for the standard man in normal conditions is 350 ml per day (15 g h,l) 
(c) Newburgh and Johnston (1942) 
At a temperature of 24°C and a relative humidity of 50% Newburgh measured an average 
RWL of25.1 g m,3. For a standard man this equates to a loss of9.1 g h,l. 
(d) Reithner (1981) 
Reithner's paper was concerned with the effect of fever on the RWL. For a patient with a 
temperature of 37°C, and a surface area of 1.75 m2 the water loss is stated to the 390 g day" I 
(16.25 g h,I). For a patient with a temperature of3goC this was found to rise to 500 g dayl. 
This represents an approximate increase of 5 g h,l for the 2°C rise in temperature. 
(e) Wilson (1992) 
Wilson states that for an average sized 70 kg man the insensible water loss from the lungs 
is approximately 700 ml day,l (29.2 g h,I). 
5.5.3.2 Summary of respiratory water loss for a standard man 
For a standard man (68 kg, BSA = 1.8m2, Cooney, 1976) in conditions approximating to 
a room temperature of 24°C and a relative humidity of 40% the values of RWL obtained 
are listed in Table 5.1 (overleaf). 
The quantitative methods used offer far more flexibility when calculating R WL. They can 
take into account the effect of variations in ambient conditions and patient variables. If the 
variables used by the model are constant, for example ambient temperature. then the 
constant can be used to simplify the model. 
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Identifier Source RWL(gh-l) RWL (ml day-I) 
1 McCutchan & Taylor (1951) 10.1 242.2 
2 Ferrus et al (1984) 11.5 276.0 
3 Cox (1987) 10.1 242.4 
4 Cooney (1976) 15.0 360.0 
5 Newburgh and Johnston (1942) 9.1 218.4 
6 Reithner (1981) 16.3 391.2 
7 Wilson (1992) 29.2 700.8 
Average 14.5 348.0 
Table 5.1 Summary of respiratory water losses 
5.5.3.4 Transepidermal water loss 
(1) Quantitative Model 
The stratum comewn performs the main barrier function in the skin. The passive diffusion 
of water through the stratum corneum can be modeled by applying Fick's law of diffusion 
( Michniak-Mikolajczak and Barry 1988), as shown in appendix C, Cl.4: 
TEWL = MJlw (Pvp(Tp) - Ps) 
RT.l 
where Mw = molecular weight of water (g mol-I) 
Dw = diffusivity of water through the stratum cornewn (m2 h-I) 
R = universal gas constant (m3 kPalkmol OK) 
T. = ambient temperature (OC) 
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(5.18) 
I = thickness of stratum corneum (m) 
Pvp(T p)= water vapour pressure at perfusion temperature (kPa) 
Ps = partial pressure of water at the skin surface (kPa) 
The diffusivity of water Dw, through the stratum corneum can vary by 20 to 30 times 
between its dry state and its fully hydrated state. Moreover, the stratum corneum exhibits 
regional differences in thickness over the body. It is as thick as several hundred 
micrometers on the soles of the feet and the palms of the hand, whilst the average thickness 
over the body is approximately ten micrometers. Due to these variations in parameters the 
coefficient of the partial pressure difference is replaced by the mass transfer coefficient k. 
This coefficient is then determined from experimental measurements and will vary between 
individuals, and with temperature. 
The subcutaneous temperature and the partial pressure at the skin surface are unknowns. 
Ultman (1987) assumed the subcutaneous temperature was equivalent to the skin 
temperature, and that the partial pressure of water vapour at the skin was equivalent to the 
ambient partial pressure. Combining these facts with the expression relating partial 
pressure and relative humidity the following expression is derived: 
TEWL = k ( Pvp(Ts) - IlvA) x RH. ) 
100 
where Pvp(Ts) = vapour pressure at skin temperature (KPa) 
Pvp(T J = vapour pressure at ambient temperature (KPa) 
RH. = ambient relative humidity 
k = mass transfer coefficient 
(5.19) 
The mass transfer coefficient has been shown to vary with temperature. From the results 
quoted by Grice et al (1971) Ultman showed that the mass transfer coefficient's dependency 
on skin temperature could be expressed by :-
k = koexp [9.119 - 2809/(273 + Ts) ] (5.20) 
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The constant lea will vary with each individual. If k is equal to 1.5 the curve representing 
TEWL over the skin temperature (Ts) range 25 to 40°C is approximately in the middle of 
the range of values reported by Grice. However, the values ofTEWL were only measured 
on the forearm by Grice, so her results do not represent the TEWL for the whole body. 
Lamke et al. (1977) performed a correlation between the average TEWL from the forearm, 
chest and abdomen and the TEWL for the whole body. The values of TEWL at the 
forearm, chest and abdomen were shown by Lamke to be equivalent at different skin 
temperatures, so the correlation can be applied to the model derived from Grice's work. 
The equation representing the correlation is (Lamke et aI., 1977): 
Total TEWL = 1.05(Local TEWL) + 3 
=TEWLr 
where TEWL is expressed in g m,2 h'l 
So, the expression for TEWL can be approximated to: 
TEWLr = 1.6 ( Pvp(Ts) - 12vp(T.)RH ) + 3 
100 
(5.21) 
(5.22) 
Applying equation 5.22 to a skin temperature of 33°C in an ambient temperature of 24°C 
and a relative humidity of 40%: 
To calculate the total TEWL per hour this would then have to be multiplied by the body 
surface area of the patient. The body surface area can be calculated using the DuBois 
method, provided the patient's weight and height are known. The formula proposed by 
Dubois is given in appendix C, C2.2. For the standard man with a body surface area of 
approximately 1.8 m2 (Cooney, 1976): 
TEWLr = 16.38 g h- I 
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(2) Estimates ofTEWL 
(a) Cox (1987) 
Cox stated that the insensible loss through the skin per day is approximately 250 ml m,2. 
(b) Wilson (1992) 
Estimated the insensible loss through the skin to be approximately 170 ml m,2 per day, 
(c) Cooney (1976) 
The insensible losses through the skin were stated to be 195 ml m,2 per day. 
(d) Lamke et aI. (1977) 
Lamke et aI., measured the insensible losses for three ambient temperatures of 22°C, 27°C 
and 30°C. The average insensible skin losses at these temperatures were 218 ml m,2 day" I , 
301 ml m·2 day" and 397 ml m,2 day,l respectively. 
(e) Rosenburg et aI. (1962) 
Rosenburg quoted the results of his own study and of a number of previous studies for the 
loss of water vapour through non-sweating skin (Table 5.2). 
Identifier Source Insensible loss (g m,2 h,l) 
1 Felsher (1944) 13 
2 Burch & Winsor (1944) 50 
3 Blank (1953) 2 
4 Mail (1956) 5 
5 Monash & Blank (1958) 60 
6 Rosenburg et aI. (1962) 2 
Table 5.2 Quoted estimates of transepidermal water loss 
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5.5.3.5 SummaI)' oftransepidermal water loss 
Table 5.3 summarises the insensible skin losses from the quantitative model and the other 
estimates quoted. 
LD. Source TEWL(gm" TEWL (ml day" 
2 per day) I) 
1 Quantitative model (Ultrnan, 218 392.4 
1987) 
2 Cox (1987) 250 450.0 
3 Wilson (1992) 170 306.0 
4 Cooney (1976) 195 351 
5 Lamkeet al, (1977) (at T.=22°C) 218 392.4 
6 Rosenberg et al, (1962) 48 86.4 
7 Felsher (1944) 312 561.6 
8 Burch & Winsor (1944) 1200 2160 
9 Blank (1953) 48 86.4 
10 Mall (1956) 120 216 
11 Monash & Blank (1962) 1440 2592 
Avg 384.6 690 
Table 5.3 Summary table for transepidermal water losses 
The results of the studies reported in 1962 and prior years have a very wide range of values. 
On the assumption that experimental and measurement techniques are more accurate in the 
later studies, the early results will not be compared with the result from the quantitative 
model. 
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So, considering only the values number 1 to 5 the quantitative model has produced a result 
in good agreement with the estimates. The quantitative model has the advantage of taking 
into account ambient conditions and the patient's skin temperature. It should be noted that 
the skin temperature should be taken from the volar surface of the forearm, as this was the 
point used by Grice to relate the local TEWL to skin temperature. 
5.5.4 ａ｣｣ｯｵｮｴｩｮｾ＠ for Sweat Losses 
The literature search to date has mainly produced studies that give estimates of sensible 
sweat losses. Moreover, the complexity of the process of sweating makes it difficult to 
apply general rules to it. In particular, Epstein and Sohar (1985) states that in a healthy 
individual the heat centre in the brain has a set point of 37°C and directs the heat dissipating 
mechanism to conserve this temperature; whilst in disease, endotoxins are released into the 
blood which affect the set-point causing it to rise to 40°C or higher. 
(a) Lamke et al. (1980) 
Lamke found that visible sweating was only observed in patients with a core temperature 
higher than 39.5°C. On average patients with an elevated temperature sweated for 
approximately 5 hours a day, and the losses through the skin due to this were approximately 
375 ml m-2 day-I. So, for a person with a body surface area (BSA) of 1.8m2 this represents 
an additional loss of 675 ml per day. 
For a guideline Lamke suggests that in an ambient temperature of 22-25°C a patient with 
highly elevated temperature will need an extra water supply of at least 500 ml a day to 
compensate for the loss due to sweating. 
(b) Reithner (1981) 
For a patient in high fever, the loss due to sweating can be in the region of 500 - 1,000 ml 
per day. 
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(c) Wilson (1992) 
Two possible methods are suggested: 
(i) Allow for 500 ml per day of increased sensible sweating per I°C of fever, 
or 
(ii) Allow: - 500 ml per day for mild sweating 
- 1000 ml per day for moderate sweating 
- 1500 ml per day for severe sweating 
Whether method a, b, or c is used to estimate losses due to sensible sweating requires 
experienced judgement. 
5.5.5 TechniQues for ｍ･｡ｳｵｲｩｮｾ＠ Eyaporation From the Skin 
The two techniques that were found to have been used to measure evaporation from the 
skin are: the ventilated chamber method, and the evaporimeter. Both of these methods are 
described in Scott et al. (1982). 
5.5.6 COnclusion on Insensible Water and Sweat Losses 
Insensible losses occur independently from sensible sweating losses. Insensible losses 
occur by the passive diffusion of water in the respiratory system and through the skin. 
Sensible sweating involves the active response of the brain to thermoregulatory or 
emotional signals. Further, sweating occurs through the apocrine and eccrine sweat glands, 
and electrolytes are excreted with the water lost. 
The insensible respiratory water loss (R WL), and the insensible transepidermal water loss 
(TEWL) can be considered separately. Quantitative models for both these losses have been 
developed. Two models for the R WL were developed, and are expressed below in their 
fullest form: 
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(1) Model based on McCutchan & Taylor (1951) 
RWL = (60xfRRxVTxdA )( 0.02761+0.0000650Ti-0.798Yi) 
where RWL = Respiratory water loss (g h'l m'3) 
fRR = Respiratory rate (min'l) 
V T = Tidal volume (m3) 
dA = Density of dry air at the ambient conditions (g m'l) 
Ti = Temperature of inspired air eC) 
Yi = Absolute humidity of the inspired air 
(2) Model based on Ferrus et al. (1984) 
where RWL = Respiratory water loss (mg h'l) 
V T = Tidal volume (dm3) 
fRR = Respiratory rate (min'l) 
Ti = Inspired air temperature eC) 
Pi = Partial pressure of inspired air (mmHg) 
dA = Density of dry air in ambient conditions (mg dm'3) 
Yi = Absolute humidity of inspired air 
The quantitative model for TEWL can be expressed as: 
TEWL = 1.05k (Pvp(Ts) -1lvp(TJxRH.) + 3 
100 
where TEWL = Transepidermal water loss g m,3 h'l 
Pvp(Ts) = the water vapour pressure at skin temperature (kPa) 
pvp(T J = the water vapour pressure at the ambient temperature (kPa) 
RH. = ambient relative humidity 
k = mass transfer coefficient (g m,2 h'l kPa,l) 
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(5.23) 
(5.24) 
(5.25) 
The mass transfer coefficient was found to vary with skin temperature as follows: 
k = leaexp [ 9.119 - .2SQ2..] 
273+Ts 
where T, = skin temperature eC) 
lea = pre-exponential constant (g m·2 h-I kPa- l ) 
(5.26) 
The pre-exponential coefficient, lea, will vary between individuals. With lea set at 1.5 the 
calculated local TEWL values were in the middle of the range of results presented by Grice 
et al. (1971). So when using the model an average, or initial value, of 1.5 could be used for 
leo· 
For a standard 68kg man the respiratory water loss estimates in table 5.1 varied from 218 
ml/day to 700 ml/day, with an average of 348 ml/day. From table 5.3 the range of 
published estimates for TEWL was 86 ml/day to 2,592 ml/day, average 690 ml/day. This 
large variation in TEWL estimates could be due to measurement of sweat loss being 
included in the water volume measurement, and poor measurement or experimental 
techniques. Indeed Lamke et al. (1977) showed that variation in water loss from different 
parts of the body and the measurement technique used can alter the environment over the 
skin. The values from the studies prior to 1963 were based on measurements taken when 
there were no visible signs of sweating. However, the very high variations in these 
estimates suggest that there has been some error in their measurement Disregarding these 
earlier estimates in table 5.3 leaves a range of 306 to 450 ml/day for a standard man, with 
an average of378 ml/day. Therefore the average estimate of the total insensible loss for 
a standard man in typical room conditions is 726 ml/day. The range of estimates is from 
524 ml/day minimum to 1,150 ml/day maximum. 
Other authors have also published estimates for the total insensible losses for a patient. 
Cox (1987) suggested using an estimate of 10 m1 per day per kg body weight. For a 68 kg 
man this equates to a loss of 680 ml/day. Eccles (1993) suggested allowing for a total 
insensible loss of 1400 ml/day, and Willats (1987) suggested 816 ml/kg per day. Wilson 
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(1992) suggested a range of total insensible losses from 600 ml/day to 1200 ml/day. 
Therefore, the range of estimates for the total insensible loss vary from 524 to 1400 ml/day. 
In the case where the lower estimate is used in fluid balance calculations, but the patient 
is losing the maximum amount estimated this could be leading to a systematic 900 ml daily 
error in fluid balance calculations. Such an error in the estimate of insensible losses will 
cause problems in keeping the patient in fluid balance causing them to be consistently 
under hydrated. The practice on the lTU at the Mayday is to allow 500 ml/day for a typical 
70 kg male patient, which is at the lower end of the range of published estimates. With the 
consideration of the possible miscalculation of insensible losses this suggests that further 
investigation into the estimation of these losses is warranted. 
On the lTV there will be many variables which will affect the actual fluid balance. From 
the models of transepidermal insensible loss the ambient temperature, ambient humidity 
and the patient's skin temperature will all affect the loss. The insensible respiratory water 
losses will depend on how the patient's respiration is being controlled. The majority of 
A TN lTV patient's are ventilated and thus the humidity of the inspired air is artificially 
controlled. Where the humidity of the inspired air is raised the respiratory water loss will 
be reduced, as is shown by equations 5.23 and 5.24. The theoretical limit being where the 
inspired air is fully saturated with water, and no water is lost through respiration. 
Moreover, the patient's respiratory rate and tidal volume will affect their respiratory water 
loss. Therefore there are many variables which can change the insensible losses. The 
quantitative models described above do allow variations to be included in the estimate, thus 
they offer the opportunity for producing more accurate patient and ambient sensitive 
estimates. However, the models have not been evaluated in the estimation of insensible 
losses for critically ill patients in the lTV. Therefore before the implementation of the 
models detailed studies of their accuracy would be required. This would require 
prospective clinical testing to gather the required data to prove the models. How the 
insensible losses are to be estimated in the computer based fluid charting system will be 
discussed in chapter 7. 
No detailed quantitative model representing sensible sweating losses has been found to 
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date. Accounting for sweat losses seems to rely mainly on using approximate estimates. 
Lamke et al. (1980) reported that patients in fever on average will sweat for 5 hours a day 
and lose approximately 375 ml m,2 per day of sweat. An alternative approach suggested 
by Wilson (1992) was to allow for 500ml of increased sensible sweating for every IOC of 
fever. 
5.6 SUMMARY 
This chapter has analysed the clinical problem that the proposed CDS system is to support. 
Knowledge of the material clinical domain is founded in the concepts of medical science. 
Therefore, an analysis of the material problem of acute renal failure in the lTV is built on 
knowledge of kidney physiology, pathophysiology and the kidney's control of the body's 
physiology. Using these concepts of medical science as a basis a model of the fluid and 
biochemical flows for a patient receiving CVVHD treatment on the lTV has been 
constructed. This is used as the basis for defining the monitoring of the patients fluid 
volumes and biochemistry. Furthermore, the model is also the foundation for the 
development of a fluid charting system, described in chapter 7. 
From the systems analysis for a patient suffering from A TN, the main treatment which acts 
to compensate for the loss of their renal function is the CVVHD. Therefore the treatment 
decision making governing the patients CVVHD treatment is the controlling factor in 
compensating for A TN. Hence the analysis of the decision making in the next chapter will 
focus on the problem of modelling the decision making controlling a patient's CVVHD 
treatment. 
-210-
Figure 5.1 The two kidneys in relation to the bladder and major blood vessels (Lote 
1982) 
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Figure 5.2 Longitudinal section of the kidney showing the major regions (Lote, 
1982) 
Figure 5.3 Renal blood supply (Lote, 1982) 
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Figure 5.4 Fluid flow through the kidney 
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Figure 5.5 Graph illustrating autoregulation of glomerular filtration rate (dotted 
line) and renal blood flow (solid line) (Lote, 1982) 
Figure 5.6 Kidney Functions (Eccles, 1993) 
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Figure 5.9 Cortical and juxtamedullary nephron (Lote, 1982) 
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Figure 5.15 Regulation of plasma osmolarity (Eccles, 1993) 
-219-
Figure 5.16 Factors influencing extracellular potassium concentration (Eccles, 1993) 
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Figure 5.18 Acid-base disturbances defined on the bicarbonate v pH graph (Eccles, 
1993) 
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Figure 5.19 Continuous venovenous haemodialysis schematic 
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CHAPTER 6 
DECISION MAKING FOR 
HAEMODIALYSIS MANAGEMENT 
6.1 INTRODUCTION 
It was established in the previous chapter that the decision making managing an ITU 
patient's loss of renal function controls their continuous venovenous haemodialysis 
(CVVHD) treatment. The aims of this chapter are: to present a model of the clinical 
decision making used to control a patient's CVVHD treatment, and to specify the clinical 
knowledge elicited for use in the CVVHD treatment advice. The model of the CVVHD 
decision making is based on the models of decision making developed in chapter 4. 
6.2 CLINICAL DECISION MAKING CONTROLLING CYYHD 
The controlling factor in the treatment of acute tubular necrosis (A TN) is the haemodialysis 
treatment. Therefore to effectively manage ATN in the ITU there needs to be effective 
management of the CVVHD treatment. The decision making which controls this treatment 
can be informed by a clinical decision support system. Before building a CDS system an 
analysis of the clinical decision making and the clinical knowledge is required. This 
requirement is clear when considering that a CDS system is a decision simulation tool, as 
depicted in figure 4.16. As a simulation tool it mirrors the decision maker at each stage of 
the decision making process. Thus, a model of the clinical decision making and an 
abstraction of the knowledge are central to this decision simulation. The knowledge 
elicited on the management of patients represents the expressed knowledge of Dr S 
Morgan, the ITU consultant who is a nephrology specialist. 
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The three main stages of the clinical decision making cycle in the lTV are patient state 
evaluation, monitoring and treatment (figure 4.12). The derivation and explanation of this 
three tier process model of decision making are given in chapter 4. The process begins with 
the collection of data from patient monitoring; this includes the fluid and biochemical data 
in addition to other clinical signs. From these data an initial evaluation of the patient state 
is made. The evaluation is carried out by the classification of the patient data into 
categories, for example low, normal and high. Individual classifications can then be 
grouped to form higher level classifications or diagnosis. Depending on the evaluation of 
the patient and prior decisions where made, options for action will be generated. The 
actions could be further monitoring and/or treatment. Choice of an action then follows and 
this is then ordered in the implementation stage. This usually leads to a treatment action 
being set up, which begins with an assessment of what is required and what is presently 
being done for the patient. The treatment decision cycle is then similar to the patient 
evaluation. The monitoring decision making begins in a similar way, although much of the 
monitoring action is at present standard and routine. From the monitoring the whole 
process then repeats itself. A decision tree can be used to represent the options for action 
in each of the decision loops. 
The analysis of the decision making views the process in reverse. For controlling a 
treatment the first stage is to define the treatment options which are implementable. These 
then need to be put into a structured format. A decision tree has been used to structure the 
model of the decision making controlling CVVHD. For each of the decision nodes a set 
of conditional propositions for making the decision are attached. Goals are attached to each 
of the options in the tree to enable testing of pragmatic effectiveness of the decision in the 
subsequent cycles of decision making. The conditional propositions depend on the 
assessment of the material problem presenting to the decision maker. The material clinical 
problem has been analysed above as the clinical state of the patient and of their treatment. 
These assessments of state depend on the variables recorded during the monitoring stage. 
So, the material state assessment required is defined by the treatment decisions and the 
patient state assessment. The variables monitored on the lTV at the Mayday are defined 
in the systems analysis above and by the patient state assessment below. 
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The decision tree with the goals and conditions for the treatment choices is described 
below. Derived from the conditions for the treatment decisions is the required patient state 
assessment to choose which options to implement. 
6.3 PROTOCOL FOR CVVHD TREATMENT DECISION MAKING 
The protocol described in this section was elicited from a series of structured interviews 
with Dr Steven Morgan, at the Mayday ITU. The structure of the protocol is defined by the 
analysis of decision making given above. The protocol includes treatment goals and the 
conditional propositions attached to the nodes of the decision tree in figure 6.1. The nodes 
and the branches of the decision tree have been defined according to the set of decision 
options which exist for operating CVVHD. These have been split into levels denoting the 
sequence of decisions which must be active before proceeding deeper into the decision 
making. Thus level A decisions must be active before proceeding to level B. The status 
of the options recommended represent the decision state at that point in time. Thus the 
decision state is dynamic. 
6.3.1 Actions. Goals and Conditions for the Knowledae Based Decision Makina 
DECISION NUMBER: At 
DECISION DESCRIPTION: TO BEGIN RRT OR NOT? 
HOW ACTION IS CHOSEN: IF any of the Tl conditions are satisfied AND none of the 
T2 conditions are satisfied then begin treatment ELSE do not begin RR T 
ACTION Tl: BEGIN RRT TREATMENT ON PATIENT 
GOAL(S) OF ADMINISTERING TREATMENT: 
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IN GENERAL TERMS: 
To prevent the patient's death from the metabolic affects of acute renal failure; these being 
fluid overload (leading to pulmonary oedema), acidosis, uraemia and hyperkalaemia. 
MORE PRECISELY: 
A) To keep the patient in the state of fluid balance prescribed by the physician for each 
24 hour period, where the RR T fluid balance is the balancing figure in the total 
patient fluid balance equation. 
B) To reach a base excess level ｯｦｾ＠ -10 mmol/l within 6 hours of beginning RRT, and 
then to maintain this level. 
C) To reach a urea concentration less than 30 mmol/l AND a creatinine concentration 
ofless than 350 Jlmol/l within 2 days of beginning RRT, and then to maintain them 
through out the treatment period. 
D) To reach a plasma potassium concentration in the range 3.5 to 4.5 mmol/l within 
6 hours of beginning RRT, and then to maintain this level. 
E) To reach a plasma phosphate concentration in the range 0.8 to 2.0 mmolll within 
2 days of beginning RRT, and then to maintain this level. 
CONDITIONS FOR BEGINNING RRT:-
CONDITIONS BASED ON ABSOLUTE REFERENCES FOR BEGINNING RRT 
1) If the urea level is high, > 30 mmol/l AND the creatinine is high, > 150 J.1molll 
AND the patient is not dehydrated AND the intravascular filling is adequate then 
start RRT. 
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2) If the potassium concentration is > 6.5 mmolll despite the patient receiving insulin 
and dextrose to reduce the concentration and any treatment aimed at correcting 
acidosis has not been effective then begin RRT. 
CONDITIONS BASED ON RATE OF CHANGE MEASUREMENTS 
1) Rate of change in the concentration of urea is ｾ＠ 10 mmol/l per day AND rate of 
change in the concentration of creatinine is ｾ＠ 100 Ilmol/l per day for the previous 
two days then begin RRT treatment. 
OR 
2) Rate of change in potassium has been ｾ＠ 0.5 mmolll per day for the previous six 
hours. 
OR 
3) The patient is overhydrated, or there is evidence of pulmonary oedema, and the 
patient has been oliguric (urine volume s 500 ml/day) for the previous two days. 
ACTION T2: DO NOT BEGIN RRT 
GOAL(S) FOR NOT STARTING RRT 
IN GENERAL TERMS: 
To allow the kidneys of the patient to remain self supporting for the next 12 hour 
prescription period, AND not to degrade the patient's state i.e. not to increase the patient's 
chances of dying. 
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MORE PRECISELY: 
A) Without the aid of RRT to allow the patient's kidneys to maintain the fluid balance 
as prescribed by the physician, and adequate plasma concentrations of: base excess 
> -10 mmolll, urea < 30 mmol/l, creatinine < 350 J,1mol/l, phosphate in the range 
0.8 to 2 mmol/l, and potassium in the range 3.5 mmolll to 4.5 mmolll. 
B) Not to cause a further drop in the blood pressure when the patient is critically 
hypotensive (systolic blood pressure below 70 mmHg). 
CONDITIONS FOR NOT STARTING RRT 
1) If the patient is in a state of hypotension which has not responded to any 
intervention such as drug therapy (refractory hypotension). 
OR 
2) If the patient is suffering a massive uncontrollable bleed. 
DECISION NUMBER: A2 
DECISION DESCRIPTION: TO CONTINUE WITH RRT OR NOT? 
HOW ACTION IS CHOSEN: IF any of the Tl conditions are satisfied AND none of the 
T2 conditions are satisfied then continue treatment ELSE do not continue RRT 
ACTION Tl: CONTINUE WITH RRT 
GOAL(S) OF ADMINISTERING TREATMENT: 
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IN GENERAL TERMS: 
To prevent the patient's death from the metabolic affects of acute renal failure; these being 
fluid overload (leading to pulmonary oedema), acidosis, uraemia and hyperkalaemia. 
MORE PRECISELY: 
A) To keep the patient in the state of fluid balance prescribed by the physician for each 
24 hour period, where the RR T fluid balance is the balancing figure in the total 
patient fluid balance equation. 
B) To reach a base excess level of ｾ＠ ·10 mmoVI within 6 hours of beginning RR T, and 
then to maintain this level. 
C) To reach a urea concentration less than 30 mmoUI AND a creatinine concentration 
in less than 350 J.1molll within 2 days of beginning RRT, and then to maintain them 
through out the treatment period. 
D) To reach a plasma potassium concentration in the range 3.5 to 4.5 mmol/l within 
6 hours of beginning RRT, and then to maintain this level. 
E) To reach a plasma phosphate concentration in the range 0.8 to 2.0 mmol/l within 
2 days of beginning RRT, and then to maintain this level. 
CONDITIONS FOR CONTINUING RRT: 
1) The plasma creatinine concentration is still above 150 J.1moUI. 
AND 
2) The daily urine output of less than 500ml/day for the previous two days. 
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ACTION T2: DO NOT CONTINUE RRT 
GOAL(S) FOR NOT CONTINUING 
IN GENERAL TERMS: 
To allow the kidneys of the patient to remain self supporting for the next 12 hour 
prescription period, or not to degrade the patient's state i.e. not to increase the patient's 
chances of dying. 
MORE PRECISELY: 
A) Without the aid ofRRT to allow the patient's kidneys to maintain the fluid balance 
as prescribed by the physician, and adequate plasma concentrations of: base excess 
> -10 mmol/l , urea < 30 mmol/l, creatinine < 350 Ilmol/l, phosphate in the range 
0.8 to 2 mmolll, and potassium in the range 3.5 mmol/l to 4.5 mmoill. 
B) Not to cause a further drop in the blood pressure when the patient is critically 
hypotensive (systolic blood pressure below 70 mmHg). 
CONDITIONS FOR NOT CONTINUING WITH RRT 
I) If the patient is in a state of hypotension which has not responded to any 
intervention such as drug therapy (refractory hypotension). 
OR 
2) If the patient is suffering a massive uncontrollable bleed. 
OR 
3) The patient's renal function is recovering, defined as urine volume> II/day and a 
fall in creatinine for the previous two days of 50 Ilmol/l per day from a two day 
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OR 
steady state range of values. A steady state range of values for creatinine is defined 
as a single value +/- 20 J,1molll. 
4) If the patient suffers a cardiac arrest. 
OR 
5) If the urine volume has been in the range 500 ml to 1000 ml and the potassium 
concentration is in the safe range 3.5 to 4.5 mmolll and the acid-base balance of the 
patient is safe, pH > 7.2 and base excess> -10 mmoVI and there has been a fall 
from a steady state value of creatinine of 50 J.1mol/l per day for the previous two 
days. 
DECISION NUMBER: BI 
DECISION DESCRIPTION: TO USE CVVHD TREATMENT AS THE SOLE MODE 
OF RRT OR TO USE ANOTHER MODALITY? 
HOW ACTION IS CHOSEN: IF any of the TI conditions are satisfied AND none of the 
T2 conditions are satisfied then use CVVHD as the sole RRT ELSE use another treatment 
regime 
ACTION TI: USE CVVHD TREATMENT FOR PATIENT 
GOAL(S) OF ADMINISTERING TREATMENT: 
IN GENERAL TERMS: 
To prevent the patient's death from the metabolic affects of acute renal failure. These being 
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fluid overload (leading to pulmonary oedema), acidosis, uraemia and hyperkalaemia. 
MORE PRECISELY: 
A) To keep the patient in the state of fluid balance prescribed by the physician for each 
24 hour period. Where the CVVHD fluid balance is the balancing figure in the total 
patient fluid balance equation. 
B) To reach a base excess level of ｾ＠ -10 mmoVl within 6 hours of beginning CVVHD 
treatment, and then to maintain this level. 
C) To reach a urea concentration less than 30 mmoVl AND a creatinine concentration 
of less than 350 ｾｭｯｖｬ＠ within 2 days of beginning CVVHD treatment, and then to 
maintain them through out the treatment period. 
D) To reach a plasma potassium concentration in the range 3.5 to 4.5 mmoVl within 
6 hours of beginning CVVHD treatment, and then to maintain this level. 
E) To reach a plasma phosphate concentration in the range 0.8 to 2.0 mmoVl within 
2 days of beginning CVVHD treatment, and then to maintain this level. 
CONDITIONS FOR USING CVVHD TREATMENT: 
1) The conditions for starting, or continuing, with CVVHD are the same as for general 
RRT, i.e. use CVVHD unless there are indicators for not using CVVHD. 
ACTION T2: USE ALTERNATIVE RRT REGIME 
GOAL(S) FOR USING AN ALTERNATIVE RRT REGIME 
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IN GENERAL TERMS: 
To more effectively treat the patient by using an alternative RRT treatment regime. 
MORE PRECISELY: 
A) To use an alternative RRT treatment regime, involving the use of intermittent 
haemodialysis (IHD), or Peritoneal haemodialysis. 
CONDITIONS FOR USING AN ALTERNATIVE RRT 
1) If patient is ITU independent (i.e. they no longer require the level of care provide 
by the ITU), then consider treating renal failure with IHD. 
2) If despite a filter change 24 hours previously. and its effective subsequent 
operation, the rate of change in the concentration of urea is ｾ＠ 10 mmolll per day 
and rate of change in the concentration of creatinine is ｾ＠ 100 IJ.molll per day for the 
previous day AND CVVHD has been administered for at least 2 days then either: 
1) Stop CVVHD at the end of the next prescription period and begin Intermittent 
Haemodialysis treatment; or 2) Run CVVHD and IHD together. The decision 
making model for these decisions is beyond the scope of this decision model. 
3) The patient is suffering from suspected lactic acidosis, this will initially observed 
as a falling pH and base excess despite the patient having received CVVHD 
treatment for 12 or more hours, (base excess s: -10 mmolll and lactate plasma 
concentration ｾ＠ 5 meqll and pH :s; 7.2) then discontinue CVVHD immediately and 
begin IHD (go to the IHD decision support module in the Patient Management 
System). 
4) If the patient cannot tolerate prostacyclin and the use of heparin will or does cause 
bleeding problems then discontinue with CVVHD. The intolerance of prostacyclin 
will be indicated by a fall in the patient's blood pressure (hypotension) and a 
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slowing of the heart rate (bradycardia). 
DECISION NUMBER: Cl 
DECISION DESCRIPTION: TO ADD POTASSIUM TO THE DIAL YSATE 
SOLUTION OR NOT? 
HOW ACTION IS CHOSEN: IF any of the TI conditions are satisfied AND none of the 
T2 conditions are satisfied then add 3 mmolll to the dialysate ELSE do not add any 
potassium to the dialysate. 
ACTION Tl: DO ADD POTASSIUM TO THE DIAL YSA TE 
GOAL(S) OF ADDING POTASSIUM TO THE DIALYSATE: 
IN GENERAL TERMS: 
To prevent the plasma concentration of potassium becoming critically low (hypokalaemia). 
MORE PRECISELY: 
A) To achieve a potassium concentration in the range 3.5 mmolll to 4.5 mmolll within 
six hours of starting to add potassium to the dialysate. 
CONDITIONS FOR ADDING POTASSIUM: 
1) The plasma concentration is in the range 3.0 to 3.5 mmolll. 
2) If a bolus of potassium was given to the patient 1 hour previously and the potassium 
concentration is now in the range 3.0 to 4.0 mmol/l then add potassium to the 
dialysate. 
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ACTION T2: DO NOT ADD POTASSIUM TO THE DIALYSATE 
GOALS FOR NOT ADDING POTASSIUM 
IN GENERAL TERMS: 
To allow for other injections of potassium, to prevent the patient becoming hyperkalaemic; 
not to elevate the potassium concentration above the target range. 
MORE PRECISELY: 
A) To allow the patient to maintain a potassium concentration in the range 3.5 to 4.5 
mmol/l within 6 hours of the addition of the potassium to the dialysate. 
CONDITIONS FOR NOT ADDING POTASSIUM TO DIALYSATE 
1) If the patient's potassium concentration is less than 3 mmoUI then do not add 
potassium to the dialysate and give a bolus of potassium chloride. 
OR 
2) If the patient's potassium concentration is greater than 4.5 mmoUI do not add any 
potassium to dialysate. 
DECISION NUMBER: C2 
DECISION DESCRIPTION: TO USE A 2 LITRE PER HOUR OR 1 LITRE PER HOUR 
DIAL YSATE INFUSION RATE? 
HOW ACTION IS CHOSEN: IF any of the TI conditions are satisfied then use a 211hour 
infusion rate OR if the T2 conditions are satisfied use a 1 llhour infusion rate 
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ACTION TI: USE A 2 LITRE PER HOUR DIALYSATE INFUSION RA IE 
GOAL(S) OF USING A 2 LITRE PER HOUR DIAL YSA IE INFUSION RA IE: 
IN GENERAL TERMS: 
To sufficiently remove excess potassium, phosphate, uraemic catabolites (urea and 
creatinine taken to be indicators of their removal) and to introduce additional buffer into 
the patient. 
MORE PRECISELY: 
A) To achieve, within 6 hours of an alteration in the rate of infusion and then maintain, 
a potassium concentration in the range 3.5 mmolll to 4.5 mmolll. 
8) To achieve, within 2 days of an alteration in the rate of infusion and then maintain, 
a urea concentration less than 30 mmolll and creatinine less than 350 J.1molll. 
C) To achieve, within 6 hours of an alteration in the rate of infusion and then maintain, 
a base excess above -10 mmolll. 
D) To achieve, within 2 days of an alteration in the rate of infusion and then maintain, 
a phosphate concentration in the range 0.8 mmolll to 2 mmolll. 
CONDITIONS FOR USING A 2 LITRE PER HOUR DIAL YSA IE INFUSION 
1) Depends on when the treatment began. If the treatment has begun within the last 
two days then go to condition 1 A. If treatment was begun more than 2 days ago 
then go to condition lB. 
TREATMENT STARTED IN THE PREVIOUS TWO DAYS 
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IA) If the treatment began in the previous two days then always use a 2 llh dialysate 
infusion rate. 
TREATMENT STARTED MORE THAN TWO DA YS AGO 
IB) If the potassium concentration is> 4.5 mmolll 
2B) If the plasma concentration of phosphate is > 2 mmolll 
3B) If the plasma base excess is < -10 mmol/l. 
4B) If the creatinine concentration is > 350 IJ.molll 
5B) If the urea concentration is > 30 mmol/l 
ACTION T2: USE A 1 LITRE PER HOUR DIALYSATE INFUSION RATE 
GOALS FOR USING A 1 LITRE PER HOUR DIALYSATE INFUSION RATE 
IN GENERAL TERMS: 
To sufficiently remove excess potassium, phosphate, uraemic catabolites (urea and 
creatinine taken to be indicators of their removal) and to introduce additional buffer into 
the patient. Whilst ensuring that the patient does not become over dialysed, removing too 
much potassium or phosphate from the patient. 
MORE PRECISELY: 
A) To achieve, within 6 hours ofan alteration in the rate of infusion and then maintain, 
a potassium concentration in the range 3.5 mmol/l to 4.5 mmolll. 
B) To achieve, within 2 days of an alteration in the rate of infusion and then maintain, 
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a urea concentration less than 30 mmolll and creatinine less than 350 ｾｭｯｬｬｬＮ＠
C) To achieve, within 6 homs of an alteration in the rate of infusion and then maintain, 
a base excess above -10 mmoVI. 
D) To achieve, within 2 days of an alteration in the rate of infusion and then maintain, 
a phosphate concentration in the range 0.8 mmoVI to 2 mmolll. 
CONDITIONS FOR USING A DIALYSATE INFUSION OF 1 LITRE PER HOUR 
1) Depends on when the treatment began. If the treatment has just begun then got 
condition lA if treatment was begun more than 2 days ago then go to condition lB. 
TREATMENT STARTED IN THE PREVIOUS TWO DAYS 
lA) If treatment began in the previous two days then do not use a 1 Vb dialysate 
infusion rate. 
TREATMENT STARTED MORE THAN TWO DAYS AGO 
IB) If the potassium concentration is < 4.5 mmolll and> 3.5 mmoVl 
2B) If the plasma concentration of phosphate is < 2 mmoVl and> 0.8 mmolll 
3B) If the plasma base excess is> -10 mmoVl. 
4B) If the creatinine concentration is < 350 J1moVl 
5B) If the urea concentration is < 30 mmoVl 
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DECISION NUMBER: C3 
DECISION DESCRIPTION: WHETHER TO USE HEPARIN AS THE 
ANTICOAGULANT INFUSION IN THE BLOOD 
CIRCUIT OR NOT? 
HOW ACTION IS CHOSEN: IF any of the TI conditions are satisfied then use a heparin 
infusion OR if the T2 conditions are satisfied then use an alternative anti-coagulant 
regime. 
ACTION TI: USE HEPARIN AS THE ANTI-COAGULANT INFUSION 
GOALS FOR USING HEPARIN AS THE ANTI-COAGULANT INFUSION 
IN GENERAL TERMS: 
To prevent the extracorporeal blood circuit becoming clotted without endangering the life 
of the patient. 
MORE PRECISELY: 
A) To prevent the blood circuit clotting for at least 48 hours without requiring a change 
of filter. 
B) Not to degrade the patient's clotting capability, to keep the patient's PTr less than 
twice the normal value. 
C) Not to cause the patient to lose more blood from their vessels. 
CONDITIONS FOR USING HEPARIN FOR THE ANTI-COAGULANT INFUSION 
I) The patient has not received any surgery in the previous 24 hours 
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AND 
2) The patient is haemostatically stable, i.e. not bleeding. 
ACTION T2: DO NOT USE HEPARIN FOR THE ANTI-COAGULANT INFUSION 
GOAL(S) OF USING AN ALTERNATIVE ANTI-COAGULANT REGIME: 
IN GENERAL TERMS: 
To prevent the extracorporea1 blood circuit becoming clotted for patient's who are at a high 
risk of bleeding. 
MORE PRECISELY: 
A) To prevent the blood circuit clotting for at least 48 hours without requiring a change 
of filter. 
CONDITIONS FOR USING AN ALTERNATIVE ANTI-COAGULANT REGIME 
1) The patient has undergone surgery within the previous 24 hours, then if the patient 
can tolerate prostacyclin use it for the infusion. 
2) There is evidence the patient is suffering continuing controlled blood loss. 
3) The patient is suffering from ARDS (adult respiratory distress syndrome), also 
known as shocked lung. 
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DECISION NUMBER: C4 
DECISION DESCRIPTION: WHETHER TO CHANGE THE FILTER OR NOT? 
HOW ACTION IS CHOSEN: IF any of the T 1 conditions are satisfied then change the 
filter OR if the T2 conditions are satisfied then do not change the filter. 
ACTION Tl: CHANGE THE FILTER 
GOAL(S) OF CHANGING THE FILTER 
IN GENERAL TERMS: 
To improve the ultrafiltrate volume, to improve the clearance of uraemic catabolites, to not 
increase the chances of patient infection, to prevent the loss of the patient's blood due to a 
ruptured filter, and to prevent the filter from becoming clotted. 
MORE PRECISELY: 
A) To increase the ultrafiltrate volume above 100 mllhour and up to as high as around 
1,000 mllhour. 
B) To attempt to keep the rate of rise in creatinine less than 100 J-lmolll per day and the 
rate of rise of urea less than 10 mmol/l per day. 
C) To reduce the risk of infection from the extracorporeal circuit. 
D) To prevent interference with the patient's blood flow. 
CONDITIONS FOR CHANGING THE FILTER 
1) The ultrafiltrate volume is less than 100 mllhour for the previous two hours. 
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2) Blood is observed in the dialysate circuit. 
3) The blood flow stops. 
4) If urea concentration is rising at a rate of 10 mmolll day and creatinine is rising at 
a rate of 100 IJ.molll per day for 2 days or more. 
5) If the filter was last changed more than 72 hours ago. (The filter must be changed 
before it has been used for 72 hours as this presents a risk of infection to the 
patient.) 
ACTION T2: DO NOT CHANGE THE FILTER 
GOALS FOR NOT CHANGING THE FILTER 
IN GENERAL TERMS: 
To allow for the continuous dialysis of the patient and the goals for the treatment are being 
satisfied. 
MORE PRECISELY: 
A) The goals for the treatment stated under the decisions number Al are being 
satisfied. 
B) For the patient to continuously receive dialysis for a continuous 24 hour period. 
CONDITIONS FOR NOT CHANGING THE FILTER 
1) All of the goals stated for decision A I and A2 are being satisfied. 
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2) The filter was changed ｾ＠ 72 hours previously. 
DECISION NUMBER: Dl 
DECISION DESCRIPTION: TO ADD POTASSIUM TO THE REPLACEMENT FLUID 
SOLUTION OR NOT? 
HOW ACTION IS CHOSEN: IF any of the TI conditions are satisfied AND none of the 
T2 conditions are satisfied then add 3 mmolll to the replacement fluid ELSE do not add 
any potassium to the replacement fluid. 
ACTION TI: DO ADD POTASSIUM TO THE REPLACEMENT FLUID 
GOAL(S) OF ADDING POTASSIUM TO THE REPLACEMENT FLUID: 
IN GENERAL TERMS: 
To prevent the plasma concentration of potassium becoming critically low (hypokalaemia). 
MORE PRECISEL Y: 
A) To keep the patient's potassium concentration in the range 3.5 mmolll to 4.5 mmol/l 
'within 6 hours of beginning the addition to the replacement fluid. 
CONDITIONS FOR ADDING POTASSIUM: 
1) The plasma concentration is in the range 3.0 to 3.5 mmolll. 
AND 
2) The addition of potassium to the dialysate solution began more than 6 hours ago. 
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ACTION T2: DO NOT ADD POTASSIUM TO THE REPLACEMENT FLUID 
GOALS FOR NOT ADDING POTASSIUM 
IN GENERAL TERMS: 
To allow for other injections of potassium, to prevent the patient becoming byperkalaemic; 
not to elevate the potassium concentration above the target range. 
MORE PRECISELY: 
1) To allow the patient to maintain a potassium concentration in the range 3.5 to 4.5 
mmolll within 6 hours of the addition of the potassium to the replacement fluid. 
CONDITIONS FOR NOT ADDING POTASSIUM TO REPLACEMENT FLUID 
1) If the patient's potassium concentration is less than 3 mmoVl then give a bolus of 
potassium chloride. 
OR 
2) If the patient's potassium concentration is greater than 3.5 mmolll do not add any 
potassium to replacement fluid. 
OR 
3) Potassium was added to the dialysate less than 6 hours ago. 
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DECISION NUMBER: D2 
DECISION DESCRIPTION: VOLUME OF INFUSION TO BE USED FOR HEPARIN 
INFUSION? 
HOW ACTION IS CHOSEN: The CVVHD protocol states that a standard mix is 5000 
units of heparin per litre of saline, i.e. a concentration of 5000 units/litre. Therefore, the 
infusion volwne depends on the dose prescribed by the physician. 
ACTION: FIXING OF THE ISOTONIC FLUID VOLUME TO INFUSE THE HEPARIN 
GOAL(S) USING A VOLUME OF FLUID TO INFUSE THE HEPARIN: 
IN GENERAL TERMS: 
To dilute the heparin sufficiently that the dosage can be accurately administered using the 
anti-coagulation pwnp on the dialysis equipment. 
MORE PRECISELY: 
A) To ensure the heparin dose calculated using the protocol below is delivered in the 
prescribed time. 
PROTOCOL FOR CALCULATING THE HEPARIN DOSE 
FOR PIT < TWICE NORMAL 
infusion dose = 10 ulkg per hour delivered in a volwne of 5u/ml. 
bolus dose = 20 ulkg delivered in a bolus volwne of 30 ml 
FOR PTT >= TWICE NORMAL 
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infusion dose = 5 ulkg per hour delivered in a volume of 5u1ml. 
bolus dose = 10 ulkg delivered in a bolus volume of 30 ml or 50 ml 
DECISION NUMBER: D3 
DECISION DESCRIPTION: VOLUME OF INFUSION TO BE USED FOR 
PROSTACYCLIN INFUSION? 
HOW ACTION IS CHOSEN: Dependent on the dose of prostacyclin required in the 
infusion, the patient's body weight and the concentration of the stock solution to set the 
infusion rate. 
ACTION: FIXING OF THE VOLUME TO INFUSE THE PROSTACYCLIN 
GOAL(S) USING A VOLUME OF FLUID TO INFUSE THE PROSTACYCLIN: 
IN GENERAL TERMS: 
To dilute the prostacyclin sufficiently that the dosage can be accurately administered using 
the anti-coagulation pump on the dialysis equipment. 
MORE PRECISELY: 
A) To ensure the prostacyclin dose calculated using the protocol is delivered in the 
prescribed time. 
PROTOCOL FOR CALCULATING THE PROSTACYCLIN DOSE 
infusion dose = a trial dose of 5 ng/kg per min is given for 20 minutes. If the patient is 
prostacyclin tolerant then continue to administer this dose of 300 ng/kg per hour. 
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infusion rate = (dose • body weight)/conc of stock solution 
DECISION NUMBER: El 
DECISION DESCRIPTION: VOLUME OF REPLACEMENT FLUID? 
HOW ACTION IS CHOSEN: Dependent on the volume of all other infusions given to the 
patient (the final balancing figure). 
ACTION : FIXING OF THE ISOTONIC FLUID VOLUME DELIVERED IN THE 
DIAL YSATE CIRCUIT 
GOAL(S) USING REPLACEMENT FLUID: 
IN GENERAL TERMS: 
To balance out the patient's fluid volume. 
MORE PRECISELY: 
A) To adhere to the 24 hour fluid prescription for the patient. 
PROTOCOL FOR CALCULATING THE REPLACEMENT FLUID VOLUME 
replacement fluid volume = planned fluid input volume - ultrafiltrate volume +1- target 
fluid balance 
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6.4 PROBLEM STATE ASSESSMENT FOR CVYHD TREATMENT PROTOCOL 
The material problem assessment in a clinical setting relies on establishing the material 
state of the patient and of their treatment, through the implementing of monitoring 
decisions. Which treatment and patient state assessments are required in the specified 
protocol have been defined above. These are condition sensitive propositions describing 
the observed state of patient and treatment. By comparing the data set defined by the 
systems analysis above with the one defined by the patient and treatment state decision 
variables below, it can be seen there are differences between the two. The proposed 
decision support system is to solely support the above protocol and thus the data set 
required is the one below. How the two data sets are to be used in the system design will 
be considered in the next system design chapter. 
6.4.1 Patient State Assessment 
For the patient state assessment the monitored variables are classified into ranges before 
being used by the clinician in the decision making process. A possible framework for 
performing this classification is specified below. 
Applying the a priori concept of space and time, the assessment of state relates to a 
particular patient at a particular time. There will be a series of assessments made in a 
chronological sequence. The relation between a series of assessments is assessed to 
identify trends in changes in the patient state. Thus, two classifications of state assessment 
will be used in the system: 
i) STATIC PATIENT STATE ASSESSMENT: 
A single patient state assessment either derived, or user entered, representing the patient 
state at a single point in time and not related to any prior state assessment. Where 
quantitative variables need to be classified into ranges the clinical classification of single 
data measurements are put into one of five classes, in a similar way to the assessments 
performed in the TANIT project (Uppsala University, 1993). The following qualitative 
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scale is proposed for this classification: 
a) CRITICALL Y HIGH - indicating that some intervention must be made to reduce 
the reading. 
b) HIGH - indicating that the reading is above the target range and should perhaps be 
monitored more closely to ensure it does not become critical. 
c) IN TARGET RANGE - the measurement is within an acceptable range 
d) LOW - indicating that the reading is below the target range and should perhaps be 
monitored more closely to ensure it does not become critical. 
e) CRITICALLY LOW - indicating that some intervention must be made to increase 
the reading. 
ii) DYNAMIC STATE ASSESSMENT: 
Two or more measurements on the patient, used to calculate and then classify the rate of 
change of the variable. The rate of change will be classified into one of the following five 
states: 
a) RISING RAPIDLY/ACUTELY - the rate of increase of the variable could be life 
threatening. 
b) RISING - the value is rising more quickly than the acceptable limits 
c ) STABLE - the rate of change is within acceptable limits. 
d) FALLING - the value is decreasing more quickly than the acceptable limits 
e) RAPIDLY FALLING, OR ACUTELY FALLING - the rate of decrease of the 
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variable could be life threatening. 
6.4.2 Patient States to be Assessed 
The CVVHD treatment decisions rely on the following categories of patient states: 
fluid state 
acid-base state 
electrolyte state 
state of catabolites 
urine volume 
cardiovascular state 
haemostasis 
lTV dependency 
anticoagulant tolerance 
respiratory state 
body mass 
A description of how these states of the patient are assessed is given below. 
6.4.2.1 Fluid state 
STATIC STATE ASSESSMENT 
i) Absolute volume assessment defined as either: 
(a) Overhydrated, total body fluid volume overload. (High) 
(b) Uvoleamic, total body fluid volume normal. (Target) 
(c) Dehydrated, total body fluid volume deficit. (Low) 
ii) The prescribed volume figure for fluid balance for the current 24 hour period. 
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iii) The intravascular filling is adequate. 
iv) Evidence of pulmonary oedema. 
DYNAMIC STATE ASSESSMENT 
i) Fluid volume balance for the previous 24 hours 
ii) Accumulated fluid balance in the current treatment period. 
iii) The remaining fluid to be lost or gained in the current treatment period. 
6.4.2.2 Electrolyte state 
STATIC STATE ASSESSMENT 
Plasma concentration of: 
i) Potassium: 
(a) >= 6.5 mmolll (CRITICALLY HIGH) 
(b) > 4.5 mmol/l and < 6.5 mmol/l (HIGH) 
(c) >= 3.5 to <= 4.5 mmolll (TARGET) 
(d) > 3.0 to < 3.5 mmolll (LOW) 
(e) <= 3 mmolll (CRITICALLY LOW) 
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I) Phosphate 
(a) > 2.0 mmolll (HIGH) 
(b) <= 0.8 to >= 2.0 mmol/l (TARGET) 
(c) < 0.8 mmolll (LOW) 
DYNAMIC STA IE ASSESSMENT 
i) Potassium 
(a) <! 0.5 mrnolll per day (RISING RAPIDLy) 
(b) < 0.5 mmolll per day (RISING) 
6.4.2.3 State ofcatabolites 
STATIC STATE ASSESSMENT 
i) Urea 
(a) > 30 mmolll (HIGH) 
(b) <= 30 mmolll (TARGET) 
ii) Creatinine 
(a) > 350 ｾｭｯｬｬｬ＠ (HIGH) 
(b) ｾ＠ 150 ｾｭｯｬｬｬ＠ to ｾ＠ 350 ｾｭｯｬｬｬ＠ (TARGET VALUE) 
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(c) < 150 Ilmol/l (LOW) 
DYNAMIC STATE ASSESSMENT 
i) Urea rate of change 
(a) ｾ＠ 10 mmol/l per day (RISING RAPIDLY) 
(b) < 10 mmolll per day (RISING) 
ii) Creatinine rate of change 
(a) ｾ＠ 100 Ilmolll per day (RISING RAPIDLY) 
(b) < 100 Ilmo11l per day (RISING) 
(c) +1- 20 Ilmo1l1 per day (STABLE) 
(d) > 50 Ilmo11l per day (FALLING) 
6.4,2.4 Urine volume 
DYNAMIC STATE ASSESSMENT 
i) Urine production rate 
(a) urine volume> II/day (TARGET) 
(b) urine volume> 500 ml/day to < 1000 ml/day (LOW) 
(c) urine volume ｾ＠ 500 ml/day (oliguric) (CRITICALLY LOW) 
-253-
6.4.2.5 Acid-base state 
STATIC STATE ASSESSMENT 
i) Blood pH (in acute renal failure concerned with treating metabolic acidosis) 
(a) >= 7.3 ,and <= 7.45 (TARGET VALUE) 
(b) > 7.2 ,and < 7.3 (LOW) 
(c) <= 7.2 (CRITICALLY LOW) 
ii) Base excess 
(a) < -10 mmol/l (LOW) 
(b) ｾ＠ -10 mmolll (TARGET) 
iii) Suspected lactic acidosis. (This will initially observed as a falling pH and base 
excess despite the patient having received CVVHD treatment for 12 or more hours. 
The measured values will be in the ranges: base excess s -10 mmol/l; lactate 
plasma concentration ｾ＠ 5 meq/l, and pH s 7.2.) 
6.4.2.6 Cardiovascular state 
STATIC STATE ASSESSMENT 
i) Systolic blood pressure below 70 mmHg (CRITICALLY LOW). 
ii) Refractory hypotension, occurs when the patient is in a state of hypotension which 
has not responded to any intervention such as drug therapy. 
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iii) Patient suffers a cardiac arrest. 
6.4.2.7 Haemostasis 
DYNAMIC STATE ASSESSMENT 
i) The patient is haemostatically stable. 
ii) If the patient is suffering a uncontrollable bleed. 
iii) There is evidence the patient is suffering continuing controlled blood loss. 
6.4.2.8 lTV dependency 
STATIC STATE ASSESSMENT 
If patient is lTV independent (i.e. they no longer require the level of care provide 
by the lTV). 
6.4.2.9 ａｮｴｩ｣ｯ｡Ｌｾｵｬ｡ｮｴ＠ tolera,nce 
STATIC STATE ASSESSMENT 
i) The intolerance of prostacyclin will be indicated by a fall in the patient's blood 
pressure (hypotension) and a slowing of the heart rate (bradycardia). 
ii) Coagulation times 
(a) PTT >= twice normal 
(b) PIT < twice normal 
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6.4.2.1 0 Respiration 
The patient is suffering from ARDS (adult respiratory distress syndrome), shocked 
lung) 
6.4.2.11 Body weiiht 
Estimate of patient weight 
6.4.3 Patient's Treatment State Assessment 
The treatment actions which have an impact on the CVVHD decision making protocol are 
listed below. 
6.4.3.1 Potassium treatment 
i) The patient has received insulin and dextrose to reduce the plasma potassium 
concentration and no change has been observed. 
ii) A bolus of potassium chloride given to the patient 1 hour or more previously 
6.4.3.2 Treatment for acid base disorders 
Patient receiving treatment aimed at correcting acidosis. 
6.4.3.3 Suriery 
The patient received any surgery in the previous 24 hours. 
6.4.3.4 CYYHD treatment state 
The state of the CVVHD treatment is defined by the possible actions in the decision tree 
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and the predetennined fixed settings. The CVVHD treatment decision making advising on 
the treatment set up is affected by the states defined below. 
FIL TER STATE 
The time of the last filter change. The age of the filter which affects the decision making 
and require classification are: 
i) Last filter change less than 24 hours ago 
ii) Last filter change 72 hours ago. 
iii) The filter was changed < 72 hours previously. 
TREATMENT TIME 
The time the CVVHD treatment has been running: 
i) CVVHD has been administered for >= 2 days 
ii) The patient having received CVVHD treatment for >= 12 
BLOOD IN DIALYSATE 
Blood observed in the dialysate circuit needs to be recorded. 
FLOW STOPS 
Any blood flow stoppage in the extracorporeal circuit. 
DIAL YSA TE COMPOSITION 
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The timing of the addition of potassium to the dialysate divides into two bands: 
i) Addition of potassium began more than 6 hours ago. 
ii) Potassium added <= 6 hours ago. 
FLUIDS 
The calculation for the replacement fluid volume requires: 
i) The planned fluid input volume. 
ii) The ultrafiltrate volume. 
In addition to a record of the ultraflltrate volume, the decision making needs to know when 
the ultrafiltrate volume has been below 100mllhour for two consecutive hourly 
measurements. 
6.5 TRUTH OF KNOWLEDGE BASE 
As discussed in section 3.3.5 applying the mental model of belief, knowledge is acquired 
through the entertaining of beliefs and then assenting to them. Then by the behaviourist's 
model the acquired knowledge is applied in actions. Thus, through experience in a domain 
a knowledge base of propositions is constructed relating to solving problems in the domain. 
The notion of expertise is centred on the assumption that the more experience gained in a 
domain leads to more knowledge of the domain. Thus, using a clinical expert as an initial 
source of clinical knowledge is a good starting point for constructing a knowledge base. 
However, using authority as source of truth, as in justified true belief, has been described 
as a non-philosophical source; non-philosophical because authorities disagree and accepting 
truth should involve some critical philosophical reflection. Therefore, any knowledge base 
elicited from an expert source needs to tested according to the three philosophical tests of 
truth: correspondence; coherence, and pragmatism. 
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The correspondence test of truth can be applied to the propositions describing the patient 
state, and the state of their treatment; the truth of the proposition relying on the observation 
of the phenomena which is described by it. The observation can proceed the proposition, 
or for confirmation of a proposition the observation can be the verification of its truth. 
The nature of clinical propositions describing the state of patients varies from the single 
measurement proposition to the grouping of single measurements into a diagnostic 
categorisation. The general form of the single measurement proposition is "(proposition 
subject) is (subject property) at (time and date) for (patient x)," the time and the patient 
identifier fix the time and space the proposition relates to; for example, "Potassium is 4.0 
mmolll at 06:50 on 23/2/96 for patient number 234567." This proposition is based on a 
single observed measurement of plasma potassium concentration for patient 234567 taken 
at 06:50. The diagnostic, or high level propositions, are of the form, "Patient number 
234567 is in renal failure at 14:00 on 25/3/96." The diagnostic proposition is arrived at by 
the amalgamation of a number of individual measurements into a single concept of which 
there is prior knowledge. Thus the process of arriving at the diagnostic proposition is a 
more complex relying on observation, reason and deep conceptual knowledge. A similar 
situation applies to treatment propositions where they vary from specific measurements of 
treatment to general descriptions of the patient treatment. For example, the dialysis 
extracorporeal blood flow is 100mllmin at 10:00 for patient 234567; which could be part 
of the proposition "patient 234567 receiving CVVHD treatment." 
For the single measurement propositions the observation should define the proposition, thus 
the truth is confirmed by a prior observation; starting with a proposition and measuring to 
see if is true is the other way to test its truth. This is applied particularly in diagnostic 
decision making where a hypothesis is proposed for the diagnosis and this is either 
confirmed or denied through further observation. For the clinical protocol above the 
correspondence test is applied to pre-defined propositions and when they correspond to an 
observed state the condition becomes true. When the proposition is true then specified 
actions are recommended in response to the material state. 
Coherence theory can be applied to a set of observations for logical coherence with one 
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another. This is done by applying conceptual knowledge of what the relationship of the 
propositions is expected to be. Any logical exceptions can be used to decide when another 
observation is required to confirm the initial observation. The coherence test is more 
relevant to the higher level diagnostic state propositions than the single measurement end 
of the spectrum of knowledge. 
Coherence theory can also be applied to a protocol by logically testing it against knowledge 
from another source for consistency. The knowledge used for coherence checking could 
have varying levels of established truth within it; from scientific knowledge as the best 
established to other clinical opinion as the least established. Considering the analogy of 
the spectrum of truth described in chapter 3, the knowledge used in the consistency test at 
the first level should be set against the knowledge with the highest level of established 
truth. In the field of medicine this is knowledge of medical science, including physiology 
and pathophysiology. At the other end of the spectrum of truth is other clinical opinion, 
where the clinical opinion represents the view of another authority and thus does not 
necessarily represent truth. Therefore, the most fundamental coherence test which can be 
applied to a clinical protocol is that of consistency with the established scientific theoretical 
concepts. Where large scale clinical trials are available they can also form the basis for 
another level of knowledge coherence testing. Other clinical opinion can be used as a basis 
for comparison, but not for the judgement of absolute truth. The proving of the knowledge 
base pragmatically has more value philosophically than using one authority's opinion in 
preference to the other. Unless the opinion of one of the authorities has been rigorously 
proven to be true using the tests described here. The classifications used in medical science 
are similar to those used in clinical practice. Therefore, the scientific knowledge applied 
in the coherence test will relate directly to the corresponding clinical specialism. 
Performing the coherence test requires the deductive linking of propositions. Thus, the 
result of the coherence test is a web of knowledge threaded by logic. The web formed by 
this process can then be used to give deep justification to the knowledge used in the 
operation of a decision support system in addition to justifying the truth of the knowledge 
base. 
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Following the application of coherence testing the most valuable test of truth in the field 
of technology applied to medicine is the pragmatic one. This test operates at a higher level, 
and is a test of the whether the knowledge applied in a practical scenario fulfils its purpose. 
For example, the highest level purpose of CDS is to improve patient care. To prove the 
truth of a knowledge base in this context would require the proof of an improvement in 
patient care. Ultimately this would involve large scale clinical trials, similar to those 
required for new drug therapies. 
At a lower level of the protocol structure decision goals can be attached to each of the 
decision options, the knowledge contained in each decision node can then be tested 
pragmatically. The testing of the knowledge base in this way can then be done as part of 
the initial knowledge base development and during the application of the CDS system to 
a particular patient. During development testing of the CDS system the conditional 
propositions can be modified to try and ensure the purpose of the decision is satisfied. 
Then during the application of the CDS system, if the goals of the decision are not being 
satisfied then a strategy beyond the scope of the system needs to be tried, for example 
intervention from a clinical expert. Therefore goals attached to each decision node are 
important to test the pragmatic validity of applying the knowledge base to a patient. One 
medium for pragmatically developing and testing the knowledge base is in the form of a 
computer program. The development of the computer based protocol is described in 
chapter 7. 
6.5.1 ｋｮｯｷｬ･､ｾ･＠ Base Coherence ｔ･ｳｴｩｮｾ＠
The knowledge in each of the decisions of the treatment protocol can be classified as either 
decision goals, or conditional propositions. Decision goals define the function of the 
decision when it is in the active, or affirmative, state. Logically the knowledge can be 
tested for relevance to the diagnosis of the patient state, and for consistency with 
knowledge of the function of the treatment. Patients treated with CVVHD in the ITU are 
generally suffering from ATN. The pathophysiology of this condition was defined in 
section 5.3.3. Table 6.1 shows the ｣ｯｭｰ｡ｲｩｳｯｾ＠ between protocol decision goals and the 
defined pathophysiology and treatment function for option T 1 of decision AI. For example 
-261-
one of the treatment goals is to reduce plasma potassium to less than 4.5mmoVl, this is a 
relevant goal as a patient suffering from A'IN will be suffering from hyperkalaemia due to 
their bodies inability to excrete potassium using their kidneys. Moreover, the CVVHD 
process removes excess electrolytes from the patients plasma. Therefore the goal is 
logically consistent with the characteristics of the patient state and the function of the 
treatment. These types of logical coherence check can be done in formal way as shown in 
table 6.1, in addition to informal checking during knowledge elicitation. 
The conditional propositions of the protocol can be similarly checked for logical 
consistency with knowledge of the likely patient state and the treatment function. For 
example, high levels of urea and creatinine are consistent with the patient not being able 
to excrete them due to lack of kidney function. Although the raised concentration may be 
due to a change in the volume of the plasma for example when the patient is dehydrated, 
which is excluded by the other parts of the treatment condition. 
By explicitly showing that the protocol does not contradict more established knowledge it 
is possible to test the reasonableness of its contents and the functionality of its advice. The 
advantage of including this as a formal stage of knowledge validation is to question the 
knowledge early in development and to construct a knowledge base which is built on the 
foundations of previously defined scientific truth. Moreover, it provides a basis for 
reasoned justification when the knowledge is applied to generate decision advice. 
6.6 SUMMARY 
The material problem analysis in chapter 5 identified the treatment used for a patient 
suffering with A'IN on the ITU is CVVHD. In this chapter the models of decision making 
developed in chapter four have been applied to the analysis and modelling of CVVHD 
decision making process. The model of the clinical decision making process provides the 
basis for a computer based simulated decision making advice system described in the next 
chapter. 
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Iable 6.la Coherence test of decision goals, for decision AI, option II. 
Decision Patient state Relevance and Knowledge of Relevance of 
Goal knowledge reasonablenes haemodialysis action to goal 
(Willats, 1987, and s of goal (Sargent and 
Eccles, 1993) Gotch, 1989) 
Potassium in Normal potassium Control of Reduces Haemodialysi 
the range 3.5 3.5 to 4.8 mmoi/i. potassium is a potassium s is able to 
to 4.5 mmolll Hyperkalaemia can relevant goal. concentration remove 
within 6 cause cardiac arrest The limits in the blood potassium 
hours of and is associated proposed are flow by from the 
beginning withARF. reasonable at diffusion and patient's 
CVVHD,and Hypokalaemia can this stage of convection plasma. 
then to stay cause respiratory development. across the Action is 
within these failure and muscle dialysis relevant. 
limits. paralysis. membrane. 
Phosphate in Normal phosphate The link with Haemodialysi An effective 
the range 0.8 0.8 to 1.35 mmolli. hypocalcaemi s reduces treatment for 
to 2.0 mmolll Phosphate is raised a is the main phosphate reducing 
within 2 days in renal failure. threat to life. concentration phosphate 
of beginning Acute Hyper- Perhaps in the blood plasma 
CVVHD phosphataemia control of by diffusion concentration 
treatment, above 1.35 mmol/l calcium and s Action is 
and then to causes concentrations convection relevant. 
stay within hypocalcaemia is equally across the 
these limits which can be life relevant. dialysis 
threatening. Upper limit of membrane. 
the goal range 
requires 
clarification. 
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Table 6.lb Coherence test of decision goals, for decision AI, option Tl 
Decision Goal Patient state Relevance and Knowledge of Relevance of 
knowledge reasonableness haemodialysis action to goal 
(Willats, 1987, of goal (Sargent and 
and Eccles, Gotch, 1989) 
1993) 
Base excess Normal range - Relevant to Buffer in the Increases 
above -10 2.3 to +2.3 control buffer dialysate amount of 
mmol/l within mmol/l (PH levels in the solution base buffer in 
six hours of around 7.36- presence of diffuses into the patient's 
starting 7.44) metabolic the patient's plasma. 
treatment, and Renal failure acidosis. plasma to Action is 
then to stay --+ metabolic The level of increase buffer relevant. 
above this acidosis, base base excess to levels in the 
limit. excess <-6 set requires patient. 
mmolll (PH < further testing. 
7.36) At present it is 
Reduction of between -6 and 
base buffer -10 mmol/l. 
due renal 
failure can 
lead to many 
clinical 
problems, 
including 
cardiac failure. 
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Table 6. Ie Coherence test of decision goals, for decision AI, option TI 
Decision Goal Patient state Relevance and Knowledge Relevance 
knowledge reasonablenes of of action to 
(Willats, s of goal haemodialysi goal 
1987,and s 
Eccles, 1993) (Sargent and 
Gotch, 1989) 
urea < 30 Normal urea Goal is Urea is An 
mmol/l within is in the range relevant to the removed effective 
2 days of 2.5 to 6.6 treatment of from the treatment 
beginning mmol/l. uraemIa. patient's for the 
CVVHD,and Ideally in The limit plasma by treatment 
then to stay ARFblood should be diffusion and of uraemia, 
below this urea should be approximately convection removing 
limit.. kept below 35 30 to 35 into the urea, 
mmolll. mmolli. The dialysate. creatinine 
High urea is time for and the 
an indicator of achieving the unidentifie 
impaired renal goal should d uraemic 
function perhaps be toxins 
High urea is a extended. 
symptom of 
uraemia 
which 
produces 
effects similar 
to systemic 
poisoning. 
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Iable 6.1 d Coherence test of decision goals, for decision AI, option II 
Decision Goal Patient state Relevance and Knowledge of Relevance of 
knowledge reasonableness haemodialysis action to goal 
(Willats, 1987, of goal (Sargent and 
and Eccles, Gotch, 1989) 
1993) 
creatinine < Normal Reduction of Creatinine is Haemodialysis 
350 ｾｭｯｬＯｬ＠ creatinine is in creatinine is removed by is an effective 
within 2 days the range 44- part of diffusion and treatment for 
of starting 124 ｾｭｯｬＯｬ＠ compensating convection the control of 
CVVHD,and High for the lost into the the levels of 
then to stay creatinine is renal function dialysate. creatinine. 
below this taken as an of the patient. 
limit. indicator of The levels of 
impaired renal the goal are 
function and a reasonably 
symptom of consistent with 
uraemia. the patient 
Paginni (1992) state 
ARF occurs knowledge. 
between 265 
ｾｭｯｬＯｬ＠ and 
442 ｾｭｯｬＯｬＮ＠
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Table 6.Ie Coherence test of decision goals, for decision AI, option TI 
Decision Goal Patient state Relevance and Knowledge of Relevance of 
knowledge reasonableness haemodialysis action to goal 
(Willats, 1987, of goal (Sargent and 
and Eccles, Gotch, 1989) 
1993) 
To keep the "Accurate Due to the Ultrafiltration Haemodialysis 
patient in the fluid balance threat to the of fluid from can be used to 
state of fluid monitoring is patient's life the patient's provide fluid 
balance essential since accurate fluid plasma passing "space" in the 
prescribed by overhydration control is through the ARF patient. 
the physician readily important. dialysis allows 
for each 24 produces for the 
hour period; pulmonary removal of 
where the oedema." excess fluid. 
CVVHD fluid Patients with 
balance is the renal failure 
balancing are unable to 
figure in the remove excess 
total patient water from 
fluid balance their bodies. 
equation. Fluids are 
required to 
administer 
drugs and 
nutrients to the 
patient. 
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CHAPTER 7 
COMPUTER SYSTEM DESIGN AND 
DEVELOPMENT 
7.1 INTRODUCTION 
The analysis in the previous two chapters provided a model of the clinical problem, and of 
the clinical decision making which can be used to control CVVHD treatment. In 
ontological terms the previous chapter defined the material and idealistic problems to be 
addressed by the decision support system. In terms of figure 4.11 the detail of the material 
clinical problem and a model of the relevant clinical decision making has been defined. 
This chapter describes the development of a computer system proposed for helping to 
alleviate the clinical problem and to provide treatment advice to the user. The computer 
system is to act as an information source for the clinical decision maker during assessment 
of the clinical problem and during their decision making process, figure 7.1. 
The clinical problem centres on the management of acute renal failure (ARF) patients on 
a general ITU. This breaks down into two main problems: 
i) Maintaining the fluid balance in ARF patients requires accurate fluid balance 
calculations. 
ii) An expert with experience in managing the CVVHD process will not be available 
24 hours a day to offer advice to staff operating the process. 
It is proposed to address these problems by the application of a computer based decision 
support tool with the following functions: 
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i) A program for charting the fluids for patients receiving CVVHD, presenting 
numerical and graphical displays of hourly and cumulative patient fluid balance. 
ii) A program which offers patient specific advice to the decision maker during the 
decision making process. 
Applying the classifications developed in chapter 4, the first function of the decision 
support tool can be classified as a knowledge support system. The fluid charting program 
contains information which can add to the decision maker's knowledge of the material 
problem being faced. The second program of the proposed system truly provides decision 
support as it actively simulates the decision making process and offers justified advice, or 
opinions, on the decision state. 
The aim of this chapter is to describe the development of the two functional components 
of the system, within an integrated systems design. The description will include: 
specification of the system requirements; specification of the system design; the design and 
development of the knowledge support system; and the design and development of the 
decision simulation component. 
7.2 SYSTEM REQUIREMENTS 
As shown in figure 7.1 the computer system acts as an information store and provider to 
the clinical decision maker. This information needs to be relevant to the clinical problem 
and to the clinical decision making process. Therefore the computer system requirements 
are founded on the problem analysis in the previous two chapters, where the fluid charting 
system adds to the decision makers knowledge of the problem and the decision support 
directly simulates the decisions to be made. 
In addition, in addressing the clinical problem other qualities are required of the computer 
system. These general qualities describe how the computer system will interact with the 
user and perform its function. The general system requirements were derived from visits 
to, and discussions with, the staff' at the Mayday lTV, the renal unit at St Helier, and St 
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George's Hospital. Supplementary to these visits, references describing the requirements 
for clinical decision support in intensive care, and expert systems in general (Hunter et aI., 
1991, Ambroso et aI., 1992, Oravec and Travis, 1992, Plant, 1992 and Eliot, 1992) were 
used to define the requirements. The requirements specified below include the system user 
groups and the general characteristics required in the system. 
7.2.1 User Groyps 
To determine system requirements it is important to first establish who the end users are 
likely to be. The system will be required to work in a number of scenarios with different 
users, or user requirements, in each scenario. It is envisaged that an operational system will 
be required to work in the following scenarios. 
7.2.1.1 Clinical 
The main function of the system will be to work in a general ITU on a daily basis. In this 
situation the following group of users will directly or indirectly interact with the system: 
i) The lTU consultant who may not be an expert in managing CVVHD. 
ii) A general medical registrar on call throughout the hospital. 
iii) Junior doctors working full-time on the lTV. 
iv) Specialist lTV nurses with additional experience or training In operating 
haemodialysis. 
v) The dietician concerned with the patient's nutritional needs. 
vi) The pharmacist concerned with the patient's drug therapy. 
vii) Patients with acute renal failure. The patients treated on the lTV will be of adult 
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size. 
The nurse will have the most interaction with the system. A diagram representing a 
possible clinical scenario is show in figure 7.2. Addressing the clinical need is the prime 
concern during development of the system, although the other user groups described below 
will also have their own requirements for the system. 
7.2.1.2 Manaiement 
The people primarily interested in management information that could be taken from the 
system are: 
i) The nursing manager responsible for the lTV. 
ii) The consultant in charge of the lTV. 
7.2.1.3 Maintenance 
There are two main pieces of equipment in the CVVHD system which will need 
maintenance: 
i) The haemodialysis equipment. The computer-based management system could be 
used as a tool in maintaining its effective operation and in this situation the end user 
would be the lTV nurse or a technician. 
ii) The computer-based management system. In the maintenance of the management 
system itself, a computer professional would be the end user. 
If the system is to operate practically on an lTV, the requirements of these groups of end 
users must be taken into account. 
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7.2.1,4 System evolution 
For the system to be effective after it is first implemented it must be easy to update in order 
to adapt to technical and medical innovations. The end users that will require access to the 
system to carry out updates will be: 
i) A computer expert 
ii) A clinical expert 
7.2.2 Clinical USer ReQuirements 
7.2.2. I Desi"n approach 
The approach of the project will be to develop a clinical patient management system which 
emulates current clinical practice. This approach has been adopted to promote the usability 
of the product. Moreover, a user centred approach will be adopted in the design. 
Documentation will be produced throughout the design process and manuals on the system 
operation will be written. The four main stages of the design process of the project 
development are: 
i) Assessment of system requirements, including an analysis of the clinical problem; 
ii) The early design phase, to include early prototyping of the system; 
iii) Development and testing; 
iv) Final acceptance of the system following satisfactory test results. 
7.2.2.2 Inputs 
Wherever possible, the aim should be to make the data capture automatic, through direct 
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interfacing between the computer and the dialysis equipment. Thus, the data entry tasks 
of the nurse should be kept to a minimum. However, there will also have to be a capability 
to capture some data through manual entry. 
The screen interface, where possible, will emulate the present paper method for displaying 
data. Prompts for recording data will appear on the screen at a pre-determined time. It 
should be possible to study all the input data on the screen, whether captured automatically 
or manually. Where necessary it must be possible to easily correct mistakes made in 
inputting the data. To make effective use of the database only data that are acted on should 
be recorded. 
7.2.2.3 Output 
Where possible the output displays should emulate the present method for representing the 
patient data. If there is no common way of representing the data a graph display will be 
used. The use of a colour display could be used to enhance the capabilities for producing 
clear graphs. It should be possible at any time to easily obtain a print-out of what is shown 
on the screen. The screens displaying output and input information should be easy to move 
between. The system will be required to produce the following reports: 
i) A paper summary of the patient's state to be kept on the lTV files; 
ii) A plan for the CVVHD therapy for the next 24 hour period. 
It would aid the production of reports if the system has some word processing capability. 
7,2,2.4 Time response 
The database system is replacing a pen and paper system that offers instant data access in 
the form of a paper chart. Therefore, the database should have as instant response as 
possible. The knowledge base is offering a decision support function to the medical staff, 
so it should act so as not to slow down or inhibit the physician's decision process. 
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7.2.2.5 ｉｮｴ･ｾｲ｡ｴｩｯｮ＠
The aim is to integrate the system with local ITU and hospital wide networks. This will 
allow the automatic transfer of data on the patient to and from other parts of the hospital. 
Integration is one of the major benefits of computer systems and from papers on expert 
systems it seems that past systems have not fully exploited the potential in this area (Oravec 
and Travis, 1992, Hunter et al., 1991). 
7.2.2.6 ｋｮｯｷｬ･､ｾ･＠ base 
The knowledge base used to offer advice on a patient's CVVHD treatment must display the 
following characteristics: 
i) It must be able to be interrogated by the physician on any suggestion put forward; 
ii) To explain its ｢･ｨ｡ｶｩｯｵｲｾ＠
iii) To demonstrate clearly that decision making based on recognised medical 
knowledge has been used; 
iv) To have the capability to be easily updated as medical knowledge changes. 
The knowledge to be used will be elicited during interviews with a clinical expert and by 
observing the CVVHD process. The clinical expert whose knowledge will be used in the 
knowledge base is Dr Steve Morgan, a nephrologist and lTV consultant. 
7.2.2.7 ｔ･ｳｴｩｮｾ＠ ｳｴｲ｡ｴ･ｾｹ＠
The fluid charting system and the decision support system will be developed and tested 
separately. The main stages of testing are: 
i) Testing the functionality of the system; 
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ii) Testing off-line, in real time, using historical data from patients; 
iii) Parallel testing of the system in real time on a patient undergoing treatment. 
7.2.2.8 Reliability 
Taking the computer system as a whole it should meet the reliability standards specified 
for the dialysis equipment, that is it should not fail more often than the dialysis equipment. 
The computer needs to be protected from computer viruses. The database will be required 
to perform validity checks on the input data, and to present reports on any spurious input. 
For example spurious data could arise where a patient is being moved. It would be 
desirable to present an indication of the reliability of a suggestion offered in the decision 
support function. In relation to computer system failure there must be adequate back-up 
to allow for near complete information retrieval. Resorting to pen and paper records should 
be a final option. To help achieve good back-up the following steps should be taken: 
i) Regular saving of data to the hard disk from the temporary memory store of the 
computer. 
ii) Regular back-up of data on the computer hard disk to a remote data medium. 
iii) An uninterruptable power supply to provide a continuous power input to the 
computer. 
7.2.2.9 Maintenance of equipment 
The computer system could offer advice on the maintenance of the dialysis equipment. 
This will include advice on when to change the 'soft' parts of the dialysis equipment, for 
example the filter change. Moreover, the system could offer advice on the setting up of the 
equipment for a new patient. For ease of maintenance of the computer system a modular 
design approach will be adopted. This should aid the fault finding and repair of system 
faults. 
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7.2.3 Clinical System Administration Requirements 
7.2.3.1 ｔｲ｡ｩｮｩｮｾ＠
There are conflicting user requirements in this area: 
On the one hand there is a management need to keep costs to a minimum. This 
would demand on the job training of staff. 
Whilst previous work (INFORM Consortium, 1990) has shown that one of the most 
important factors in implementing a new computer system is the training of staff; 
nurses have expressed a preference for this formal training to take place away from 
the concerns of caring for a patient. 
A major criterion for judging the success of a system is how much it is used by the medical 
staff. Adequate training is needed to encourage system use. Therefore, formal training 
away from the pressures of patient care should be offered if possible. To support the 
training of staff help screens will be required. The general help screens will offer advice on 
how to use the system, whilst specific help screens for the knowledge base will offer advice 
on the decision making process. 
7.2.3.2 Resources 
The system will be implemented on a bedside IBM compatible PC. A printer local to the 
ITU ward will also be needed. This will involve having a connection to the networked 
printer on the lTV ward. The cost of the hardware required for the implementation of the 
system on the lTV will be met jointly by the Mayday University Hospital and City 
University. 
7.2.3.3 Security of information 
A password will be required to gain access to the system. The level of access into the 
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system will vary with the needs of the end-user. For example the consultant will have 
access to more system capabilities than the nurses. Any data copied onto data media 
remote from the bedside computer hard disk will also be protected. 
7.3 SYSTEM DESIGN 
The system requirements above specify the need for an integrated and modular system 
structure, with two modules clinically specified in the system: the fluid charting 
information system, and the CVVHD decision support system. The aim of this section is 
to specify the system design which these two modules are part of. This includes the: 
i) Specification of the structure of the renal replacement therapy (RRT) management 
system. 
ii) Specification of all the sub-systems of the RRT management system. 
7.3.1 System Structure 
The RRT management system is intended to be one of the components in a total patient 
data management system (PDMS), where, the total PDMS is concerned with the 
management of all patient data and information. Other components of the PDMS will be 
concerned with other aspects of patient management, such as ventilator therapy. Figure 7.3 
shows how the sub-systems of the RRT management system will be linked with each other 
and with the lTV PDMS. The four sub-systems of the RRT management system are: 
i) The user interface, through which all user observed data enter the system, and all 
information is presented to the user. 
ii) The system manager which controls information and data flows, and manages the 
system operation. 
iii) The data and information system, where all data and information are stored. 
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iv) Decision support sub-system, which will offer advice to the clinicians and nurses 
on the management of CVVHD. 
A detailed description of the intended purpose and function of these sub-systems follows. 
7.3.2 User Interface 
7.3.2.1 Purpose 
The main purpose of the user interface is to provide a user friendly front end to the system 
for the clinical staff. It is intended that the clinical user will not require detailed knowledge 
of how the system operates. A graphical user interface will be used, utilising a point and 
click windows approach. A rollerball will be used to perform the point and click operation. 
The information and data presented will be in a format familiar to the clinical staff, using 
recognised clinical terms and language. 
7.2.3.2 Function 
Functions of the user interface: 
i) Data input medium - initially this will be via a keyboard, with the possibility of 
automatic data input to be added in the future. 
ii) System gateway - windows with menus and icons for the selection of system data 
and functions. The structure in the windows system will be similar to the structure 
in the information system. When a menu item or icon is selected the opening of all 
relevant files will be automatic. 
iii) System introduction and initial help screens - description of how to get started for 
the clinical user. 
iv) System set up - to allow for the tailoring of the system to different operating 
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environments on both the clinical and technical level. 
v) Knowledge base maintenance and update interface - to allow for direct access, 
maintenance and updates to the knowledge base. 
vi) System administration interface - for maintaining and updating the system 
operation. To include administration of the password structure to be used for access 
to different levels of the system. 
Each of these six functions will be contained in a separate module of the user interface sub 
system. The user interface will be implemented using an approach similar to that of the 
windows environment. Its development will follow the development of the other sub 
systems. 
7.3.3 System ｍ｡ｮ｡ｾ･ｲ＠
7.3.3.1 Purpose 
To control: 
i) The flows of data and information around the RRT management system, in addition 
to the flows to and from the other components of the PDMS. 
ii) The processes and tasks that need to be performed between the different sub-
systems or modules. For example, the user may request a simulation of urea 
kinetics of A. Smith. The manager will then retrieve the necessary information and 
data, order the simulation from the DSS and return the results to the user. 
In addition to this the system manager should act as a central connector into which other 
systems, yet to be defined, are plugged into. 
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7.3.3.2 Function 
In fulfilling the first of the purposes outlined above the system manager is essentially 
enabling and controlling communication in the system. This involves performing the 
following functions: 
i) Interpreting encoded incoming messages into a language understood by the sub-
system receiving the message. For example converting data code from the data and 
information sub-system into a form readable by the DSS. 
ii) Providing a clear route for communication between sub-systems. 
iii) Ensuring the data and information required arrive at the correct destination in the 
time required. 
iv) Sorting and packaging data and information. 
v) Finding and requesting data and information. 
vi) Dealing with requests for data and information. 
vii) Logging the outstanding requests. 
viii) Sending data and information for storage in the data and information sub-system. 
The second purpose of the system manager is essentially to perform the role of a general 
manager. Where the role of a general manager is the organisation of a group to achieve a 
desired goal; here the group consists of the sub-systems of the RR T management system. 
To fulfill the second purpose the system manager could offer the following functionality: 
i) Definition of the system goals 
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ii) Ensuring the system goals are being satisfied. 
iii) Administration of the processes and tasks performed by the other sub-systems. 
An important aspect of the management of the system is that any tasks are performed in a 
timely manner. 
7.3.4 Data and Infoonation System 
7.3.4.1 Pmpose 
To store all patient specific data and information for current manipulation and possible 
future recall. The four main components of this are: 
i) Data and information capture 
ii) Data and information processing 
iii) Data and information management 
iv) Data and information presentation 
Information will be presented on the screen with the option of a paper copy of any of the 
on screen displays. 
The components of the patient specific data include data relating to patient state and 
treatment state, as specified in the problem assessment chapter. These contents of the data 
and information system define the view of the material patient and treatment state. Thus 
any decision advice offered by the decision support system is dependent on the contents of 
the data and information system. 
In addition to data relating to the material problem, information on the outputs of the 
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system processes also have to be stored. For example when running the simulated decision 
making its recommendations will need to be stored for future decision evaluation, and for 
comparison with the actual actions taken. Similarly the output of the patient state 
assessment and the simulation module will also be stored. 
Information from individual patient's could be combined within the system to produce data 
on the patient populations for use in research and medical audit. Other non patient specific 
information relates to the administration of the computer system. A detailed development 
record giving details of any system updates will have to be incorporated. Furthermore, 
records relating to the authorised users will be part of the administrative function. 
7.3.4.2 Function 
The primary function of the data and information system centres on patient specific data 
and information. All these data and information stored must be identified with an 
individual patient. Therefore, central to the primary function is a module containing the 
patient identifiers, as shown in figure 7.4. This shows the following modules: 
i) Patient identification data, which will include their hospital number, surname, first 
name and date of birth. 
ii) Fluid volume data, containing all the measurements and analysis of the fluid input 
and output volumes for the patient. 
iii) Lab results summary chart giving details of laboratory measurements of the 
patient's measured blood variables. 
iv) Blood-gas analyser results for plasma electrolytes and acid-base variables. 
v) Patient state assessment, partially to be entered by the clinician and the remainder 
derived by classification of input data into ranges. 
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vi) Treatment state assessment to be entered by the clinician. 
vii) CVVHD treatment advice module, to include the module input, the advice offered 
and the actual course of action taken with some measure of outcome. 
viii) Simulation input data and output results. 
The data items in the above modules are defined in subsequent sections. The other required 
modules of the information system which are not patient specific are: 
i) Module for the collection and storage of statistical patient data, e.g. average 
duration of CVVHD treatment. 
ii) CVVHD inventory and maintenance management, for stock ordering and machine 
maintenance scheduling. 
iii) Development record, giving details of any updates made to the computer system. 
7.3.5 Decision Support System 
7.3.5.1 Purpose 
To offer advice to the clinical staff on the operational management of the renal replacement 
therapy. The decision support will be offered for the period of time the patient is receiving 
the renal replacement therapy. The simulated decision making will be based on the three 
tier model of decision making developed in chapter 4. The first stage of patient 
management is to establish the current patient state then to apply the CVVHD therapy to 
reach the desired state. Within the decision support system the patient and treatment state 
assessment feeds into the therapy management module. The monitoring decisions required 
will be performed outside of the decision support system. Treatment advice is generated 
depending on the state assessments. The goal of the advised therapy action is to bring the 
patient state variables into a predefmed target range within a specified time frame. Prior 
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to the decision support system recommending a course of action it will be simulated using 
a model of the material domain. The prediction from this model based simulation is then 
compared to the goal state to evaluate the likely effectiveness of the decision. 
7.3.5.2 Patient state assessment 
The full diagnosis of patient state will be carried out externally to the CVVHD management 
system. It is envisaged this is either done by the physician or another part of the patient 
data management system. However, some simple classification of patient variables into 
ranges will be carried out by the system. 
During the RRT management system development the patient state assessment will be 
entered by the physician from a list of options describing patient state. The states of the 
patient to be assessed are defined in section 6.4.1 of the previous chapter. The concepts 
used to describe the patient states used in the system could be encoded using a system such 
as Read codes (Computer Aided Medical Systems Limited, 1994). 
7.3.5.3 Treatment state assessment 
The treatment state assessment falls into two categories: CVVHD treatment state, and other 
treatment state. The first is important to assess the present operating state of the CVVHD 
treatment, while assessment of other treatment feeds directly into the conditions used in the 
treatment advice decision tree. 
7.3.5.4 Monitorin& state assessment 
During the initial system development it will be assumed that all the required monitoring 
resources are available to the physician. Moreover, it is assumed that the data set required 
for the material problem assessment, figure 4.8, is fixed and the timing of the measurements 
is either defined by the system or by the clinician supervising the patient. It was not 
explicitly specified during development that the system should offer monitoring decision 
support other than that which is implied by the structure of the information system, for 
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example in the fluid charting. Thus, at this stage of development no monitoring state 
assessment is included in the system. 
7.3.5.5 CYYHD treatment advice module 
The function of this module is to choose the recommended options for CVVHD treatment, 
which are then tested in the simulation module. The options for CVVHD treatment and the 
knowledge used to make the choices is defined in the decision tree in chapter 6. The 
decision tree uses a rule based protocol at the decision nodes for defining the advice 
offered. The advice offered by the treatment advice module is tested by running a 
simulation of the material domain in the simulation module of the DSS. 
7.3.5.6 Simulation module 
Quantitative or qualitative models as patient simulators are needed to assist prognosis and 
treatment planning (Carson et aI., 1991). This module tests the chosen therapy settings 
through simulation of the patient state and the proposed treatment. The therapy settings 
could be those offered by the RRT management system, or they could be chosen by the 
physician. Simulation offers the capability to predict the decision outcome before 
implementation, and thus the potential effectiveness of the chosen therapy settings can be 
evaluated prior to implementation. Evaluation of the potential effectiveness being 
performed by comparing the predicted outcome with the decision goals. Figure 7.5 shows 
how the use of simulation and prior evaluation adds complexity to the choice stage of the 
decision making process. Here the choice stage is a three stage process where the output 
of the decision tree is followed by the action simulation, and finally the predicted decision 
evaluation prior to implementation. The outputs from each of the three stage process are: 
the recommended course of action with goals and justification for the action; the result of 
the simulation in relation to the goals, and a predicted evaluation of whether the goals will 
be achieved. 
To evaluate the chosen action the simulation model needs to be able to predict the values 
of the goal variables. For example when the choice is made to start CVVHD a complete 
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simulation model would be required to predict what the patient's plasma potassium 
concentration will be after 6 hours of treatment. If the predicted concentration is within the 
target range the decision goal is satisfied. Thus the action proposed represents the optimum 
solution according to the patient and treatment simulation. However, if it is predicted the 
that goal will not be satisfied then the user will be advised that the chosen treatment may 
not be adequate. Justification of the predicted effectiveness of the proposed action will be 
offered to the user in the form of: a quantification of the predicted change in the goal 
variables, and the difference between the predicted outcome and the goal. 
Taking the recommendation to begin CVVHD treatment as an example a complete 
simulation model will need to predict the patient's: fluid volume change; plasma potassium 
concentration; plasma phosphate concentration; urea plasma concentration; creatinine 
plasma concentration, and base excess. 
Each of these goal variables are then evaluated as described above. Depending on the 
evaluation and the users judgement an action will then be performed. According the model 
of decision making in section 4.2.3 the action will be followed by a new problem 
assessment and an evaluation of the action outcome. During evaluation of outcome the 
effectiveness of the action taken and the accuracy of the simulation will be assessed. 
The simulation module needs to be able to simulate changes in the patient state and the 
treatment state. Candidate models for the simulation of patient state include: 
i) A single compartment model of urea kinetics. (Leypoldt et al., 1991, and Sargent 
and Gotch, 1980) 
ii) Comprehensive model of the dynamic exchange processes during haemodialysis, 
including creatinine, potassium, urea and water distribution. (Thews and Hutten, 
1990, and Thews 1992) 
iii) A systems simulation model of renal dialysis (Uttamsingh, 1981, and Leaning et al., 
1985) 
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iv) The course of ARF modelled by creatinine kinetics. (Moran and Myers, 1985) 
v) A single pool heparin model (Sargent and Gotch, 1989) 
For the model of the processes in the dialyser the models of continuous haemodialysis 
described by Pallone et al. (1989) and Sigler and Teehan (1987) could be used. An 
introductory description of these models is given below; for a fuller description the reader 
is referred to the references cited. 
7.4 SIMULATION MODELLING OF HAEMODIALYSIS 
Kinetic modelling has been used extensively to model haemodialysis. Such models allow 
for the prediction and control of substances during haemodialysis treatment. This section 
reviews some of the quantitative models of the dialysis process. These models may be 
useful in the problem of haemodialysis management if they can fulfill the goal for 
mathematical modelling defined by Sargent and Gotch (1980): 
"The ultimate goal of mathematic modelling is to elucidate the effect of the various 
biochemical processes described and through greater understanding of these processes to 
be able to modify treatment or to predict clinical therapy for the better management of the 
haemodialysis patient." 
The better management of the patient is one of the goals of the decision support system 
being designed. Therefore, the use of mathematical models of dialysis is a viable option 
for the simulation of treatment. 
1.4.1 ｓｩｮｾｬ･＠ Pool Urea Kinetics 
Urea kinetic modelling is a quantitative approach for controlling urea concentration (BUN), 
for evaluating patient nutrition, and for prescribing and monitoring patient's haemodialysis 
therapy. Urea is a major product of protein catabolism and is used as an indicator of 
uraemia. Sargent and Gotch (1980) proposed a single pool model of urea kinetics for 
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dialysis patients, figure 7.6, and the model is reported to have gained large popularity 
(Liberati et al., 1993). The single pool is an approximate representation of total body water 
and the urea is assumed to be evenly distributed in it. The model applies the principle of 
mass conservation to model urea kinetics. The pool contains the mass of urea in the body, 
the flow into the pool is urea production, and the outflow, the urea clearance from the body. 
The mass of urea in the pool is taken to be the pool volume, V, multiplied by the urea 
concentration, C. Urea is generated from protein catabolism in the liver. This is 
represented in the model by a single generation rate with dimensions of mass per unit time, 
G. F or a dialysis patient the clearance of urea from the body has two components, the 
residual clearance of the kidney, Kr, and the clearance of the dialysis ｰｲｯ｣･ｳｳＬｾＮ＠ Thus, the 
rate of change of mass in the single pool can be expressed in the equation: 
d(VC) = 
dt 
Vgc+cgy = 
dt dt 
(7.1) 
(7.2) 
In normal physiology, homeostasis, the change in urea concentration and total body water 
volume are negligible. This can be considered to be the steady state condition where 
dialysis is not required. In this condition the equation is: 
G=K,C (7.3) 
Consideration of this equation is important in the use of raised BUN as an indicator of renal 
function. From equation 7.3 it is obvious that either raised protein catabolism or decreased 
renal function can cause increased BUN. For the correct patient management it is 
important that the correct cause is identified. Moreover, for the patient with a varying 
volume of total body water the BUN could vary with state of hydration; in a dehydrated 
state BUN could be increased just because of lack of fluids. 
The general solution of equation 7.1 can be used in two ways: to establish patient 
parameters (V and G) from clinical data, and to predict the effect of therapy changes and 
prescribe dialysis treatment to achieve clinical goals. Before use as a predictive tool the 
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patient parameters have to established. When applied to intermittent haemodialysis 
management this requires the establishing of the patient's dry weight, V 0' the change of 
weight between treatment and G from measurements of BUN post and pre-dialysis. Once 
these have been calculated the model can then be used to determine the required dialysis 
clearance, the duration of dialysis sessions, and the interval between them. 
Leypoldt et al. (1991) applied the model to the prescription of maintenance haemodialysis 
for chronic renal failure patients. The model was applied to the time period of a week, T. 
The assumptions used in the application of the single pool model were: a time averaged 
BUN concentration TACurea is the same during inter and intra dialysis treatment; the 
residual renal clearance is constant; the dialysis clearance during treatment is constant, and 
the rate of urea generation, G, is constant. For a total dialysis treatment time in the week 
oftd equation 7.1 can be rearranged to: 
G = T ACurea (Kr ＫｾｴＯｦＩ＠ (7.4) 
This approach is a simplified version of the technique proposed by Sargent and Gotch, 
requiring less measurements and being simpler to apply. 
Application of the single pool model to the management of acute renal failure in the lTV 
will require estimating the patient parameters V and G, then the application of these 
parameters to predict what the patient's urea concentration will be following a period of 
treatment. This will be more complicated for the acute renal failure patient as they are not 
only suffering from a loss of renal function, but often changes in their catabolic rate and in 
their total body water volume. 
7.4.2 A Simulation Model for Renal Dialysis 
An objective of the model described by Uttamsingh (1981) and Leaning et al., (1985) was 
to provide good predictions of patient state under a given course of dialysis. The 
predictions were intended to be used to improve the treatment of the patient, minimising 
dialysis time, avoiding periods of toxicity. The other objectives of the model were: to 
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explain hidden physiological responses caused by dialysis, and to investigate various 
hypotheses of kidney function and fluid-electrolyte dynamics, in particular neuroendocrine 
control. 
The model of a patient receiving dialysis contains sub-models of the: thermoregulatory 
system; cardiovascular system; fluid and electrolyte balance; kidney function; urea and 
creatinine dynamics; haemodialysis machine (ultrafiltration and diffusion of urea, 
creatinine, potassium and sodium), and models of the hormones renin, angiotensin, 
aldosterone and ADH. These are represented by sixteen first order differential equations 
and fifty algebraic equations. Operating the model requires six patient state parameters to 
be estimated and 23 input variables. The predicted outputs from the simulation of 
haemodialysis are: mean arterial blood pressure; weight loss; plasma sodium; plasma 
potassium; plasma urea; and plasma creatinine. 
The model has been tested for normal physiology without dialysis and applied to the 
management of chronic renal failure patients. When applied to acute renal failure it was 
found that repeated parameter estimates were required as the renal function varied with the 
course of the renal failure. 
The problem with this model and other large models is that of identifiability and the 
estimation of parameters. Moreover, the model needs a large number of inputs and 
considerable processing power for its operation. Therefore it is likely to be of limited use 
in the acute clinical setting where timely decision making is required. 
7.4.3 A Comprehensive Model ofHaemodialysis 
Thews and Hutten (1990) expressed the views that the complex dynamic behaviour of the 
most relevant state variables and their interaction during haemodialysis should be taken into 
account for optimisation of the exchange processes during treatment. Furthermore they 
believed that this could only be achieved by employment of a model considering relevant 
patient and treatment parameters. 
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Their model is indeed comprehensive and includes sub-models for the following 
substances: urea; creatinine; vitamin BI2 (as an indicator of middle molecules, molecular 
weight between 500 and 5000g/mol); potassium; sodium; oxygen; chloride; acetate; water, 
and acid-base status (C02, pH and bicarbonate). The principle of mass balance is applied 
in the following models: 
i) Models of creatinine and vitamin BI2 represented by three compartments of 
intracellular, interstitial and plasma fluid. 
ii) Urea, potassium and sodium in two compartments of intra and extracellular fluid. 
iii) Chloride in three compartments: extracellular; intra-erythrocyte cells, and intra 
other cells. 
iv) Acetate in a single extracellular compartment 
v) The oxygen model uses two compartments: arterial, and venous blood. 
vi) Water is distributed in three compartments: plasma, interstitial, and intracellular 
fluid. 
vii) The model of acid-base status consists of three sub-models: Eight compartments for 
CO2 - interstitial, intracellular, and 6 in the blood (vascular space), and a similar 
structure for H ions (PH) and for bicarbonate. 
The complete model consists of 50 coupled differential equations, more than 50 state 
variables, and several non-linear relationships. So there is a large data gathering burden on 
the user and a high processing requirement. 
The model can be used to analyse the exchange processes during haemodialysis. 
Specifically it allows for the exploration of the effect of changing control parameters of 
dialysis therapy on the homeostasis of fluid, electrolyte and acid-base balance. Thews 
-292-
(1992) describes the application of the model to studying the effect of varying: 
i) Dialysate composition: sodium; potassium; bicarbonate. and acetate. 
ii) Dialysate device parameters: ultrafiltration rate, and rate of blood flow. 
iii) Control parameters: dialysate sodium concentration profile. and ultrafiltration rate 
profile. 
The simulation was run for 124 dialysis sessions of chronic renal failure patients on 
bicarbonate (89 sessions) and acetate (35 sessions) dialysis. The results of the simulation 
are described in detail in Thews (1992). The model can also be used to plan the optimum 
dialysis course for an individual. with the prediction of the course of therapy and of likely 
complications. Although this model would allow for the prediction of the majority of the 
decision goal variables it does have the same disadvantages for use in the lTV as the 
previous model described, section 7.4.3. 
7.4.4 ｓｩｭｾｬ･＠ Compartment Model of Creatinine Kinetics 
Moran and Myers' (1985) model was used to predict the relationship between creatinine 
clearance and plasma creatinine concentration during the course of acute tubular necrosis 
(A 1N). Creatinine was used as the filtration marker during A 1N as it provides a clinically 
useful indication of filtration rate. The authors defined two distinguishable phases of A 1N 
characterised by creatinine clearance: 
i) Maintenance phase, often 1 to 2 weeks in length. The clearance is depressed to 5 
to 15% of normal. 
ii) Resolving phase. a progressive rise in clearance. It can be up to 8 weeks before the 
clearance is back in the normal range. 
These were modelled using a single pool model of creatinine. The structure of the model 
-293-
is similar to the single pool model of urea kinetics discussed above. The assumptions in 
the application of the model were that: production rate of creatinine into the pool was 
constant; the volume of distribution approximates to the total body water; changes in total 
body water may be equated to changes in weight, and creatinine is a reliable filtration 
marker. The study showed that the plasma creatinine concentration alone was not a 
sufficient predictor of GFR. In particular it was found that rising creatinine concentration 
could be associated with rising creatinine clearance. 
The main problem with the application of the model in the ITU is the assumption that 
creatinine production remains constant. The authors admit that no study has been made of 
the stability of creatinine production during A TN. This assumption could be particularly 
limiting in the ITU, where the patient is likely to be in a highly catabolic state. If this 
problem can be overcome the model could be used to predict the creatinine plasma 
concentration and the creatinine clearance. 
7.4.5 Modellin& of He.parin Activity 
Biological sensitivity to and elimination of heparin has been found to vary widely so 
Sargent and Gotch (1983) proposed a single compartment model of heparin kinetics to take 
account of this. The parameter modelled is the clotting time prolongation in response to 
the heparin loading. 
The single compartment model has a constant infusion rate Ir This is multiplied by a linear 
sensitivity to heparin factor S to convert infusion rate to clotting time response. The 
response of the system, R, is proportional to the mass of heparin introduced, and the output 
is first order and a product of the elimination constant K and the response R. 
(7.5) 
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In the steady state condition where the rate of response is constant: 
(7.6) 
This can then be used to calculate the required infusion rate in the steady state. S and K are 
patient specific parameters which have to be determined. S can be determined by use of 
the step response of the patient to a bolus dose of heparin. K is calculated by taking two 
clotting time responses and performing an iteration until K is determined. This model 
could be applied to predicting the change in the patient's measure clotting time for a given 
infusion of heparin. 
7.4.6 Simulation of Continuous Arterioyenous Haemodialysis 
Pallone et al. (1989) developed a model to predict the performance of continuous 
arteriovenous haemodialysis (CA VHD). From patient and dialysate input variables this 
model of CA VHD predicts: hydraulic and oncotic pressure distributions in the ､ｩ｡ｬｹｳ･ｲｾ＠
filtration rate; blood flow, and total, diffusive and convective clearances of urea. Therefore 
it could be used to model the convective and diffusive clearance of urea across the dialysis 
membrane. However, several limitations of the model were reported including: systematic 
over estimates of blood flow rate and the filtration ｲ｡ｴ･ｾ＠ difficulty in calculating the 
parameters defining the conductance of urea, and most significantly it has only been tested 
using bovine blood in the extracorporeal circuit. 
Sigler et al. (1987) modelled solute transport in the continuous haemodialysis circuit. 
Using the model studies were performed on fifteen critical care patients. The model was 
used experimentally to demonstrate the advantages of continuous arteriovenous 
haemodialysis over continuous arteriovenous haemofiltration. This required the sampling 
of blood from the arterial and venous end of the dialyser, in addition to the sampling of the 
waste dialysate. The solute concentrations in these samples were measured and combined 
with the measured flow rates to calculate the solute clearances. The solute clearances 
calculated were: urea; sodium; potassium; creatinine; phosphate; bicarbonate; calcium, and 
glucose. Applying this model to the calculation of CVVHD clearances would require 
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considerably more sampling and measuring of blood and dialysate than is routinely 
performed on the Mayday lTV. Furthermore, the extra data gathered would only inform 
the calculation of dialysis clearances; they would not wholly inform the simulation of the 
patient goal variables as required. 
7.4.7 Haemodialysis Simulation Summmy 
The simulation of patient and treatment state is highly complex due to the unstable nature 
of lTV patients. To model all the patient's goal variables would require a large complex 
model of the type proposed by Thews (1990). However, for application of a model in 
routine clinical practice the model needs to be simple with a minimum number of variables 
to be measured and processed (Sprenger et al., 1983). Therefore it is proposed that the 
model to be implemented in the initial development is Sargent and Gotch's single pool 
model of urea kinetics. This is a simple, well established model which has been previously 
applied to the management of chronic maintenance haemodialysis. 
7.5 SYSTEM DEVELOPMENT 
The development of the system design will proceed by building prototype sub-systems, and 
finally a complete prototype system. The first sub-systems to be developed are the ones 
which address the expressed clinical need. The clinical need for accurate fluid charting 
suggests the need for a computer based fluid charting system, which is a component of the 
information system. The other clinical need identified is for advice on the operation of 
CVVHD treatment. Therefore the second prototype system to be developed will be the 
CVVHD advice system. The design and development of these components of the system 
design is described below, in addition to a discussion of the development of other 
components of the system design. 
7.5.1 Computer Based Fluid Chartina 
The fluid charting system is one of the components of the data and information system as 
described in section 7.3.4. At the Mayday lTV this is performed manually using paper 
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charts. The initial clinical need to be addressed is an automation of this process, which it 
is anticipated will make charting easier and more accurate. 
The volumes of fluid which need to be measured or estimated have been described in the 
systems analysis in chapter 5. These can be classified as fluid input volumes for drug 
delivery, nutrition, and colloid volumes; and fluid outputs volumes corresponding to blood 
losses, urine, gastric fluid loss, insensible losses, and sweat losses. For an A TN patient the 
balance of these fluid inputs and outputs is the CVVHD treatment, where there can be a net 
fluid removal or addition to the patient. The majority of the fluid input and output volumes 
are directly measured, however the insensible losses and the sweat losses are estimated. 
Alternative estimates for and models of the insensible respiratory and skin losses were 
given in chapter 5. It was concluded that the quantitative models described would give 
more patient and ambient sensitive estimates of the insensible losses. However, the 
accuracy of the models for the prediction of patient's insensible losses in the ITU requires 
further testing before they can be implemented. Although this is a problem which does 
need addressing it is only a sub-problem of charting a patient's fluid balance. Moreover, 
performing the required testing to evaluate the accuracy of the quantitative insensible loss 
models is beyond the immediate scope of this project. Therefore, without further data 
available on the use of models in the ITU the present clinical practice will not be changed 
(for 70 kg man an estimate of total insensible loss of 500ml/day is used). Although it is 
obvious from the different estimates and from the models of insensible loss the losses will 
vary with factors not included in this estimate. Thus it is not an optimum and an alternative 
more accurate technique does need to be found. 
The layout of the computerised charts reflects the layout of the manual charts used for fluid 
charting in the Mayday lTU. The paper charts were used as a model for the computer 
charts to ensure inclusion of the fluid volumes which are typically monitored for an ARF 
patient, and to have some inherent familiarity in the system for the user. The features of 
the computer system which go beyond the present paper based system have been specified 
in consultation with Dr Morgan and Dr Collinson. 
To test the spreadsheet operation and to show some of the possible graphical presentations, 
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data from an lTV patient have been entered into the system. The data entered represent 
eight days of data for a patient who has received haemodialysis on the lTU at the Mayday 
Hospital. The patient identifiers are all fictitious, and the dates have been set at an arbitrary 
time. The fluid and haemodialysis data match those recorded on the bedside paper chart. 
The core temperature data have been defaulted to 37 .5OC, apart from a period of four hours 
on the 8/6/95 where the temperature has been artificially inflated to show the calculation 
of sweat volume. Additionally the target data have been set artificially to be close to the 
actual fluid balance. 
7.5.2 Fluid ｃｨ｡ｲｴｩｭｾ＠ System 
It is intended that the fluid charting system should chart all the patient fluid volume data, 
estimate the insensible losses, and offer fluid planning advice to the nurse. The computer 
based charts have been modelled on the existing bedside chart, with additions to give the 
computer based system the capabilities specified in the system requirements. The system 
has been developed on a PC in a Windows environment. 
The present paper-based system resembles a spreadsheet, so all the initial development of 
the system has been carried out on the spreadsheet application, Excel 4.0. Additional 
reasons for choosing Excel are that it has capabilities for once only entry of all data items, 
statistical analysis of data, straight forward graphing of data, and has the mathematical 
functions required to construct quantitative models when required. By linking spreadsheet 
cells data can be shared between numerous locations, thus ensuring each data item only has 
to be entered into the system once. Included in Excel's statistical capabilities is the ability 
to calculate data trends. Calculating the trend in data has been highlighted in previous 
studies (European survey of computers in intensive care, 1990) as being one of the 
properties of data that is useful in a clinical setting. Around the spreadsheet based charts 
two other main components need to be constructed: 
i) A database to store past patient data. 
ii) A user interface to simplify and automate system operation. 
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Figure 7.7 shows how the spreadsheets interact as part of this system. There is one set of 
active spreadsheets for the patient who is presently being monitored on the ITU. Onto 
these spreadsheets data for the patient are entered, either via the user interface or from the 
database. The user enters and views all the data through the spreadsheets and their related 
graphs. All the processing of data is carried out on the spreadsheet. When the patient data 
no longer need to be displayed, for example when the patient is discharged from the ITU, 
then the data are sent to the database and the spreadsheets are cleared ready to load in the 
next patient's fluid data. 
An operational system will need a custom built user interface. The purpose of the interface 
is to make the system practical for users who have no knowledge of the operation of the 
application the system has been written in; at present this is Excel. However, during 
development the user interface will be the one offered by Excel, so knowledge of its 
operation will be required to develop and operate the system. 
7.5.3 Fluid Chart Desian 
Figure 7.8 shows the six different charts in the fluid charting system and where there are 
connections between them. These are: 
i) PATIENT IDENTIFIERS - records and displays the identifiers used for each 
patient. 
ii) BEDSIDE CHART - records, displays and calculates all the hourly and 
accumulated values presently recorded on the paper bedside fluid chart. 
iii) INSENSIBLE AND SWEAT LOSS ESTIMATES - calculates and displays the 
estimated patient fluid losses. The model used to calculate the insensible and sweat 
losses is stored and called up from the adjacent model component. 
iv) SUMMARY FLUID CHART - summarises the hourly values from the connected 
charts. 
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v) DOCTOR'S SUMMARY CHART - shows the patient fluid chart data at twelve 
hourly intervals. 
vi) FLUID PRESCRIPTION CHART - used to plan twelve hourly fluid target input, 
output and balance volumes. 
A detailed description of each of the charts is given below. The description includes an 
illustration of the chart and its associated graphs. In addition to tables defining the data 
items shown in the chart. Each chart is described in terms of: 
i) AIM - the purpose of the chart. 
ii) LAYOUT - a brief description of the main points to note about the chart layout. 
iii) INPUTS - the data flows into the chart. 
iv) CALCULATED FIELDS - the calculations, where relevant, on each chart. 
v) GRAPHICAL PRESENTATION - a description of the graphical output generated 
from the charts. 
vi) OUTPUTS - the flow of outputs from the chart to other charts in the system. 
vii) DESIGN OPTIONS - possible alternatives in each of the chart designs. 
7.5.3.1 Patient identifers (TABLE 7.2 & FIGURE 7.9) 
AIM;. To enter the patient details required to uniquely identify all the entered and the 
processed data in the system with the patient it refers to. 
LAYOUT: The layout of the chart is based on the present paper based bedside chart. The 
identifiers selected from the bedside chart are taken in an attempt to make the association 
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of the data easy without too much duplication of infonnation already recorded on the paper 
based chart. 
INPUT: All the patient identifiers are entered into the chart via the user interface. The 
patient data items only have to be entered into the charting system once per patient. 
OUTPUT: Hospital number, surname, first name and date of birth are linked to all of the 
other patient specific charts. These items appear in the top of each of the other charts and 
on the first page of each of the chart's printed output. Moreover, the identifiers appear on 
each of the graphs output from the system as well. 
DESIGN OPTIONS: A unique ITU number allocated to the patient on admission to the 
ITU could be used as the main unique patient identifier. This number would give 
infonnation on which admission the related data refer to. 
7.5.3.2 Bedside chart (TABLE 7.3 & FIGURE 7.10) 
ｾ＠ This chart records all relevant hourly measurements, thus replacing the present paper 
bedside fluid chart. All the hourly fluid input and output volumes are recorded, and the 
patient's core temperature is recorded for use in estimating the patient's sweat losses. 
LAYOUT: Again the structure of the layout is based on the present paper bedside chart. 
All the measurements are recorded against time, for the fluid values this represents the 
volume in the hour preceding the time shown. The fluid inputs are entered on the left hand 
side, followed by the fluid output data and the calculated fields on the right. A new chart 
is created for each new twenty four hour period with the relevant start date recorded at the 
top of each one. 
INPUT: The patient identifiers come automatically from the identifiers spreadsheet. All 
the measurements will be entered at the bedside by the ITU nurse via the user interface. 
CALCULATED FIELDS: From the data entered the following are calculated on the 
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spreadsheet: 
i) Accumulated urine output. 
ii) Ultrafiltrate (dialysate output-dialysate input). 
iii) Hourly and accumulated input fluid volume. 
iv) Hourly and accumulated output volume. 
v) Hourly and accumulated measured fluid balance (fluid input-fluid output). 
The accumulated totals show the volumes for the 24 hour chart only, i.e. the totals do not 
include any brought forward totals from previous days' charts. 
GRAPHICAL PRESENTATION: It is possible to plot the variation of any of the 
quantities on the chart, or the trend in their variation, against time. From a group of seven 
possible graphs three were specified by the clinicians as being useful presentations. The 
graphs showing trends in data were not liked as it was felt that by extracting the trend from 
the data some information was being lost in the presentation. 
The preferred graphs are shown in figures 7.11 to 7.13. The measure fluid balance graph, 
figure 7.11, shows the hourly and accumulated fluid balances for the patient. This graph 
is useful as an overall summary of the pattern of the patients fluid balance over the twenty 
four hour period. Related to this graph is figure 7.12 showing the total inputs and output 
volumes together. The graph ofultrafiltrate volume, figure 7.13, is useful to monitor the 
performance of the dialysis filter. It can be seen from the graph that after the filter is 
changed, around 20:00 hours, the ultrafiltration volume increases more than three times. 
OUTPUTS: The measured balance figures are linked to the summary fluid chart for the 
corresponding day. Fluid data from the chart are linked to the doctor's summary chart. 
Data from the chart are transferred to the database upon completion of the fluid charting 
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for the patient. 
DESIGN OPTIONS: The accumulated totals for the fluid quantities could include the 
brought forward values, thus showing totals for the whole charted period not just a single 
24 hour period. This would give an instant idea of the long term fluid balance of the 
patient. Colour could also be introduced to enhance the on screen display of the chart; in 
particular to distinguish between fluid inputs, outputs and totals. 
7.5.3.3 Insensible loss estimate (TABLE 7.4 & FIGURE 7.14) 
ｾ＠ To calculate, display and record an estimate for the patient's insensible and sweat 
volumes. The different basis for making these estimates was discussed in section 5.5 and 
7.5.1. The present model to be adopted is the same as the one used on the lTV at the 
Mayday. 
INPUTS: The patient identifiers and temperature come automatically from linked cells on 
the identifers and the bedside chart respectively. The patient weight is entered from the 
patient state assessment module of the information system. 
CALCULATED FIELDS; The models of insensible loss use in the system at present are 
based on current clinical practice, these are: 
i) Insensible loss = (500170) ml/kglday 
ii) Sweat volume = (500170) ml/kglday/every toc rise in temperature above 37.5°C. 
GRAPHICAL PRESENTATION: A bar graph showing the insensible loss and sweat loss 
is included in figure 7.15. The input data have been artificially increased for the first four 
hours to show how sweat loss is calculated and displayed. This graph will convey more 
information to the user where a model which takes into account varying patient and 
environmental conditions is used to estimate the losses. 
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OUTPUTS: The totals for the estimated losses are automatically transferred to the fluid 
chart summary and the doctor's summary chart. 
DESIGN OPTIONS: The model used to estimate the losses could be changed to one of 
those proposed in section 5.5, although this would require further evaluation of the models 
prior to implementation. 
7.5.3.4 Summary fluid chart (TABLE 7.5 & FIGURE 7.16) 
ｾ＠ The two main aims of the summary chart are: 
i) To show the patient fluid balance after all the measured and estimated variables 
have been included. 
ii) To be a planning aid to the nurse, offering advice on the fluid balance to aim for at 
the end of the next hour. 
LAYOUT: As for all the charts the variables are recorded against time. The first half of 
the spreadsheet displays past information and the second half of the chart shows target, or 
future, information. 
INPUTS: The measured balance and the insensible losses are taken directly from the 
relevant spreadsheets. The prescribed target balance is linked into the fluid prescription 
chart. 
CALCULATED FIELDS: 
i) The estimated losses are taken off the measured balance to arrive at an estimate of 
the actual fluid balance for the patient. 
ii) The planned fluid balance is calculated by a linear division of the 12 hour 
prescribed balance from the fluid prescription chart. Thus spreading the required 
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fluid loss or gain for the patient evenly over the 12 hours producing the minimum 
rate of change in the patients fluid volume. 
iii) The revised target balance is intended to be a guide to the nurses for the fluid 
balance to be achieved in the next hour. It is the target fluid balance for the hour 
less the accumulated error bought forward. Thus any previous excess fluid removal 
or overload can be adjusted for in the next hour. It can be calculated using the 
formula: 
(Revised target balance at time, t) = (Accumulated target balance at time, t) -
(Accumulate aggregate balance at time, t-}) 
Thus, from figure 7.16, on 8/6/95 the accumulated actual balance at 1400 hours is 
-315.7 ml and the planned accumulated balance for 1500 hours is -375 ml. Then 
the revised fluid balance for the hour 1400 to 1500 hours is -59.3 ml, i.e. the patient 
needs to lose approximately 60 ml of fluid in the next hour. 
GRAPHICAL PRESENTATION: Illustrations of the graphical output from this 
spreadsheet are shown in figures 7.17 to 7.18. Where the estimated fluid losses are varying, 
then the graphs from this chart can provide potentially more information on the patient's 
fluid balance than the bedside chart. 
OUTPUTS: There are no flows of data directly to other charts in the system. 
DESIGN OPTIONS; The chart could be split into two, one only summarising past fluid 
data and the other presenting hourly target advice. Additionally either chart could be 
expanded to show more data. For example more fluid variables could be included to give 
broader advice to the nurse on the fluid inputs and outputs required to meet the fluid 
balance target at the end of the next hour. 
7.5.3.5 Doctor's SUIl1IJl8l'Y chart (TABLE 7.6 & FIGURE 7.19) 
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AIM.;, To summarise the fluid data for the patient using a time period relevant to the 
physician's decision making. 
LAYOUT: The time period used here is 12 hours, taken between the hours of 0:01 to 12:00 
and 12:01 to 24:00 in each 24 hour period. The time periods were chosen to be centred 
around the midday ward round. The timings are recorded against the corresponding date. 
The layout of the remainder of the chart is similar to the other charts, with the inputs on the 
left, followed by the outputs and the calculated fields on the right. 
INPUTS: All the data input are captured automatically from the bedside chart and the 
insensible loss chart. 
CALCULATED FIELDS: All the inputs from the other charts are summed into 12 hour 
totals on this chart. The aggregate fluid balance is the summation of all the values in the 
preceding columns. On the example chart shown the bought forward fluid balance has been 
added into the accumulated aggregate balance. Therefore, the total in the accumulated 
column shows the on-going fluid balance, not just a summary total for the single chart. 
GRAPHICAL PRESENTATION: The graph displaying the largest amount of information 
is the plot showing the period and accumulated aggregate balance, figure 7.20. The graph 
plotting the actual fluid data shows that the initial charted balance prior to dialysis 
beginning was above 5000 ml and after eight days the charted balance is now below -4000 
ml. In addition a histogram showing the half day totals for urine output could be useful in 
following the course of ARF in the patient, figure 7.21. 
OUTPUTS; The period totals of the aggregate fluid balance values are shown on the fluid 
prescription chart. 
DESIGN OPTIONS: The time interval used to summarise the data could be changed, to 
say one summary per day. 
7.5.3.6 Fluid prescription chart (TABLE 7.7 & FIGURE 7.22) 
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ｾ＠ For the doctor to prescribe the 12 hourly fluid balance, and to allow for the 
calculation of ultrafiltrate volume required for specified variations in the other fluid 
volumes. 
LA YOUT: The layout of the chart is designed to be similar to the doctor's summary, so 
enabling comparison between the planned fluid volumes and the actual fluid volumes. 
INPUTS: The target fluid balance, crystalloid input, colloid input and the estimate of other 
fluid losses are entered via the user interface. The actual balance is linked to the doctor's 
summary chart. 
CALCULATED FIELDS: The ultraftltrate is calculated as the difference between the 
target balance and the estimates of the other fluid variables. So for a required fluid input 
the volume of ultrafiltrate needed to provide the necessary fluid space can be easily 
calculated. The difference column is merely the difference between the actual and planned 
fluid balance. As mentioned previously the planned targets are artificial and hence the 
differences are all small. 
GRAPHICAL PRESENTATION: The graph plotted in figure 7.23 shows how the 
aggregate fluid balance follows the prescribed fluid balance. 
OUTPUTS: The target fluid balance is linked to the fluid summary chart. 
DESIGN OPTIONS; The time period could be changed in a similar manner to the doctor's 
summary chart. The output to other charts could be extended to include an hourly 
breakdown of all the prescribed fluid input volumes. 
7.5.3.7 Database 
ｾ＠ To record all data entered by the medical staff, and to allow for retrieval of data back 
into the spreadsheet system. 
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INPUTS: The data recorded on the fluid balance charts. 
LAYOUT: The structure of the database will be based on the structure of the charts it is 
linked to. 
OUTPUTS: All recalled data on a patient required by the user. 
7.5.4 Further Deyelopment of Fluid Chartina System 
The fluid charting system described above will form the basis for future development of 
the fluid charting system. However, the present system consists of a spreadsheet and 
network database for inputting and storing all the patient data. The operation of the system 
could be simplified by using only a database, where the present spreadsheets are replaced 
by database forms. This is with the proviso that the database application used has all the 
data analysis and presentation capabilities presently specified in the spreadsheet 
application. The database used will be dictated by the availability of database applications 
and their suitability for meeting system requirements. The type used will be either 
relational or object oriented. To allow for integration with the object oriented decision 
support module an object oriented database would be preferable. 
Even without the above mentioned changes before an operational fluid charting system 
could be offered: the database must be developed; many of the processes in Excel need to 
be automated, and the user interface has to be designed. The optimistic estimate for 
completing the database development using available resources went beyond the time 
available within the PhD project. This time estimate allowed for time spent automating 
processes within Excel, designing a user interface, prototype testing on the ward, and for 
some time spent in the cycle of test and development. It was felt that the sole pursuit of the 
development of an operational fluid charting system would not have made a sufficient 
contribution to knowledge. Thus, despite the fluid charting system existing as an early 
prototype the project development moved onto the decision support module design and 
development. 
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7.5.6 Other Components of Data and Information System 
The set of modules to be included in the data and information system were specified in the 
system design. The first two modules have been specified above in the description of the 
fluid charting system. The charts summarising the laboratory data and the blood gas 
analyser results are shown in figures 7.23 and figures 7.24. The layouts of these charts 
were based on the existing paper based records. The information required in the patient and 
treatment assessments was specified in the chapter 6. The treatment advice module inputs 
and outputs were specified in the decision tree structure of chapter 6. The model-based 
simulation input and output data will depend on the model being used. The non patient 
specific modules required in the system have not yet been specified. 
7.5.7 Decision Sypport System Deyelopment 
The operation of decision support was modelled in figure 4.16. The model showed 
decision support operating in parallel to the decision maker, offering them advice at each 
stage of the process. Therefore a decision support system requires an in built model of 
decision making to operate. The in built model of decision making adopted here is the five 
stage process shown in figure 4.8. 
As discussed in chapter 4 clinical decision making has three tiers: patient state assessment; 
treatment, and monitoring. The five stage decision making model was used in section 4.2.4 
to represent these tiers operating together, figure 4.13. The requirement for the decision 
support system is to support CVVHD treatment decision making. The system is only 
considering one treatment option for the patient. Thus, the system's patient state decision 
making is simplified to only an assessment of patient state. Moreover, the monitoring 
decisions are made externally to the system, and the product of the monitoring activity is 
entered into the data and information system. Thus it is only the treatment decision making 
which is represented in full in the system. Figure 7.25 represents a model of the systems 
internal decision making, which is a simplified version of the full decision making 
representation in figure 4.13. 
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The decision support system's patient and treatment assessments come from externally 
entered data and internally generated patient data classifications. The evaluation is 
performed by comparing the goals of the previous decision with the present assessments. 
The treatment options are represented by the structure of the decision tree. Clinical 
knowledge attached to the decision nodes is used to choose the options to recommend. The 
structure of the decision tree output is a set of recommended actions with attached goals 
and justifications. The recommended action is then simulated using the most recent patient 
and treatment state assessment to produce a predicted outcome. The simulation offers the 
user an assessment of the likely effectiveness of the advice offered. During the 
implementation of the users chosen action they record whether they acted on the advice or 
not. After further patient and treatment data input the cycle repeats. 
A complete DSS decision simulation includes all the stages described above. However, 
during the early phases of system development decision evaluation will be performed 
externally to the DSS. This is because the knowledge base used to make the decisions and 
define the goals is still a naive one, and requires further complex testing before 
implementation. Until such testing is completed the validity of goals as a basis for judging 
the decision effectiveness will not be known. Thus the initial decision support system will 
consist of three main components: patient and treatment state assessment; treatment 
advisor, and patient and treatment simulation. The basis for the treatment advisor is the 
decision tree defined in the previous chapter. Derived from this the patient and treatment 
state assessments were also defined. Moreover, a candidate set of kinetic models for 
haemodialysis simulation have been previously defined . 
The main function of the system is to make CVVHD treatment recommendations to the 
user. Moreover, the decision tree is at the hub of the decision simulation. Thus the 
development of the decision support system began with the programming of the decision 
tree. 
7.5.7.1 ｃｯ､ｩｮｾ＠ the CYYHD decision tree 
The first issue to be addressed is how to encode the decision tree. Specifically the problem 
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with the coding is to find a technique which can be used to naturally represent the decision 
tree model, so that the program structure is a transparent representation of the model 
already developed. More generally the other qualities the implementation language should 
have are: it should be easy to update and maintain, and allow for integration with other 
applications. The language must be easy to update as clinical decision support is developed 
by iterative prototyping (Heathfield et al., 1991). Moreover, integration of decision support 
is a basic requirement which is reflected in the system design, figure 7.3. 
Object-oriented design techniques seek to mimic the way that people form models of 
reality. Typically the reality referred to is a material one, and objects are thought of as 
material entities with attributes and behaviour in the material world. An object in a 
computer program is not a material object it is an expression of the abstract conceptual 
model of the object. An object can be more usefully thought of as a representation of the 
idealistic abstractions formed of reality, whether that reality is material or idealistic. 
Examples of models of material objects are obvious, such as the descriptive model of a car: 
four wheels, a chassis, an engine, and a gearbox with the ability to move forward and 
backwards. The strength of object oriented programming applied in artificial intelligence 
is in the representation of models of idealist reality such as the model of a decision. So 
object oriented programming can be used to produce a transparent representation of the 
decision tree. 
The advantages of object oriented programming over procedural languages include: 
encapsulation; inheritance, and polymorphism (Parsons, 1994). Encapsulation is the 
combining of object states and functions into a single file. This allows for easier 
maintenance than with more procedural languages. Changes can be made to an object 
definition without having to change code throughout the program. Inheritance is the 
derivation of one class, the sub-class, from another class, the base class. Through 
inheritance the attributes and functions of the base class are part of the sub-class. Thus the 
sub-class relationship is a type of the base class. Related to inheritance is aggregation, 
where a class can be composed of other classes or contain other classes. In the first 
instance the containment class is built from component classes. In the second the class 
contains other classes but they do not form part of its structure. Polymorphism is the ability 
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of classes of object to respond to the same message in different, class specific ways. 
Polymorphic functions have the same name but different implementations for different 
classes. 
All of the previously mentioned characteristics of object oriented promote the reuse of 
code. Encapsulation of a class allows for the multiple creation of objects from the class. 
Inheritance allows sub-classes to re-use code in the base classes. Aggregation allows for 
the re-use of existing classes as components for new ones. While polymorphism is the 
reuse of symbols, operators and names, to apply to different object behaviours. It was 
because of these reported advantages and the representational power of object oriented 
programming that it was selected to encode the decision tree. 
7.5.7.2 Software desian 
To allow for the economic use of code the decision tree, figure 6.1 has to be broken down 
into its constituent parts and common features of those parts defined and represented. 
There are two categories of decision in the decision tree. The first catagory of decision is 
essentially the choice between two courses of action, and the second is the calculation of 
a numerical value. Eight of the decisions are of the type one and three are type two 
decisions. The structure of the program for type one decisions will be considered first. 
The basic unit of the type one decision is a decision node, figure 4.9. Each node has two 
possible options or states, action A or action B. Each option has a separate set of 
conditions for determining when it should be active, or "true". The sequence for choosing 
between options begins with testing the conditions using the patient and treatment 
assessment. After the conditions are tested the results are combined logically to generate 
the DSS advice. The results of the condition testing are logically combined to ensure that 
the safest course of action is chosen. So every decision has: a state which represents the 
results of the condition test and the advice offered; logic for choosing between the two 
possible options, and a set of conditions which define when the options are active. All 
decision nodes have a state, so they can be represented by the same structure in the system. 
Moreover, the logic for choosing the state from the two possible actions is common to all 
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decisions. However, the functions or conditions which make the options active are unique 
to each decision. Thus it is possible to define the hierarchy of the decision tree with the 
generalised structure in figure 7.26. The general decision class at the top of the hierarchy 
consists of the decision state structure and the logical combination function. Below this are 
a number of sub-classes defining the conditions for activating the options of each of the 
type one decisions. 
The C++ code for the general decision class, decision.h, and the decision state class, state.h, 
are in appendix D. The files are documented to explain their function and commented on 
in the program code to explain individual sections and lines. All the comments follow the 
double parallel lines, II. The file state.h defines the class state which is a component of the 
decision class. The decision class is defined in the decision.h file. This class defines the 
data structure of a decision using the component data type state. It also declares and 
defines the logical function for choosing which action to recommend. Table 7.8 is the truth 
table for this logic function. From the table it can be seen that intervening action will only 
be recommended when there are positive indications for intervention, and no contra-
indicators for intervention. The logic function in decision.h has been derived from the truth 
table. 
As shown in figure 7.26 the individual decision functions are defined in different class 
declarations. So for each of the decisions in the tree there are separate files declaring their 
functions. Whilst the data structure and high level function are inherited from the decision 
base class. Taking decision Al as an example, figure 7.27 represents the structure ofthe 
function defining files. File dec_aI.h declares the rule based functions which are used to 
activate the begin RRT and the do not begin RRT options. The advice to be offered to the 
user is also defined here. The functions, including the advice, are defined in dec al-f. 
Each of the functions uses its own data type defined in classes al_conlsvar to 
aI_conOIsvar. These data types define the patient and treatment assessments which feed 
into the decision functions. Thus they form a data interface between the assessment 
modules and the decision tree module. For decision Al there are six conditional functions 
which depend on the treatment and patient state assessments. The output of the decision 
is the advice to either begin RRT or not to begin RRT. Therefore, the decision is run before 
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beginning treatment. Once treatment has begun decision A2 is run in place of A 1. The 
structure of decision A2 and all the other type one decisions in the tree are similar to those 
of A 1. The functions for all these decisions are defined in section 6.3.1, and their C++ 
coding is similar to the code for decision AI. 
The type two decisions are simpler as they consist of a numerical output which is produced 
by a quantitative function. For example the volume of replacement fluid volume can be 
simply calculated as shown in a single file. Only this one file is required; it contains the 
single function required to calculate the volume, and the variables used are fed in directly 
from the information system. 
7.5.7.3 Software ｴ･ｳｴｩｮｾ＠
The decision tree programs have been tested for functionality by running them using the 
files main-dal.h to main-dd2.h in combination with the test files test_al.h and test_al.epp. 
Main-dal.h controls and runs the testing of the decision node AI, while test_al.h initialises 
the test values in the decision data objects according to the test number selected. The 
connection between these and the other programs is shown in figure 7.28. From the figure 
it can be seen that the test programs act as artificial data input to the decision node, while 
the main program is essentially the decision sequence controller. 
There are eight test data states set by the test programs, test_al.h and test_al.cpp. For 
decision A 1 six of the tests set each of the six conditions of the decision node to active 
individually, figures 7.29 and 7.30. Figure 7.29 illustrates the operation of test five where 
condition 3d is activated, and the decision advice correctly given is to begin renal 
replacement therapy. Test 6 (figure 7.30) prompts the advice to not begin treatment. The 
seventh test (figure 7.31) sets all of the data objects to the active state to test the advice 
when all conditions are active. The eighth is the default test when all the conditions are 
inactive. Thus the first six tests ensure the functioning of the six individual test conditions, 
and the seventh and eighth the functioning of the logical conflict control. Other 
combinations of conditions could be activated by the addition of other test numbers to the 
test program. 
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The test programs initialise the values of the condition data objects, alconlsvar etc .. The 
initialisation is perfonned by the function iniat_ var in each of these data objects. The 
values set in the iniat_ var function depend on the value at a point in the test array. The 
values in the array are set by the test number in the test program. The activation of the 
conditions in the decision functions depends on the initialised test values of the condition 
variables. Each of the conditions are set to active by different positions in the test array. 
Thus any number of tests can be defined where each decision condition is turned on or off 
by the array. 
All of the files of decision A 1 are invoked by the decision node control program main-
dal.h. Running main-dal.h perfonns the following functions: 
Creates the decision objects to be tested 
Creates data objects for each of the decision conditions and initiates their values 
according the test number entered 
Runs each of the decision conditions to detennine the decision state 
Invokes the advice function to detennine decision node advice and outputs the 
advice to the screen 
Main-dal.h has been run successfully for all eight test conditions described above (figure 
7.32). Thus the functionality of the decision node Al has been validated. The functionality 
of all the other decision nodes has been tested using the same technique (figures 7.33 to 
7.40). Thus the function of all of the decision nodes has been proven, and all were found 
to operate as expected. Thus proving the concept of modelling decisions as objects with 
states and decision functions. 
The next stage of development of the decision tree will include connecting together the 
decision nodes to produce a unified treatment advisor. The other required elements of the 
future development of the complete treatment advisor are: the advice justification 
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component; attachment of goals to the advice, and the meta control of the decision tree for 
controlling several decision cycles. Moreover, the integration of the decision tree with the 
data and information system will be required in a fully operational system. The work 
described above on the functional units of the decision tree is a good foundation for the 
future development of the fully operational treatment advisor. 
7.5.7.4 Other components of the decision sup,port system 
The other components required in the decision support system are: the patient and treatment 
state assessment, and the simulation component. The designs for these other components 
is at the conceptual stage. The patient and treatment state assessments required in the 
decision making simulation are defined in section 6.4. Some of the assessments required 
will be entered directly by the users whilst others will be derived from classifications of 
patient data. The system classifications will be performed on patient electrolyte, urea, 
creatinine, urine volume, and acid-base data using the bands defined in section 6.4.1. The 
other data not already entered into the information system, could be gathered by a series of 
direct questions to the system user. 
It was proposed in section 7.4 that the model to be implemented in the initial development 
is Sargent and Gotch's (1980) single pool model of urea kinetics. This means initial 
simulation development will proceed with the simulation of only one of the patient goal 
variables; plasma urea concentration. Using a model based on Sargent and Gotch's in a 
prototype will allow for the testing of the feasibility of using a quantitative model to predict 
treatment outcomes in the lTV. The other models of the goal variables, although required 
in the complete management of the patient are too complex and unproven to use in the early 
stages of development. 
7,6 SUMMARY 
This chapter has described the design and development of a prototype computer based RRT 
management system building upon the clinical analysis in chapters 5 and 6. In addition to 
the clinical analysis the design has also used the general system requirements for a clinical 
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decision support system in the lTV defined in this chapter. In compliance with these 
requirements the system design produced is an integrated design incorporating the modules 
of the RRT management system with a general lTV PDMS. From the RRT management 
system design the two prototype sub-systems developed were the fluid charting module and 
the treatment advice module. The fluid charting module has been designed to record and 
present fluid volume data, and to act as a fluid balance planning aid. The treatment advice 
module design has been based on the decision tree model of CVVHD decision making 
described in chapter 6. The functionality of the nodes of the decision tree has been 
validated by encoding them using object oriented programming. This was used to allow 
for ease of updating and maintenance of the program code. Moreover, using object oriented 
tools and techniques allowed for a natural representation of the decision tree model, thus 
demonstrating the use of the tools and techniques for the implementation of models of the 
idealist reality. 
The following discussion chapter reviews the major issues raised in this and previous 
chapters. 
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TABLE TITLE: DATA TYPE CLASSIFICATION 
The table below gives a description of the data classification used in tables 2 to 7. 
DATA TYPE DESCRIPTION 
RD Raw data, entered onto the chart via the user 
interface by medical staff. 
SO Data which are part of the structure of the blank 
chart, and therefore do not have to be entered into 
the chart. 
CD A calculated value. Calculated using other data in 
the charting system. 
LD An input which originates from another fluid chart, 
and is automatically linked into the chart. By 
linking the data any change in the original data 
is shown automatically in the linked, or 
destination, data. 
Table 7.1 Fluid chart data classification 
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CHART NAME: PATIENT IDENTIFIERS 
EXCEL FILENAME: FLUHDPAT 
ITEM NO. TITLE DEFINITION DATA TYPE 
HDP1 HOSPITAL NO The unique seven digit number allocated to the RD 
patient by the hospital 
HDP2 SURNAME The patient's last or family name RD 
HDP3 FIRST NAME(S) The patient's first names RD 
HDP4 DATE OF BIRTH The patient's date of binh RD 
HOPS ADMISSION DATE The date of the patient's admission to the RD 
ITU 
HOPS PATIENT'S WEIGHT The most recent measurement or estimate of RD 
the patient's weight 
Table 7.2 Data definitions for the pateint identifiers chart 
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CHART NAME: BEDSIDE CHART 
EXCEL FILENAME: FLUBSCHT 
ITEM NO. TITLE DEFINITION DATA TYPE 
BSC1 HOSPITAL NO Equivalent to data item HDP1 on the identifiers LD 
chart 
BSC2 SURNAME Equivalent to data item HDP2 on the identifiers LD 
chart 
BSC3 FIRST NAME(S) Equivalent to data item HDP3 on the identifiers LD 
chart 
BSC4 DOB Equivalent to data item HDP4 on the identifiers LD 
chart 
BSC5 DATE Date at 0800 hours when the data began on the RD 
attached chart 
BSCB TIME The time, to the nearest hour, the readings were SO 
recorded, B/FWD signifies the fluid balance 
bought forward from the previous 24 hour 
chart 
BSC7 CORE TEMP The hourly recording of the patient's core body RD 
temperature (set to a default level of 37,5 C), 
BSC8 PMP SPD The volume of blood being pumped into the RD 
dialysis blood circuit per minute 
BSC9 VEN PRS The pressure reading in the venous return line RD 
in the dialysis blood circuit 
BSC10 DIAL INF The volume of dialysate infused into the RD 
dialyser in the preceding hour 
BSC11 HEP Total volume of heparin infused into the patients RD 
blood system 
BSC12 REP FLU The volume of replacement fluid introduced into RD 
the patient in the dialysis circuit 
BSC13 FLSH Definition uncertain RD 
BSC14 TPN Volume of total parenteral nutrition RD 
BSC15 NG Volume of entral nutrition delivered to the patient RD 
BSC16-19 INFUSIONS Four columns for entering the volume of drug RD 
infusions. The nurse enters the name of the 
drug in the top of the column. 
Table 7.3 Data definitions for the bedside chart 
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CHART NAME: BEDSIDE CHART 
EXCEL FILENAME: FLUBSCHT 
ITEM NO TITLE DEFINITION DATA TYPE 
BSC20-21 BOLUS Two columns for entering the volume of RD 
injections. The nurse enters the name of the 
drug in the top of the column. 
BSC22 COLl The total volume of colloids given to the patient RD 
BSC23 DIAL OIP The volume of used dialysate collected in the RD 
waste bag in the dialysate circuit 
BSC24 NG DRAIN The volume of output via the naso-gastric drain RD 
BSC25 GAST OIP The volume of output from the patient's bowel RD 
BSC26 BLD DR Volume of blood drained from the patient RD 
BSC27 URIN Volume of urine output RD 
BSC28 URIN- ACC TOT Accumulated total of the urina output from 0700 CD 
hours on the date indicated 
BSC29 ULT FILT The volume of ultrafiltrate removed in the CD 
haemodialysis 
BSC30 TOT liP HR The total volume of fluid input for the hour CD 
BSC31 ACC liP The accumulated fluid inputs delivered to the CD 
patient since 0700 hours on the date indicated 
BSC32 TOT OIP HR The total volume of fluid output for the hour CD 
BSC33 ACC OIP The accumulated fluid outputs delivered to the CD 
patient since 0700 hours on the date indicated 
BSC34 HR FLU BAL The measured fluid balance li/p-o/p) for the hour CD 
BSC35 ACC FLU BAl The accumulated measured fluid balance for the CD & LD 
patient since 0700 hours on the date indicated. 
The first number in this column is the previous 24 
fluid balance, and is linked to the accumulated 
fluid balance on the previous days chart. 
Table 7.3 Data definitions for the bedside chart 
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CHART NAME: INSENSIBLE LOSS ESTIMATES 
EXCEL FILENAME: FLUINSEN 
ITEM NO. TITLE DEFINITION DATA TYPE 
INSl HOSPITAL NO Equivalent to data item HDPl on the identifiers LD 
chart 
INS2 SURNAME Equivalent to data item HDP2 on the identifiers LD 
chart 
INS3 FIRST NAME(S) Equivalent to data item HDP3 on the identifiers LD 
chart 
INS4 DOB Equivalent to data item HDP4 on the identifiers LD 
chart 
INS5 PAT WEIGHT Equivalent to data item HDP6 on the identifiers LD 
chart 
INS6 DATE Date at 0800 hours on the attached chart RD 
INS7 TIME The time, to the nearest hour, the estimates SO 
relate to 
INS7·8 INSENSIBLE LOSS The hourly and accumulated estimates for the CD 
insensible loss 
INS9 CORE TEMP Equivalent to data item BSC7 on the bedside LD 
chart 
INS10·11 SWEAT LOSS The hourly and accumulated estimates for the CD 
sweat loss 
INS12·13 TOT AL INSENSIBLE + The sum of the estimates for sweat volume and CD 
SWEAT LOSS insensible loss 
Table 7.4 Data definitions for the insensible loss estimate chart 
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CHART NAME: SUMMARY FLUID CHART 
EXCEL FILENAME: FLUCHTSUM 
ITEM NO. TITLE DEFINITION DATA TYPE 
CHT1 HOSPITAL NO Equivalent to data item HDP1 on the identifiers LD 
chart 
CHT2 SURNAME Equivalent to data item HDP2 on the identifiers LD 
chart 
CHT3 FIRST NAME(S) Equivalent to data item HDP3 on the identifiers LD 
chart 
CHT4 DOB Equivalent to data item HDP4 on the identifiers LD 
chart 
CHT5 DATE Date at 0800 hours on the attached chart RD 
CHT6 TIME The time. to the nearest hour. the readings were SO 
recorded. 
CHT7-8 MEASURED BALANCE Equivalent to data item BSC34 and BSC35 on LD 
the bedside chart 
CHT9-10 INSENSIBLE AND Equivalent to data item INS 12 and INS 13 on the LD 
SWEAT LOSS insensible estimates 
CHT11-12 AGGREGATE FLUID The measured fluid balance less the estimated CD 
BALANCE insensible and sensible sweat loss 
CHT13·14 TARGET FLUID The prescribed fluid balance for the LD & CD 
BALANCE corresponding period split into 12 equal 
amounts 
CHT15·16 DIFFERENCE The aggregate balance less the linear target CD 
balance 
CHT17 REVISED TARGET The balance in the next hour required to CD 
BALANCE achieve the state where the accumulated 
aggregate balance is equal to the prescribed 
accumulated target balance. 
It is calculated by subtracting the accumulated 
aggregate balance at the end of last hour from 
the accumulated target balance at the end of 
the next hour. 
Table 7.5 Data definitions for the summary fluid chart 
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CHART NAME: DOCTOR'S SUMMARY CHART 
EXCEL FILENAME: FLUDRSUM 
ITEM NO, TITLE DEFINITION DATA TYPE 
ORSl HOSPITAL NO Equivalent to data item HOPl on the identifiers LO 
chart 
ORS2 SURNAME Equivalent to data item HDP2 on the identifiers LD 
chart 
DRS3 FIRST NAME(S) Equivalent to data item HDP3 on the identifiers LD 
chart 
DRS4 DOB Equivalent to data item H DP4 on the identifiers LD 
chart 
DRS5 TIME PERIOD The twelve hour time period up to the time SO 
shown, For the chert shown either 00:01 to 12:00. 
or 12:01 to 24:00 
DRS6 DATE The date at the end of the corresponding time RO 
period 
DRS7-8 TOTAL CRYSTALLOIDS The total crystalloids entered on the bedside LD &CD 
chart in the period and accumulated over the 
time periods, This is calculated by linking the 
bedside chart and calculating the period total 
on the doctor's summary 
DRS8-9 COLLOIDS The total colloids entered on the bedside LD & CD 
chart in the period and accumulated over the 
time periods. This is calculated by linking the 
bedside chart and calculating the period total 
on the doctor's summary 
ORS10-ll TOTAL INPUTS The twelve hour period totals and the CD 
accumulated totals of the fluid input volumes 
ORS12-13 UL TRAFIL TRA TE The total ultrafiltrate entered on the bedside LO & CD 
chart in tha period and accumulated over the 
time periods. This is calculated by linking the 
bedside chart and calculating the period tot81 
on the doctor's summary 
ORS14-15 URINE The total urine volume entered on the bedside LD & CD 
chart in the period and accumulated over the 
time periods. This is calculated by linking the 
bedside chart and calculating the period total 
on the doctor's summary 
DRS1S·17 OTHER MEASURED The total of the other losses entered on the LD & CD 
LOSSES bedside chsrt in the period and accumulated 
over the time periods, Thi. is calculated by 
linking the bedside chart and calculating the 
period total on the doctor's summary 
DRS18-19 INSENSIBLE & SWEAT The total of the estimated insensible and sweat LD & CD 
LOSSES losse. on the insensible loss estimates in the 
period .nd .ccumulated over the time periods. 
This is calculated by linking the bedside chart 
and calculating the period total on the doctor's 
summary 
DRS20-21 TOTAL OUTPUTS The twelve hour period totals and the CD 
accumulated totals of the fluid output volumes 
DRS22·23 AGGREGATE FLUID The period total for the fluid inputs less the fluid RD & CD 
BALANCE outputs. and the accumulated balance including 
the previous charted balance bought forwerd , 
Table 7,6 Data definitions for the doctor's summary chart 
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CHART NAME: FLUID PRESCRIPTION CHART 
EXCEL FILENAME: FLUPRES 
ITEM NO. TITLE DEFINITION DATA TYPE 
PREl HOSPITAL NO Equivalent to data item HDPl on the identifiers LD 
chart 
PRE2 SURNAME Equivalent to data item HDP2 on the identifiars LD 
chart 
PRE3 FIRST NAME(S) Equivalent to data item HDP3 on the identifiers LD 
chart 
PRE4 DOB Equivalent to data item HDP4 on the identifiers LD 
chart 
PRE5 TIME PERIOD The twelve hour time period up to the time SO 
shown. For the chart shown either 00:01 to 12:00, 
or 12:01 to 24:00 
PRE6 DATE The data at the end of the corresponding time RD 
period 
PRE7 TOTAL CRYSTALLOIDS The total prescribed crystalloids, estimated and, RD 
entered as the required input for the time period 
PRE8 COLLOIDS The total prescribed colloids, estimated and, RD 
entered as the required input for the time period 
PRE9 TOT AL INPUTS The sum of the estimates for the ne)(t time CD 
period of colloid and crystalloid inputs 
PRE10 UL TRAFIL TRATE The ultrafiltrate estimate calculated from all the CD 
other prescribed fluid variables entered on the 
chart 
PREll OTHER LOSSES The total fluid losses other than the ultrafiltrate RD 
estimated and entered for the time period 
PRE12 TOT AL OUTPUTS The sum of the estimates for the next time CD 
period of ultrafiltrate and other fluid outputs 
PRE13 AGGREGATE FL SAL Equivalent to data item DRS22 on tha doctor's LD 
summary fluid chart chart 
PRE14 DIFF Aggregate less target fluid balance CD 
Table 7.7 Data definitions for the fluid prescription chart 
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option A state option B state decision state 
0 0 0 
0 1 0 
1 0 1 
1 1 0 
Table 7.8 Truth table for decision arbitration function 
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Figure 7.2 Clinical scenario 
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Figure 7.3 Integrated system design 
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Figure 7.4 Information system modules 
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Figure 7.5 Three stages of decision option choice 
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(Volume = V, 
Urea cone. = C) 
Figure 7.6 Single pool model of urea kinetics 
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Figure 7.8 Fluid chart spreadsheet linkage 
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HOSPITAL NO 11234567 
SURNAME IBROOM 
FIRST NAME(S) IPETER 
DATE OF BIRTH 11/12/45 
ADMISSION DATE 11 /6/95 
ADMISSION TIME 113:30 
PATIENT'S WEIGHT \70 
(IN KILOGRAMS) 
DIALYSIS START 
DATE: 1°5/06/95 
TIME: 15:40 
Figure 7.9 Patient identifers for the fictitious pateint Peter Broom 
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I,;.) 
I,;.) 
IV 
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HOSPITAL NO 
SURNAME 
FIRST NAME(SJ 
DOB 
DATE: 
8/6/95 
TIME TEMP 
HOUR CORE 
UP TO TEMP 
deaC 
B/FWD 
0800 38.5 
0900 38.2 
1000 3B 
1100 37.8 
1200 37.5 
1300 37.5 
1400 37.5 
1500 37.5 
1600 37.4 
1700 37.5 
1800 37.5 
1900 37.5 
2000 37.5 
2100 37.2 
2200 37.5 
2300 37.5 
2400 37.5 
0100 37.5 
0200 37.2 
0300 37.5 
0400 37.5 
0500 37 
0600 37.5 
0700 37.5 
TOTAL 
(1234567 
(BROOM 
1 PETER 
101112/45 
DIALYSIS 
PMP VEN DIAL 
SPO PRS INF 
ml/min mmHg mI 
100 50 1000 
100 50 1000 
100 35 1000 
80 35 1000 
80 35 1000 
80 35 1000 
80 35 1000 
100 40 1000 
100 40 1000 
100 40 1000 
100 40 1000 
100 40 1000 
nawfll' 
100 80 1000 
100 70 1000 
100 60 1000 
100 60 1000 
100 60 1000 
100 60 1000 
100 60 1000 
100 70 1000 
100 60 1000 
100 60 1000 
100 70 1000 
23000 
FLUID INPUTS 
FLSH 
HEP REP 
FLU 
mI mI mI 
2 400 12 
2 300 12 
2 300 12 
2 150 12 
2 150 12 
2 150 12 
2 150 12 
2 150 12 
2 175 12 
2 12 
2 12 
2 150 12 
2 12 
2 100 12 
2 400 12 
2 600 12 
2 600 12 
2 800 12 
2 600 12 
2 500 12 
2 600 12 
2 400 12 
2 200 12 
2 800 12 
48 7675 
Figure 7.10 Bedside chart for Peter Broom on 8I6/9S 
DIET DRUG 
TPN NG INFUSIONS 
'op all 
ml ml ml ml 
106 7 4.2 
106 7 4.2 
106 7 4.2 
106 7 4.2 
106 3 4.2 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
106 3 2.1 
2544 0 88 60.9 
-
FLUID OUTPUTS MEASURED 
BALANCE 
COlL DIAL URiN TOT ACC TOT ACC HR ACC 
BOLUS DIAL NG GAST BLO URIN Ace UlT lIP liP DIP DIP FLU FLU 
drug kel OIP DRN OIP DR TOT ALT HR HR BAL BAL 
ml ml ml ml ml ml ml mI ml mI ml mI ml ml ml ml ml ml 
·668.2 
1520 0 520 531.2 531.2 520 520 11.2 11.2 
1440 0 440 431.2 962.4 440 960 ·S.8 2.4 
1350 0 350 431.2 1394 350 1310 Bl.2 83.6 
30 120 1360 100 0 360 431.2 1825 460 1770 ·28.8 54.8 
1400 0 400 217.2 2102 400 2170 ·122.8 ·68 
1320 0 320 275.1 2317 320 2490 ·44.9 ·112.9 
1280 0 280 275.1 2652 280 2170 ·4.9 ·117.8 
1300 0 300 275.1 2927 300 3070 ·24.9 ·142.7 
1320 14 14 320 300.1 3227 334 3404 ·33.9 ·176.6 
1340 2 16 340 125.1 3353 342 3746 ·216.9 ·393.5 
100 1310 16 310 225.1 3578 310 4056 -84.9 ·478.4 
1300 16 300 275.1 3853 300 4356 ·24.9 ·503.3 
100 16 100 125.1 3978 100 4456 25.1 ·478.2 
150 2080 1 17 1080 375.1 4353 1081 5537 ·705.9 ·1184 
150 1780 2 19 780 675.1 5028 782 6319 ·106.9 ·1291 
30 150 1670 19 670 905.1 5933 670 6989 235.1 ·1056 
1670 19 670 725.1 6658 670 7659 55.1 ·1001 
1630 19 630 925.1 7583 630 8289 295.1 ·705.7 
1570 19 570 725.1 8308 570 8859 155.1 ·550.6 
1600 19 600 625.1 8934 600 9459 25.1 ·525.5 
1600 19 600 725.1 9659 600 10059 125.1 ·400.4 
1370 19 370 525.1 10184 370 10429 155.1 ·245.3 
1720 150 19 720 325.1 10509 870 11299 ·544.9 ·790.2 
1530 2 21 530 925.1 11434 532 11831 393.1 ·397.1 
_0 60 120 550 34560 250 0", 0 21 21 11560 11434 11434 11831 11831 ·397.1 ·397.1 
HOSPIT AL NO: 1234567 
SURNAM: : BROOM 
FIRST Nt>M: : PETER 
DATE : EY6$ 
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Figure 7.11 Graph of measured fluid balance for fictitious patient Peter Br am 
HOSPITAL NO: 1234567 
SURNAME: BROOM MEASURED FLUID INPUTS AND OUTPUTS 
FIRST NAME : PETER 
DAT E: 8 '6 '95 
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7.12 Measured fluid input and output volumes 
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HOSPIT AL NO: 1234567 
SURNAME: BJrOOM-- UL TRAFIL TRATE OUTPUT PER HOUR 
FIRST NAME: pETER 
DATE: S'6!95 
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Figure 7.13 Ultrafiltrate output per hour 
HOSPITAL NO 
ｓｕｾｎａｍｅ＠ IBROOM 
FIRST NAMEISI ｉｐｅｔｅｾ＠
OOB 
PA T WE IG M T po 
2200 
OAT E: INSENSIBLE TEMP. ｓＢＧｅｾｔ＠ LOSS 
8/8/95 LO SS 
TIME MR Ace CORE MR Ace 
MOUR TOT TOT 'Tf M P. TOT TOT 
UP TO 
ml ml de. C ml ml 
0800 2 , 2 , 38.5 2' 
0900 2 , 42 38.2 , 5 
'000 2 , 83 38 '0 
" 00 21 .3 37.8 6 
'200 21 '04 37.5 0 
'300 21 , 2S 37.5 0 
HOD 21 lH 37.5 0 
HOO 2 , 187 37.5 0 
1600 2' '88 37.4 0 
'700 2' 208 37 5 0 
1100 2 , 228 37.5 0 
\VOO 2' 60 37.5 a 
2000 2' 27, 37.5 0 
2100 2 , 212 3' .2 0 
2200 2' 313 37 .6 0 
UOO 2 I 333 37.6 0 
2400 21 3U 31·,6 0 
0100 21 375 37.5 0 
0200 21 386 37. 0 
0300 21 4'7 37.5 0 
0400 2' .3. 37 .5 0 
0600 2' 461 37 I) 
0800 2' 
." 3 7.5 0 
0700 2 , 500 37 .5 0 
TO AL 600 500 52 
Figure 7.14 Insensible and sweat loss estimates 
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I 
2400 200 400 600 
TOTAL INSENSIBLE 
+ SWEAT LOSS 
MR Ace 
TOT TOT 
ml ml 
2 , 
'2 42 
3S 35 7? 
46 3 , '08 
S2 27 , 3 ｾ＠
52 2 , '56 
S2 2' 177 
52 2 , '98 
52 2' 2' 9 
52 2 , 2'0 
52 2' 260 
52 2 , 2.' 
52 2' 302 
52 2' 323 
52 2' 344 
12 2' 365 
52 2 , 315 
52 21 406 
52 21 427 
62 21 44. 
52 2' 469 
52 2 , 410 
52 2' 5,0 
62 2 , 52' 
62 2' 562 
52 liS 2 552 
HOSPIT AL NO: 1234567 
SURNAME : BROOM 
FIRST NAME: PETER 
DATE : 8'6'95 
...J 
ｾ＠
.... 
til 
UJ 
til 
til 
0 
...J 
u.. 
0 
UJ 
ｾ＠
ｾ＠
...J 
0 
> 
ｾＵ＠ __ _ _ _ ,_ - . 
, 
40 J ____ ｾ＠
35 
- - i -
30 
25 
20 
15 
10 
5 
0 
INSENSIBLE WATER AND SENSIBLE SWEAT LOSS 
a INSE NSIBLE LOSSES mSWEATVOLUME 
800 ,CXXl ,200 ＱｾＰＰ＠ ,600 1800 2CXXl 2200 Ｒ ｾＰＰ＠ 200 ｾｯｯ＠
TIME IHOUR 
Figure 7.15 Plot of insensible and sweat loss volume estimates 
H05PI,AL NO ＱＮＮＡＡ Ｇ Ｎ［ＮＱＮＺＺＺＺ Ｂ ＺＮＮＺｾｾＶＬＭＬＷ＠ _________ .J 
Ｕ ｕｾｎ Ｂｍｅ＠ l:!S::,;R.:::O.:::O"'M'_ ________ --' 
ｆ ｉ ｾＵＬ＠ NAME lSI L::!P.!.E.:,:' ,:.,:.:.....-_________ ...J 
DOB ｬＺＡｏｾＧＮＺＮＺ Ｌ Ｇ ｾ ｬ ｾＧｾｾＧ｟＠ ________ ...J 
DA,E : ｍｅａｓｕｾｅｏ＠ ｲｴ［ｓｅｴｾｓ Ａ ｂ ｌ ｅ＠ AGGREG.a 'JoRGEl 01" [REN e E . EVISED ,.0GEl 
Ｘ Ｏ Ｖ Ｑ Ｙｾ＠ SALANCE , SWEA'r LOSS FLUID S<L."'CEIAI FLUID SALANCEITi I" · TI SALANCE 
,'ME ｈｾ＠ ACC M. ACC H. ACC M. ACC H. ACC FOR HO UR 
I HOUO flUID flU ID ,0, ,0, BM BA L SAL SAL SAL SA L PREC£EDING 
UP '0 BAl SAL llM[ SI-I O WN 
ml ml ml ml ",I ",I ml ml ml ",I ",I 
0800 11 .2 11 .2 ., '2 · 30 ｾ＠ ·3 0 ｾ＠ ·a .o ﾷ Ｒｾ Ｎ Ｐ＠ Ｎ ｾ＠ ｾ＠ Ｎ ｾ Ｎ ｾ＠ 26 8.2 
0900 ·S .8 2 • "5 
" 
· •• . 2 . 7< .1 · '5 .0 ﾷ ｾ ｯ＠ 0 . , 9 .2 ·2' .1 . , 8 S 
'000 81.2 S3 .6 ;; , '08 ｾｏ Ｎ ｏ＠ ·24 .1 ·25 .0 ·H.O 75 .0 bO 3 ·0 .3 
"00 ·16 .8 ｾＧ Ｎ Ｘ＠ 27 , Ｓｾ＠ ﾷ ｾＵ Ｎ Ｘ＠ ·80.6 ·25 .0 · '00.0 · 30 .i , 9 4 Ｎ Ｗ ｾ Ｎ Ｓ＠
1200 "22 .8 ·68 2 ' 1\6 · " 3.6 ·224 .3 ·25 .0 . , 2b .0 . 118.6 ·99 .3 . 4 • .• 
'300 .'4 ,9 ., 12 .9 2 , ,,, ·65 .1 · 290.0 ·83 .3 ·208 .3 17 .6 ·8' .7 , b.9 
"00 .4.9 ., 17 .8 2 , '98 ﾷ Ｒｾ Ｎ Ｗ＠ ·3H.7 ·83 .3 · 29 ' .7 57 .6 ·24 . , ". 
,500 ·24 .9 '''2 .7 2' 2'9 .45 .1 ﾷ ＳＶＱＮｾ＠ ·83 .3 ﾷ ＳＷｾ Ｎ Ｐ＠ 37 .6 , 3 .6 ·59 .3 
'600 ·33 .9 ., 76 .6 2' 2'0 . !l4 , 7 ," 6.2 ·83 .3 Ｎ ＴｾＸ Ｎ Ｓ＠ 28 .6 42 .2 ·96 .8 
1700 ' 216.9 ·393 .5 2' 260 · 231 .7 ﾷＶｾＳ Ｎ Ｘ＠ ·83 3 ·S41 .1 . , S' 4 . " 2 .3 . , Ｒｾ Ｎ Ｖ＠
'800 ·84 .9 ... 7e .• 2' 26' , 'O S.l ﾷ Ｗ ｾＹ Ｎ Ｗ＠ ·83 .3 ﾷＶＲｾ Ｎ Ｐ＠ · 22 .4 . , J. , 7 28 .8 
'900 ," .9 ·503 .3 2' 302 .4S .7 ﾷ ＸＰｾ Ｎ Ｔ＠ ·83 .3 ·708 .3 37 .6 ·97 .0 b1.3 
2000 Ｒｾ Ｎ＠ , .418.2 2' 323 4 .3 ·80, . , ·83 .3 ·791.7 Bl .6 ·9 .4 , 3.7 
2'00 · 705.9 .1164 21 3" · 726 .7 ., 527 .9 ·83 .3 ·876 .0 ·643 .4 ·652 .9 .73.i 
2200 · '06 .8 ·'29' 2' Ｓ Ｖ ｾ＠ ,'21 .7 , ,655 .6 ·83 .3 ·958 .3 ·" .4 ·69 7.3 b69 .5 
2300 235.' , '056 
" 
385 2" .3 ""1.3 ·83.3 , '041.7 297 .6 · 399 .1 6' 3.9 
2400 55. , · '00, 2 , 406 34 .3 ' ''07 . ' ·83.3 . , 1 Ｒｾ Ｎ Ｐ＠ , 17 .6 · 282 . , 3'6 .3 
0,00 295. ' · 705.7 2' 4" 274 .3 . " 32 .8 25 .0 " '00 .0 249 .3 ·32 .8 307.1 
0200 '55. ' ·550.6 2' 448 , 3' .3 ·998 .5 25 .0 " 015 .0 '09.3 76 .5 57 .8 
0300 25 . ' ·525.5 2' 469 4.3 ·994 .3 25.0 " 050 .0 ·20 .1 55 .8 ·5 1.5 
0400 125. ' .400.4 21 490 '04.3 ·890.0 25 .0 , '025 .0 78 .3 ' 3b .0 ·30 .8 
ｏｾｏｏ＠ Ｑｓｾ Ｎ＠ , ·24b.3 2' b'O , 34 .3 · ? bb .? a .o " 000 .0 '09 .3 2" .3 " '0.0 
0600 ·5" .9 · 790.2 2' b3' ·bOb.? · '32' .5 2b .0 ·815 .0 · b80 .1 · 346 .5 ·2' 9 .3 
0700 393.1 · 397. ' 2' ｾ｢Ｒ＠ 312 .3 ·948 .2 2& .0 ·9bO.0 341 .3 O.B 371 .& 
,O,AL ·397 . ' ·391 . ' ｢ｾＲ＠ .06 bb2 .083 ·949 . ' 833 ·9<S. ,833 ·9bO .0 ·9bO .0 0 .8 ' 61 0 .8 ' til 
Figure 7.16 Summary fluid chart showing aggregate fluid balance 
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Figure 7.17 Aggregate fluid balance 
HOSPITAL NO : 1234567 
SURNAME : ｾ＠
FIRST NAME : PETER 
DATE : S'f>'95 
TARGET AND AGGREGATE FlUID BALANCE 
__ TARGET BALANCE __ AGGREGAlE BALANCE 
200 400 
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Figure 7.18 Target vs aggregate fluid balance 
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2200 2400 200 400 600 
, 
w 
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-....I , 
HOSPITAL NO 11234561 -----) 
SUflNAME I BROOM 
FIRST NAMEIS. I PETER 
008 101112/45 ----.. -- -- - -----
FLUID IHPUTS f LUID QUIPU TS 
TOTAL COlLOIDS TOTAL Ul 'RAft\. fAA IE 
CRVSTAllOIDS IM'UTS 
TIME aNDAlE I'£AIOO ACC P£AIOO ACC I'£RIOO ACC I'(ROOO 
12 HI! TOT TOT TOT TOT TOTAL TOTAL r o rAl 
UP TO mI mI mI mI ... ... ... 
9/fWD 
1200 01106195 0 .0 0 .0 0 .0 0 .0 0 .0 00 0 .0 
2000 0 1106195 3501.6 3501.6 290.0 290.0 3 197 .6 319 1.6 .. ｾＮＩＨＩ Ｎ ｯ＠
1200 02106195 3 308.0 6815.6 100.0 390.0 3 408 .0 7205.6 3530.0 
2 000 02106195 5411 .2 12226.8 200.0 590.0 !,fil1. } 12" 16 ." 5R}!) 0 
1200 OJI06f9S 3109.2 15936.0 0 .0 5<10.0 3109 '1. 16!JJ.60 4]AO f) 
2<00 03106195 "817 .• 20153 .< 200.0 790.0 SOl 7 .• 11!J4)." 5460 0 
1200 04/06195 3825.5 24518 .9 100.0 ... ｾ Ｎ ｏ＠ 4 52S.5o Ｒｲｾｾ Ｎ Ａｊ＠ ｾｮＮＱＰＰ＠
2<00 04106/95 5358. 1 29931.0 0 .0 ＧＧＧ ｾ Ｎ ｏ＠ ＡＩｊ ｾ ｒ Ｎ ｉ＠ 3147. / .0 5 J'lO.n 
1200 05/06/95 4S64 .8 J.SO' . 8 100.0 1590.0 4(164 .8 ｝ＨＮｯｾｬ Ｎ ｒ＠ ｾｽＧＱＰ＠ 0 
2<00 05106195 <815.6 39311.< 100.0 1290.0 5515.6 ＴＱｲｾＯ Ｎ Ｔ＠ !J4tO I) 
1200 06106195 6395. 1 4 S112 .!t 100.0 1390.0 ｴ［ＴＹｾ Ｎ Ｑ＠ .. RIO} . .... ftli J n f) 
2'00 06106/95 !Jl!.6.4 50868.9 300.0 16900 S4 !J6 .. ＡＧ ｝ ｾＡＧ ｒ Ｎ ＡＩ＠ 5 610.0 
1200 01106/95 61"2 .4 57611 .3 0 .0 1690.0 6/4] .. ftIJ ]O l .3 63/00 
2'00 07/06195 6}.C .4 63855. 1 0 .0 1.90.0 Ill"" .• ff 6 !)"S , Ｖ Ｂ ｾｏｏ＠
1200 08106195 .,20 .• 68576. 1 0 _0 2"90.0 .'10 .4 11166 1 .l;fiOO 
2'00 08106195 4006. 2 12582 .3 550.0 32·00 Ｎ ｾ ｾ＠ } 15Rll .3 5 4 1()O 
1100 
1400 
1200 
2<00 
1200 
2400 
1200 
2400 
FIGURE 7. 1& DOCTOR'S SUMMARY FWID CHART FOR PETER BROOM 
URlHt OTHER MEASURED INSENSIBlE .. TOTAL AGGREGATE 
LOSSES SWEAT LOSSES OUTPUTS fL . OAl. 'A, 
ACe: P(ntOO ACC I'(ROOO ACC I'(RlOD ACC 1'(11,00 ACC ""AlOO ACC 
TOT TOT TO T TOT TOT TOTAL TOTAL TOTAL TOTAL BAl BAl 
mI mI 
"" 
mI mI mI mI mI mI mI 
5324 .0 
0 .0 0 .0 0 .0 0 .0 0 .0 0 .0 0 .0 0 .0 0 .0 0 .0 5324 .0 
"!)10.0 1r, .0 lG 0 110 .0 120.0 229.2 229.2 0095.2 <095 .2 -1091.6 41264 
R0600 56 .0 12.0 150.0 270.0 250.0 479.2 3986.0 8881.2 ·578.0 3648 .4 
l JRM 0 290 101.0 60.0 330.0 250.0 729 . 2 6159.0 15040. 2 -541 ." 3100.6 
1 AlfiO .O ' .0 1050 200.0 530.0 250.0 9 79 .2 '83<.0 19814 .2 · 11 ' • . 8 1915 ｾ＠
}J/JO.n 00 105.0 100.0 I JO.O 250.0 1229.2 59 10.0 25 78· . 2 ·892 .6 101i] ) 
2RI50 0 0 .0 1050 14 5 .0 975.0 250.0 1419. 2 5525.0 31309.2 ·999.5 81 , 
] <11 00 (I 0 .0 105 0 1000 1075.0 250.0 1129. 2 5100.0 J 100'). 2 .J41 !) ] S8 ] 
.111'lO 0 0 0 10!, !') 0 .0 10 15 .0 2'>0.0 1979.1 55<0.0 42549 . 7 ·815 .2 . 1 131 .. 
"" ROO 0 0 0 IOS.O 0 .0 1015.0 250.0 2229.1 5660.0 48209.2 .'.4." 11 11 e 
ｾＱＴ Ｎｬ ｮ＠ Q 00 lOr, 0 00 1015.0 2'>0.0 2419.1 6880.0 55089.2 ·384 .1 Ｎ ＱＶｾ Ｉ＠ 1 
!,1I00 I') 00 lOS 0 330 .0 1405.0 250.0 2129.2 6250.0 61339.2 · 79 3.6 ｝ Ｔ ｾ Ｖ＠ 3 
6 14 1() I) ｾ＠ 1050 Ｌｾ Ｎ ｏ＠ 1555.0 250.0 2979.2 6110.0 68109. 2 · 21 6 }4fU 9 fl9!)]O 0 00 10 5 0 2000 1155.0 250.0 3229.2 6900.0 15009.2 ·6 55.6 · 3 1)1 ｾ＠
''' 5fVJ 0 0 .0 10 5.0 11 50 18100 302 . 1 3531.3 :,011. 1 80086. 3 ·356 . 1 · 3 436 } 
AOO'>O 0 ｉ ｾ＠ 0 1]4 0 0 .0 1810.0 145. 8 3611. 1 563< .8 85721.1 · 10 18.6 4S14 F1 
HOSPITAL NO : 1234567 
SURNAME : BR OOM 
FIR ST NA'ME : PE TE R 
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Figure 7.19 Twelve hourly fluid balance 
HOSPIT AL ｎｏ Ｚ ｾＳＴＵＶＷ＠
SURNAME : BROOM 
FIR ST NAME: PE TE R 
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Figure 7.20 Twelve hourly totals of urine output 
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06J06I95 07/06195 08106195 
DO . 
, ... ,:;c.n 
' ,M E 
I"(HIII 
ON l e t .. \. ｴ ｏｾｾｏｉｏＤ＠ 10 1&1. ｕｌＧＧＧ ｕ ｉｾＧＧＧ ＧＧＧｬ｛＠ ＱＰＱ Ｎ ｾ＠ 1 • • (al IoC.OIII I O . ' 1 01" 
O.,( c: .. ... Sl. UOlO I 1"''' U'S Oull'U'1 qUID ･Ｎ ｾ ｵ Ｎ｣ Ｈ＠ tll Ｌ ｾ＠ lI' l ,.I. , , .. 11 
1 2 "''' 
U"0 
1" (111 100 " l I\ IOO "(11" 0 0 " ("" 0 0 "1111 100 "1" '00 "111 100 " P Il OO 
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1 :000 0' Ａｏ Ｇ ｉ Ｇｾ＠
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Figure 7.2 1 fluid volume prescription chm1 
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Figure 7.22 Prescribed target balance vs aggregate fluid balance 
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RESULTS FLOW SHEET · BLOOD 
HaSP. NO . 
SURNAME 
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Na+ 
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Figure 7.23 Laboratory results for blood tests 
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Figure 7.24 ITU blood gas analyser results 
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PATIENT AND EVALUATE DECISION CHOICE IMPLEM ENT 
TREATMENT f-+- PREVIOUS ｾ＠ TREE r-. OF ｾ＠ ACTION 
STATE TREATMENT OPTIONS OPTIONS 
ASSESSMENT DECISION 
Figure 7.25 Decision making structure in decision support function 
GENERAL DECISION 
- BASE CLASS 
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SPECIFIC DECISION I SPECIFIC DECISION i 
- SUB-CLASS Al I - SUB-CLASS A2 ETC. I 
L _______________ ______ , 
Figure 7.26 Object oriented general class structure 
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dec_al.h - DECISION Al 
FUNCTION DECLARATION 
t 
dec_al-f.cpp -FUNCTION 
alc1svar.h -
COMPONENT 
DATA CLASS 1 
DEFINITION 
.. . · · -T · . .... 
alc2svar.h -
COMPONENT 
DATA CLASS 2 
Figure 7.27 Decision A 1 file structure 
-oT-tiER ------
COMPONENT 
DATA CLASSES 
dec_al - DECISION Al main-dal.h -DECISION 
CLASS CONTROLLER 
! 
alc2svar.h -
COMPONENT 
DATA CLASS 2 
t 
test_al- SElS TEST 
VALUES 
Figure 7.28 Decision Al file testing structure 
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Creating object of type state 
reating object of type decision 
Creating object of type dec_a1 
Input the nunber of the test set : 5 
Condition nUfflber 15 is set to inactive 
state of option A after running condition 15 0 
ndition nUfflber 25 is set to inactive 
state of option A after running condition 2s 0 
ondition nUfflber 1d is set to inactive 
e state of option A after running condition 1d 0 
ondition nUfflber 2d is set to inactive 
he state of option A after running condition 2d 0 
Condition nUfflber 3d is set to active 
he state of option A after running condition 3d 1 
Condition nUfflber 01s is set to inactive 
he state of option B after running condition 01s 0 
decision advice frOffl running decision A1 is: 
Begin Renal Replacefflent Therapy 
Figure 7.29 Test results for decision AI , showing operation of test 5 
= (Inactive C:\DAVEM\CPPALES\DECTREE\MAIN·DAI.D<EI aa 
FUHCTIOHAL TEST RESULTS FOR DECISIOH A1 + 
Creating object of type state 
Creating object of type decision 
Creating object of type dec_a1 
Input the nUfflber of the test set: 6 
Condition nUfflber 15 is set to inactive 
The state of option R after running condition 1s 0 
Condition nUfflber 2s is set to inactive 
The state of option R after running condition 2s 0 
Condition nUfflber 1d is set to inactive 
The state of option A after running condition 1d 0 
Condition nUfflber 2d is set to inactive 
The state of option R after running condition 2d 0 
Condition nUfflber 3d is set to inactive 
The state of option A after running condition 3d 0 
Condition nunber 01sis set to active 
The state of option B after running condition 015 1 
The decision advice fron running decision A1 is: 
Do not begin Renal Replacefflent Therapy 
+ 
Figure 7.30 Test results for decision AI, showing operation of test 6 
-343-
II (Inactive C:\DAVEM\CPPALES\DECTREE\MAIN-DA1 .EXE) aa 
FUHCTJOHAL TEST RESULTS FOR DECISJOH A1 
Creating object of type state 
Creating object of type decision 
Creating object of type dec_a1 
Input the number of the test set: 7 
Condition number 15 is set to active 
The state of option A after running condition 15 1 
Condition nunber 25 is set to active 
The state of option A after running condition 25 1 
Condition nunber 1d is set to active 
The state of option A after running condition 1d 1 
Condition nunber 2d is set to active 
The state of option A after running condition 2d 1 
Condition number 3d is set to active 
The state of option A after running condition 3d 1 
Condition nunber 01sis set to active 
The state of option B after running condition 01s 1 
The decision advice from running decision A1 is: 
Do not begin Renal Replacement Therapy 
ｾｬ＠ J -, ... :. 
Figure 7.31 Test results for decision AI, showing operation of test 7 
.t 
--
I' 
1+ 
= (Inactive C:\OAVCM\CppnU:::S\OI::: CTR[T\MAIN-DA 1.£X1:) an 
FUHCTIOHAL TEST RESULTS FOR OECISIOH A1 
Input the ｮｵｾ｢･ｲ＠ of the test set: 0 
The decision aduice ｦｲｯｾ＠ running decision A1 is: 
00 not begin Renal ｒ･ｰｬ｡｣･ｾ･ｮｴ＠ Therapy 
Input the ｮｵｾ｢･ｲ＠ of the test set: 1 
The decision aduice ｦｲｯｾ＠ running decision A1 is: 
Begin Renal Replacement ｔｨ･ｲｾｰｹ＠
Input the ｮｵｾ｢･ｲ＠ of the test set : 2 
The decision aduice From running decision A1 is: 
Begin Renal Replacement Therapy 
Input the ｮｵｾ｢･ｲ＠ of the test set: 3 
The decision aduice from running decision A1 is: 
Begin Renal Replacement Therapy 
Input ｴｨｾ＠ ｮｵｾ｢･ｾ＠ of ｴｨｾ＠ test set: ｾ＠
The decision aduice from running decision A1 is: 
Bpg1n Aena1 Replace_rnt Therapy 
Input the number of the test set: S 
The decision advice From running decision A1 is: 
Begin Renal Replacement Therapy 
Input the number of the test set: 6 
The decision aduice from running decision A1 is: 
Do not begin Renal Replacement Therapy 
Input the number of the test set: 7 
The decision advice frOm running decision A1 is: 
Do not begin Renal Replacement Therapy 
Figure 7.32 Test results from decision Al 
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• 
= fl"acllve C:\IlAVEM\CPPFILES\DECmfE\t.4AIN OA2.EX[J DD 
FUHCli OHAL nST RESULl S FOR DEC I S I OH A2 
Input tho nu"".r of tho tpst s.t: • 
Thp dreldon iduicf frollll running dpcision 1112 is: 
Stop R.n.l R.plot."",nt Thpr.py 
Input the nUNItr of the test su: 1 
Thr drcision iduicf fro .. running deci s ion 1\2 1s: 
Continu. R.ni} A.pl.ic ••• nt Th.,.iPY 
Input th. nu..tl.,. of th. test s.t: 2 
Tht drcision iduic. frolll running dpci si on 142 1s : 
Stop R.n.l R.plot .... nt Thpr.py 
Input tho nu""" of tho t.st •• t: 3 
Th. 0.c1s10n icluier frolll running decision A2 Is: 
Stop R.n.l R.plot ..... nt Th.r.py 
Input tho nu"",r of tho tost .ot: _ 
The d.clsion idui e . fro III running d.cislon 1\2 1s: 
Stop R.noT R.plot.""nt Th .. opy 
tnput th. nu.br,. of th. t.5t 5.t : 5 
The d.cl.lon .dultt fro. running dod.ion A2 i s : 
Stop R.n.l R.platt •• nt Thorapy 
Input th, nUlliber of the test set: 1 
The decision idvicr f"olll running d.c ision A2 i s: 
Stop Atni} A'plic • •• nt Th.riPY 
Figure 7.33 Test results from decision A2 
=:I (Inactive C:\DAVEM\CPPFILES\DECmEE\MAIN-DBI.EXEI an 
FUNCTIONAL TEST RESULTS FOR DECISION 81 
Input the nunber of the test set: 0 
The decision advice ｦｲｯｾ＠ running decision 81 is: 
Use CUUHD as the sole Renal ReplaceAent Therapy 
Input the ｮｵｾ｢･ｲ＠ of the test set: 1 
The decision advice frOA running decision 81 is: 
Use CUUHD as the sole Renal R@placeAent Therapy 
Input the ｮｵｾ｢･ｲ＠ of the test set: 2 
The decision advice ｦｲｯｾ＠ running decision 81 is: 
Use an alternative Renal ｒ･ｰｬ｡｣･ｾ･ｮｴ＠ Therapy 
Input the ｮｵｾ｢･ｲ＠ of the test set: 3 
The decision advice ｦｲｯｾ＠ running decision 81 is: 
Use an alternative Renal ｒ･ｰｬ｡｣･ｾ･ｮｴ＠ Therapy 
Input the nUAber of the test set: 4 
The decision advice ｦｲｯｾ＠ running decision 81 is: 
Use an alternative R@nal ReplaceAent Therapy 
Input the nuaber of the test set: 7 
The decision advice ｦｲｯｾ＠ running decision 81 is: 
Use an alternative Renal R@ laceAent Thera • 
Figure 7.34 Test results from decision B 1 
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= (Inactive C:\OAVEM\CPPFllES\OECffiEE\MAlN-DCI.EXEI aa 
FUHCTIOHAL TEST RESULTS FOR DECISIOH C1 + 
Input the nunber of the test set: B 
The decision aduice ｦｲｯｾ＠ running decision C1 is: 
Do not add any potassiuR to the dialysate 
Input the nuftber of the test set: 1 
The decision aduice ｦｲｯｾ＠ running decision C1 is: 
Add 3 ftRoI /L of ｰｯｴ｡ｳｳｩｵｾ＠ to the dialysate 
Input the nunber of the test set: 2 
The decision aduice fron running decision C1 is: 
Do not add any potassiuR to the dialysate 
Input the nuftber of the test set: 7 
The decision aduice fron running decision C1 is: 
Add 3 RRol /L of ｰｯｴ｡ｳｳｩｵｾ＠ to the dialysate 
• 
Figure 7.35 Test results from decision Cl 
1:1 (Inactive C:\OAVEM\CPPFILES\DECffiEE\MAIN-DC2.EXE) aa 
FUHCTIOHAL TEST RESULTS FOR DECISIOH C2 
Input the nuRber of the test set: 0 
The decision aduice froft decision C2 is: 
Use a dialysate flow rate of 1 litre per hour 
Input the nunber of the test set: 1 
The decision aduice froft decision C2 is: 
Use a dialysate flow rate of 2 litres per hour 
Input the nunber of the test set: 2 
The decision aduice fron decision C2 is: 
Use a dialysate flow rate of 1 litre per hour 
Input the nunber of the test set: 7 
The decision aduice froft decision C2 is: 
Use a dialysate flow rate of 2 litres per hour 
• 
Figure 7.36 Test results from decision C2 
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, . , 
UHCllOHAl T[ST R[SULTS fOR O[CISIOH C3 lIH1<£D WITII 02 "HI> 03 
Input thf' nu",btor of tht' tr5t srt: • 
Th. dpcision ｾ､Ｂｩ｣Ｎ＠ frOfll df'cisiDn C3 1s ! 
USf h.pI,.!n .5 ttl. inticolgul.nt 1n ttl. PMtracorpf'rei l blood ctrcu1 t 
Input ttl. nu"b.,. of th. ust s.t: , 
Ttl. r.co .... ndpd dos. for h.pirin infudon is , •• 
Th. rfco-.ndpd "OlUM for ,..ep.rtn infusi on 1s 1"0 
Ttl. ,..co .... nd.d dose for hfp.dn bolus is H,"D 
Tht r.co .... ndf'd \lolu ... for hepArin bolus i s 31 
Input tft. nu",bto,. of thp t.st 5ft: 1 
Th. dfcision Iduicp Fro" decision C3 is: 
Us. prosticyclin is tnt int1coiguhnt 1n thl' ｴＧＩｃｴＢＬｾ｣ｯＬＮｰＮｲｦＮｬ＠ blood circuit 
1ft. rtcoftMOnd.d dost fa,. prostic.!Jcltn infusion is 210 •• 
Th. r,coNWndpd voluM for prost,nyc)!n infusion 1s: 21aO 
Input th. nu_b ... of th. t.5t set: 
Ttl. dpcision .IIduit. fro", dt'cision C3 is: 
Us. ｨＮｰｾｲｩｮ＠ .s th. ｉｮｴｩ｣ｯ｡ｧｵｬｾｮｴ＠ in th •• liCtrlcorp.,.,.l bloOd cit·edt 
Input thr nuM).r of thl' tfst s.t: • 
Th. rlfco ..... nd.d dos. for hl'parin infusion 15 710 
Th. r.cOlUWnd.d uolu ... for h'plrin infusion is 1'" 
Th. r.co ..... nd.d dost for hrplrin bolus is 1_00 
Th. r,co ... nd.d ,",olu ... for h'plrin bolus is 30 
Input thf nu...r>rr of thr trst s.t: 1 
Thp d.cision Aduice fro_ decision C3 15 : 
US. h.pArin IS th. Int1colgullnt in the 'Mtrleorp.r l!l l blood cireu1 t 
Input thr nu.t).r of th. h s t s.t: 1 
Th. r.co ...... nd.d dos. for hl'plrin infusion is 3Sft 
Th. r,cDftllWnd.d uolu ... for h'plrin infusion is 10 
Th. rl'cDJUWnd.d dos . for hl'plrin bolus 1s 101 
Th. r.coIWWnd.d uolu .... for h'plrin bolus 15 50 
Figure 7.37 Test results from decision C3 with 02 and D3 
= pnOclM: C:\DAVfl.A\CPPflI FS\IlFCrnFF\MAIN OC4.Fxrl an 
Ut«:TlONAl lEST RESULTS fOR DECISIOH C_ 
Input th. nunb.r of th. trs:t Sft: 0 
lh. d.e1s10 •• du1e. fro. d.e1s10. C_ 1s: 
h. orUriehl kidn'lI OIUst b. CHAHCED for • nn on. 
Input tho nuOllo.r of th. t.st S.t: 1 
Th. drcision Aduit. fro" d.cis1on etl is: 
lh. orUFiehl kidn'lI b.ing USOd is still uhbl. 
Input tho nuOllo .. of tho tut Sft: 2 
lh. d.clsion .duie. fro. d.eision C_ is: 
Th. ArtificiAl kidnry .ust b. CHAHCtb for. n". onr 
Input ttl. nulll\b.r of ttl" trst Sft: 3 
lh. d.eision .duie. Fro. d.eh1on C_ is: 
Tho ortiFiehl kidn'lI aust b. CHAHCED For 0 n •• on. 
Input th. nulllb.r of th. t.st s.t: _ 
lh. d.eidon .duie. Fro. drcisian C_ 15: 
lh. irtiFiehl kidn.lI .ust b. CHAHCED For. n •• on. 
J nput th. nultbpr of thr tp5t s.t: 5 
lh. d.eisian .duic. Fra. d.eision C_ is: 
lh. ortiFiehl kidn'lI ""st b. CHAHCED For 0 n •• on. 
Input tho nullb .. of th. trst s.t: 7 
lh. d.eisian .duie. Fro. d.ddon C' is: 
lh. irtiF1ehl kidn'lI "'1St b. CHAHCED for 0 n.w on. 
• 
Figure 7.38 Test results from decision C4 
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= (Inactive C:\OAVEM\CPPRLES\OEClREE\MAlN-DD1 .EXEI aa 
FUHCTIOHAl TEST RESULTS FOR DECISIOH D1 
Input the nuQber of the test set: 0 
The decision advice ｦｲｯｾ＠ decision D1 is: 
Do not add any ｰｯｴ｡ｳｳｩｵｾ＠ to the dialysis replacenent fluid 
Input the ｮｵｾ｢･ｲ＠ of the test set: 
The decision advice ｦｲｯｾ＠ decision D1 is: 
Add 3 ｾｾｯｬＯｬ＠ of ｰｯｴ｡ ｳｳｩ ｵｾ＠ to the dialysis replacenent fluid 
Input the ｮｵｾ｢･ｲ＠ of the test set: 2 
The decision advice ｦｲｯｾ＠ decision D1 is: 
Do not add any ｰｯｴ｡ｳｳｩｵｾ＠ to the dialysis replacement fluid 
Input the ｮｵｾ｢･ｲ＠ of the test set: 7 
The decision advice ｦｲｯｾ＠ decision D1 is: 
Do not add any potassium to the dialysis replacenent fluid 
• 
+1.1 
Figure 7.39 Test results from decision D 1 
II (Inactive C:\DAVEM\CPPRlfS\DECTREE\MAIN-DD2.EXE) aa 
FUHCTIOHAl TEST FOR DECISIOH E1 
Planned input fluid ｵｯｬｵｾ･＠ for the next 24 hours is 3700 ml 
Planned ultrafiltrate volume for the next 24 hours is 11000 ml 
Insensible loss ｵｯｬｵｾ･＠ estimate for the next 24 hours is 500 ml 
Planned fluid balance volume for the next 24 hours is -500 ｾｬ＠
Therefore, 
The ｲ･ｰｬ｡｣･ｾ･ｮｴ＠ fluid uolume required in the next 24 hours is 8300 ｾｬ＠
Figure 7.40 Test results from decision E1 
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• 
CHAPTER 8 
DISCUSSION 
8.1 INTRODUCTION 
This chapter discusses the main points relating to philosophy, methodology, method, 
technique, and tool application in the thesis. The structure used in the discussion is the 
same as that used to structure the chapters of the thesis. 
Chapter 2 established that there is a lack of a coherent framework for analysing the problem 
domain of clinical decision support (CDS). Chapter 3 presented a framework for analysing 
CDS (figure 3.1), constructed a practical ontology and epistemology, in addition to 
characterising CDS in terms of technology, medicine and science. Chapter 4 applied the 
ontology and epistemology in an analysis of clinical decision making and of clinical 
decision support. From this analysis process models of decision making and decision 
support were also developed. 
Chapter 5 analysed the material clinical problem of managing acute renal failure patients 
in the lTV. Chapter 6 produced a decision making model for the management of CVVHD 
therapy. Finally chapter 7 described the design and development of a prototype clinical 
decision support computer based tool for renal replacement therapy management. 
8.2 REFLECTIONS ON CLINICAL DECISION SUPPORT 
Chapter two aimed to give the justification for the philosophical framework developed in 
the thesis. To achieve this aim the objectives of chapter two were: to give a classic 
definition of clinical decision support; to review the current state of the field of CDS; to 
question the assumptions at the basis of CDS; to highlight inherent problems with CDS, 
and to justify the need for a coherent philosophical foundation in clinical decision support. 
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Clinical decision support (CDS) has been defined as any computer program that deals with 
clinical data or medical knowledge (Shortliffe, 1987). This view is a reflection of the 
predominantly technology centred approach in the field. This narrow technocentric view 
of CDS is thought to be the cause of the apparent failure of CDS technology to be widely 
implemented (Coeira, 1995). This lack of anticipated success has led to questioning of the 
basic assumptions of CDS (Coeira, 1994), and to the conclusion that a more problem 
focused approach is required in CDS. 
Some of the fundamental problems inherent in CDS were highlighted in the views of 
physicians reviewed in Shortliffe (1989). Clinicians quoted in this paper expressed the 
belief that if a problem is messy and difficult to understand and solve for a clinician then 
surely it will be so for a computer system. This indicates that an important early stage in 
CDS development is to model clinical decision making, and to apply the understanding 
gained in clinical practice and in decision support models of decision making. Another 
inherent problem relating to the nature of clinical decision making is the notion of 
expertise. There is suspicion of the concept of artificial intelligence, and in particular 
expert systems. The concerns raised in Shortliffe (1989) question the very concept of 
expertise, "(Medical) expert systems suffer from the fact, in my view, the experts aren't 
expert and I wouldn't listen to their judgement in person. Having their views distilled in 
a machine wouldn't give them any more credibility .... When you find an expert who will 
talk on anyone field, you can find another expert who will say something a little different." 
This implies that a better understanding of the concept of clinical expertise, and clinical 
knowledge, is required before attempting to effectively distil clinical knowledge into a 
knowledge based system. 
Adopting a problem focused approach helps to analyse the inherent problems in CDS 
highlighted above. At the base of a problem focused approach it has been proposed that 
a coherent philosophy is required to construct a consistent analytical methodology for 
analysing the problem domain and developing future CDS systems (Heathfield and Wyatt, 
1993). Such a philosophy will provide: a framework for forming a systemic view of the 
problem domain and the role of CDS in the domain (Lincoln and Essin, 1992; Musen, 
1993), and a coherent epistemology for building a clinical knowledge base (VanDer Lei, 
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1993). 
To build a coherent methodology on the coherent philosophy there is a need to clarify the 
eclectic nature of CDS. Shortliffe's definition of CDS identifies engineering and medicine 
as two of the disciplines in the field; while Lincoln and Essin (1992), and Seelos (1992) 
advise that science has a role in CDS. Therefore, a coherent philosophical framework for 
CDS will unify the eclectic nature of decision support, and acknowledge the role of 
engineering, science and medicine in the field. 
8.3 AN ONTOLOGICAL AND EPISTEMOLOGICAL FRAMEWORK FOR CDS 
Following on from the identification of a need for a coherent philosophy the aim of chapter 
three was to construct an ontological and epistemological framework for clinical decision 
support. The objectives of the chapter were: 
i) To present an analytical structure linking philosophy, methodology, method, 
techniques and tools 
ii) To present a systematic review of the relevant fundamental concepts of philosophy 
which are used to construct the ontology and epistemology. 
iii) To use concepts of philosophy to construct an ontology and epistemology as the 
basis for an analytical framework in CDS. 
iv) To apply the ontological and epistemological concepts to CDS. 
v) To characterise the multi-disciplinary nature of CDS in terms of the nature of 
science, technology and medicine. 
vi) To state the ethical codes defining good clinical behaviour. 
Figures 3.1. and 3.2 show how a coherent philosophy is the foundation for building a 
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coherent methodology. At the core of philosophy is an analysis of what reality is, ontology, 
and what is knowledge of reality, epistemology. Applying an ontological and 
epistemological analysis produces a generic categorisation of reality and knowledge which 
can be used to give insight and clarity into any problem situation (Sowa, 1995). Moreover, 
philosophical classes represent the generic classification for building a structure that 
permits knowledge sharing and reuse between applications (Gruber, 1993). Therefore, by 
using philosophical principles and models it is possible to form the coherent basis for an 
analytical framework in CDS. 
8.3.1 Ontolo&y 
Systematically building a philosophy begins with constructing answers to the questions: 
what is reality? and what is knowledge of reality? The question of what is reality can be 
broken down into two further questions: how many realities are there? and what are the 
possible natures of these realities? Traditionally there are three views of the numbers of 
reality: monism; dualism, and pluralism (Ferm, 1969). Monism views reality as being 
represented by one unifying nature. Dualism views reality as being represented by two 
different natures; whilst pluralism views the world as consisting of multiple realities and 
is the least analytical view. The views on the possible nature of reality expressed in 
philosophy are either: idealist, reality is essentially ideas; materialist, reality is matter only; 
dynamist, the only constant in reality is change or flux, and neutralism holds that reality has 
no identifiable nature (Fenn, 1969). Decision making and system analysis have been 
identified as being best represented by the classic dualist view of idealism existing with 
materialism, figure 3.4. The connection between the two is viewed as a dynamic energy 
flux. The ontological model represents a generic view of the whole of reality. Thus, it is 
the start point for building a generic representation of any problem and proposed solution 
in a domain. 
8.3.2 Epistemoloa;y 
Knowledge is a fundamental concept in developing knowledge based systems. However, 
in the field of knowledge based systems definitions of knowledge deal primarily with the 
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expression of knowledge in the material domain (Tans ley and Hayball, 1993, Shortliffe, 
1990, and Deutsch et al., 1994), whilst rational decision making involves the application 
of knowledge in the mind. Therefore, to model the use of knowledge in decision making 
requires a deeper epistemological analysis. The four epistemological questions to be 
addressed in an analysis of knowledge are: the nature of knowledge; the source of 
knowledge; the scope of knowledge, and the validity of knowledge. 
The nature of knowledge is defined epistemologically as justified true belief (O'Connor and 
Carr, 1987). Thus the concepts applied in an understanding of knowledge are belief and 
truth. A belief exists in the mind, and is acquired from and expressed in an interaction with 
the material domain (figure 3.5). The act of believing can be viewed as the activity of 
acquiring a belief or expressing a belief. Acquiring a belief is an activity of the mind where 
a proposition is first entertained and then assented to. Expression of a belief occurs where 
a proposition is believed and then action is performed in accordance with the belief. Thus 
knowledge as a belief exists in the mind and is expressed in the material domain. 
The distinction between a general belief and knowledge rests on the concept of truth. The 
judgement of truth has been classified as philosophical or non-philosophical. Philosophical 
judgements, or tests, of truth allow for critical reflection on truth. Non-philosophical truths 
are not explicitly based in the application of observation or reason, and therefore cannot be 
judged critically. Three philosophical tests of truth have been proposed for testing a 
knowledge base: correspondence testing, a proposition corresponds to an observed 
phenomena; coherence testing, a proposition is logically consistent with prior knowledge; 
and pragmatic testing, if an idea satisfies a purpose then it is held to be true. The non-
philosophical bases for truth are: truth from authority; truth appealing to feeling; truth by 
majority agreement; self evident truths which are prior to experience; and intuitive truth. 
These non-philosophical bases for truth are not true in the sense of being by nature open 
to critical question, and are thus not inherently defendable through the application of reason 
and observation. An important impact of this is that a statement from an expert authority 
should not be accepted without question as being true. The reason put forward for the 
questioning of truth from authority is that they often disagree and accepting one without 
question leads to a confusion of authority arguing against authority. 
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The scope of knowledge, figure 3.6, covers the whole of the ontological model. The 
highest level knowledge is conceptual knowledge used to make sense of reality. Below this 
level exists state knowledge, for example that snow is white, and know how for interacting 
with the external material reality. These different classifications of knowledge are tested 
using the philosophical tests described above. State knowledge is tested using 
correspondence, confirmation through observation, and coherence, confirmation through 
the application of logic in comparison to prior knowledge. Coherence can also be applied 
to know how, but the primary test of know how is pragmatism, therefore if it satisfies a 
predefined goal it is functionally true. Conceptual knowledge is tested over time by the 
application of correspondence and coherence to numerous observations of phenomena. 
Having established the nature and scope of knowledge the next question to address is where 
does new knowledge originate from. This is particularly relevant when considering the 
question of what source to use when constructing a knowledge base. The source of new 
knowledge is considered to be phenomenological. The view of phenomenology is that 
empirical sensory experience is interpreted using a priori knowledge to form perceptions 
of material phenomena. These perceptions are then combined with other prior conceptual 
knowledge in a rational manner to form new knowledge. Thus new knowledge of a 
material domain will rely on the observation of that domain, and having the necessary prior 
conceptual knowledge to interpret the observations. 
The concept of an expert is that they possess a higher than normal level of conceptual 
knowledge and know how of a specific domain, and more experience in the domain. This 
leads to the idea that experts are a good source of domain knowledge, where the assumption 
is that the expert has many justified true beliefs on the domain, which constitute a 
knowledge base useful to less experienced individuals in the domain. In a complex domain 
such as medicine different experiences of individual experts will lead them to develop 
different knowledge of a domain. Therefore, by the nature of having had different 
experience, observed different material phenomena, the knowledge of any expert in a field 
is individualised to some degree and not absolutely universal. This is consistent with the 
view stated above that authorities often hold different opinions on what constitutes 
knowledge and thus any knowledge derived from an authority requires further testing. 
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Therefore, evaluating an elicited knowledge base by simply comparing different expert 
opinion will merely expose the natural differences in opinion amongst experts. So, by 
nature there will always be disagreement between clinical experts, and the extrapolation of 
the expert knowledge model into a computer system will not change the nature of experts 
disagreeing. At present it is the effectiveness of an expert's knowledge which is the 
ultimate test of their knowledge in medicine, and provides the basis for others seeking 
repeated consultation with the expert (Shortliffe, 1989). The future of evaluating 
knowledge based systems should apply the same model when validating knowledge bases. 
Applying the pragmatic test to knowledge requires the explicit linking of knowledge to 
actions and goals for the action. Only then can the knowledge be evaluated as true or valid. 
Therefore within the structure of a knowledge base it is necessary to link goals for actions 
to any knowledge used to decide on the action. 
8.3.3 Nature of Clinical Decision SYRPort 
The multi-disciplinary field of CDS includes application of processes and knowledge 
defined in engineering, medicine and science. Under Shortliffe's (1987) definition of CDS 
it is primarily a technology driven process with the goal of producing computer based tools, 
or artifacts, for use in clinical practice. Therefore, the main methodology of CDS is defined 
by technology. However, within this methodology there is a growing appreciation for the 
need for an analysis and understanding of the medical domain, and the role of CDS in this 
domain. One important philosophical aspect of the medical domain is that it is essentially 
a morally driven activity, where clinicians attempt to act for the good of others. Thus 
applying decision support systems in the medical domain means they should not offer 
advice, or operate in a manner, which is inconsistent with the morality defined in 
physicians ethical codes. 
The role of science in CDS is essentially as a knowledge source and a method for solving 
problems which are subordinate to the main design process. The product of applying 
science is knowledge not technological artifacts. Therefore, its use in CDS is to find 
solutions to sub-problems of the design, not to describe the main methodology or the tools 
produced. Thus scientific knowledge can be utilised in the process of design but it does not 
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define the technological design process of producing a CDS tool. 
8.4 DECISION MAKING AND DECISION SUPPORT 
In Chapter four the ontology and epistemology of chapter three were applied to an analysis 
of generic decision making and the role of decision support in the process of decision 
making. To this end the objectives were: 
i) To develop an ontological, epistemological and process model of decision making. 
ii) To analyse the clinical decision making process. 
iii) To develop a model of the process of rational clinical decision making. 
iv) To propose a technique for analysing clinical treatment decisions. 
v) To build a conceptual model of clinical decision support with an ontological and 
epistemological basis. 
vi) To define clinical decision support in terms used in the decision analysis. 
8.4.1 OntoloiY and EpistemoloiY of Decision Makin" 
Philosophy provides a basis for analysing reality and knowledge of it at a generic level. 
Generically decision making centred on solving a material problem has the ontology shown 
in figure 4.1. The problem exists in the material domain and the decision making in the 
realm of the mind. Thus the process hegins with the mind1s perception of a problem in the 
material domain. The product of the process is a decision action to either increase 
knowledge of the problem or to dynamically impact on the material problem. 
The classifications of the natures of the idealist reality given in chapter three were rational, 
emotional, and voluntaristic. Thus if decision making is considered as an activity of the 
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mind acting on the material reality, it can be based on any of these natures. It can be 
emotional, governed by feeling, voluntaristic, driven by the will to survive, or rational, 
guided by the application of logic. For coherence from a consistent approach the 
application of rationalism in decision making is required, as opposed to romanticism or 
voluntarism. Emotion and free will are too variable and individual to give a meaningful 
basis for decision making or system analysis. 
The epistemology of rational decision making rests on the logical and explicit application 
of knowledge during the decision making process. Thus available knowledge is maximally 
applied during rational decision making. Knowledge applied during decision making can 
be classified as: state knowledge, knowledge of material phenomena; know how. 
knowledge of relevant techniques, and conceptual knowledge. State knowledge can be 
expressed as a set of propositions. Know how or techniques can be expressed as a set of 
actions with a goal for the actions, whilst conceptual knowledge exists as a knowledge map. 
or web, of interconnected concepts with associated meanings, figure 4.6. 
8.4.2 Process Model of Decision Makina 
Figure 4.8 shows the five stage process model of decision making derived from Bidgoli's 
four stage model, figure 4.7. The first stage of the decision making following the 
accumulation of state knowledge is an assessment of the problem. A problem exists where 
there is knowledge that a goal state A is different from the actual state B. Following the 
problem assessment is the pragmatic evaluation of the previous decision to assess its 
effectiveness and efficiency. Effectiveness of a decision is how well the action performed 
satisfies the pre-defined goal, and efficiency is a measure of the resources used to meet the 
goals. After evaluating the effectiveness and efficiency of the previous decision options 
for action are generated from knowledge of previous actions applied to similar problems. 
Then depending on the specifics of the state knowledge actions are chosen and 
implemented. Following implementation further observations oflater material phenomena 
begin the cycle again. 
Epistemologically the decision making process begins with the accumulation of state 
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knowledge from perceptions of material phenomena. As illustrated in figme 4.1 the source 
of problem knowledge which begins the decision making cycle is the observed material 
phenomena. If there is no knowledge of the material phenomena which constitute the 
problem there will be no perception of the problem state. This perception of a problem 
relies on prior know how and conceptual knowledge being applied to the phenomenal 
knowledge to form an abstracted view of the problem. Prior knowledge of strategies for 
solving the problem is then applied to generate options for solving the problem. Further 
knowledge of the previous effectiveness of the options at achieving the goals will then be 
applied to make the choice of options. Then know how will be applied in actions to 
perform the intervention in, or further assessment of, the material problem. The 
observation of later phenomena will produce further state knowledge of the material 
domain, and potential understanding of the effectiveness of the previous action. 
The validity of the knowledge applied in the decision will be judged by the perceived 
outcome in the material domain. If the purpose or goal of the decision maker has been 
satisfied then it can be pragmatically judged that the knowledge applied is valid. The 
decision evaluation stage is thus dependent on the goals of the decision maker, which are 
defined during the problem assessment. The pragmatic validity of the know how and 
conceptual knowledge will be further reinforced by their application to similar future 
problem scenarios. Thus expertise is built up by exposure to similar problem and decision 
situations. 
8.4.3 Clinical Decision Makina 
Three stages of clinical decision making are generally identified (Friesdorf et al., 1994): 
monitoring; evaluation, and treatment. The first stage is to gather information on the state 
of the patient in a problem assessment or evaluation of their state. Then depending on the 
evaluation of the patient treatment mayor may not be administered. During treatment in 
the lTV the patient state and the treatment the patient is receiving are monitored. The 
relationship between monitoring, patient assessment and treatment is depicted in figure 
4.12, thus if no treatment is undertaken then further monitoring may be conducted to 
reassess the patient's state. Each of these three decision making stages can be represented 
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by the process model described above. This leads to the derivation of the model of clinical 
decision making shown in figure 4.13. The controlling process is the patient assessment 
decision; depending on this assessment certain treatment and monitoring actions will be 
ordered. This model provides a framework for analysing decision making in an ITU, and 
it was applied in the analysis of the decision making controlling a patient's renal 
replacement therapy. 
8.4.4 Clinical Decision SUl)port 
The place of decision support onto logically is as a material abstraction of the decision 
making process, figure 4.15. Decision support exists to offer advice to the decision maker. 
The functionality of decision support is essentially an epistemological one, offering 
information to the decision maker which gives them knowledge relevant to solving the 
material problem. The epistemological function is analysed in greater depth below. 
Decision support supplements the decision making in the idealist reality; its main use being 
when uncertainty exists in the decision maker's mind, the idealist reality, on what the 
decision should be. Where the decision maker has no uncertainty on the problem 
assessment or on course of action then they will not require decision support. Therefore, 
the ideal role for decision support is where it can offer advice to the decision maker who 
has a high degree of uncertainty on how to reach a decision. This may be due to 
inexperience of the decision maker, or high complexity of the problem. Both of these 
factors are relevant to the problems faced in clinical decision making. 
How decision support can complement the decision making process is shown in figure 
4.16. Again decision support is shown as a separate entity to the decision maker. Within 
the decision maker and the decision support figure 4.16 depicts the parallel operation of the 
model of decision making. Thus there is an active support of the decision making by the 
CDS system through the generation of a structured, patient specific, decision simulation. 
This is different from the support offered by a clinical information system merely 
containing medical knowledge, or data; this is acting as another knowledge source for the 
decision maker. In such a system the knowledge provided mayor may not help the 
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decision making process, it may even increase the decision maker's confusion. The type 
of support provided by the clinical information system is more accurately labelled clinical 
knowledge support. Where the knowledge provide is either: state knowledge (patient data); 
knowledge of treatment techniques, or conceptual medical knowledge. The important 
distinction is that the knowledge provided by the information system is not applied in either 
solving or structuring the decision problem faced by the clinician. 
Thus clinical decision support is the material patient specific simulation of the decision 
making process. The simulation provides a structuring of the process, and advice at any, 
or all, of the stages of the decision making process. Knowledge support can inform the 
decision process but it does not actively support the decision making process, its purpose 
is to increase the decision maker's knowledge. 
8.S CLINICAL PROBLEM ANALYSIS 
Chapter five defines the material clinical problem to be addressed by the introduction of 
a clinical decision support system. The objectives of the chapter were: 
i) To specify the clinical problem as presented by clinicians. 
ii) To present the clinical domain knowledge required in the analysis of the clinical 
problem. 
iii) To produce a systems analysis of the clinical problem. 
Clinicians at the Mayday University Hospital identified two clinical problems with treating 
renal failure on a general intensive therapy unit (lTV) using continuous venovenous 
haemodialysis (CVVHD): 
i) A large quantity of fluid is exchanged in patients undergoing CVVHD. 
Maintaining the fluid balance in these patients requires accurate fluid balance 
calculations. At present there is scope for inconsistencies in the fluid balance 
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calculations. 
ii) An expert with experience in managing fluid and electrolyte balance will not be 
available 24 hours a day to offer advice to staff operating the CVVHD. 
The epistemological analysis of the clinical problem was based on medical science 
concepts of physiology and pathophysiology of the kidney. Such an examination is 
necessary to build up an understanding of the vocabulary used to express knowledge in the 
field. Thus medical science formed the conceptual knowledge foundation for the problem 
system analysis and the knowledge elicitation during the analysis of the decision making. 
8.5.1 Medical Domain Knowledae 
The kidney plays a central role in the regulation of the cellular environment of the body. 
The kidney's functions are summarised in figure 4.7, and a more detailed description of 
these functions is given below: 
i) The kidney excretes waste products of the metabolism by a combination of 
ultrafiltration and secretion. 
ii) The blood pH is regulated by the control of the plasma concentration of free 
hydrogen ions. 
iii) The effective circulating fluid volume is regulated by responding to control signals 
from the sympathetic nervous system and the hormone control system. 
iv) Regulation of plasma osmolarity is achieved through the response of the 
hypothalamus to changes in the plasma osmolarity. 
v) Control of plasma electrolyte levels is effected by the processes of ultrafiltration, 
secretion and reabsorption. Thus, the kidney exerts indirect control over the level 
of electrolytes in the other fluid compartments of the body. 
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vi) Regulation of the red blood cell mass is achieved by the excretion of erythropoietin 
which acts in the stem cells of the bone marrow, stimulating red blood cell 
production. 
These kidney functions rely on the operation of the central functional unit of the kidney, 
the nephron. It is through the interaction of the nephron with the renal capillaries, the 
kidney's interstitial fluid space, and the collecting tubules, figure 5.8, that the kidney 
performs the above functions. During acute tubular necrosis (A TN) the nephrons of the 
impaired kidney cease to perform their function effectively. Loss of the functioning 
nephrons then needs to be compensated for by renal replacement therapy (RRT). 
Haemodialysis is an option for RRT which acts to compensate for the loss of functions (i) 
to (v). 
A popular and efficacious treatment for replacing the vital renal functions described in the 
lTV is continuous venovenous haemodialysis (CVVHD). This removes excess fluid from 
the patients plasma by a process of ultrafiltration. While solutes such as urea, creatinine 
and potassium are removed by processes of diffusion and convection. Whilst a buffer in 
the dialysate diffuses into the patients plasma across the semi-permeable dialysis membrane 
to counteract the affects of metabolic acidosis. 
8.5.2 Systems Analysis of the Clinical Domain 
The aim of the systems analysis was to form clinically specific knowledge of the problem 
on top of the conceptual scientific medical knowledge reviewed above. The clinically 
specific knowledge built up during the systems analysis included a profile of the patient 
group, and of the management of their condition. Thus systems analysis is an important 
stage in formulating a solution to a clinical problem. 
The patient group being considered in the project are lTV patients with two or more 
compromised organ functions, where the kidney is one of the organs in failure. The cause 
of the loss of the patient's renal function is AlN, and they will require renal replacement 
therapy (RRT). In the past the Mayday University Hospital, a district general hospital, has 
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had to send these patients requiring RRT to St Helier Hospital, where there is a renal unit 
to support the lTU. To overcome this problem Dr S Morgan set up the operation of the 
CVVHD service at the Mayday, thus reducing the need to transfer acutely ill patients. 
However, this has created the local difficulties described at the start of this section (8.5). 
From the medical domain knowledge reviewed above it is apparent that haemodialysis 
essentially controls the fluid and biochemical balances of a patient's body. Therefore, to 
build up an understanding of the use ofCVVHD on the lTU an analysis ofa patient's fluid 
and biochemical flows is required. A flow diagram representing a patient receiving 
haemodialysis on the lTV is shown in figure 5.21. Between each of the boxes in the 
diagram flows a volume of fluid and a quantity of biochemical substances. Each of the 
flows represents a factor which can potentially change the patients fluid balance and their 
biochemistry. The problems with this process highlighted above are: accuracy in fluid data 
management, and a lack of constantly available expertise to manage the process. 
Accurate fluid data management is particularly important for a patient receiving 
haemodialysis to keep the patient in a uvolaemic state and avoid complications of 
hypovolaemia or hypervolaemia. The fluid balance calculations performed involve the 
measurement of input and output fluid volumes, and estimation of insensible and sweat 
losses. At present the charting and estimates are produced manually. Typically this means 
performing approximately 15 hourly measurements and up to 10 repeated numerical 
calculations. Repeated manual calculations using many variables are prone to producing 
calculation errors. As was demonstrated in chapter 7 the automation of the process using 
computer technology can eradicate calculation errors, provide more sensitive estimates of 
insensible losses, and provide a planning aid for fluid delivery to the patient. Moreover, 
guidance can be given to produce controlled gradual changes in the patient's total body 
water when required. 
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8.5.2.1 Fluid loss estimates 
During analysis of the fluid charting the need for a scientific analysis of insensible losses 
was highlighted by a review of estimates for daily amounts. These ranged from a daily 
total insensible losses of 500001 to 1400001 per day. In the worst case this represents a 
possible error of 900 001 per day in estimates of insensible loss. A possibility for producing 
estimates that are more sensitive to changes in patient and ambient conditions are the 
quantitative models of respiratory and transepidermallosses described in section 5.5.3. 
Thus, application of these models in a computer based fluid charting system will improve 
the sensitivity of the estimated insensible losses. However, no evidence has been found 
of the evaluation of the quantitative models for estimating insensible losses in the ITIJ 
setting. Therefore, further scientific study is required to establish the accuracy of these 
models when applied to calculating an lTV patient's insensible losses under varying 
conditions. It is anticipated that such a study will lead to an improvement in the accuracy 
of insensible loss estimates, and hence the fluid balance calculations. There is similar 
scope for a improvement in the accuracy of fluid charting for ITIJ patient's suffering from 
fever through further scientific investigation and modelling of cutaneous sweat losses. 
8.6 DECISION MAKING FOR HAEMODIALYSIS MANAGEMENT 
Chapter six produced a model of the decision making managing a patient's continuous 
venovenous haemodialysis treatment. The objectives were: 
i) To apply the models of clinical decision making to the problem of clinical decision 
support in the management of renal failure in intensive care. 
ii) To produce a protocol for making the CVVHD treatment decisions, and for 
qualitatively assessing the patient and treatment states. 
The commonly used treatment compensating for a patient's loss of renal function in the lTV 
is CVVHD. Therefore, the decisions managing the CVVHD process are controlling the 
adverse affects of the ARF. The generic process model for analysing clinical decision 
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making is shown in figure 4.8. There are three levels of decision making in this model: 
patient assessment; treatment, and monitoring. For the case being considered here there is 
only one modality of treatment being considered, CVVHD. This simplifies the process to 
only having to model the treatment decision making, with inputs from an assessment of the 
patient. Within the treatment decision making process the options for the set up of the 
treatment are represented graphically by a decision tree. 
The standard set up of the treatment equipment was analysed in the clinical problem 
assessment, section 5.3.4.2. This included an analysis of the equipment used and its 
configuration during treatment. Having established the fixed parameters of the treatment 
the next stage was to establish the options when implementing the treatment. As mentioned 
above the elicited treatment options are represented in a decision tree. The structure of each 
of the decision nodes in the tree was, a choice of two options with clinical knowledge in 
the fonn of rules defining when the options should be active (figure 4.9). For the decision 
state when both of the options were active a controlling logic function was specified to 
control the output of the decision node. In addition goals for each of the possible options 
represented in the tree were defined, to facilitate the pragmatic evaluation of the decisions 
made. The connection of the individual decision nodes is illustrated in figure 6.1. On level 
A the decisions represented by the tree include whether to begin renal replacement 
treatment or not, and on lower levels range to the more specific decisions such as whether 
to add potassium to the replacement fluid or not (D 1). 
The source of clinical expertise used for deriving the decision options and knowledge for 
choosing between options was Dr S Morgan a nephrologist and ITU consultant. The clear 
intuitive arrangement of the decision tree helped to structure this process of knowledge 
elicitation. 
From the model of clinical decision making (figure 4.13) the output of the decision tree 
depends on assessments of the patient's state and of the state of the treatment the patient is 
receiving. The patient and treatment assessments required were derived from the decision 
rules represented in the tree. The assessment of patient state is broken down into two main 
categories: static and dynamic. The static category represents the classification of a single 
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measurement of a variable, whilst the dynamic category is a classification of a change 
between measurements of a variable. Each category is split into a maximum of five levels 
based on the classification of patient variables used in the T ANIT project (Uppsala 
University, 1993). For static patient assessment these are: critically high; high; in target 
range; low, and critically low. For dynamic patient assessment they are: rising acutely; 
rising; stable; falling, and falling acutely. The treatment assessment required includes the 
present state of the CVVHD treatment and of related treatment which affects the patients 
electrolyte, acid base and fluid balance. For example an assessment of the presence of 
insulin and dextrose therapy to reduce plasma potassium. A fuller description of the patient 
and treatment state assessments required is given in section 6.4 of the thesis. 
The bases for testing the truth of the knowledge in the decision making model are the 
philosophical tests of truth: correspondence; coherence, and pragmatism. The knowledge 
in the decision goals was tested for coherence with knowledge from Willats (1987). These 
tests showed that the goals were reasonable and relevant for a patient suffering from ARF. 
In addition to the pathophysiological knowledge, knowledge of the CVVHD treatment 
supported the relevance of the actions to achieving the goals. Using the coherence test to 
explicitly evaluate and link knowledge in this way is the basis for validating and building 
justification into a knowledge based system. Further pragmatic testing of the knowledge 
base is required to show that the advice generated by the tree is effective, i.e. it satisfies the 
specified goals. Encapsulating the knowledge and applying it in a computer based decision 
simulation provides an opportunity for performing the pragmatic test on the knowledge 
base. 
8.7 CDS TOOL DESIGN AND DEVELOPMENT 
Chapter seven described the prototype computer system design and development, through 
satisfying the following objectives: 
i) To specify the system requirements. 
ii) To develop a system design for lTV patient management, incorporating the design 
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for a CVVHD decision support system. 
iii) To design and develop a prototype information system for the management of an 
lTV patient's fluid balance. 
iv) To specify the other modules required in the information system. 
v) To assess the feasibility of designing a clinical decision support treatment advice 
system for continuous haemodialysis in the lTV. 
vi) To program the clinical decision support function using the object oriented 
language C++, and to test its functionality. 
The first stage of developing a computer based tool is to determine the system 
requirements. These were derived from the clinical problem assessment, hospital visits and 
references on requirements for clinical decision support systems. From the clinical problem 
assessment there is the need for: 
i) A program for charting the fluids for patients receiving CVVHD, presenting 
numerical and graphical displays of hourly and cumulative patient fluid balance. 
ii) A program which offers patient specific advice to the decision maker during the 
decision making process controlling the CVVHD treatment. 
The potential user groups were derived from interviews at hospitals with, doctors, nurses, 
managers, a dietician and haemodialysis technicians. Four categories of user groups were 
identified: clinical; management; maintenance, and system evolution. The clinical 
requirements were the focus for the prototype system development, although for a system 
to be integrated with hospital management systems the requirements of other potential users 
will need to be taken into account in future system updates. The specific operational 
system requirements were derived from a mixture of hospital visits and from the general 
references on the requirements for CDS, many derived from the European INFORM project 
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(Hunter et aI., 1991, and Ambroso et aI., 1992). Thus the characteristics specified in the 
system requirements represent a review of both local opinion and wider published opinion. 
These requirements include specification of the importance of automatic data capture where 
ever possible, highlighting the importance of the user interface. Other requirements 
specified are the presentation of the data, operation of the knowledge base, and the 
administrative requirements for the system. An important requirement which has been 
identified in many sources is the need for an approach which integrates the decision support 
function with the information system. 
The integrated approach was encapsulated in a modular system design (figure 5.3). The 
system design shows the modules of the renal replacement therapy management system 
(RRT) integrated with a total lTV patient data management system (PDMS). The RRT 
management system is one component of a total PDMS. Where, the total PDMS is 
concerned with the management of all patient data and information, and decision support 
for the patient as a whole. The other components of the PDMS will be concerned with 
other aspects of patient management, such as ventilator therapy. A fully integrated PDMS, 
like the one described, is required to give a holistic view to the lTU clinician of the patient 
and the treatment they are receiving. Using a single interface to this fully integrated PDMS 
will mean that the clinician will only have to use a single source to gather all relevant 
patient data and run the available decision support. This overcomes the potential 
complication of having multiple systems all with different bits of data on in multiple 
locations, and represents a considerable improvement over the existing disparate paper 
based system. 
The separate modules in the system design are connected to each other and with the PDMS 
via a system manager. This controls information and data flows, manages the system 
operation, and acts as the interface for modules of the system to plug into. Connected to 
the system manager is the user interface, through which all user observed data enters the 
system, and all information is presented to the user. The data and information relevant to 
the management of ARF are stored in the RRT data and information system. The fourth 
module of the RRT system is the decision support sub-system, which will offer advice to 
the clinicians on the management ofCVVHD. 
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8.7.1 Computer Based Fluid Chartin" 
The RR T data and infonnation system is further broken down into modules shown in figure 
7.4. The primary function of the RRT data and information system focuses on patient 
specific clinical data and infonnation. Thus the data and information stored must be 
identified with a specific patient. Part of the patient specific clinical data is in the computer 
based fluid charting system, which includes patient identifier and fluid volume data. The 
prototype computer based fluid charting system produced was based on the paper based 
system used at present. The prototype developed routinely performs calculations of fluid 
input, output and balance, in addition to offering graphical displays of all the fluid volume 
data. There is also a fluid planning capability for the physician to plan the fluid therapy for 
the next 12 or 24 hour treatment period, and linked to this a chart for calculating the volume 
of fluid to administer in the next hour. Thus a computer based fluid charting system has 
the advantages of offering automatic fluid balance calculations, graphical presentation of 
data, and presentation of fluid volume planning aids. These advantages of a computer 
based system have been demonstrated by the rapid production of the prototype fluid 
charting system described in section 7.5.1. Furthermore, the prototype provides the basis 
for the future development of an operational fluid charting system. 
8.7.2 Clinical Decision Sypport System 
The decision support system will operate on the basis of simulated decision making to offer 
advice to the clinical staff on the operational management of the patient's CVVHD 
treatment. The simulation is based on the model of the decision making controlling 
CVVHD developed in chapter 6. Applying this decision model the first stage of the 
decision process is to establish the current patient and treatment states, as defined in section 
6.4. These state assessments then feed into the decision tree and treatment advice is 
generated according to rules defined in section 6.3. The goal of the advised therapy action 
is to bring the patient state variables into a defined target range within a defined time frame. 
To test the potential effectiveness of the proposed action against the defined goals prior to 
it being recommended to the user the action will be simulated using a model of the material 
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domain. The prediction from the model based simulation is then compared to the goal state 
to evaluate the predicted effectiveness of the decision. The decision support module 
containing the models tests the chosen therapy settings through simulation of the patient 
state and the proposed treatment. The therapy settings tested by the simulation module 
could be those recommended by the CVVHD management system, or they could be chosen 
by the physician. Using simulation in this way offers the capability to predict the decision 
outcome before implementation, and thus the potential effectiveness of the chosen therapy 
settings can be evaluated prior to implementation. Taking the recommendation to begin 
renal treatment as an example a complete simulation model will need to predict the 
patient's: fluid volume change; plasma potassium; plasma phosphate; plasma urea; plasma 
creatinine, and base excess. In the complete model each of these goal variables are 
simulated and then depending on the evaluation and the users judgement an action will be 
performed. According the model of decision making in section 4.2.3 the action will be 
followed by a new problem assessment and an evaluation of the action outcome. During 
the evaluation the actions effectiveness and the accuracy of the action simulation are 
assessed. 
To perform the simulation of treatment actions the simulation module needs to be able to 
simulate changes in the patient state and the treatment state. Section 7.4 reviewed existing 
models for utilisation in the simulation of patient and treatment state. None of the models 
proposed have been used in the intensive care setting, so use of any of the models would 
be experimental. The simplest and most established of the models is Sargent and Gotch's 
(1980) single compartment model of urea kinetics. For reasons of identifiability some of 
the more complex models would not be a suitable start point for building a simulation 
model. It is better to begin with the simple model of urea kinetics on an experimental basis 
to test the feasibility of using a quantitative model, and to assess the impact of its use in the 
lTV setting. 
8.7.3 EncodjnK the Decision Tree 
The main function of the CVVHD treatment advice module is to make treatment 
recommendations to the user. The basis for making the treatment recommendations is the 
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decision tree representing the treatment options and knowledge (section 6.3). Using the 
decision tree as the start point the intention is to build a decision simulation for CVVHD 
treatment. 
The first issue to be addressed is how to encode the decision tree. Specifically the problem 
with the coding is to find a technique which can be used to naturally represent the decision 
tree, so that the program structure is a transparent representation of the model already 
developed. More generally the other qualities the implementation language should have 
are: it should be easy to update and maintain, and allow for integration with other 
applications. The language must be easy to update as clinical decision support is developed 
by iterative prototyping (Heathfield et al., 1991). Object-oriented design techniques seek 
to mimic the way that people form models of reality. Typically the reality referred to is a 
material one, and objects are thought of as material entities with attributes and behaviour 
in the material world. An object in a computer program is not a material object it is an 
expression of the abstract conceptual model of the object. An object can be more usefully 
thought of as a representation of the idealistic abstractions formed of reality, whether that 
reality is material or idealistic. Examples of models of material objects are obvious, such 
as the descriptive model of a car. The strength of object oriented programming applied in 
artificial intelligence is in the representation of models of idealist reality such as the model 
of a decision. So object oriented programming provides a transparent representation of the 
decision tree. 
The advantages of object oriented programming over procedural languages include: 
encapsulation; inheritance, and polymorphism (Parsons, 1994). Encapsulation is the 
combining of object states and functions into a single file. This allows for easier 
maintenance than with procedural languages. Inheritance is the derivation of one class, the 
sub-class, from another class, the base class. Polymorphism is the ability of classes of 
object to respond to the same message in different, class specific ways. All of the 
mentioned characteristics of object oriented have the advantage of allowing for the reuse 
of code. Encapsulation of a class allows for the multiple creation of objects from the class. 
Inheritance allows sub-classes to re-use code in the base classes. While polymorphism is 
the reuse of symbols, operators and names, to apply to different object behaviours. It was 
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because of these reported advantages and the representational power of object oriented 
programming that it was selected to encode the decision tree. 
The decision tree model can be viewed as a set of decision nodes, each one representing an 
option in the decision making process. Each of the decision nodes in the tree have 
similarities which can be represented in a base decision class, and differences which have 
to be represented in separate sub-classes. All decision nodes have a similar decision state 
structure, so they can be represented by the same structure in the program code. Moreover, 
the logic for determining the output state from the two mutually exclusive actions is 
common to all nodes. However, the functions or conditions which make the options active 
are unique to each decision node. Thus it is possible to define the object oriented hierarchy 
of the decision nodes using the generalised structure in figure 7.26. The general decision 
class at the top of the hierarchy consists of the generic decision state structure and the 
logical arbitration function. Below this are a number of sub-classes defining the conditions 
for activating the options of each decision node. For example decision node A 1 has the file 
structure shown in figure 7.27. The decision rules are declared and defined in dec _a I.h and 
dec_al-f.cpp respectively, whilst each of the functions has its own data type defined in 
classes al_conlsvar to al_conOlsvar. The C++ code for the generic decision class and 
decision class Al is in appendix D. 
Each of the decision nodes of the decision tree (figure 6.1) have been coded in a similar 
manner to decision node AI. Using test files the functionality of all of the decision nodes 
has been validated (figures 7.29 to 7.40), and all were found to offer the correct advice for 
the test conditions set, thus proving the concept of modelling decisions as objects with 
states and decision functions. Moreover, it has been shown that object oriented 
programming techniques offer a coherent representation and implementation of models of 
the idealist reality. Thus the use of modelling and object oriented techniques in knowledge 
based systems has been demonstrated. 
The next stage of development of the decision tree will include connecting together the 
decision nodes to produce a unified treatment advisor. The other required elements of the 
future development of the complete treatment advisor are: the advice justification 
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component; attachment of goals to the advice, and the meta control of the decision tree for 
controlling several decision cycles. Moreover, the integration of the decision tree with the 
data and information system will be required in an operational system. 
8.8 SUMMARY 
This chapter has discussed the main points relating to philosophy, methodology. method, 
technique, and tool application in the thesis. The aims, objectives and main points of each 
chapter have been considered individually. The following conclusions will consider how 
the aims of the thesis as a whole have been addressed, the contributions made to 
knowledge, and the possible directions for future work. 
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CHAPTER 9 
CONCLUSION 
9.1 MEETING THE OBJECTIVES 
9.1 ,1 A Coherent ｏｮｴｯｬｯｾｹ＠ and EpistemoloK)' for Clinical Decision SUlWOrt 
The central hypothesis of this thesis is that the paradigm for clinical decision support needs 
to shift from a technology centred paradigm to a coherent ontological-epistemological 
paradigm. In testing this hypothesis the fIrst objective to be satisfIed was the construction 
of a generic philosophical ontology and epistemology as an holistic analytical foundation 
for clinical decision support. This was done by systematically reviewing fundamental 
concepts of ontology and epistemology. From the systematic study generic analytical 
ontological and epistemological models were constructed. Following on from this the 
second objective was to apply these models in an analysis of clinical decision making and 
of clinical decision support. Application of the models produced an ontology and 
epistemology for decision making and decision support, and from these models process 
models of decision making and decision support were derived. 
The third objective was to practically apply the ontological and epistemological framework 
to a clinical problem analysis; as the basis for the design of a clinical decision support tool. 
Applying the ontological model structured the analysis of the clinical problem into a 
model-based analysis of the material domain, followed by a model-based analysis of the 
idealist decision making domain. The epistemological models provided a basis for an 
analysis of the nature of knowledge and how it may be evaluated; in addition to providing 
a structure for building up knowledge in the analysis of the clinical problem. 
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9.1.2 Clinical Decision S\Jllport for the ManaKement of Acute Renal Failure in the lTV 
Objective four was to analyse and model the clinical problem of the management of acute 
renal failure (ARF) patients in the lTV. Analysis of this material clinical problem was 
based on conceptual knowledge of medical science. This knowledge was coupled with an 
analysis of the treatment of ARF in the lTV to construct a model of the material processes 
relevant to the management of ARF. Producing a decision making model for the 
management of CVVHD therapy was the fifth objective of the thesis. To meet this 
objective the analysis of clinical decision making was applied to produce a novel decision 
making model for the management of CVVHD therapy. Satisfying objectives four and five 
led to the sixth objective; designing and developing a prototype clinical decision support 
computer tool for continuous haemodialysis management. The prototype system developed 
demonstrated the capabilities of computer based fluid charting, and also demonstrated the 
use of object oriented programming to implement decision models of the idealist reality. 
9.1.3 Insiahts from the !\mllication of OntolOKY and Epistemo!oay 
Thus it has been shown that a coherent ontological and epistemological framework does 
provide insight into: clinical decision making; clinical decision support, and the 
development of an application specific system. Therefore, a coherent philosophy does 
provide clarity in the analysis for and design of clinical decision support tools, and it will 
be an aid in future CDS system analysis and design. 
9.2 CONTRIBUTIONS TO KNOWLEDGE 
9.2.1 Applied ｑｮｴｯｬｯｾ＠ and EpistemoloiY 
At the philosophical level a novel formalism of a dualist ontology has been derived and 
used as an analytical tool in the thesis. There is also novelty in the explicit application of 
epistemology to CDS. This application has provided a new perspective of knowledge in 
the field of CDS in relation to its nature, source, scope, and validation. The nature of 
knowledge in epistemology is a justified true belief. The truth of a belief which 
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distinguishes it as knowledge is judged according to three philosophical criteria: 
correspondence; coherence, and pragmatism. The critical appraisal of any knowledge base 
relies on the application of these three criteria. Applying the classifications of knowledge 
shown in figure 3.6 to a clinical decision support system, the truth of the information in the 
system representing state and conceptual knowledge is tested according to: correspondence 
with an observation, and coherence with another knowledge base; whilst the know how in 
the CDS system is tested through the application of coherence, and pragmatism in the 
application of the know how to the fulfilment of a predefined purpose. The use of the 
pragmatic test for know how demands that the knowledge used is explicitly linked to a 
goal. Thus to evaluate a knowledge base pragmatically requires the linkage of decision 
goals and decision rules in the structure of a knowledge base. This requirement is reflected 
in the structure of the decision nodes of the CVVHD decision tree. 
When applying the coherence test a major problem is that of selecting the other knowledge 
base to be used in the test. Through the consideration of phenomenology as the source of 
knowledge, using different sources of expertise has been argued to be an insufficient basis 
for coherence testing. The most reliable knowledge base available in the clinical domain 
is the medical science knowledge base. Therefore medical science should feature in the 
coherence testing of a clinical knowledge base. However, further work is required to better 
define the linkages in medical knowledge, and to more clearly define the clinical 
knowledge bases that should be applied in the coherence testing. 
9.2.1 Clinical Decision S\lP.Port 
The insights and understanding of CDS gained from the application of ontological and 
epistemological concepts include the representation of decision making and the role of 
decision support. From this application, decision support is viewed as being offered where 
a problem-specific decision simulation is performed by the decision support tool, and 
decision advice is given to the user. This is contrasted with knowledge support which gives 
the user access to knowledge for use in the decision making process, but does not offer 
decision advice at any stage of the process. 
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Other contributions of the thesis relate to the novel clinical decision support problem of 
managing acute renal failure in the lTU. The analysis of the clinical problem has produced 
a novel model of the management of an ARF patient being treated with CVVHD on the 
lTU, and a new protocol for prescribing CVVHD treatment. During the clinical problem 
analysis a review of the published estimates for insensible and sweat losses produced 
significantly different values for these losses, and candidate quantitative models for 
calculating the insensible losses. The quantitative models show that insensible losses 
depend on variations in patient and ambient conditions, and using them would offer greater 
sensitivity to variations in these conditions than presently used estimates of the losses. 
However, the models have not yet been tested in the lTU setting and further scientific study 
is required before they can be implemented in an automatic fluid volume charting system. 
From the development of the prototype decision support system the contributions include 
the systems requirements, and the conceptual integrated system design. The prototype fluid 
charting system developed has the advantages of offering: automatic fluid charting; 
graphical presentation of data, and fluid balance planning aids. The object-oriented 
programming of the decision tree nodes has shown that the concept of modelling decisions 
as objects with states and decision functions is functionally correct. Moreover, it has been 
shown that object-oriented programming techniques offer a coherent representation and 
implementation of models of the idealist reality. For the prognosis of a patient state 
following a proposed treatment action the use of quantitative models was investigated. 
However, to date quantitative simulation models have been applied to management of 
chronic renal failure but not in acute care; therefore the application of these models in the 
prediction of the effectiveness of actions requires further study. 
9.3 THE WAY AHEAD 
The future contributions of the work described in this thesis include further additions to the 
debate on the philosophical foundation for clinical decision support development. From 
such debate, and through further pragmatic application, the paradigm will be more fully 
developed. Through the application of the paradigm it is envisaged that there will be a 
change in the focus of the development of CDS from disparate tool development to 
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problem understanding based on a coherent philosophy and modelling approach. During 
the development of the paradigm a fundamental epistemological question to be answered 
in relation to testing newly formulated knowledge is: what established medical knowledge 
base is sufficiently proven to be used in coherence testing? 
Clinically the protocol for CVVHD treatment still requires pragmatic testing to demonstrate 
its effectiveness. These tests could be effectively performed using a more fully developed 
decision support prototype system. The other future technological developments of the 
prototype system worth pursuing are the implementation and proving of the integrated 
decision support system design, and the completion of an implementable CVVHD decision 
support system. During the further development of the system the quantitative models of 
insensible loss, and patient state will require evaluation in the lTU setting. Then depending 
on the outcome of this evaluation the models will be incorporated into the CVVHD 
decision support system for a comprehensive evaluation in the ITU environment. 
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ApPENDIX B 
RESPIRATORY WATER Loss 
THEORY 
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RESPIRATORY WATER LOSS THEORY 
1. Mass flow of air. m. 
ma = (minute volume.V m. x density of dry air.d. x 60 minutes) 
= V m x d. x 60 g hel (14 1.1 ) 
From the American Institute of Physics handbook d. at 200c and I atmosphere is 
1.204 g me3 
V m = Respiratory Rate x Tidal Volume 
(H 1.2) 
The respiratory rate. fRJlo and the tidal volume. V-r. are defined in Wilson (1992). 
page 366. 
m. = 72,204 x fRR x Vr g hel 
2. Absolute Humidity. Y CTreybal. 1968) 
Y= mass of water vapour in grams in 1 gram of dry air 
= partial pressure of water vAPOur x molecular weiaht water 
partial pressure of air molecular weight air 
= llw x Mw = -llw _ x Mw 
P. M. Pr-Pw M. 
where Pr = total pressure of the gas and vapour mixture. 
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(81.3 ) 
(B2.1) 
3. Relatiye Humidity. RH (Treybal. 1968) 
RH = partial pressure of water vapour x 100% 
vapour pressure of water 
=.Jlw x 100% (83.1) 
(Note: Relative Humidity is not the same measure of humidity as percentage saturation). 
4. Vapour Pressure. Pvp (Treybal. 1968) 
The vapour pressure of a liquid is the equilibrium pressure it exerts on the gas above it. 
Vapour pressure vwies with temperature. At the normal boiling point of the liquid, water 
1000<:, the vapour pressure of the liquid equals the pressure of the atmosphere acting on it. 
There are tables that give values of the vapour pressure of water across a range of 
temperatures. However, in a computational model it is more convenient to use an equation 
such as the Antoine vapour pressure equation, (Reid, 1987) : 
loglo (Vapour Pressure) = A -...lL 
T+C 
(84.1) 
Where T is in degrees celsius, and the constants A, B and C vary with the temperature 
range being considered and the identity of the liquid. Reid states that the Antoine equation 
gives accurate results provided it is used over a limited temperature range and within the 
pressure range 7.6 to 1520 mmHg. 
Ultman (1987) derived the following equation from the values for A, 8 and C given in 
Foust et al. (1980): 
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10g10 (Pvp) = 7.09161 - 1668.21 
228+T 
where the vapour pressure is express in kPa. 
(84.2) 
Unfortunately Foust does not state a range of temperatures which these constants arc villid 
for. When the calculated values of vapour pressure at OOC and JOO"C are compared to 
tabulated values, errors of -2.60% and -0,003% are found. Vapour pressures outside ｴｨｩｾ＠
range of temperatures will not have to be calculated. Therefore. the quantitative 
significance of errors in the calculated value of vapour pressure is negligible. 
5. Absolute humidity. Y. in terms ofrelatiye humidity. RH 
From the definition of RH 
& 
Pw= RH x Pvp 
100 
Y = -llw- x Mw 
PT-Pw M. 
From Treybal (1968, page 188) Mw= 0.622 
M. 
and substituting for Pw in equation 85.2 
Y = 0.622 x RH x Pvp 
100PT - RH x Pvp 
6. Conversion of Fahrenheit. tF to Celsius. L 
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(BS.I) 
(BS.2) 
(145.3) 
(1l6.1) 
7. Mass of water vapour per unit volume. MY 
MV = density of dry gas x Absolute humidity 
y = 0.622.RH x Pvp; dA = 1.204g1dm3 
100PT - RHpvp 
Therefore, 
MV = O.749RH x pyP 
100PT - RHpvp 
8. Density of water 
(B7.1) 
(B7.2) 
From tables at O°C the density of water is 0.999 g mI') and at lOO'C it is 0.958 g mI'I. 
Therefore an approximation of I g ml') will be used for the density of water. 
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THEORY FOR TEWL 
1. Fick's law 
Flux = - Diffusivity (Concentration "radient) 
Change in distance 
(C 1.1) 
The negative sign indicates that the direction of flux flow is in the direction of a decreasing 
concentration gradient. The diffusivity is a measure of the ability of the molecules to 
diffuse in the medium being considered. This ability is determined by the size of all the 
molecules in the system, the density of the molecules in the system and the velocity of the 
molecules whose diffusivity is being measured. The dimensions of diffusivity are unit area 
squared per unit time. 
If in the above expression the concentration is measured in moles per metre cubed the S.1. 
units of flux are : 
Flux = moles m·2 S·I 
This can be thought of as the number of moles of molecules of A passing through a unit 
area in a second. 
To convert a molar flux into a mass flux the expression is multiplied by the molecular mass 
MA• 
therefore 
Mass = ＭｍａＮｄＮｾ＠ = -D.dd (C1.2) 
dx dx 
where d = density 
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Now, 
d=Ml2 
RT 
where, M = molecular mass 
p = partial pressure 
R = universal gas constant (8.205xl()=l m3 atmJkmol OK) 
T = temperature in degrees kelvin 
Therefore, 
Mass flow = - ｍａｬｬＮｾ＠
RT dx 
(C1.3) 
(CI.4) 
Applying this formula to the stratum corneum, where its thickness is denoted by 1, and the 
partial pressure gradient is the difference between the partial pressure of water in the 
subcutaneous layer and at the skin surface. Subcutaneous partial pressure is approximately 
equal to the vapour pressure at the perfusion temperature, then 
TEWL = MwDw ( Pvp(T p) - Ps ) 
RT.l 
where Ps<pvp(Tp) and TEWL is expressed in g.m-2.s- l • 
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(C1.5) 
2. Body Surface Area (BSA) 
The original fonnula quoted by DuBois and DuBois (1916) was: 
BSA = 71.85 x WO·425 x HO.725 
where W = weight (kg) 
H = height (cm) 
BSA = body surface area (cm2) 
For units of metres and kilograms the expression is: 
BSA = 0.2025 WO·42S ｾＮＷＲｓ＠
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(C2.1) 
(C2.2) 
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V'============================ 
II 
I!FILENAME: 
I !FILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDATE CREATED: 
II 
state.h 
C++ header class for STATE 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
V __________________________________________________ __ 
II 
IIDESCRIPTION: Class STATE represents the data type which is a component 
II part of the structure ofa decision node. Hence, state is a 
II component class of the DECISION class. 
II 
IIBASE CLASSES: None 
IIDERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: None 
II 
I/uSAGE: The basis for the attributes of the decisions in the decision tree 
II 
IIKNOWN BUGS: None 
V __________________________________________________ __ 
II 
I/MODIFICATION HISTORY 
IIDATE: 
IIAUTHOR: 
IIDESCRIPTION: 
V __________________________________________________ __ 
II----------PRE-PFtOCESSOR MACROS------------------------------------------------
#ifndef STATE 
#define STATE 
11------------------------------------------------------------------------------
II DECLARATION OF CLASS STATE 
II 
//------------------------------------------------------------------------------
class state 
{ 
public: 
char *thestate;llthe character string defining the decision output, or state 
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unsigned int begin: 1 ;lldefines the state of the begin action conditions 
unsigned int nbegin: 1 ;lldefines the state of the do not begin action 
conditions 
unsigned int bt: 1; Ildefines the decision state which is a function of the states 
of I I begin and nbegin 
}; 
state(char* astate,unsigned int a,unsigned int b, unsigned int c);llconstructor 
-stateO;lldestructor 
II -----------------constructor definition---------------------------------------
inline state::state(char*astate=O , unsigned int a=O, unsigned int b=O, unsigned int c=O) 
: thestate(astate), begin(a), nbegin(b), bt(c)lIinline intialisation of the state constructor 
{ 
#ifDEBUG 
cout« "\n Creating object of type state\n"; 
#endif 
} 
/ / -----------------destructor definition----------------------------------------
inline state: :-stateO/linline definition of the state destructor 
{ 
#ifDEBUGl 
cout« " Inside the state destructor \n"; 
#endif 
} 
ｉｉＭＭＭＭＭＭＭｅｾｄ＠ ＨＩｾ＠ ｾＱｲＩ｜Ｑｲｅ＠ ｄｅｃｾＩ｜ｆｬｉ｜ＱｲｉＨＩｾＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
#endif 
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11============== 
II 
I!FILENAME: 
I !FILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDATE CREATED: 
II 
decision.h 
C++ header class for DECISION 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
fi __________________________________________________ _ 
II 
IIDESCRIPTION: Class DECISION represents the attributes of the decision nodes 
II in the decision tree. In addition to declaring the functions 
II which are common to all the sub-classes. 
II 
II 
II 
II 
II 
II 
The attributes are defined in the data structure defined by the 
component state class. 
Sets the DEBUG condition to true for testing files during development. 
IIBASE CLASSES: None 
IIDERIVED CLASSES: None 
IICOMPONENT CLASSES: STATE 
IICONT AlNS CLASSES: None 
II 
I/uSAGE: The decision class forms the structure of all the decision nodes 
II 
IIKNOWN BUGS: None fi __________________________________________________ __ 
II 
I/MODIFICATION HISTORY 
IIDATE: 
IIAUTHOR: 
IIDESCRIPTION: 
fi ________________________________________________ __ 
ｉｉＭＭＭＭＭＭＭＭＭＭｐｒｅＭｐｒｏｃｾｓｓｏｒ＠ ｾｃｒｏｓＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
#ifndef ｄｾｃｉｓｉｏｎ＠
#defme ｄｾｃｉｓｉｏｎ＠
#define ｄｾｂｕｇ＠ 0 
#include <iostream.h> 
#include "state.h" 
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11------------------------------------------------------------------------------
II DECLARATION FOR DECISION CLASS 
II 
II 
11------------------------------------------------------------------------------
class state;llpre-declaration of class state, because data type state used in 
Iidecision class. (For the benefit of the compiler) 
class decision 
{ 
protected: 
state &dec_state;lldecision attributes 
public: 
virtual unsigned int action(decision & );I/function for giving action choice 
- /1 contains logic 
}; 
decision(state& a_state);llconstructor 
virtual -decisionO;I/destructor 
II -----------------constructor defini tion---------------------------------------
inline decision::decision(state& a_state):dec_state(a_state)//inline definition of the dec_al 
constructor 
{ 
#ifDEBUG 
cout« "Creating object of type decision \n"; 
#endif 
} 
II -----------------destructor defini tion----------------------------------------
inline decision::-decisionOllinline definition of the dec_al destructor 
{ 
#ifDEBUG 
cout« " Inside the decision destructor \n"; 
#endif 
} 
//----------definition of action function containing logic for action choice----
inline unsigned int decision::action(decision &) 
{ 
if (dec_state. begin && (!dec_state.nbegin»llif there are reasons for starting 
treatment and I I no reasons not to then begin CVVHD 
{ 
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dec_state. bt= 1 ; 
} 
if ((!dec_state.begin && !dec_state.nbegin)1I dec_state.nbegin)//ifthere are reasons 
to not start treatment then the advice is not to start 
#endif 
{ 
dec_state. bt=O; 
} 
return dec_state.bt; 
} 
ＯＯＭＭＭＭＭＭＭｾｾｉＩ＠ ()l' ｉＩｾ＼ＺｉｓｉｻＩｾ＠ ＱＩｾ＼Ｚｾｽ｜ｦｴｪ｜ＱｲｉｻＩｾＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
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II 
============== 
II 
IIFILENAME: 
IIFILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDATE CREATED: 
II 
dec al.h 
C++ header class for DEC_AI 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
V __________________________________________________ __ 
II 
IIDESCRIPTION: Class DEC_AI represents the knowledge base used to decide which 
I I action to take at point A 1 in the decision tree. This class 
I I contains only the functions for making the decision, its 
II attributes are derived from its base class DECISION. 
II 
II 
II 
II 
II 
II 
II 
The functions firstly set the begin, or nbegin, to be true or 
false. The state of these two is then tested to decide on 
whether to begin treatment or not. If any of the conditions 
to not begin treatment are satisfied then the advice offered 
will be to not begin treatment. 
IIBASE CLASSES: DECISION, in file decision.h 
IIDERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: AI_CON 1 SVAR, Al_CON2SVAR, AI_CONI DVAR, 
A 1_ CON2DV AR, 
II 
II 
I/uSAGE: The data objects (contained classes) are used to feed in the classified 
I I patient and treatment state assessments, into the decision functions. 
II 
I/KNOWN BUGS: None 
11 ______ ----------------------
II 
I/MODIFICATION HISTORY 
IIDATE: 
IIAUTHOR: 
IIDESCRIPTION: 
11----------_--------------------------------------
II----------PRE-PROCESSOR MACROS------------------------------------------------
#ifndefDEC_Al Ilmacro if condition to prevent multiple definitions of dec_a 1 
#define DEC_AlI/action to be taken if DEC_AI not defined 
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#include "decision.h"ll file containing the decision and state declaration 
#include "alclsvar.h"l/ file containing data object al_conlsvar declaration 
#include "alc2svar.h"l/ file containing data object al_con2svar declaration 
#include "alcldvar.h"l/ file containing data object al_conldvar declaration 
#include "alc2dvar.h"l/ file containing data object al_con2dvar declaration 
#include lal c3dvar.h"11 file containing data object al_con3dvar declaration 
#include lalcOlsva.h"/lfile containing data object al_conOlsvar declaration 
11------------------------------------------------------------------------------
II DECLARATION FOR DECISION Al CLASS 
/I 
11 ______ --------------------
class dec _a I :public decision! Ithe decision structure attributes are inherited 
{ 
public: 
II----------condition statements for begin treatment set beginal----------------
unsigned int condition 1 s( const al conlsvar & );1 Imemeber 
containing the rules 
unsigned int condition2s( const a 1_ con2svar & );1 Imemeber 
containing the rules 
unsigned int condition 1 d( const al conldvar &);llmemeber 
containing the rules 
unsigned int condition2d( const al con2dvar &);llmemeber 
containing the rules 
unsigned int condition3d( const al con3dvar &);llmemeber 
containing the rules 
II------------condition statements for not begin treatment set nbeginal--------
function 
function 
function 
function 
function 
unsigned int conditionOls(const al_conOlsvar &);llmemeber function 
containing the rules 
II------------------protoype for set the state string function------------------
char· advice( decision &);11 member function which sets advice statement 
II ---------dec _a 1 constructor and destructor protoypes--------------------------
}; 
dec_al(state& a_state);llconstructor for the class dec_al 
-dec_al0;lldestructor for the class dec_al 
//-----------------constructor definition---------------------------------------
inline dec_al ::dec_al(state &a_state):decision(a_state)llinline definition of the 
-445-
dec a 1 constructor 
{ 
#if DEBUGllonly when DEBUG is = 1 will these be printed onto the screen. 
DEBUG defined in the decision base class 
cout« " Creating object of type dec_a1\n"; 
#endif 
#ifDEBUGl 
cout« "State_al in dec_at constructor = " «a_state.thestate«"\n"; 
cout« "Beginal in dec_al constructor = " «a_state.begin«"\n"; 
cout« "nBeginal in dec_al constructor =" «a_state.nbegin«"\n"; 
#endif 
} 
II -----------------destructor definition----------------------------------------
inline dec_al ::-dec_alOllinline definition of the dec_at destructor 
{ 
#ifDEBUGl 
cout« " Inside the dec_al destructor \n"; 
cout « "dec state.thestate in dec al 
- -
dec_state. thestate«"\n"; 
destructor = " « 
cout« "dec_state.begin in dec_al destructor ="« dec_state.begin«"\n"; 
cout « "dec_state.nbegin in dec al denstructor = " « 
dec_state.nbegin«"\n"; 
#endif 
} 
#include "dec_al-f.cpp" Ilinclude the definitions of the condition member functions 
#endifl I endif statement for the ifndef at the top of the file. 
II -------End of DEC A 1 class file-----------------------------------------------
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11======================= 
II 
IIFILENAME: 
IIFILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDA TE CREATED: 
II 
dec_aI-f.cpp 
C++ function definition file for DEC Al 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
V ____________________________________________________ ___ 
II 
IIDESCRIPTION: Class DEC_AI represents the knowledge base used to decide which 
II action to take at point Al in the decision tree. This class 
II contains only the functions for making the decision, its 
II attributes are derived from its base class DECISION. 
II 
II 
II 
II 
II 
II 
II 
The functions firstly set the begin, or nbegin, to be true or 
false. The state of these two is then tested to decide on 
whether to begin treatment or not. If any of the conditions 
to not begin treatment are satisfied then the advice offered 
will be to not begin treatment. 
IIBASE CLASSES: DECISION, in file decision.h 
I/DERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: AI_CONISVAR, Al_CON2SVAR, AI_CON 1 DVAR, 
Al_CON2DVAR, 
II 
II 
I/uSAGE: The data objects (contained classes) are used to feed in the classified 
I I patient and treatment state assessments, into the decision functions. 
II 
I/KNOWN BUGS: None 
V ____________________________________________________ ___ 
II 
I/MODIFICATION HISTORY 
IIDATE: 
VAUTHOR: 
IIDESCRIPTION: V __________________________________________________ __ 
II--------SET OF FUNCTIONS WHICH TEST THE BEGIN TREATMENT 
RULES-----------------
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IIFUNCTION CONDITIONIS DEFINES RULES FOR FIRST STATIC DATA 
CONDITION 
unsigned int dec_al ::conditionls(const al_conlsvar & var) 
{ 
if (var.urest =4 && var.crtst 4 && var.hydst >=3 && var.ivfst >=3)llusing 
integars to represent the classification gap 
{ 
dec_state. begin= 1 ;Ilbegin a 1 conditions satisfied, needs to be set before test for 
state _a 1 output 
} 
else Ilifnone of these condions are satisfied then do not begin 
{ 
dec_state.begin= 0;// begin al conditions not satisfied 
} 
#ifDEBUGl 
«"\n"; 
#endif 
} 
cout« "\n The state of dec_state_beginal in the function is" «dec_state.begin 
return dec_state. begin; 
/IFUNCTION CONDITION2S DEFINES RULES FOR SECOND STATIC DATA 
CONDITION 
unsigned int dec_al ::condition2s(const al_con2svar & var) 
{ 
if (var.potst =5 && var.idtst=l && var.acbst<=2 && var.abtst l)llusing 
integars to represent the classification gap 
{ 
dec_state.begin= l;/lbegin al conditions satisfied, needs to be set before test for 
state_a I output 
} 
else Ilifnone of these condions are satisfied then do not begin 
{ 
dec_state.begin= 0;11 begin al conditions not satisfied 
} 
return dec_state. begin; 
} 
IIFUNCTION CONDITIONlD DEFINES RULES FOR FIRST DYNAMIC DATA 
CONDITION 
unsigned int dec_al::conditionld(const al_conldvar & var) 
{ 
if (var.crtdy 4 && var.uredy 4 && var.time>=48)lIusing integars to represent 
the classification gap 
{ 
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dec_state.begin= 1;//begin al conditions satisfied, needs to be set before test for 
state_a 1 output 
} 
} 
else Ilifnone of these condions are satisfied then do not begin 
{ 
dec_state.begin= 0;11 begin al conditions not satisfied 
} 
return dec_state. begin; 
IIFUNCTION CONDITION2D DEFINES RULES FOR SECOND DYNAMIC DATA 
CONDITION 
unsigned int dec_al ::condition2d(const al_con2dvar & var) 
{ 
if (var.potdy =5 && var.time>=6)llusing integars to represent the classification 
gap 
{ 
dec_state.begin= 1;//begin al conditions satisfied, needs to be set before test for 
state _a 1 output 
} 
else Ilifnone of these condions are satisfied then do not begin 
{ 
dec_state.begin= 0;11 begin al conditions not satisfied 
} 
return dec_state. begin; 
} 
IIFUNCTION CONDITION3D DEFINES RULES FOR THIRD DYNAMIC DATA 
CONDITION 
unsigned int dec_al::condition3d(const al_con3dvar & var) 
{ 
if (var.hydst 4 && var.pulst =1 && var.urvdy<=1 && var.time>=48)llusing 
integars to represent the classification gap 
{ 
dec_state.begin= 1;//begin al conditions satisfied, needs to be set before test for 
state_a 1 output 
} 
else Ilifnone of these condions are satisfied then do not begin 
{ 
dec_state.begin= 0;11 begin al conditions not satisfied 
} 
return dec_state.begin; 
} 
II--------SET OF FUNCTIONS WHICH TEST THE DO NOT BEGIN TREATMENT 
RULES----------
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IIFUNCTION CONDITIONIS DEFINES RULES FOR FIRST STATIC DATA 
CONDITION 
unsigned int dec_a 1 ::condition01s(const aI_conOIsvar & var) 
{ 
if «var.blpst <=2 && var.bptst=I) II var.bldst =1 )//using integars to represent 
the classification gap 
{ 
dec _ state.nbegin= 1;1 /begin a 1 conditions satisfied, needs to be set before test for 
state _a 1 output 
} 
else Ilif none of these condions are satisfied then do not begin 
{ 
dec_state.nbegin= 0;11 begin al conditions not satisfied 
} 
return dec _ state.nbegin; 
} 
II----------------FUNCTION FOR DECIDING ON WHAT ADVICE TO GIVE TO 
USER----------
char· dec_aI::advice(decision & aI_I) 
{ 
action(aI_I ); 
if (dec_state.bt=I)llifthere are reasons for starting treatment and no reasons not 
to then begin CVVHD 
{ 
dec_state.thestate = "Begin Renal Replacement Therapy"; 
} 
if(dec_state.bt O)llifthere are reasons to not start treatment then the advice is not 
to start 
{ 
dec_state.thestate = "Do not begin Renal Replacement Therapy"; 
} 
#ifDEBUGI 
cout « "\n Inside the function call The decision state for decision al is: " « 
dec_state.thestate « "\n"; 
#endif 
return dec_state. thestate; 
} 
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II 
II 
I!FILENAME: 
I !FILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDATE CREATED: 
II 
alclsvar.h 
C++ header class for A I_CON 1 SV AR 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
V ____________________________________________________ ___ 
II 
IIDESCRIPTION: Class Al_CONISV AR represents the data struture and the data 
II interface for function conditionls in class DEC_AI. 
II 
1/ 
II 
II 
II 
II 
The data items represent those used in the function to set 
begin for decision AI. The functions form the interface to 
the test functions and the patient and treatment state 
assessment. 
IIBASE CLASSES: None 
IIDERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: None 
1/ 
I/uSAGE: Data interface for the treatment prescription knowledge base. 
II 
IIKNOWN BUGS: None 
11 ______ --------------------
II 
I/MODIFICA TION HISTORY 
IIDATE: 
IIAUTHOR: 
IIDESCRIPTION: V _______________________________ __ 
II··········PRE·PROCESSOR MA<:ROS······_····_···_·· __ ··_···_···_··_····_··_···_·· 
#ifndef A I_CON 1 SV AR Ilmacro if condition to prevent mUltiple definitions 
#define AI_CONISVAR 
#include "test_a1.h" 
class dec al ;llpre·definition of class dec al 
- -
11·················_······_·························_-.. _ .•. _ ... _ .. _._ ...••••••• 
II DECLARATION FOR Al_<:ONISVAR CLASS 
·451· 
II 
v __________________________________________________ __ 
class a 1 con 1 svar 
{ 
11--------------------l)j\1[j\ ｓＱ｛ｆｴｬｊｾＱｬｬｊｆｬｊｪＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
private: 
int urest; 
int crtst; 
int hydst; 
int ivfst; 
ＱＱＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭｉｾＱ｛ｾｆｴｊｆｪ｜ｾｾ＠ ｦＧｾｾＱ｛ｉＨＩｾｓＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
public: 
friend dec _ a 1 ; 
al_conlsvar(int, int, int, int); 
void iniat_var(int "', al_conlsvar "'); 
} ; 
II -----------------constructor definition---------------------------------------
inline al_conlsvar::al_conlsvar(int a=O, int b=O, int c=O, 
crtst(b ),hydst( c ),ivfst( d) 
{ 
#if ｬＩｾｂｬｊｇ＠ 1 
cout« " Inside the al_conlsvar constructor \n"; 
#endif 
}; 
II -----------------test conditions----------------------------------------------
void al_conlsvar::iniat_ var(int "'arr, al_conlsvar "'vars) 
{ 
vars->urest=O; 
vars->crtst=O; 
vars->hydst=O; 
vars->ivfst=O; 
if(arr[O]=I) 
{ 
vars->urest=4; 
vars->crtst=4; 
vars->hydst=3 ; 
vars->ivfst=3; 
ＣｩｦｬＩｾｂｬｊｇ＠
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#endif 
cout« " Condition number Is is set to active \nil; 
#endif 
} 
else 
{ 
#ifDEBUG 
cout«" Condition number Is is set to inactive \n"; 
#endif 
} 
return; 
} 
/ / -------End of a 1 con 1 svar class file-----------------------------------------
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II 
--------------
II 
IIFILENAME: 
IIFILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
lID ATE CREATED: 
II 
aIc2svar.h 
C++ header class for Al CON2SVAR 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
11-----------------------------------------------------
II 
I!DESCRIPTION: Class AI_CON2SVAR represents the data stroture and the data 
II interface for function condition2s in class DEC _AI. 
II 
II 
II 
II 
II 
II 
The data items represent those used in the function to set 
begin for decision A 1. The functions fonn the interface to 
the test functions and the patient and treatment state 
assessment. 
I!BASE CLASSES: None 
I!DERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: None 
II 
I!USAGE: Data interface for the treatment prescription knowledge base. 
/I 
I!KNOWN BUGS: None 
1/-------------------------------------------------------
/I 
I!MODIFICATION HISTORY 
I!DATE: 
IIAUTHOR: 
I !DESCRIPTION: 
1/--------------------------------------------------
11----------PRE-PR OCES SO R MA CROS------------------------------------------------
#ifndef AI_CON2SVAR Ilmacro if condition to prevent multiple definitions of dec_a I 
#define Al_CON2SVAR 
#include "test aI.h" 
class dec _a I ;class dec _a 1 ;I/pre-definition of class dec _ a 1 
11------------------------------------------------------------------------------
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II DECLARATION FOR A1_CON2SVAR CLASS 
II 
fi ____________________________________________________ ___ 
class a1 con2svar 
{ 
II--------------------DATA STRlJCTlJRE--------------------------------------------
private: 
int potst; 
int idtst; 
int acbst; 
int abtst; 
II------------------INTERFACE FlJNCTIONS-----------------------------------------
public: 
friend dec_a1; 
a1_con2svar(int, int, int, int); 
void iniat_ var(int *, a1_con2svar *); 
}; 
II-----------------constructor definition---------------------------------------
inline a1_con2svar::a1_con2svar(int a=O, int b=O, int c=O, 
idtst(b), acbst( c), abtst( d) 
{}; 
II -----------------test conditions----------------------------------------------
void a1_con2svar::iniat_ var(int *arr, a1_con2svar ·vars) 
{ 
vars->potst=O; 
vars->idtst=O; 
vars->acbst=O; 
vars->abtst=O; 
if (arr[l]=l) 
#ifDEBlJG 
{ 
vars->potst=5 ; 
vars->idtst= 1 ; 
vars->acbst=2; 
vars->abtst= 1 ; 
cout«" Condition number 2s is set to active \n"; 
#endif 
} 
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intd=O):potst( a), 
#endif 
else 
{ 
#ifDEBUG 
cout« II Condition number 2s is set to inactive \nil; 
#endif 
} 
return; 
} 
/ / -------End of file------------------------------------------------------------
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II 
II 
IIFILENAME: 
IIFILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDATE CREATED: 
II 
alcldvar.h 
c++ header class for AI_CONI DVAR 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
V __________________________________________________ _ 
II 
I IDESCRIPTION: Class A I_CON 1 DV AR represents the data struture and the data 
I I interface for function condition 1 d in class DEC _AI. 
II 
II 
II 
II 
II 
II 
The data items represent those used in the function to set 
begin for decision A I. The functions form the interface to 
the test functions and the patient and treatment state 
assessment. 
IIBASE CLASSES: None 
IIDERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: None 
II 
I/uSAGE: Data interface for the treatment prescription knowledge base. 
II 
I/KNOWN BUGS: None 
11-----------------------------------------------------
II 
I/MODIFICA TION HISTORY 
IIDATE: 
IIAUTHOR: 
IIDESCRIPTION: 
11-----------------------------------------------------
II----------PRE-PROCESSOR MACROS------------------------------------------------
#ifndef Al_CONIDV AR Ilmacro if condition to prevent multiple definitions 
#define Al_CONtDVAR 
#include "tesCal.h"lltest file which sets the test conditions for dec_at 
class dec_al ;llpre-definition of class dec_al 
11------------------------------------------------------------------------------
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II DECLARATIONFORAl CONlDVARCLASS 
II 
1/ __________________________ _ 
class a 1 con 1 dvar 
{ 
II--------------------DATi\ STRlJCTlJRE--------------------------------------------
private: 
int crtdy; 
int uredy; 
int time; 
II------------------INTERFACE FlJNCTIONS-----------------------------------------
public: 
friend dec_al; 
al_conldvar(int, int, int); 
void iniat_ var(int *, al_conldvar *); 
}; 
II -----------------constructor definition---------------------------------------
inline al_conldvar::al_conldvar(int a=O, int b=O, 
time(c) 
{}; 
int c=O):crtdy(a), uredy(b), 
II -----------------test condi tions----------------------------------------------
void al_conldvar::iniat_var(int *arr, al_conldvar *vars) 
{ 
vars->crtdy=O; 
vars->uredy=O; 
vars->time=O; 
if(arr[2]=l) 
{ 
vars->crtdy=4; 
vars->uredy=4; 
vars->time=48 ; 
#ifDEBlJG 
cout«" Condition number Id is set to active \n"; 
#endif 
} 
else 
{ 
#ifDEBlJG 
cout«" Condition number ld is set to inactive \n"; 
#endif 
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} 
return; 
} 
#endif 
/ / -------End of a 1 con 1 dvar class file-----------------------------------------
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II 
============= 
II 
IIFILENAME: 
IIFILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDATE CREATED: 
II 
alc2dvar.h 
C++ header class for A 1_ CON2DV AR 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
11 ____________________________________________________ _ 
II 
IIDESCRIPTION: Class Al_CON2DVAR represents the data struture and the data 
II interface for function condition2d in class DEC AI. 
II 
II 
II 
II 
II 
II 
The data items represent those used in the function to set 
begin for decision A 1. The functions form the interface to 
the test functions and the patient and treatment state 
assessment. 
IIBASE CLASSES: None 
IIDERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: None 
II 
I/uSAGE: Data interface for the treatment prescription knowledge base. 
II 
I/KNOWN BUGS: None 
11------------------------------------------------------
II 
I/MODIFICATION HISTORY 
IIDATE: 
/IAUTHOR: 
/IDESCRIPTION: 
/1 ______ -------------------
II----------PRE-PFtOCESSOFt MACROS------------------------------------------------
#ifndef Al_CON2DVAFt Ilmacro if condition to prevent multiple definitions of dec_at 
#define Al_CON2DV AFt 
#include "test aI.h" 
class dec _ a I ;llpre-definition of class dec _a 1 
11------------------------------------------------------------------------------
II DECLARATION FOFtAI_CON2DVAR CLASS 
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II 
ｾＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
class a 1_ con2dvar 
{ 
ＱＱＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭｉ＾ｾＱｬｾ＠ ｾｬｬｆｴｬｊｾｬｬｬｊｾＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
private: 
int potdy; 
int time; 
ＱＱＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭｾｬｬｾｆｴｊｆｾｾｾ＠ ｾｾｾｬｬｉＨＩｾｾＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
public: 
friend dec_al; 
al con2dvar(int, int ); 
void iniat_var(int *, al_con2dvar *); 
}; 
II -----------------constructor definition---------------------------------------
inline al_con2dvar::al_con2dvar(int a=O, int b=O):potdy(a), time(b) 
{}; 
II -----------------test conditions----------------------------------------------
void al_con2dvar::iniat_ var(int *arr, al_con2dvar *vars) 
{ 
vars->potdy=O; 
vars->time=O; 
if (arr[3]=I) 
Ｃｩｦｉ＾ｾｂｬｊｇ＠
{ 
vars->potdy=5 ; 
vars->time=6; 
cout«" ｾｯｮ､ｩｴｩｯｮ＠ number 2d is set to active \n"; 
#endif 
} 
else 
{ 
Ｃｩｦｉ＾ｾｂｬｊｇ＠
cout«" ｾｯｮ､ｩｴｩｯｮ＠ number 2d is set to inactive \n"; 
#endif 
return; 
} 
#endif 
} 
ｉｉＭＭＭＭＭＭＭｾｮ､＠ of al con2dvar class file------------------------------------------
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II 
================ 
II 
IIFILENAME: 
IIFILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDATE CREATED: 
II 
alc3dvar.h 
C++ header class for Al CON3DV AR 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
V ____________________________________________________ _ 
II 
IIDESCRIPTION: Class Al_CON3DVAR represents the data struture and the data 
II interface for function condition3d in class DEC_AI. 
II 
II 
II 
II 
II 
II 
The data items represent those used in the function to set 
begin for decision A 1. The functions form the interface to 
the test functions and the patient and treatment state 
assessment. 
IIBASE CLASSES: None 
IIDERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: None 
II 
I/uSAGE: Data interface for the treatment prescription knowledge base. 
II 
IIKNOWN BUGS: None 
11----------------------------------------------------
II 
I/MODIFICA nON HISTORY 
IIDATE: 
IIAUTHOR: 
IIDESCRIPTION: 
V ________________________________________________ _ 
II ----------PRE-PROCESSOR MACROS------------------------------------------------
#ifndef AI_CON3DV AR Ilmacro if condition to prevent multiple definitions of dec_a I 
#define Al CON3DVAR 
#include "test_aI.h" 
class dec _a I ;llpre-definition of class dec _a 1 
11------------------------------------------------------------------------------
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II DECLARATIONFORAI CON3DVARCLASS 
II V ______________________________________________________ ___ 
class al_con3dvar 
{ 
II--------------------DAllA ｓｬｬｒｬｊｾｬｬｬｊｒｅＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
private: 
int hydst; 
int pulst; 
int urvdy; 
int time; 
ＱＱＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭｾＱｬｅｒｆａｃｅ＠ FlJNCllIONS-----------------------------------------
}; 
public: 
friend dec_al; 
al_con3dvar(int, int, int, int); 
void iniat_ var(int *, al_ con3dvar *); 
II-----------------constructor definition---------------------------------------
inline al_con3dvar::al_con3dvar(int a=O, int b=O, int c=O, int d=O):hydst(a), pulst(b), 
urvdy(a), time(b) 
0; 
II-----------------test conditions----------------------------------------------
void al_con3dvar::iniat_var(int *arr, al_con3dvar *vars) 
{ 
vars->hydst=O; 
vars->pulst=O; 
vars->urvdy=O; 
vars->time=O; 
if (arr[4]=1) 
#ifDEBlJG 
{ 
vars->hydst=4; 
vars->pulst= 1 ; 
vars->urvdy= 1 ; 
vars->time=48; 
cout«" Condition number 3d is set to active \n"; 
#endif 
} 
else 
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{ 
#ifDEBUG 
cout« " Condition number 3d is set to inactive \n"; 
#endif 
return; 
} 
#endif 
} 
//-------End offile------------------------------------------------------------
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II 
II 
I!FILENAME: 
I!FILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
I!DATE CREATED: 
II 
alcOlsva.h 
C++ header class for A 1_ CONO 1 SV AR 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
"-----------------------------------------------------
II 
I!DESCRIPTION: Class Al_CONOISVAR represents the data struture and the data 
II interface for function conditionOls in class DEC_AI. 
II 
II 
II 
II 
II 
II 
The data items represent those used in the function to set 
nbegin for decision A 1. The functions form the interface to 
the test functions and the patient and treatment state 
assessment. 
IIBASE CLASSES: None 
I!DERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONT AINS CLASSES: None 
II 
I/uSAGE: Data interface for the treatment prescription knowledge base. 
II 
I/KNOWN BUGS: None 
"-------------------------------------------------------
II 
I/MODIFICATION HISTORY 
I!DATE: 
IIAUTHOR: 
IIDESCRIPTION: 
11 __________________________________________________ _ 
II----------PRE-PROCESSOR ｾｃｒｏｓＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
#ifndef A 1_ CONO 1 SV AR Ilmacro if condition to prevent multiple definitions 
#define Al_CONOlSVAR 
#include "test_al.h"lltest file which sets the test conditions for dec_at 
class dec_al ;llpre-definition of class dec_at 
11------------------------------------------------------------------------------
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II DECLARATION FOR AI-CONOlSVAR CLASS 
II 
11 ____________________________________________________ _ 
class a 1 conO 1 svar 
{ 
II--------------------DATA STRlJC1llJRE--------------------------------------------
private: 
int blpst; 
int bptst; 
int bldst; 
ｉｉＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭｾｔｅｒｆａｃｅ＠ ｆｾｃｔｉｏｎｓＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭﾭ
public: 
}; 
friend dec_al; 
al_conOlsvar(int, int, int); 
void iniat_ var(int *, al_conOlsvar *); 
II -----------------constructor definition---------------------------------------
inline al_conOlsvar::al_conOlsvar(int a=O, int b=O, int c=O ):blpst(a), bptst(b), bldst(c) 
0; 
II -----------------test conditions----------------------------------------------
void al_conOlsvar::iniat_var(int *arr, al_conOlsvar *vars) 
{ 
vars->blpst=3 ; 
vars->bptst=O; 
vars->bldst=O; 
if (arr[5]=1) 
{ 
vars->blpst=2; 
vars->bptst= 1 ; 
vars->bldst=l ; 
#ifDEBlJG 
} 
cout«" Condition number Olsis set to active \n"; 
#endif 
} 
else 
{ 
#ifDEBlJG 
cout« " Condition number Ols is set to inactive \n"; 
#endif 
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return; 
} 
#endif 
II-------END OF al conO 1 svar class file-----------------------------------------
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II 
II 
IIFILENAME: 
IIFILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDATE CREATED: 
II 
main-dal.h 
c++ main function for testing DEC_AI 
Borland C++ version 4.5 
David Murley, City University 
24 July 1995 
11 _________________________ _ 
II 
IIDESCRIPTION: This program sets the test conditions for the decision AI. It 
I I uses all the files of the decision hierarchy, and the test file 
II test aI.h to select one of seven test conditions. Test 
I I numbers I to 6 make the conditions individually active/true, 
/! test number 7 makes all the conditoins active. Tests I to 6 
II are used to test the operation of the individual conditions. Test 
II 7 is used to ensure that when nbegin is true then the advice is 
I I to not begin treatment. 
II 
/! 
I/BASE CLASSES: None 
I/DERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: None 
II 
I/uSAGE: the process control program for decision Al 
II 
IIKNOWN BUGS: None 
11 ______ ---------------------
II 
I/MODIFICATION HISTORY 
I/DATE: 
IIAUTHOR: 
IIDESCRIPTION: 
11 ______ ---------------------
II ----------PRE-PROCESSOR MACROS------------------------------------------------
#define TEST 1 
#include "dec_aI.h" 
void main Ollshould keep to a absolute minimum what is defined in mainO 
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{ 
cout« "FUNCTIONAL TEST RESULTS FOR DECISION Al\n"; 
int i; 
for(i=l;i<9;i++) 
{ 
state state 1 (,'hello" ,0,0); 
dec_al run 1 (statel);//defines runl as an instant of the the decision at intialises the 
argument state-a 1 to 0 
int beginact=O; 
int nbeginact=O; 
char· state_a 1 =0; 
#ifTEST 
#endif 
test_al test1(O); 
int a=O; 
int * arrptr; 
arrptr=new int[6]; 
test 1. testset( a,arrptr); 
#ifTEST 
#endif 
al_conlsvar varsl0; 
al_conlsvar ·varsl; 
vars 1 =new a I_con 1 svar; 
varsl0.iniat_var( arrptr, varsl); 
//put the start condition into function conditionls and do the same for all other functions 
if (beginact ==0) 
{ 
beginact = run1.conditionls(*varsl); 
} 
#ifDEBUG 
cout « "The state of option A after running condition Is " « beginact «"\n"; 
#endif 
#ifTEST 
delete vars 1 ; 
#endif 
#ifTEST 
al_con2svar vars20; 
al_con2svar ·vars2; 
vars2=new al_ con2svar; 
vars20.iniat_ var( arrptr, vars2); 
-469-
#endif 
if (beginact =0) 
{ 
beginact = runl.condition2s(*vars2); 
} 
#ifDEBUG 
cout« "The state of option A after running condition 2s " «beginact «"\n"; 
#endif 
#ifTEST 
#endif 
delete vars2; 
al_conldvar varsdlO; 
al_conldvar *varsdl; 
varsd 1 =new a I_con 1 dvar; 
varsdlO.iniat_var( arrptr, varsdl); 
if (beginact =0) 
{ 
beginact = runl.conditionld(*varsdl); 
} 
#ifDEBUG 
cout« "The state of option A after running condition Id " «beginact «"\n"; 
#endif 
#ifTEST 
#endif 
delete varsd 1 ; 
al_con2dvar varsd20; 
al_con2dvar *varsd2; 
varsd2=new al_ con2dvar; 
varsd20.iniat_ var( arrptr, varsd2); 
if (beginact ==0) 
{ 
beginact = runl.condition2d(*varsd2); 
} 
#ifDEBUG 
cout« "The state of option A after running condition 2d " «beginact «"\n"; 
#endif 
#ifTEST 
delete varsd2; 
-470-
#endif 
al_ con3dvar varsd30; 
al_ con3dvar *varsd3; 
varsd3=newal_con3dvar; 
varsd30.iniat_ var( arrptr, varsd3); 
if (beginact =0) 
{ 
beginact = runl.condition3d(*varsd3); 
} 
#ifDEBUG 
cout« "The state of option A after running condition 3d " «beginact «"\n"; 
#endif 
#ifTEST 
#endif 
delete varsd3; 
al_conOlsvar varsdOlO; 
a 1_ conO 1 svar *varsO 1 ; 
varsO 1 =new a 1_ conO 1 svar; 
varsdOlO.iniat_ var( arrptr, varsOl); 
if (nbeginact =0) 
{ 
nbeginact = runl.conditionOls(*varsOl); 
} 
#ifDEBUG 
cout« "The state of option B after running condition 01s " «nbeginact «"\n"; 
#endif 
#ifDEBUGl 
cout« "\n The state ofnbeginal just before the 'if query is" «nbeginact «"\n"; 
cout« "\n The state of beg ina 1 just before the 'if query is " «beginact «"\n"; 
#endif 
#ifTEST 
delete varsO 1 ; 
#endif 
state_al=runl.advice(runl);//the if control structure used to set the 
cout« "The decision advice from running decision Al is:\n"« state_a I «"\n"; 
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#ifTEST 
delete arrptr; 
#endif 
} 
return; 
} 
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II 
II 
IIFILENAME: 
IIFILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
I/DATE CREATED: 
II 
test al.h 
C++ test function for testing DEC_AI 
Borland C++ version 4.5 
David Murley, City University 
2 August 1995 
" ______ ---------------------
II 
I/DESCRIPTION: This program declares the test functions for setting the test 
II values for checking the functioning of the decision A 1. The 
I I values depend on the configuration of a six element test array. 
II The configuration of the test array is set according to a number 
II entered by the user running main-dal.h. 
II 
II 
I/BASE CLASSES: None 
I/DERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: None 
II 
I/uSAGE: to set the test states for decision Al 
II 
I/KNOWN BUGS: None 
" ______ --------------------
II 
I/MODIFICATION HISTORY 
I/DATE: 
IIAUTHOR: 
I/DESCRIPTION: 
" ______ ------------------------------------
II----------PRE-PROCESSOR MACROS------------------------------------------------
# include <iostream.h> 
#ifndef TEST _A 1 IImacro if condition to prevent mUltiple definitions of dec _a 1 
#define TEST_AI 
private: 
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}; 
int testset_no; 
public: 
test al(int); 
void testset(int & ,int *); 
inline test_al ::test_al (int testno) 
{ 
testset_ no=testno; 
} 
#include "test_alf.cpp" II the file defining the the test functions 
#endif 
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II 
II 
IIFILENAME: 
IIFILE TYPE: 
IICOMPILER USED: 
IIAUTHOR: 
IIDATE CREATED: 
II 
test aIf.h 
C++ test functions for testing DEC_AI 
Borland C++ version 4.5 
David Murley, City University 
2 August 1995 
V ____________________________________________________ _ 
II 
IIDESCRIPTION: This program defines the test functions for setting the test 
II values for checking the functioning of the decision AI. The 
II configuration of the test array is set by the function testsetO. 
II 
II 
IIBASE CLASSES: None 
IIDERIVED CLASSES: None 
IICOMPONENT CLASSES: None 
IICONTAINS CLASSES: None 
II 
I/uSAGE: to set the test states for decision Al 
II 
I/KNOWN BUGS: None V ____________________________________________________ ___ 
II 
I/MODIFICATION HISTORY 
IIDATE: 
IIAUTHOR: 
IIDESCRIPTION: 
11-------------------------------------------------------
void test_al ::testset(int & testno, int ·aptr) 
{ 
testno=O; 
cout« "Input the number of the test set \n"; 
cin» testno; 
int con[6]={ O,O,O,O,O,O}; 
if (testno =1) 
{ 
con[O]=I; 
} 
if(testno =2) 
{ 
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con[1]=I; 
} 
if(testno ==3) 
{ 
con[2]=1; 
} 
if (testno =4) 
{ 
cont31=1; 
) 
if (testno ==5) 
{ 
con[41=1; 
} 
if (testno ==6) 
{ 
con[S]=1; 
} 
if (testno ==7) 
int i; 
{ 
con[01=1; 
con[I]=1 ; 
con[2]=1; 
con[3]=1; 
con[4]=1; 
con[S]=1; 
} 
for (i=O; i<6 ; itt) 
aptr[i]=con[i]; 
return; 
} 
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